<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27659841</PMID><DateCompleted><Year>2017</Year><Month>07</Month><Day>26</Day></DateCompleted><DateRevised><Year>2018</Year><Month>06</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1744-8360</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>3</Issue><PubDate><Year>2017</Year><Month>03</Month></PubDate></JournalIssue><Title>Expert review of neurotherapeutics</Title><ISOAbbreviation>Expert Rev Neurother</ISOAbbreviation></Journal><ArticleTitle>Neuroprogression and illness trajectories in bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>277-285</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/14737175.2017.1240615</ELocationID><Abstract><AbstractText Label="INTRODUCTION">The longitudinal course of bipolar disorder is highly variable, and a subset of patients seems to present a progressive course associated with brain changes and functional impairment. Areas covered: We discuss the theory of neuroprogression in bipolar disorder. This concept considers the systemic stress response that occurs within mood episodes and late-stage deficits in functioning and cognition as well as neuroanatomic changes. We also discuss treatment refractoriness that may take place in some cases of bipolar disorder. We searched PubMed for articles published in any language up to June 4<sup>th</sup>, 2016. We found 315 abstracts and included 87 studies in our review. Expert commentary: We are of the opinion that the use of specific pharmacological strategies and functional remediation may be potentially useful in bipolar patients at late-stages. New analytic approaches using multimodal data hold the potential to help in identifying signatures of subgroups of patients who will develop a neuroprogressive course.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kapczinski</LastName><ForeName>Natália S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>a Bipolar Disorder Program , Laboratory of Molecular Psychiatry, Hospital de Clínicas de Porto Alegre (HCPA) , Porto Alegre , Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Graduation Program in Psychiatry and Department of Psychiatry , Universidade Federal do Rio Grande do Sul (UFRGS) , Porto Alegre , Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mwangi</LastName><ForeName>Benson</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>c Department of Psychiatry and Behavioral Sciences , University of Texas Health Science Center at Houston , Houston , TX , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cassidy</LastName><ForeName>Ryan M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>c Department of Psychiatry and Behavioral Sciences , University of Texas Health Science Center at Houston , Houston , TX , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Librenza-Garcia</LastName><ForeName>Diego</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>d Graduation Program in Psychiatry , Universidade Federal das Ciências da Saúde , Porto Alegre , Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bermudez</LastName><ForeName>Mariane Bagatin</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>d Graduation Program in Psychiatry , Universidade Federal das Ciências da Saúde , Porto Alegre , Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kauer-Sant'anna</LastName><ForeName>Márcia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>a Bipolar Disorder Program , Laboratory of Molecular Psychiatry, Hospital de Clínicas de Porto Alegre (HCPA) , Porto Alegre , Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Graduation Program in Psychiatry and Department of Psychiatry , Universidade Federal do Rio Grande do Sul (UFRGS) , Porto Alegre , Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kapczinski</LastName><ForeName>Flávio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>a Bipolar Disorder Program , Laboratory of Molecular Psychiatry, Hospital de Clínicas de Porto Alegre (HCPA) , Porto Alegre , Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Graduation Program in Psychiatry and Department of Psychiatry , Universidade Federal do Rio Grande do Sul (UFRGS) , Porto Alegre , Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Passos</LastName><ForeName>Ives Cavalcante</ForeName><Initials>IC</Initials><AffiliationInfo><Affiliation>a Bipolar Disorder Program , Laboratory of Molecular Psychiatry, Hospital de Clínicas de Porto Alegre (HCPA) , Porto Alegre , Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Graduation Program in Psychiatry and Department of Psychiatry , Universidade Federal do Rio Grande do Sul (UFRGS) , Porto Alegre , Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>10</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Expert Rev Neurother</MedlineTA><NlmUniqueID>101129944</NlmUniqueID><ISSNLinking>1473-7175</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Bipolar disorder</Keyword><Keyword MajorTopicYN="Y">allostatic load</Keyword><Keyword MajorTopicYN="Y">big data</Keyword><Keyword MajorTopicYN="Y">machine learning</Keyword><Keyword MajorTopicYN="Y">neuroprogression</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27659841</ArticleId><ArticleId IdType="doi">10.1080/14737175.2017.1240615</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24786695</PMID><DateCompleted><Year>2015</Year><Month>10</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1948-7193</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>6</Issue><PubDate><Year>2014</Year><Month>Jun</Month><Day>18</Day></PubDate></JournalIssue><Title>ACS chemical neuroscience</Title><ISOAbbreviation>ACS Chem Neurosci</ISOAbbreviation></Journal><ArticleTitle>Lithium and the other mood stabilizers effective in bipolar disorder target the rat brain arachidonic acid cascade.</ArticleTitle><Pagination><MedlinePgn>459-67</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/cn500058v</ELocationID><Abstract><AbstractText>This Review evaluates the arachidonic acid (AA, 20:4n-6) cascade hypothesis for the actions of lithium and other FDA-approved mood stabilizers in bipolar disorder (BD). The hypothesis is based on evidence in unanesthetized rats that chronically administered lithium, carbamazepine, valproate, or lamotrigine each downregulated brain AA metabolism, and it is consistent with reported upregulated AA cascade markers in post-mortem BD brain. In the rats, each mood stabilizer reduced AA turnover in brain phospholipids, cyclooxygenase-2 expression, and prostaglandin E2 concentration. Lithium and carbamazepine also reduced expression of cytosolic phospholipase A2 (cPLA2) IVA, which releases AA from membrane phospholipids, whereas valproate uncompetitively inhibited in vitro acyl-CoA synthetase-4, which recycles AA into phospholipid. Topiramate and gabapentin, proven ineffective in BD, changed rat brain AA metabolism minimally. On the other hand, the atypical antipsychotics olanzapine and clozapine, which show efficacy in BD, decreased rat brain AA metabolism by reducing plasma AA availability. Each of the four approved mood stabilizers also dampened brain AA signaling during glutamatergic NMDA and dopaminergic D2 receptor activation, while lithium enhanced the signal during cholinergic muscarinic receptor activation. In BD patients, such signaling effects might normalize the neurotransmission imbalance proposed to cause disease symptoms. Additionally, the antidepressants fluoxetine and imipramine, which tend to switch BD depression to mania, each increased AA turnover and cPLA2 IVA expression in rat brain, suggesting that brain AA metabolism is higher in BD mania than depression. The AA hypothesis for mood stabilizer action is consistent with reports that low-dose aspirin reduced morbidity in patients taking lithium, and that high n-3 and/or low n-6 polyunsaturated fatty acid diets, which in rats reduce brain AA metabolism, were effective in BD and migraine patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rapoport</LastName><ForeName>Stanley I</ForeName><Initials>SI</Initials><AffiliationInfo><Affiliation>Brain Physiology and Metabolism Section, Laboratory of Neurosciences, National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>05</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>ACS Chem Neurosci</MedlineTA><NlmUniqueID>101525337</NlmUniqueID><ISSNLinking>1948-7193</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018020">Lithium Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011619">Psychotropic Drugs</NameOfSubstance></Chemical><Chemical><RegistryNumber>27YG812J1I</RegistryNumber><NameOfSubstance UI="D016718">Arachidonic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016718" MajorTopicYN="N">Arachidonic Acid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018020" MajorTopicYN="N">Lithium Compounds</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011619" MajorTopicYN="N">Psychotropic Drugs</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Lithium</Keyword><Keyword MajorTopicYN="N">antidepressant</Keyword><Keyword MajorTopicYN="N">antipsychotics</Keyword><Keyword MajorTopicYN="N">arachidonic acid</Keyword><Keyword MajorTopicYN="N">biotype</Keyword><Keyword MajorTopicYN="N">bipolar disorder</Keyword><Keyword MajorTopicYN="N">brain</Keyword><Keyword MajorTopicYN="N">carbamazepine</Keyword><Keyword MajorTopicYN="N">mood stabilizers</Keyword><Keyword MajorTopicYN="N">rat</Keyword><Keyword MajorTopicYN="N">valproic acid</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>10</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24786695</ArticleId><ArticleId IdType="doi">10.1021/cn500058v</ArticleId><ArticleId IdType="pmc">PMC4063504</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hum Psychopharmacol. 2008 Mar;23(2):87-94</Citation><ArticleIdList><ArticleId IdType="pubmed">18172906</ArticleId></ArticleIdList></Reference><Reference><Citation>J Lipid Res. 2010 May;51(5):1049-56</Citation><ArticleIdList><ArticleId IdType="pubmed">20040630</ArticleId></ArticleIdList></Reference><Reference><Citation>J Nucl Med. 2012 Sep;53(9):1383-91</Citation><ArticleIdList><ArticleId IdType="pubmed">22851635</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Biol Med (Maywood). 2008 May;233(5):507-21</Citation><ArticleIdList><ArticleId IdType="pubmed">18375835</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim Biophys Acta. 2011 Feb;1811(2):111-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21070866</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2317-21</Citation><ArticleIdList><ArticleId IdType="pubmed">8637870</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2007 Oct 15;62(8):934-43</Citation><ArticleIdList><ArticleId IdType="pubmed">17628508</ArticleId></ArticleIdList></Reference><Reference><Citation>Prostaglandins Leukot Essent Fatty Acids. 2011 Dec;85(6):361-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21880477</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2012 Jan;136(1-2):63-71</Citation><ArticleIdList><ArticleId IdType="pubmed">21925739</ArticleId></ArticleIdList></Reference><Reference><Citation>Prostaglandins Leukot Essent Fatty Acids. 2015 May;96:25-30</Citation><ArticleIdList><ArticleId IdType="pubmed">25638779</ArticleId></ArticleIdList></Reference><Reference><Citation>Prostaglandins Leukot Essent Fatty Acids. 2010 Jan;82(1):9-14</Citation><ArticleIdList><ArticleId IdType="pubmed">19939659</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Jun 25;9(6):e100858</Citation><ArticleIdList><ArticleId IdType="pubmed">24963629</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurochem. 2001 May;77(3):796-803</Citation><ArticleIdList><ArticleId IdType="pubmed">11331408</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2010 Jun;12(4):376-82</Citation><ArticleIdList><ArticleId IdType="pubmed">20636634</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim Biophys Acta. 2013 Apr;1831(4):880-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23354024</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2009 Aug;116(3):184-91</Citation><ArticleIdList><ArticleId IdType="pubmed">19103464</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Rheumatol. 2002 Sep-Oct;20(5 Suppl 27):S1-13</Citation><ArticleIdList><ArticleId IdType="pubmed">14989423</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 1980;67(3):297-305</Citation><ArticleIdList><ArticleId IdType="pubmed">6155678</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2001 Mar;158(3):360-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11229973</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 1989 Oct 6;262(13):1834-41</Citation><ArticleIdList><ArticleId IdType="pubmed">2674489</ArticleId></ArticleIdList></Reference><Reference><Citation>Prostaglandins Leukot Essent Fatty Acids. 2012 Aug-Sep;87(2-3):71-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22841517</ArticleId></ArticleIdList></Reference><Reference><Citation>Med J Aust. 1949 Sep 3;2(10):349-52</Citation><ArticleIdList><ArticleId IdType="pubmed">18142718</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2009 Aug;70(8):1078-90</Citation><ArticleIdList><ArticleId IdType="pubmed">19497250</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Pharmacol. 1998 Jul;54(1):94-104</Citation><ArticleIdList><ArticleId IdType="pubmed">9658194</ArticleId></ArticleIdList></Reference><Reference><Citation>Prostaglandins Leukot Essent Fatty Acids. 2008 Sep-Nov;79(3-5):153-6</Citation><ArticleIdList><ArticleId IdType="pubmed">18973997</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Open. 2012 Feb 22;2(1):e000643</Citation><ArticleIdList><ArticleId IdType="pubmed">22357572</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurobiol Dis. 2010 Mar;37(3):596-603</Citation><ArticleIdList><ArticleId IdType="pubmed">19945534</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2008 Feb;13(2):197-207</Citation><ArticleIdList><ArticleId IdType="pubmed">17486107</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurochem. 2013 Feb;124(3):376-87</Citation><ArticleIdList><ArticleId IdType="pubmed">23121637</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurochem Res. 2012 May;37(5):903-10</Citation><ArticleIdList><ArticleId IdType="pubmed">22311128</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Neurosci. 2009 Sep 28;10:123</Citation><ArticleIdList><ArticleId IdType="pubmed">19785755</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pharmacol Exp Ther. 1996 Jan;276(1):143-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8558424</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1995 Dec;52(12):998-1007</Citation><ArticleIdList><ArticleId IdType="pubmed">7492260</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacogenomics. 2010 Oct;11(10):1439-65</Citation><ArticleIdList><ArticleId IdType="pubmed">21047205</ArticleId></ArticleIdList></Reference><Reference><Citation>J Nucl Med. 2008 Sep;49(9):1414-21</Citation><ArticleIdList><ArticleId IdType="pubmed">18703605</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Lett. 1996 Dec 20;220(3):171-4</Citation><ArticleIdList><ArticleId IdType="pubmed">8994220</ArticleId></ArticleIdList></Reference><Reference><Citation>Prostaglandins Leukot Essent Fatty Acids. 2007 Nov-Dec;77(5-6):251-61</Citation><ArticleIdList><ArticleId IdType="pubmed">18060754</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2006 Mar 1;59(5):401-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16182257</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim Biophys Acta. 2009 Feb;1791(2):132-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19073280</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurochem Res. 2008 Jul;33(7):1373-83</Citation><ArticleIdList><ArticleId IdType="pubmed">18302021</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 2006 Jan;184(1):122-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16344985</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurochem Res. 2005 May;30(5):677-83</Citation><ArticleIdList><ArticleId IdType="pubmed">16176072</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann N Y Acad Sci. 1989;559:37-55</Citation><ArticleIdList><ArticleId IdType="pubmed">2672943</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2014 Dec;16(8):875-80</Citation><ArticleIdList><ArticleId IdType="pubmed">25041123</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim Biophys Acta. 2000 Oct 31;1488(1-2):1-19</Citation><ArticleIdList><ArticleId IdType="pubmed">11080672</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2010 Apr;15(4):384-92</Citation><ArticleIdList><ArticleId IdType="pubmed">19488045</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2006 Jul;11(7):680-4</Citation><ArticleIdList><ArticleId IdType="pubmed">16491133</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2013 Jun;147(1):24-31</Citation><ArticleIdList><ArticleId IdType="pubmed">23566496</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurochem. 2011 Oct;119(2):364-76</Citation><ArticleIdList><ArticleId IdType="pubmed">21812779</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2008 Mar;65(3):255-63</Citation><ArticleIdList><ArticleId IdType="pubmed">18316672</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychopharmacology. 2004 Jan;29(1):32-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12942141</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Res Rev. 2009 Oct;61(2):185-209</Citation><ArticleIdList><ArticleId IdType="pubmed">19555719</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurochem. 2003 May;85(3):690-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12694395</ArticleId></ArticleIdList></Reference><Reference><Citation>Prostaglandins Other Lipid Mediat. 2004 Apr;73(3-4):155-72</Citation><ArticleIdList><ArticleId IdType="pubmed">15290791</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Res Bull. 2005 Apr 30;65(4):331-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15811599</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Opin Ther Targets. 2009 Jun;13(6):719-31</Citation><ArticleIdList><ArticleId IdType="pubmed">19456273</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim Biophys Acta. 2011 Mar;1811(3):163-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21184843</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 2006 Aug;187(3):303-11</Citation><ArticleIdList><ArticleId IdType="pubmed">16786332</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 1987 Oct;48(10):425</Citation><ArticleIdList><ArticleId IdType="pubmed">3117778</ArticleId></ArticleIdList></Reference><Reference><Citation>J Lipid Res. 2010 Aug;51(8):2334-40</Citation><ArticleIdList><ArticleId IdType="pubmed">20388940</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 2007 Jan;190(1):103-15</Citation><ArticleIdList><ArticleId IdType="pubmed">17093977</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropharmacology. 2011 Dec;61(8):1256-64</Citation><ArticleIdList><ArticleId IdType="pubmed">21839100</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurochem. 2003 Jun;85(6):1553-62</Citation><ArticleIdList><ArticleId IdType="pubmed">12787074</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatr Genet. 2013 Apr;23(2):86-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23277130</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychopharmacology. 2005 Nov;30(11):2006-13</Citation><ArticleIdList><ArticleId IdType="pubmed">15827566</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Res Mol Brain Res. 1997 Oct 15;50(1-2):171-80</Citation><ArticleIdList><ArticleId IdType="pubmed">9406932</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2002 Jul;59(7):592-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12090811</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2010 Jun;15(6):602-14</Citation><ArticleIdList><ArticleId IdType="pubmed">18982003</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2006 Aug;189:124-31</Citation><ArticleIdList><ArticleId IdType="pubmed">16880481</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesiology. 2005 Feb;102(2):409-15</Citation><ArticleIdList><ArticleId IdType="pubmed">15681959</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2008 Jun;13(6):585-96</Citation><ArticleIdList><ArticleId IdType="pubmed">18347600</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 2007 Sep;193(4):467-74</Citation><ArticleIdList><ArticleId IdType="pubmed">17487474</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurochem. 2006 Aug;98(3):801-11</Citation><ArticleIdList><ArticleId IdType="pubmed">16787416</ArticleId></ArticleIdList></Reference><Reference><Citation>Transl Psychiatry. 2011 Aug 16;1:e31</Citation><ArticleIdList><ArticleId IdType="pubmed">22832605</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuropathol Exp Neurol. 1999 Jun;58(6):637-43</Citation><ArticleIdList><ArticleId IdType="pubmed">10374754</ArticleId></ArticleIdList></Reference><Reference><Citation>Pain. 2013 Nov;154(11):2441-2451</Citation><ArticleIdList><ArticleId IdType="pubmed">23886520</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2007 Jan 15;61(2):246-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16697355</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurochem. 1995 Jun;64(6):2765-72</Citation><ArticleIdList><ArticleId IdType="pubmed">7760057</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychopharmacology. 2006 Aug;31(8):1659-74</Citation><ArticleIdList><ArticleId IdType="pubmed">16292331</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim Biophys Acta. 2006 Sep;1761(9):1050-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16920015</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2012 Jun 1;71(11):939-46</Citation><ArticleIdList><ArticleId IdType="pubmed">22297150</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurochem Res. 2008 Nov;33(11):2229-40</Citation><ArticleIdList><ArticleId IdType="pubmed">18461450</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychosom Res. 1996 Jan;40(1):53-8</Citation><ArticleIdList><ArticleId IdType="pubmed">8730644</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Res Brain Res Rev. 1992 Sep-Dec;17(3):187-214</Citation><ArticleIdList><ArticleId IdType="pubmed">1467810</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2004 Aug 15;56(4):248-54</Citation><ArticleIdList><ArticleId IdType="pubmed">15312812</ArticleId></ArticleIdList></Reference><Reference><Citation>FASEB J. 1995 May;9(8):619-25</Citation><ArticleIdList><ArticleId IdType="pubmed">7768353</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurochem Res. 2008 Nov;33(11):2318-23</Citation><ArticleIdList><ArticleId IdType="pubmed">18500552</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Neuropsychopharmacol. 2012 Aug;15(7):931-43</Citation><ArticleIdList><ArticleId IdType="pubmed">21733229</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychopharmacology. 2005 Mar;30(3):461-72</Citation><ArticleIdList><ArticleId IdType="pubmed">15562295</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2011 Apr;16(4):419-28</Citation><ArticleIdList><ArticleId IdType="pubmed">20038946</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biochem. 1997 Jul;122(1):1-16</Citation><ArticleIdList><ArticleId IdType="pubmed">9276665</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2003 Aug;5(4):295-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12895207</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychopharmacology. 2005 Jun;30(6):1064-75</Citation><ArticleIdList><ArticleId IdType="pubmed">15812572</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2003 Dec;160(12):2222-7</Citation><ArticleIdList><ArticleId IdType="pubmed">14638594</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Res Bull. 2004 Jul 15;63(6):485-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15249113</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2012 Jan;73(1):81-6</Citation><ArticleIdList><ArticleId IdType="pubmed">21903025</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28754344</PMID><DateCompleted><Year>2018</Year><Month>04</Month><Day>05</Day></DateCompleted><DateRevised><Year>2018</Year><Month>08</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7972</ISSN><JournalIssue CitedMedium="Internet"><Volume>656</Volume><PubDate><Year>2017</Year><Month>Aug</Month><Day>24</Day></PubDate></JournalIssue><Title>Neuroscience letters</Title><ISOAbbreviation>Neurosci Lett</ISOAbbreviation></Journal><ArticleTitle>The effect of childhood trauma on serum BDNF in bipolar depression is modulated by the serotonin promoter genotype.</ArticleTitle><Pagination><MedlinePgn>177-181</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0304-3940(17)30615-8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neulet.2017.07.043</ELocationID><Abstract><AbstractText>In healthy humans, both childhood trauma and the short form of the serotonin promoter transporter genotype (5-HTTLPR) are associated with lower levels of brain-derived neurotrophic factor (BDNF). In subjects with bipolar disorder (BD), lower levels of BDNF and a higher degree of childhood trauma were observed compared with healthy controls. However, is still unknown if the functional 5-HTTLPR polymorphisms exerts an effect on both abnormalities. In 40 inpatients affected by a major depressive episode in the course of BD, we genotyped 5-HTTLPR, measured serum BDNF with ELISA, and assessed early adversities by the childhood trauma questionnaire (CTQ). Data were analyzed in the context of the general linear model correcting for age, sex, ongoing lithium treatment, severity of current depression, and CTQ minimization/denial scores to investigate the effect of 5-HTTLPR polymorphism and childhood trauma on BDNF levels. Early trauma were negatively associated with BDNF serum levels (higher CTQ scores, lower BDNF; p=0.0019). 5-HTTLPR l/l homozygotes showed significantly higher BDNF levels than 5-HTTLPR*s carriers (30.57±6.13 vs 26.82±6.41; p=0.0309). A separate-slopes analysis showed that 5-HTTLPR significantly influenced the relationship between early trauma and adult BDNF (interaction of 5-HTTLPR with CTQ scores: p=0.0023), due to a significant relationship between trauma and BDNF in 5-HTTLPR*s carriers, but not among l/l homozygotes. Putatively detrimental effects of childhood trauma exposure on adult BDNF serum levels are influenced by 5-HTTLPR genotype in patients affected by BD. Possible mechanisms include epigenetic modulation of BDNF gene expression, due to different reactivity to stressors in 5-HTTLPR genotype groups.</AbstractText><CopyrightInformation>Copyright © 2017 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Benedetti</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Neuroscience, Scientific Institute Ospedale San Raffaele, Milano and University Vita-Salute San Raffaele, Milano, Italy. Electronic address: benedetti.francesco@hsr.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ambrée</LastName><ForeName>Oliver</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Münster, Münster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Locatelli</LastName><ForeName>Clara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Neuroscience, Scientific Institute Ospedale San Raffaele, Milano and University Vita-Salute San Raffaele, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorenzi</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Neuroscience, Scientific Institute Ospedale San Raffaele, Milano and University Vita-Salute San Raffaele, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poletti</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Münster, Münster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colombo</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Neuroscience, Scientific Institute Ospedale San Raffaele, Milano and University Vita-Salute San Raffaele, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arolt</LastName><ForeName>Volker</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Münster, Münster, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>07</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Neurosci Lett</MedlineTA><NlmUniqueID>7600130</NlmUniqueID><ISSNLinking>0304-3940</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019208">Brain-Derived Neurotrophic Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C493230">SLC6A4 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050486">Serotonin Plasma Membrane Transport Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>7171WSG8A2</RegistryNumber><NameOfSubstance UI="C579455">BDNF protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019208" MajorTopicYN="N">Brain-Derived Neurotrophic Factor</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002649" MajorTopicYN="Y">Child Abuse</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="N">Epigenesis, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011401" MajorTopicYN="N">Promoter Regions, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050486" MajorTopicYN="N">Serotonin Plasma Membrane Transport Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BDNF</Keyword><Keyword MajorTopicYN="N">Bipolar disorder</Keyword><Keyword MajorTopicYN="N">Childhood trauma</Keyword><Keyword MajorTopicYN="N">Serotonin promoter</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>03</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>07</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>07</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>4</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28754344</ArticleId><ArticleId IdType="pii">S0304-3940(17)30615-8</ArticleId><ArticleId IdType="doi">10.1016/j.neulet.2017.07.043</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31121524</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>20</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-1582</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>NeuroImage. Clinical</Title><ISOAbbreviation>Neuroimage Clin</ISOAbbreviation></Journal><ArticleTitle/><Pagination><MedlinePgn>101854</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S2213-1582(19)30204-9</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nicl.2019.101854</ELocationID><Abstract><AbstractText>Despite the traditional view of Schizophrenia (SZ) and Bipolar disorder (BD) as separate diagnostic categories, the validity of such a categorical approach is challenging. In recent years, the hypothesis of a continuum between Schizophrenia (SZ) and Bipolar disorder (BD), postulating a common pathophysiologic mechanism, has been proposed. Although appealing, this unifying hypothesis may be too simplistic when looking at cognitive and affective differences these patients display. In this paper, we aim to test an expanded version of the continuum hypothesis according to which the continuum extends over three clusters: the psychotic, the cognitive, and the affective. We applied an innovative approach known as Source-based Morphometry (SBM) to the structural images of 46 individuals diagnosed with SZ, 46 with BD and 66 healthy controls (HC). We also analyzed the psychological profiles of the three groups using cognitive, affective, and clinical tests. At a neural level, we found evidence for a shared psychotic core in a distributed network involving portions of the medial parietal and temporo-occipital areas, as well as parts of the cerebellum and the middle frontal gyrus. We also found evidence of a cognitive core more compromised in SZ, including alterations in a fronto-parietal circuit, and mild evidence of an affective core more compromised in BD, including portions of the temporal and occipital lobes, cerebellum, and frontal gyrus. Such differences were confirmed by the psychological profiles, with SZ patients more impaired in cognitive tests, while BD in affective ones. On the bases of these results we put forward an expanded view of the continuum hypothesis, according to which a common psychotic core exists between SZ and BD patients complemented by two separate cognitive and affective cores that are both impaired in the two patients' groups, although to different degrees.</AbstractText><CopyrightInformation>Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sorella</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Psychology and Cognitive Science (DiPSCo), University of Trento, Rovereto, Italy. Electronic address: sara.sorella@unitn.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lapomarda</LastName><ForeName>Gaia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Psychology and Cognitive Science (DiPSCo), University of Trento, Rovereto, Italy. Electronic address: gaia.lapomarda@unitn.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Messina</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Universitas Mercatorum, Roma, Italy. Electronic address: irene.messina@unimercatorum.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frederickson</LastName><ForeName>Jon Julius</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Washington School of Psychiatry, Washington, DC, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siugzdaite</LastName><ForeName>Roma</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Experimental Psychology, Faculty of Psychological and Pedagogical Sciences, Ghent University, Ghent, Belgium. Electronic address: Roma.Siugzdaite@ugent.be.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Job</LastName><ForeName>Remo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Psychology and Cognitive Science (DiPSCo), University of Trento, Rovereto, Italy. Electronic address: remo.job@unitn.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grecucci</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Psychology and Cognitive Science (DiPSCo), University of Trento, Rovereto, Italy. Electronic address: alessandro.grecucci@unitn.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>fre</Language><GrantList CompleteYN="Y"><Grant><GrantID>MC_UP_A060_1103</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_UU_00005/2</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Testing the expanded continuum hypothesis of schizophrenia and bipolar disorder. Neural and psychological evidence for shared and distinct mechanisms.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2019</Year><Month>05</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Neuroimage Clin</MedlineTA><NlmUniqueID>101597070</NlmUniqueID><ISSNLinking>2213-1582</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009415" MajorTopicYN="N">Nerve Net</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012559" MajorTopicYN="N">Schizophrenia</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012565" MajorTopicYN="Y">Schizophrenic Psychology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Bipolar disorder</Keyword><Keyword MajorTopicYN="Y">Continuum hypothesis</Keyword><Keyword MajorTopicYN="Y">Psychosis</Keyword><Keyword MajorTopicYN="Y">Schizophrenia</Keyword><Keyword MajorTopicYN="Y">Source-based morphometry</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>02</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>04</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>05</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31121524</ArticleId><ArticleId IdType="pii">S2213-1582(19)30204-9</ArticleId><ArticleId IdType="doi">10.1016/j.nicl.2019.101854</ArticleId><ArticleId IdType="pmc">PMC6529770</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Epidemiol Psychiatr Sci. 2016 Aug;25(4):312-6</Citation><ArticleIdList><ArticleId IdType="pubmed">27095442</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2006 Sep 21;443(7109):287</Citation><ArticleIdList><ArticleId IdType="pubmed">16988702</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Pharm Des. 2012;18(4):486-94</Citation><ArticleIdList><ArticleId IdType="pubmed">22239579</ArticleId></ArticleIdList></Reference><Reference><Citation>Prog Neuropsychopharmacol Biol Psychiatry. 2016 Feb 4;65:127-33</Citation><ArticleIdList><ArticleId IdType="pubmed">26382757</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2004 Oct 15;56(8):544-52</Citation><ArticleIdList><ArticleId IdType="pubmed">15476683</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 2007 Nov-Dec;48(6):583-91</Citation><ArticleIdList><ArticleId IdType="pubmed">17954145</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2017 Nov 14;12(11):e0188000</Citation><ArticleIdList><ArticleId IdType="pubmed">29136642</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2002;7(4):405-11</Citation><ArticleIdList><ArticleId IdType="pubmed">11986984</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerebellum Ataxias. 2015 Dec 09;2:17</Citation><ArticleIdList><ArticleId IdType="pubmed">26664729</ArticleId></ArticleIdList></Reference><Reference><Citation>Riv Psichiatr. 2014 May-Jun;49(3):124-31</Citation><ArticleIdList><ArticleId IdType="pubmed">25000888</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Brain Mapp. 2009 Mar;30(3):711-24</Citation><ArticleIdList><ArticleId IdType="pubmed">18266214</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Psychiatry. 2007 Jul;20(4):365-79</Citation><ArticleIdList><ArticleId IdType="pubmed">17551352</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res Treatment. 2014;2014:785310</Citation><ArticleIdList><ArticleId IdType="pubmed">25024847</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2007 Dec;97(1-3):215-25</Citation><ArticleIdList><ArticleId IdType="pubmed">17851044</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2008 Sep;118(3):172-87</Citation><ArticleIdList><ArticleId IdType="pubmed">18699952</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1997 Mar 14;275(5306):1586-93</Citation><ArticleIdList><ArticleId IdType="pubmed">9054346</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Public Health. 2015 May 05;3:66</Citation><ArticleIdList><ArticleId IdType="pubmed">26000269</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(9):e45263</Citation><ArticleIdList><ArticleId IdType="pubmed">23028892</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2008 Jul 1;64(1):40-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18549875</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2003 Jul;160(7):1313-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12832247</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychopharmacology. 2009 Aug;34(9):2081-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19295511</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2010 Feb;196(2):92-5</Citation><ArticleIdList><ArticleId IdType="pubmed">20118450</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2000 Jun;11(6 Pt 1):805-21</Citation><ArticleIdList><ArticleId IdType="pubmed">10860804</ArticleId></ArticleIdList></Reference><Reference><Citation>Braz J Psychiatry. 2011 Dec;33(4):319-20</Citation><ArticleIdList><ArticleId IdType="pubmed">22189920</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2013 Jul;147(2-3):301-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23664588</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2016 Sep;18(6):502-510</Citation><ArticleIdList><ArticleId IdType="pubmed">27759213</ArticleId></ArticleIdList></Reference><Reference><Citation>Neural Comput. 1995 Nov;7(6):1129-59</Citation><ArticleIdList><ArticleId IdType="pubmed">7584893</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Hum Neurosci. 2012 May 23;6:137</Citation><ArticleIdList><ArticleId IdType="pubmed">22654746</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Biol. 1995 May 1;5(5):552-63</Citation><ArticleIdList><ArticleId IdType="pubmed">7583105</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2017 May 15;81(10):818-820</Citation><ArticleIdList><ArticleId IdType="pubmed">28063469</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Psychiatry. 2013 Aug 08;4:87</Citation><ArticleIdList><ArticleId IdType="pubmed">23964248</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2009 May 8;324(5928):811-3</Citation><ArticleIdList><ArticleId IdType="pubmed">19423830</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2005 Jan;10(1):105-16</Citation><ArticleIdList><ArticleId IdType="pubmed">15340357</ArticleId></ArticleIdList></Reference><Reference><Citation>F1000Res. 2017 Jul 28;6:1262</Citation><ArticleIdList><ArticleId IdType="pubmed">29152222</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Brain Mapp. 2010 Feb;31(2):300-10</Citation><ArticleIdList><ArticleId IdType="pubmed">19777553</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2003;64 Suppl 6:23-7; discussion 28</Citation><ArticleIdList><ArticleId IdType="pubmed">12720477</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Psychiatry. 2015 Apr;72(4):305-15</Citation><ArticleIdList><ArticleId IdType="pubmed">25651064</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2007 Jul 15;62(2):179-86</Citation><ArticleIdList><ArticleId IdType="pubmed">17161829</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2004 Jan 13;62(1):110-3</Citation><ArticleIdList><ArticleId IdType="pubmed">14718709</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Arch Psychiatry Clin Neurosci. 2004 Apr;254(2):61-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15146334</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 2014 Nov;44(15):3239-48</Citation><ArticleIdList><ArticleId IdType="pubmed">25066202</ArticleId></ArticleIdList></Reference><Reference><Citation>Soc Cogn Affect Neurosci. 2006 Jun;1(1):65-71</Citation><ArticleIdList><ArticleId IdType="pubmed">17387382</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2014 Feb;129(2):100-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23600731</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage Clin. 2015 Apr 22;8:202-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26106544</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Psychiatry. 2001 Apr;16(3):167-72</Citation><ArticleIdList><ArticleId IdType="pubmed">11353595</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2015 Mar;131(3):223-33</Citation><ArticleIdList><ArticleId IdType="pubmed">25430729</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2003 Oct 15;54(8):777-91</Citation><ArticleIdList><ArticleId IdType="pubmed">14550677</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Lett. 2011 Feb 4;489(2):94-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21138758</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 2003 Jul-Aug;44(4):263-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12923703</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2002 Jun;159(6):975-82</Citation><ArticleIdList><ArticleId IdType="pubmed">12042186</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychopharmacology. 2014 Jan;39(2):456-63</Citation><ArticleIdList><ArticleId IdType="pubmed">23963117</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Neuropsychopharmacol. 2008 Mar;11(2):185-96</Citation><ArticleIdList><ArticleId IdType="pubmed">17681086</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychol Rev. 2018 Dec;28(4):509-533</Citation><ArticleIdList><ArticleId IdType="pubmed">30343458</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2002 Nov;59(11):1011-20</Citation><ArticleIdList><ArticleId IdType="pubmed">12418934</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Neurosurg Psychiatry. 2018 Aug;89(8):879-885</Citation><ArticleIdList><ArticleId IdType="pubmed">29332009</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Psychol Sci. 2014 Mar;2(2):119-137</Citation><ArticleIdList><ArticleId IdType="pubmed">25360393</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Arch Psychiatry Clin Neurosci. 2011 Aug;261(5):313-22</Citation><ArticleIdList><ArticleId IdType="pubmed">21188405</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2005 Nov 1;58(9):713-23</Citation><ArticleIdList><ArticleId IdType="pubmed">15993858</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2017 Nov;257:45-50</Citation><ArticleIdList><ArticleId IdType="pubmed">28719831</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuropsychiatry Clin Neurosci. 1991 Winter;3(1):6-9</Citation><ArticleIdList><ArticleId IdType="pubmed">7580174</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2002 Apr;159(4):539-45</Citation><ArticleIdList><ArticleId IdType="pubmed">11925290</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatr Res. 2012 May;46(5):651-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22385661</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2010 Mar;117(1):1-12</Citation><ArticleIdList><ArticleId IdType="pubmed">20071149</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2005 Dec 15;80(2-3):137-49</Citation><ArticleIdList><ArticleId IdType="pubmed">16183257</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1987 Jul;44(7):634-41</Citation><ArticleIdList><ArticleId IdType="pubmed">3606329</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2015 Jul;165(2-3):212-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25935815</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2015 Sep;41(5):1133-42</Citation><ArticleIdList><ArticleId IdType="pubmed">25548384</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2013 May;146(1-3):10-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23498153</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2009 Dec 1;66(11):988-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19900610</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2013 Nov;39(6):1288-95</Citation><ArticleIdList><ArticleId IdType="pubmed">23104865</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2004 Jun 15;55(12):1154-62</Citation><ArticleIdList><ArticleId IdType="pubmed">15184034</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Schizophr Relat Psychoses. 2012 Oct;6(3):145-51</Citation><ArticleIdList><ArticleId IdType="pubmed">23006239</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Cogn Sci. 2012 Jan;16(1):27-34</Citation><ArticleIdList><ArticleId IdType="pubmed">22169777</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatr Res. 2013 Nov;47(11):1564-71</Citation><ArticleIdList><ArticleId IdType="pubmed">23907000</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Hum Neurosci. 2010 Oct 26;4:189</Citation><ArticleIdList><ArticleId IdType="pubmed">21103008</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2014 Jun;16(4):354-65</Citation><ArticleIdList><ArticleId IdType="pubmed">24382259</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neurosci. 2017 Sep 26;11:533</Citation><ArticleIdList><ArticleId IdType="pubmed">29018322</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2011 Dec;133(1-3):250-4</Citation><ArticleIdList><ArticleId IdType="pubmed">21996268</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Behav Neurosci Rep. 2015 May 1;2(2):80-89</Citation><ArticleIdList><ArticleId IdType="pubmed">26052479</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychiatr Dis Treat. 2015 Dec 17;11:3111-25</Citation><ArticleIdList><ArticleId IdType="pubmed">26719696</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2009 Jan 17;373(9659):234-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19150704</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Clin Psychopharmacol. 2002 Aug;17 Suppl 3:S11-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12570067</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Cogn Sci. 2010 Jul;14(7):317-24</Citation><ArticleIdList><ArticleId IdType="pubmed">20630350</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2013 Sep;15(6):680-93</Citation><ArticleIdList><ArticleId IdType="pubmed">23796123</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 2013 Sep 4;33(36):14307-17</Citation><ArticleIdList><ArticleId IdType="pubmed">24005284</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Data. 2016 Dec 06;3:160110</Citation><ArticleIdList><ArticleId IdType="pubmed">27922632</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2013 Nov;170(11):1275-84</Citation><ArticleIdList><ArticleId IdType="pubmed">23771174</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2007 Jan;89(1-3):198-210</Citation><ArticleIdList><ArticleId IdType="pubmed">17010573</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2009 May;11(3):280-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19419385</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 1986 Oct;149:419-29</Citation><ArticleIdList><ArticleId IdType="pubmed">3814925</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2013 Mar 15;73(6):555-64</Citation><ArticleIdList><ArticleId IdType="pubmed">22985694</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2017 Nov 27;7(1):16405</Citation><ArticleIdList><ArticleId IdType="pubmed">29180712</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Hum Neurosci. 2012 Jun 22;6:180</Citation><ArticleIdList><ArticleId IdType="pubmed">22737114</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2012 Mar 15;71(6):552-60</Citation><ArticleIdList><ArticleId IdType="pubmed">22281121</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Neuropsychopharmacol. 2015 Feb;25(2):151-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25661911</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2009 Sep;195(3):194-201</Citation><ArticleIdList><ArticleId IdType="pubmed">19721106</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2011 Nov 30;194(2):149-56</Citation><ArticleIdList><ArticleId IdType="pubmed">21924872</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2000 Jan;157(1):40-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10618011</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2007 Jul;164(7):1090-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17606661</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Clin Psychol. 2015;11:251-81</Citation><ArticleIdList><ArticleId IdType="pubmed">25581236</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2016 Sep;42(5):1149-57</Citation><ArticleIdList><ArticleId IdType="pubmed">27060129</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatr Res. 2007 Apr-Jun;41(3-4):265-72</Citation><ArticleIdList><ArticleId IdType="pubmed">16762369</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2014 Mar;40 Suppl 2:S131-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24562492</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2015 Sep;41(5):1095-104</Citation><ArticleIdList><ArticleId IdType="pubmed">25616505</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2008 Mar;106(3):209-17</Citation><ArticleIdList><ArticleId IdType="pubmed">17719092</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Neurosci. 2018 Mar;47(6):690-700</Citation><ArticleIdList><ArticleId IdType="pubmed">28921735</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 2017 Jul;47(10):1848-1864</Citation><ArticleIdList><ArticleId IdType="pubmed">28241891</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Exp Neuropsychol. 2018 Feb;40(1):84-94</Citation><ArticleIdList><ArticleId IdType="pubmed">28562181</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Neuropsychopharmacol. 2007 Apr;17(5):313-20</Citation><ArticleIdList><ArticleId IdType="pubmed">17140772</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2014;204:290-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24434074</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2017 May 15;81(10):821-831</Citation><ArticleIdList><ArticleId IdType="pubmed">27865453</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2007 Jul;33(4):905-11</Citation><ArticleIdList><ArticleId IdType="pubmed">17551090</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2014 Jul;40 Suppl 4:S305-16</Citation><ArticleIdList><ArticleId IdType="pubmed">24936089</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2009 Aug;66(8):811-22</Citation><ArticleIdList><ArticleId IdType="pubmed">19652121</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2011 Jul 27;477(7363):171-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21796121</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2012 Apr;69(4):349-59</Citation><ArticleIdList><ArticleId IdType="pubmed">22474104</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2014 Nov 30;219(3):464-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25017619</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortex. 2006 Jul;42(5):666-74</Citation><ArticleIdList><ArticleId IdType="pubmed">16909625</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Biol Psychiatry. 2003 Apr;4(2):81-92</Citation><ArticleIdList><ArticleId IdType="pubmed">12692779</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2018 Nov;20(7):604-613</Citation><ArticleIdList><ArticleId IdType="pubmed">29777563</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2016 Mar 1;192:109-15</Citation><ArticleIdList><ArticleId IdType="pubmed">26720009</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 1990 Jun;156:788-97</Citation><ArticleIdList><ArticleId IdType="pubmed">2207509</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Clin Neurosci. 2016 Oct;70(10):424-433</Citation><ArticleIdList><ArticleId IdType="pubmed">27233969</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Neurosci. 2004 Jan;7(1):75-9</Citation><ArticleIdList><ArticleId IdType="pubmed">14699419</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Psychiatry. 2017 Sep;45:121-128</Citation><ArticleIdList><ArticleId IdType="pubmed">28756110</ArticleId></ArticleIdList></Reference><Reference><Citation>Neural Comput. 1999 Feb 15;11(2):417-41</Citation><ArticleIdList><ArticleId IdType="pubmed">9950738</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Lett. 2009 May 29;456(1):44-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19429131</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2014 Jan;137(Pt 1):12-32</Citation><ArticleIdList><ArticleId IdType="pubmed">23869106</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroscientist. 2005 Feb;11(1):16-24</Citation><ArticleIdList><ArticleId IdType="pubmed">15632275</ArticleId></ArticleIdList></Reference><Reference><Citation>Epilepsy Res Treat. 2012;2012:809843</Citation><ArticleIdList><ArticleId IdType="pubmed">22957244</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neurosci. 2016 Aug 31;10:388</Citation><ArticleIdList><ArticleId IdType="pubmed">27630538</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">10847314</PMID><DateCompleted><Year>2000</Year><Month>06</Month><Day>21</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0160-6689</ISSN><JournalIssue CitedMedium="Print"><Volume>61</Volume><Issue>5</Issue><PubDate><Year>2000</Year><Month>May</Month></PubDate></JournalIssue><Title>The Journal of clinical psychiatry</Title><ISOAbbreviation>J Clin Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Modafinil augmentation of antidepressant treatment in depression.</ArticleTitle><Pagination><MedlinePgn>378-81</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Despite a relative lack of controlled data, stimulants are often used to augment antidepressant treatment in patients who have had only a partial response to first-line therapy. Modafinil is a novel psychostimulant that has shown efficacy in, and was recently marketed for, treating excessive daytime sleepiness associated with narcolepsy. The mechanism of action of modafinil is unknown, but, unlike other stimulants, the drug is highly selective for the central nervous system, has little effect on dopaminergic activity in the striatum, and appears to have a lower abuse potential.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">In this retrospective case series, we describe 7 patients with DSM-IV depression (4 with major depression and 3 with bipolar depression) for whom we used modafinil to augment a partial or nonresponse to an antidepressant. The Hamilton Rating Scale for Depression was administered as part of routine clinical practice prior to treatment and at each subsequent visit.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">At doses of 100 to 200 mg/day, all 7 patients achieved full or partial remission, generally within 1 to 2 weeks. All patients had some residual tiredness or fatigue prior to starting modafinil, and this symptom was particularly responsive to augmentation. Side effects were minimal and did not lead to discontinuation of the drug in any of the patients.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Modafinil appears to be a drug with promise as an augmenter of antidepressants, especially in patients with residual tiredness or fatigue. It is a particularly attractive alternative to other stimulants because of its low abuse potential and Schedule IV status.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Menza</LastName><ForeName>M A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway 08854, USA. menza@umdnj.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaufman</LastName><ForeName>K R</ForeName><Initials>KR</Initials></Author><Author ValidYN="Y"><LastName>Castellanos</LastName><ForeName>A</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Psychiatry</MedlineTA><NlmUniqueID>7801243</NlmUniqueID><ISSNLinking>0160-6689</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000928">Antidepressive Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001559">Benzhydryl Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000697">Central Nervous System Stimulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>R3UK8X3U3D</RegistryNumber><NameOfSubstance UI="D000077408">Modafinil</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Clin Psychiatry. 2006 Nov;67(11):1817</RefSource><PMID Version="1">17196066</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000928" MajorTopicYN="N">Antidepressive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001559" MajorTopicYN="N">Benzhydryl Compounds</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000697" MajorTopicYN="N">Central Nervous System Stimulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003866" MajorTopicYN="N">Depressive Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077408" MajorTopicYN="N">Modafinil</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2000</Year><Month>6</Month><Day>10</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2000</Year><Month>6</Month><Day>24</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2000</Year><Month>6</Month><Day>10</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">10847314</ArticleId><ArticleId IdType="doi">10.4088/jcp.v61n0510</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">6767189</PMID><DateCompleted><Year>1980</Year><Month>05</Month><Day>23</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0028-4793</ISSN><JournalIssue CitedMedium="Print"><Volume>302</Volume><Issue>16</Issue><PubDate><Year>1980</Year><Month>Apr</Month><Day>17</Day></PubDate></JournalIssue><Title>The New England journal of medicine</Title><ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal><ArticleTitle>TRH test in depression.</ArticleTitle><Pagination><MedlinePgn>923-4</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Extein</LastName><ForeName>I</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Pottash</LastName><ForeName>A L</ForeName><Initials>AL</Initials></Author><Author ValidYN="Y"><LastName>Gold</LastName><ForeName>M S</ForeName><Initials>MS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>N Engl J Med</MedlineTA><NlmUniqueID>0255562</NlmUniqueID><ISSNLinking>0028-4793</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>5Y5F15120W</RegistryNumber><NameOfSubstance UI="D013973">Thyrotropin-Releasing Hormone</NameOfSubstance></Chemical><Chemical><RegistryNumber>9002-71-5</RegistryNumber><NameOfSubstance UI="D013972">Thyrotropin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013972" MajorTopicYN="N">Thyrotropin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013973" MajorTopicYN="Y">Thyrotropin-Releasing Hormone</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1980</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1980</Year><Month>4</Month><Day>17</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1980</Year><Month>4</Month><Day>17</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">6767189</ArticleId><ArticleId IdType="doi">10.1056/NEJM198004173021620</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">29120844</PMID><DateCompleted><Year>2018</Year><Month>10</Month><Day>30</Day></DateCompleted><DateRevised><Year>2019</Year><Month>01</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7123</ISSN><JournalIssue CitedMedium="Internet"><Volume>259</Volume><PubDate><Year>2018</Year><Month>01</Month></PubDate></JournalIssue><Title>Psychiatry research</Title><ISOAbbreviation>Psychiatry Res</ISOAbbreviation></Journal><ArticleTitle>Prevalence and clinical-demographic correlates of hyperhomocysteinemia in inpatients with bipolar disorder in a Han Chinese population.</ArticleTitle><Pagination><MedlinePgn>364-369</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0165-1781(16)31117-9</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.psychres.2017.08.063</ELocationID><Abstract><AbstractText>Recent studies have reported that hyperhomocystinemia (HHcy) is highly prevalent in patients with bipolar disorder (BD), placing them at greater risk of cardiovascular disease and possibly serving as a disease biomarker. However, the correlation of HHcy with demographic or clinical parameters is not well known. In this study, we examined the prevalence of HHcy and its association with these parameters in a sample of Chinese BD patients. Fasting plasma homocysteine (Hcy) levels were determined in 198 BD inpatients and 84 healthy controls. HHcy was defined when Hcy concentration exceeded 15.0µmol/L. Affective symptomatology was assessed by the Young Mania Rating Scale, Hamilton Depression Rating Scale and the Clinical Global Impressions severity scale. Compared to healthy controls, BD patients had a significantly higher prevalence (34.85% vs. 19.05%) of HHcy and a higher absolute level of homocysteine. Logistic regression analysis demonstrated that BD patients with HHcy were more likely to be male, have elevated BMI, more frequent treatment on lithium but less on valproate. These results suggest that Chinese inpatients with bipolar disorder have a higher rate of HHcy than the general population, and those at greatest risk are male, have an elevated BMI, and take more lithium but less valproate therapy.</AbstractText><CopyrightInformation>Copyright © 2017. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Shuang-Jiang</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Beijing Hui-Long-Guan Hospital, Peking University, Beijing 100096, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Li-Gang</ForeName><Initials>LG</Initials><AffiliationInfo><Affiliation>Beijing Hui-Long-Guan Hospital, Peking University, Beijing 100096, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Hong-Mei</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Beijing Hui-Long-Guan Hospital, Peking University, Beijing 100096, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ju-Yan</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Beijing Hui-Long-Guan Hospital, Peking University, Beijing 100096, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ran</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Beijing Hui-Long-Guan Hospital, Peking University, Beijing 100096, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xi-Mei</ForeName><Initials>XM</Initials><AffiliationInfo><Affiliation>Beijing Hui-Long-Guan Hospital, Peking University, Beijing 100096, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ning</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Beijing Hui-Long-Guan Hospital, Peking University, Beijing 100096, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soares</LastName><ForeName>Jair C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cassidy</LastName><ForeName>Ryan M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Yingjun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou Huiai Hospital, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ning</LastName><ForeName>Yuping</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou Huiai Hospital, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Shao-Li</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Beijing Hui-Long-Guan Hospital, Peking University, Beijing 100096, China. Electronic address: wangshl82@sina.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jing-Xu</ForeName><Initials>JX</Initials><AffiliationInfo><Affiliation>Beijing Hui-Long-Guan Hospital, Peking University, Beijing 100096, China. Electronic address: chenjx1110@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiang-Yang</ForeName><Initials>XY</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA; The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou Huiai Hospital, Guangzhou, China. Electronic address: Xiang.y.zhang@uth.tmc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>TL1 TR000369</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>08</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Psychiatry Res</MedlineTA><NlmUniqueID>7911385</NlmUniqueID><ISSNLinking>0165-1781</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0LVT1QZ0BA</RegistryNumber><NameOfSubstance UI="D006710">Homocysteine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006710" MajorTopicYN="N">Homocysteine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020138" MajorTopicYN="N">Hyperhomocysteinemia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007297" MajorTopicYN="N">Inpatients</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Bipolar disorder</Keyword><Keyword MajorTopicYN="Y">Body mass index</Keyword><Keyword MajorTopicYN="Y">Homocysteine</Keyword><Keyword MajorTopicYN="Y">Lithium</Keyword><Keyword MajorTopicYN="Y">Prevalence</Keyword><Keyword MajorTopicYN="Y">Valproate</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>07</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>05</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>08</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>10</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29120844</ArticleId><ArticleId IdType="pii">S0165-1781(16)31117-9</ArticleId><ArticleId IdType="doi">10.1016/j.psychres.2017.08.063</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">7067431</PMID><DateCompleted><Year>1982</Year><Month>06</Month><Day>14</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0010-440X</ISSN><JournalIssue CitedMedium="Print"><Volume>23</Volume><Issue>2</Issue><PubDate><MedlineDate>1982 Mar-Apr</MedlineDate></PubDate></JournalIssue><Title>Comprehensive psychiatry</Title><ISOAbbreviation>Compr Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Relationship between plasma lithium levels and prophylaxis against depression in bipolar I, bipolar II, and cyclothymic patients.</ArticleTitle><Pagination><MedlinePgn>176-80</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Peselow</LastName><ForeName>E D</ForeName><Initials>ED</Initials></Author><Author ValidYN="Y"><LastName>Gulbenkian</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Dunner</LastName><ForeName>D L</ForeName><Initials>DL</Initials></Author><Author ValidYN="Y"><LastName>Fieve</LastName><ForeName>R R</ForeName><Initials>RR</Initials></Author><Author ValidYN="Y"><LastName>Deutsch</LastName><ForeName>S I</ForeName><Initials>SI</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Compr Psychiatry</MedlineTA><NlmUniqueID>0372612</NlmUniqueID><ISSNLinking>0010-440X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9FN79X2M3F</RegistryNumber><NameOfSubstance UI="D008094">Lithium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003527" MajorTopicYN="N">Cyclothymic Disorder</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008094" MajorTopicYN="N">Lithium</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019964" MajorTopicYN="N">Mood Disorders</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1982</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1982</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1982</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">7067431</ArticleId><ArticleId IdType="pii">0010-440X(82)90062-1</ArticleId><ArticleId IdType="doi">10.1016/0010-440x(82)90062-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">12788245</PMID><DateCompleted><Year>2003</Year><Month>08</Month><Day>20</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0006-3223</ISSN><JournalIssue CitedMedium="Print"><Volume>53</Volume><Issue>11</Issue><PubDate><Year>2003</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>Biological psychiatry</Title><ISOAbbreviation>Biol Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Family psychoeducation: an adjunctive intervention for children with bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>1000-8</MedlinePgn></Pagination><Abstract><AbstractText>Childhood onset bipolar disorder is associated with significant morbidity and mortality, yet effective treatment strategies have remained underdeveloped and understudied. While some headway is being made vis-a-vis pharmacologic treatments, empirical efforts have not focused on adjunctive psychosocial interventions for childhood bipolar disorder. In this review, we discuss psychoeducation, delivered via workshops, multifamily psychoeducation groups, or individual-family psychoeducation, as an adjunct to the ongoing pharmacotherapy, psychotherapy, and school-based interventions for children with bipolar disorder. We review the theoretical rationale for psychoeducation, including expressed emotion and caregiver concordance; summarize findings in the adult literature; and then describe our development and testing of psychoeducational interventions for mood-impaired children. Data from three pilot studies are reviewed, and progress on two studies currently underway is presented. We conclude with current limitations of psychoeducation and recommendations for future study to develop psychoeducation as an empirically supported adjunctive intervention for children with bipolar disorder.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fristad</LastName><ForeName>Mary A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychology, The Ohio State University, Columbus, Ohio 43210, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gavazzi</LastName><ForeName>Stephen M</ForeName><Initials>SM</Initials></Author><Author ValidYN="Y"><LastName>Mackinaw-Koons</LastName><ForeName>Barbara</ForeName><Initials>B</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 MH61512-01</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biol Psychiatry</MedlineTA><NlmUniqueID>0213264</NlmUniqueID><ISSNLinking>0006-3223</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000339" MajorTopicYN="Y">Affect</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001294" MajorTopicYN="Y">Attitude to Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019260" MajorTopicYN="Y">Expressed Emotion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005192" MajorTopicYN="N">Family Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005196" MajorTopicYN="N">Family Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009820" MajorTopicYN="N" Type="Geographic">Ohio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010347" MajorTopicYN="N">Patient Care Planning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010353" MajorTopicYN="N">Patient Education as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002666" MajorTopicYN="N">Psychology, Child</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>68</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>6</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>8</Month><Day>21</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>6</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12788245</ArticleId><ArticleId IdType="pii">S0006322303001860</ArticleId><ArticleId IdType="doi">10.1016/s0006-3223(03)00186-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">11150895</PMID><DateCompleted><Year>2001</Year><Month>07</Month><Day>05</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0302-282X</ISSN><JournalIssue CitedMedium="Print"><Volume>43</Volume><Issue>1</Issue><PubDate><Year>2001</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Neuropsychobiology</Title><ISOAbbreviation>Neuropsychobiology</ISOAbbreviation></Journal><ArticleTitle>Maintenance electroconvulsive therapy in affective and schizoaffective disorder.</ArticleTitle><Pagination><MedlinePgn>23-8</MedlinePgn></Pagination><Abstract><AbstractText>Twenty-one patients (13 depressives and 8 schizoaffectives) who underwent maintenance electroconvulsive therapy (M-ECT) were compared with controls who received maintenance pharmacotherapy alone. Measures of effectiveness and safety of maintenance treatment were prospectively obtained during a 1-year follow-up. Survival analysis demonstrated a significantly better outcome defined by time to rehospitalization for all patients of the M-ECT group. Regarding the subgroups, depressives of the M-ECT group had markedly decreased rehospitalization rates compared to depressive controls. Furthermore, M-ECT in depressives resulted in a significant reduction in hospitalization rates and duration during follow-up. In schizoaffective patients, a significant difference in survival time was found in favor of the M-ECT group. In both groups, schizoaffectives had a markedly poorer outcome compared to depressive subjects. Our results indicate that in selected patients M-ECT, at least in combination with supporting medication, may be an efficient and safe alternative to pharmacological continuation or maintenance therapy alone.</AbstractText><CopyrightInformation>Copyright 2001 S. Karger AG, Basel</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Swoboda</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Psychiatry I, Landeskrankenhaus Rankweil, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conca</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>König</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Waanders</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Hansen</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Neuropsychobiology</MedlineTA><NlmUniqueID>7512895</NlmUniqueID><ISSNLinking>0302-282X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000928">Antidepressive Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000928" MajorTopicYN="N">Antidepressive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014150" MajorTopicYN="N">Antipsychotic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003865" MajorTopicYN="N">Depressive Disorder, Major</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004565" MajorTopicYN="Y">Electroconvulsive Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008134" MajorTopicYN="N">Long-Term Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010359" MajorTopicYN="N">Patient Readmission</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011618" MajorTopicYN="N">Psychotic Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2001</Year><Month>1</Month><Day>11</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2001</Year><Month>7</Month><Day>6</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2001</Year><Month>1</Month><Day>11</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">11150895</ArticleId><ArticleId IdType="pii">54861</ArticleId><ArticleId IdType="doi">10.1159/000054861</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">4014503</PMID><DateCompleted><Year>1985</Year><Month>08</Month><Day>02</Day></DateCompleted><DateRevised><Year>2016</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0002-953X</ISSN><JournalIssue CitedMedium="Print"><Volume>142</Volume><Issue>7</Issue><PubDate><Year>1985</Year><Month>Jul</Month></PubDate></JournalIssue><Title>The American journal of psychiatry</Title><ISOAbbreviation>Am J Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Bipolar I, bipolar II, and nonbipolar major depression among the relatives of affectively ill probands.</ArticleTitle><Pagination><MedlinePgn>817-21</MedlinePgn></Pagination><Abstract><AbstractText>An earlier report described symptoms and background features in depressed probands grouped by polarity: bipolar I, bipolar II, and nonbipolar. The present study made similar comparisons among relatives with a lifetime history of major depression. The 73 relatives with bipolar II disorder had the highest rates of marital disruption, psychopathology in the previous month, nonserious suicide attempts, and nonaffective syndromes and were the youngest when first treated.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Coryell</LastName><ForeName>W</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Endicott</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Andreasen</LastName><ForeName>N</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Keller</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 MH025478</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MH-25416</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Psychiatry</MedlineTA><NlmUniqueID>0370512</NlmUniqueID><ISSNLinking>0002-953X</ISSNLinking></MedlineJournalInfo><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000553" MajorTopicYN="N">Ambulatory Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003702" MajorTopicYN="N">Delusions</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003866" MajorTopicYN="N">Depressive Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006212" MajorTopicYN="N">Hallucinations</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008393" MajorTopicYN="N">Marriage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001523" MajorTopicYN="N">Mental Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013406" MajorTopicYN="N">Suicide, Attempted</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1985</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1985</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1985</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">4014503</ArticleId><ArticleId IdType="doi">10.1176/ajp.142.7.817</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">31331636</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>08</Day></DateCompleted><DateRevised><Year>2020</Year><Month>05</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7123</ISSN><JournalIssue CitedMedium="Internet"><Volume>282</Volume><PubDate><Year>2019</Year><Month>12</Month></PubDate></JournalIssue><Title>Psychiatry research</Title><ISOAbbreviation>Psychiatry Res</ISOAbbreviation></Journal><ArticleTitle>Patients with rheumatoid arthritis have a higher risk of bipolar disorder: A systematic review and meta-analysis.</ArticleTitle><Pagination><MedlinePgn>112484</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0165-1781(19)31220-X</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.psychres.2019.112484</ELocationID><Abstract><AbstractText>The current study was conducted with the aim to investigate the relationship between rheumatoid arthritis (RA) and bipolar disorder (BD). Potentially eligible studies were identified from Medline and EMBASE databases from inception to May 2019. Eligible cohort studies must include patients with RA and comparators without RA, follow them for incident BD and report the relative risk, hazard risk ratio or standardized incidence ratio and associated 95% confidence intervals (CI) comparing the incidence of BD between the two groups. Eligible case-control studies must include cases with BD and controls without BD, explore prior history of RA and report the odds ratio and associated 95% CI for this association. Point estimates with standard errors were extracted from individual study and were combined together using random-effect model, generic inverse variance method. A total of six studies fulfilled the inclusion criteria and were included into the meta-analysis. The risk of developing BD was significantly higher among patients with RA than individuals without RA with the pooled relative risk of 2.06 (95% CI, 1.34-3.17; I<sup>2</sup> 86%). Chronic inflammation is a potential mechanism and could be a modifiable risk factor of BD. However, further studies are still required to confirm this.</AbstractText><CopyrightInformation>Copyright © 2019 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Charoenngam</LastName><ForeName>Nipith</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ponvilawan</LastName><ForeName>Ben</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ungprasert</LastName><ForeName>Patompong</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Clinical Epidemiology Unit, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Prannok Road, Bangkoknoi, Bangkok, Thailand 10700. Electronic address: Papong.unp@mahidol.ac.thtom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Psychiatry Res</MedlineTA><NlmUniqueID>7911385</NlmUniqueID><ISSNLinking>0165-1781</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Bipolar disorder</Keyword><Keyword MajorTopicYN="Y">Epidemiology</Keyword><Keyword MajorTopicYN="Y">Meta-analysis</Keyword><Keyword MajorTopicYN="Y">Rheumatoid arthritis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>06</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>07</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>07</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31331636</ArticleId><ArticleId IdType="pii">S0165-1781(19)31220-X</ArticleId><ArticleId IdType="doi">10.1016/j.psychres.2019.112484</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21897858</PMID><DateCompleted><Year>2011</Year><Month>12</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>8</Issue><PubDate><Year>2011</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Combinations of SNPs related to signal transduction in bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>e23812</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0023812</ELocationID><Abstract><AbstractText>Any given single nucleotide polymorphism (SNP) in a genome may have little or no functional impact. A biologically significant effect may possibly emerge only when a number of key SNP-related genotypes occur together in a single organism. Thus, in analysis of many SNPs in association studies of complex diseases, it may be useful to look at combinations of genotypes. Genes related to signal transmission, e.g., ion channel genes, may be of interest in this respect in the context of bipolar disorder. In the present study, we analysed 803 SNPs in 55 genes related to aspects of signal transmission and calculated all combinations of three genotypes from the 3×803 SNP genotypes for 1355 controls and 607 patients with bipolar disorder. Four clusters of patient-specific combinations were identified. Permutation tests indicated that some of these combinations might be related to bipolar disorder. The WTCCC bipolar dataset were use for replication, 469 of the 803 SNP were present in the WTCCC dataset either directly (n = 132) or by imputation (n = 337) covering 51 of our selected genes. We found three clusters of patient-specific 3×SNP combinations in the WTCCC dataset. Different SNPs were involved in the clusters in the two datasets. The present analyses of the combinations of SNP genotypes support a role for both genetic heterogeneity and interactions in the genetic architecture of bipolar disorder.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Koefoed</LastName><ForeName>Pernille</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Laboratory of Neuropsychiatry, Department of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen, Denmark. pkoefoed@sund.ku.dk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andreassen</LastName><ForeName>Ole A</ForeName><Initials>OA</Initials></Author><Author ValidYN="Y"><LastName>Bennike</LastName><ForeName>Bente</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Dam</LastName><ForeName>Henrik</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Djurovic</LastName><ForeName>Srdjan</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Hansen</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Jorgensen</LastName><ForeName>Martin Balslev</ForeName><Initials>MB</Initials></Author><Author ValidYN="Y"><LastName>Kessing</LastName><ForeName>Lars Vedel</ForeName><Initials>LV</Initials></Author><Author ValidYN="Y"><LastName>Melle</LastName><ForeName>Ingrid</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Møller</LastName><ForeName>Gert Lykke</ForeName><Initials>GL</Initials></Author><Author ValidYN="Y"><LastName>Mors</LastName><ForeName>Ole</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Werge</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Mellerup</LastName><ForeName>Erling</ForeName><Initials>E</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G1001799</GrantID><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>076113</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>08</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="Y">Computational Biology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006579" MajorTopicYN="N">Heterozygote</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006720" MajorTopicYN="N">Homozygote</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year><Month>06</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>07</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21897858</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0023812</ArticleId><ArticleId IdType="pii">10-PONE-RA-20023</ArticleId><ArticleId IdType="pmc">PMC3163586</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bioinformatics. 2009 Feb 15;25(4):504-11</Citation><ArticleIdList><ArticleId IdType="pubmed">19098029</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Neurosci. 2003 Dec;4(12):968-80</Citation><ArticleIdList><ArticleId IdType="pubmed">14682359</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuron. 2004 Jul 22;43(2):183-91</Citation><ArticleIdList><ArticleId IdType="pubmed">15260955</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Brain Behav. 2004 Apr;3(2):90-100</Citation><ArticleIdList><ArticleId IdType="pubmed">15005717</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Genet. 2009 Aug;126(2):289-301</Citation><ArticleIdList><ArticleId IdType="pubmed">19408013</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 1982 Sep;4(3):237-47</Citation><ArticleIdList><ArticleId IdType="pubmed">6215442</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Res Bull. 2005 Apr 30;65(4):331-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15811599</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2006 Aug;94(1-3):35-66</Citation><ArticleIdList><ArticleId IdType="pubmed">16753223</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2007 Jun 7;447(7145):661-78</Citation><ArticleIdList><ArticleId IdType="pubmed">17554300</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 Sep 6;362(9386):798-805</Citation><ArticleIdList><ArticleId IdType="pubmed">13678875</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2007 Jul;12(7):630-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17505464</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2007 Jul;39(7):906-13</Citation><ArticleIdList><ArticleId IdType="pubmed">17572673</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mol Genet. 2006 Mar 1;15(5):743-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16434481</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroscience. 2009 Nov 24;164(1):331-43</Citation><ArticleIdList><ArticleId IdType="pubmed">19358880</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2001 Jun;65(1):95-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11426517</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 1989 Mar-Jun;16(2-3):259-67</Citation><ArticleIdList><ArticleId IdType="pubmed">2537861</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Genet. 2009 Feb;125(1):63-79</Citation><ArticleIdList><ArticleId IdType="pubmed">19052778</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2011 Mar;16(3):286-92</Citation><ArticleIdList><ArticleId IdType="pubmed">20157312</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2009 Jun;10(6):392-404</Citation><ArticleIdList><ArticleId IdType="pubmed">19434077</ArticleId></ArticleIdList></Reference><Reference><Citation>Genet Epidemiol. 2010 Apr;34(3):275-85</Citation><ArticleIdList><ArticleId IdType="pubmed">20088021</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Hum Genet. 2009 May;73(Pt 3):360-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19291098</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2007 May 8;104(19):8131-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17483467</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2005 Jul 15;6 Suppl 2:S4</Citation><ArticleIdList><ArticleId IdType="pubmed">16026601</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci Res. 2004 Jun 15;76(6):749-57</Citation><ArticleIdList><ArticleId IdType="pubmed">15160387</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Cell Biol. 2007 Jul;9(7):755-64</Citation><ArticleIdList><ArticleId IdType="pubmed">17576410</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Hypotheses. 2001 Jun;56(6):672-85</Citation><ArticleIdList><ArticleId IdType="pubmed">11399118</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2008 Jun;13(6):558-69</Citation><ArticleIdList><ArticleId IdType="pubmed">18317468</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2004 Nov;9(11):1007-29</Citation><ArticleIdList><ArticleId IdType="pubmed">15314610</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2009 Sep 15;25(18):2444-6</Citation><ArticleIdList><ArticleId IdType="pubmed">19628508</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Genet. 2004 Dec;20(12):640-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15522460</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2004 Mar;9(3):287-92</Citation><ArticleIdList><ArticleId IdType="pubmed">15094789</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Genet. 2009 Jun;5(6):e1000529</Citation><ArticleIdList><ArticleId IdType="pubmed">19543373</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurochem Int. 2007 Feb;50(3):461-90</Citation><ArticleIdList><ArticleId IdType="pubmed">17239488</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Hypotheses. 2004;63(3):464-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15288370</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet B Neuropsychiatr Genet. 2010 Jan 5;153B(1):86-96</Citation><ArticleIdList><ArticleId IdType="pubmed">19350560</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet C Semin Med Genet. 2003 Nov 15;123C(1):1-9</Citation><ArticleIdList><ArticleId IdType="pubmed">14601031</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2001 Mar 15;49(6):500-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11257235</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2920-5</Citation><ArticleIdList><ArticleId IdType="pubmed">16473933</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2005 Nov;37(11):1217-23</Citation><ArticleIdList><ArticleId IdType="pubmed">16244653</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatr Genet. 2009 Oct;19(5):269-72</Citation><ArticleIdList><ArticleId IdType="pubmed">19478689</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Hypotheses. 2001 Dec;57(6):679-92</Citation><ArticleIdList><ArticleId IdType="pubmed">11918426</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Hypotheses. 1999 Jan;52(1):77-83</Citation><ArticleIdList><ArticleId IdType="pubmed">10342675</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2006 Aug;94(1-3):15-33</Citation><ArticleIdList><ArticleId IdType="pubmed">16725206</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011 Apr 29;6(4):e19073</Citation><ArticleIdList><ArticleId IdType="pubmed">21559500</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2010 Jan 18;11 Suppl 1:S18</Citation><ArticleIdList><ArticleId IdType="pubmed">20122189</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Appl Genet Mol Biol. 2007;6:Article37</Citation><ArticleIdList><ArticleId IdType="pubmed">18171321</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24330276</PMID><DateCompleted><Year>2015</Year><Month>06</Month><Day>22</Day></DateCompleted><DateRevised><Year>2014</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-5618</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>7</Issue><PubDate><Year>2014</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Bipolar disorders</Title><ISOAbbreviation>Bipolar Disord</ISOAbbreviation></Journal><ArticleTitle>Reversible abnormality of the splenium in a bipolar patient with neuroleptic malignant syndrome.</ArticleTitle><Pagination><MedlinePgn>773-5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/bdi.12157</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To report reversible abnormality of the splenium in a bipolar patient with neuroleptic malignant syndrome (NMS).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We studied a 23-year-old male who received oral and parenteral neuroleptics, atypical antipsychotic agents, and mood stabilizers, as well as a course of six electroconvulsive therapy treatments, for an episode of mania. He improved. Five days after discharge on maintenance atypical antipsychotic agents and mood stabilizers, he returned with symptoms suggestive of NMS. Laboratory investigations revealed leucopenia, thrombocytopenia, and elevated creatine phosphokinase levels. Brain magnetic resonance imaging showed swelling of the splenium with centrally restricted diffusion; there was no other abnormality. He was defensively treated with antimicrobials, methylprednisolone, and bromocriptine.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Clinical recovery was complete after nine days, and the splenium lesion resolved after four further days; there were no neuropsychiatric sequelae. Nine months later, the patient remains well on maintenance lithium therapy.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This is the first report of an isolated splenial lesion reversing within days of resolution of NMS. The outcome supports the recent literature which suggests that an isolated splenial lesion does not need investigation, and that prognosis depends on the underlying disorder, and not on the presence or absence of the splenial lesion.</AbstractText><CopyrightInformation>© 2013 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Achalia</LastName><ForeName>Rashmin</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Government Medical College, Aurangabad, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andrade</LastName><ForeName>Chittaranjan</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>12</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Bipolar Disord</MedlineTA><NlmUniqueID>100883596</NlmUniqueID><ISSNLinking>1398-5647</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003337" MajorTopicYN="N">Corpus Callosum</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009459" MajorTopicYN="N">Neuroleptic Malignant Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antipsychotic agents</Keyword><Keyword MajorTopicYN="N">bipolar disorder</Keyword><Keyword MajorTopicYN="N">corpus callosum</Keyword><Keyword MajorTopicYN="N">neuroleptic malignant syndrome</Keyword><Keyword MajorTopicYN="N">neuroleptics</Keyword><Keyword MajorTopicYN="N">splenium</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>06</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>09</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24330276</ArticleId><ArticleId IdType="doi">10.1111/bdi.12157</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">12974995</PMID><DateCompleted><Year>2005</Year><Month>07</Month><Day>18</Day></DateCompleted><DateRevised><Year>2016</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1461-1457</ISSN><JournalIssue CitedMedium="Print"><Volume>6</Volume><Issue>3</Issue><PubDate><Year>2003</Year><Month>Sep</Month></PubDate></JournalIssue><Title>The international journal of neuropsychopharmacology</Title><ISOAbbreviation>Int J Neuropsychopharmacol</ISOAbbreviation></Journal><ArticleTitle>Recent placebo-controlled acute trials in bipolar depression: focus on methodology.</ArticleTitle><Pagination><MedlinePgn>285-91</MedlinePgn></Pagination><Abstract><AbstractText>The completion of three recent large-scale, double-blind controlled acute trials in bipolar I depression has improved our understanding of the management of major depressive episodes associated with bipolar disorder. In contrast to the cross-over designs used in the early studies of lithium in bipolar depression, the designs utilized in these recent studies have employed random assignment to parallel arms including the use of placebo as a monotherapy in one study. The analyses of recent studies have all been conducted on intent-to-treat data, and included two types, change from baseline analyses and responder analyses. Lamotrigine monotherapy was shown to be superior to placebo with both types of analyses on the Montgomery-Asberg Depression Rating Scale (MADRS) and the Clinical Global Impressions (CGI) scales, but not the 17-item Hamilton Depression Rating Scale (HAMD) (n=195). The percentage of patients responding to placebo as a monotherapy were 29, 26 and 37%, respectively; there were no differences in switch rates (5% vs. 5%). Paroxetine augmentation was no better than placebo augmentation overall with both types analyses on the CGI and HAMD (n=117); the MADRS was not used. In patients with lithium levels &lt; or =0.8 mequiv./l, the change from baseline analysis showed paroxetine to be superior to placebo, but responder analyses were negative; switch rates with paroxetine, imipramine, and placebo were 0, 8 and 2%. Moclobemide monotherapy was similar in efficacy to imipramine (n=156), but had a lower rate of switching (4% vs. 11%).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Muzina</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Cleveland Clinic Foundation, Cleveland, Ohio, USA. muzinad@ccf.org</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calabrese</LastName><ForeName>Joseph R</ForeName><Initials>JR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Neuropsychopharmacol</MedlineTA><NlmUniqueID>9815893</NlmUniqueID><ISSNLinking>1461-1457</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000928">Antidepressive Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010919">Placebos</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Int J Neuropsychopharmacol. 2004 Mar;7(1):105-6; author reply 107</RefSource><PMID Version="1">14731315</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000928" MajorTopicYN="N">Antidepressive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003866" MajorTopicYN="N">Depressive Disorder</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010919" MajorTopicYN="N">Placebos</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>28</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2003</Year><Month>01</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>9</Month><Day>17</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>7</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>9</Month><Day>17</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12974995</ArticleId><ArticleId IdType="doi">10.1017/S1461145703003559</ArticleId><ArticleId IdType="pii">S1461145703003559</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">8012380</PMID><DateCompleted><Year>1994</Year><Month>07</Month><Day>25</Day></DateCompleted><DateRevised><Year>2010</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1061-4036</ISSN><JournalIssue CitedMedium="Print"><Volume>6</Volume><Issue>3</Issue><PubDate><Year>1994</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Nature genetics</Title><ISOAbbreviation>Nat Genet</ISOAbbreviation></Journal><ArticleTitle>Is bipolar disorder linked to Xq28?</ArticleTitle><Pagination><MedlinePgn>224</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bocchetta</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Piccardi</LastName><ForeName>M P</ForeName><Initials>MP</Initials></Author><Author ValidYN="Y"><LastName>Del Zompo</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016420">Comment</PublicationType><PublicationType UI="D016422">Letter</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Genet</MedlineTA><NlmUniqueID>9216904</NlmUniqueID><ISSNLinking>1061-4036</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005819">Genetic Markers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nat Genet. 1994 Aug;7(4):461-2</RefSource><PMID Version="1">7951314</PMID></CommentsCorrections><CommentsCorrections RefType="CommentOn"><RefSource>Nat Genet. 1993 Jan;3(1):49-55</RefSource><PMID Version="1">8490654</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008040" MajorTopicYN="N">Genetic Linkage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005819" MajorTopicYN="N">Genetic Markers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005955" MajorTopicYN="N">Glucosephosphate Dehydrogenase Deficiency</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014960" MajorTopicYN="Y">X Chromosome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1994</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1994</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1994</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">8012380</ArticleId><ArticleId IdType="doi">10.1038/ng0394-224</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">1555823</PMID><DateCompleted><Year>1992</Year><Month>05</Month><Day>04</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-1597</ISSN><JournalIssue CitedMedium="Print"><Volume>43</Volume><Issue>3</Issue><PubDate><Year>1992</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Hospital &amp; community psychiatry</Title><ISOAbbreviation>Hosp Community Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Differences in social resources and treatment history among diagnostic groups of older adults.</ArticleTitle><Pagination><MedlinePgn>270-4</MedlinePgn></Pagination><Abstract><AbstractText>Differences in demographic and social characteristics and treatment history of 407 patients age 55 or older were examined in relation to diagnosis. Seven diagnostic groups in three mental health service programs were studied, all of which were characterized by surprisingly high rates of previous treatment (75 percent overall). Patients in the dysthymia, adjustment disorder, and V code groups appeared to be the most similar and to have the greatest psychosocial resources and fewest indicators of chronicity. Schizophrenic and bipolar patients had the least resources and most indicators of chronicity. Substance abuse patients tended to live alone, while those with major depression seemed to have more resources and later onset of their illness than schizophrenic and bipolar patients. About half of those with milder diagnoses had received prior outpatient treatment, suggesting that perhaps past treatment success leads older adults to revisit mental health services.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Speer</LastName><ForeName>D C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Department of Aging and Mental Health, University of South Florida, Tampa 33612.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hosp Community Psychiatry</MedlineTA><NlmUniqueID>0040250</NlmUniqueID><ISSNLinking>0022-1597</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="N">Activities of Daily Living</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003866" MajorTopicYN="N">Depressive Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005431" MajorTopicYN="N" Type="Geographic">Florida</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008393" MajorTopicYN="N">Marriage</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001523" MajorTopicYN="N">Mental Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000534" MajorTopicYN="Y">rehabilitation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012559" MajorTopicYN="N">Schizophrenia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012565" MajorTopicYN="N">Schizophrenic Psychology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012931" MajorTopicYN="Y">Social Environment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012944" MajorTopicYN="Y">Social Support</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1992</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1992</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1992</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1555823</ArticleId><ArticleId IdType="doi">10.1176/ps.43.3.270</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22682679</PMID><DateCompleted><Year>2013</Year><Month>04</Month><Day>24</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8384</ISSN><JournalIssue CitedMedium="Internet"><Volume>53</Volume><Issue>8</Issue><PubDate><Year>2012</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Comprehensive psychiatry</Title><ISOAbbreviation>Compr Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Age-grouped differences in bipolar mania.</ArticleTitle><Pagination><MedlinePgn>1110-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.comppsych.2012.04.011</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0010-440X(12)00075-2</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This review of published studies compares scores on individual items of mania rating scales that systematically recorded symptom severity in persons diagnosed with bipolar disorder to identify age-grouped differences.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">An extensive literature search identified item scores from mania rating scales, with a particular emphasis on baseline Young Mania Rating Scale (YMRS) item scores in published double-blind, placebo-controlled studies of bipolar I manic disorder. These baseline YMRS item scores were assessed as a proportion of the total YMRS score and compared by age group. Additional YMRS item/total scores in subjects with bipolar spectrum disorders were added to expand the analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Preadolescents with bipolar disorder had significantly higher YMRS item scores than adolescents on aggression, irritability, and motor activity. Young Mania Rating Scale baseline item scores relative to the YMRS total score revealed that adolescents diagnosed with bipolar I mania scored comparatively higher than did adults on YMRS aggression and irritability items, whereas adults with bipolar I manic disorder scored comparatively higher on the grandiosity and sexual interest items. Age-grouped findings from subjects diagnosed with bipolar I, II, and Not Otherwise Specified (NOS) disorders yielded similar age-grouped results.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In age-grouped YMRS item assessments of bipolar mania, anger dyscontrol was most prominent for youth, whereas disordered thought content was paramount for adults.</AbstractText><CopyrightInformation>Copyright © 2012 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Safer</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Departments of Psychiatry and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. dsafer@jhmi.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magno Zito</LastName><ForeName>Julie</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Safer</LastName><ForeName>Alan M</ForeName><Initials>AM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>06</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Compr Psychiatry</MedlineTA><NlmUniqueID>0372612</NlmUniqueID><ISSNLinking>0010-440X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010879">Piperazines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015363">Quinolones</NameOfSubstance></Chemical><Chemical><RegistryNumber>12794-10-4</RegistryNumber><NameOfSubstance UI="D001569">Benzodiazepines</NameOfSubstance></Chemical><Chemical><RegistryNumber>82VFR53I78</RegistryNumber><NameOfSubstance UI="D000068180">Aripiprazole</NameOfSubstance></Chemical><Chemical><RegistryNumber>N7U69T4SZR</RegistryNumber><NameOfSubstance UI="D000077152">Olanzapine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000374" MajorTopicYN="N">Aggression</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000786" MajorTopicYN="N">Anger</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014150" MajorTopicYN="N">Antipsychotic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000068180" MajorTopicYN="N">Aripiprazole</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019958" MajorTopicYN="N">Attention Deficit and Disruptive Behavior Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001569" MajorTopicYN="N">Benzodiazepines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003674" MajorTopicYN="N">Defense Mechanisms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007508" MajorTopicYN="N">Irritable Mood</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009043" MajorTopicYN="N">Motor Activity</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077152" MajorTopicYN="N">Olanzapine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010879" MajorTopicYN="N">Piperazines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011594" MajorTopicYN="N">Psychometrics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015363" MajorTopicYN="N">Quinolones</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012725" MajorTopicYN="N">Sexual Behavior</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013850" MajorTopicYN="N">Thinking</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>12</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2012</Year><Month>04</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>04</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22682679</ArticleId><ArticleId IdType="pii">S0010-440X(12)00075-2</ArticleId><ArticleId IdType="doi">10.1016/j.comppsych.2012.04.011</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">8348197</PMID><DateCompleted><Year>1993</Year><Month>09</Month><Day>16</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1040-1237</ISSN><JournalIssue CitedMedium="Print"><Volume>5</Volume><Issue>1</Issue><PubDate><Year>1993</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists</Title><ISOAbbreviation>Ann Clin Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Barbiturate anticonvulsants in refractory affective disorders.</ArticleTitle><Pagination><MedlinePgn>35-44</MedlinePgn></Pagination><Abstract><AbstractText>Despite an increasing literature demonstrating both acute and long-term positive psychopharmacological effects of both valproate and carbamazepine, phenytoin has remained a controversial intervention, and barbiturate anticonvulsants have generally received poor press with regard to psychotropic effects. In the present investigation, 27 seizure-free, affectively ill patients who received therapeutic trials of primidone and/or mephobarbital after failing on antidepressants, lithium, carbamazepine, valproate, and phenytoin were analyzed with regard to effects on illness severity and affective cycle rate over a period of as long as four years. Nine (33%) of the patients had a sustained positive therapeutic effect on affective state and/or psychotic symptoms to primidone and three (11%) had positive effects on mephobarbital after primidone failure. Four (15%) had brief positive effects that were not sustained, and the remaining 11 (41%) had no effects or negative effects to these agents. The theoretical and practical implications of this new and unexpected finding are discussed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hayes</LastName><ForeName>S G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Southern California School of Medicine.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Clin Psychiatry</MedlineTA><NlmUniqueID>8911021</NlmUniqueID><ISSNLinking>1040-1237</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000927">Anticonvulsants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001463">Barbiturates</NameOfSubstance></Chemical><Chemical><RegistryNumber>13AFD7670Q</RegistryNumber><NameOfSubstance UI="D011324">Primidone</NameOfSubstance></Chemical><Chemical><RegistryNumber>5NC67NU76B</RegistryNumber><NameOfSubstance UI="D008618">Mephobarbital</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000927" MajorTopicYN="N">Anticonvulsants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001463" MajorTopicYN="N">Barbiturates</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003866" MajorTopicYN="N">Depressive Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008618" MajorTopicYN="N">Mephobarbital</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011324" MajorTopicYN="N">Primidone</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011618" MajorTopicYN="N">Psychotic Disorders</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>118</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1993</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1993</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1993</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">8348197</ArticleId><ArticleId IdType="doi">10.3109/10401239309148922</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28503114</PMID><DateCompleted><Year>2018</Year><Month>03</Month><Day>05</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1875-6190</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>3</Issue><PubDate><Year>2017</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Current neuropharmacology</Title><ISOAbbreviation>Curr Neuropharmacol</ISOAbbreviation></Journal><ArticleTitle>Antidepressant-induced Dopamine Receptor Dysregulation: A Valid Animal Model of Manic-Depressive Illness.</ArticleTitle><Pagination><MedlinePgn>417-423</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2174/1570159X14666160715165648</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Mania seems to be associated with an increased dopamine (DA) transmission. Antidepressant treatments can induce mania in humans and potentiated DA transmission in animals, by sensitizing DA D2 receptors in the mesolimbic system. We have suggested that the sensitization of D2 receptors may be responsible of antidepressant-induced mania. This review aims to report the experimental evidence that led to the hypothesis that antidepressant-induced DA receptors dysregulation can be considered an animal model of bipolar disorder.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We reviewed papers reporting preclinical and clinical studies on the role of DA in the mechanism of action of antidepressant treatments and in the patho-physiology of mood disorders.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A number of preclinical and clinical evidence suggests that mania could be associated with an increased DA activity, while a reduced function of this neurotransmission might underlie depression. Chronic treatment with imipramine induces a sensitization of DA D2 receptors in the mesolimbic system, followed, after drug discontinuation, by a reduced sensitivity associated with an increased immobility time in forced swimming test of depression (FST). Blockade of glutamate NMDA receptors by memantine administration prevents the imipramine effect on DA receptors sensitivity and on the FST.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We suggest that chronic treatment with antidepressants induces a behavioural syndrome that mimics mania (the sensitization of DA receptors), followed by depression (desensitization of DA receptors and increased immobility time in the FST), i.e. an animal model of bipolar disorder. Moreover the observation that memantine prevents the "bipolar-like" behavior, suggests that the drug may have an antimanic and mood stabilizing effect. Preliminary clinical observations support this hypothesis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Demontis</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serra</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of General Psychology, University of Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serra</LastName><ForeName>Gino</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United Arab Emirates</Country><MedlineTA>Curr Neuropharmacol</MedlineTA><NlmUniqueID>101157239</NlmUniqueID><ISSNLinking>1570-159X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000928">Antidepressive Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011954">Receptors, Dopamine</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C564108">Major Affective Disorder 2</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000928" MajorTopicYN="N">Antidepressive Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040181" MajorTopicYN="N">Genetic Diseases, X-Linked</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011954" MajorTopicYN="N">Receptors, Dopamine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Animal models</Keyword><Keyword MajorTopicYN="Y">bipolar disorder</Keyword><Keyword MajorTopicYN="Y">depression</Keyword><Keyword MajorTopicYN="Y">mania</Keyword><Keyword MajorTopicYN="Y">memantine</Keyword><Keyword MajorTopicYN="Y">mood stabilizer</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>01</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>03</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>05</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28503114</ArticleId><ArticleId IdType="doi">10.2174/1570159X14666160715165648</ArticleId><ArticleId IdType="pii">CN-15-417</ArticleId><ArticleId IdType="pmc">PMC5405612</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Psychopharmacology (Berl). 2002 Jun;161(4):370-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12073164</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Toxicol. 1992;71 Suppl 1:72-85</Citation><ArticleIdList><ArticleId IdType="pubmed">1480562</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2009 Dec;11(8):787-806</Citation><ArticleIdList><ArticleId IdType="pubmed">19922550</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Pharmacol. 1997 Mar 19;322(2-3):123-7</Citation><ArticleIdList><ArticleId IdType="pubmed">9098678</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Psychol. 1989;40:191-225</Citation><ArticleIdList><ArticleId IdType="pubmed">2648975</ArticleId></ArticleIdList></Reference><Reference><Citation>Prog Drug Res. 1998;50:155-92</Citation><ArticleIdList><ArticleId IdType="pubmed">9670779</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Res Bull. 2000 Apr;51(6):485-92</Citation><ArticleIdList><ArticleId IdType="pubmed">10758338</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Neuropsychopharmacol. 1999 Dec;9(6):507-14</Citation><ArticleIdList><ArticleId IdType="pubmed">10625119</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 1983 May-Jun;24(3):249-58</Citation><ArticleIdList><ArticleId IdType="pubmed">6872538</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cereb Blood Flow Metab. 1997 Mar;17 (3):331-42</Citation><ArticleIdList><ArticleId IdType="pubmed">9119906</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychopharmacol. 2013 Oct;27(10):869-77</Citation><ArticleIdList><ArticleId IdType="pubmed">23904408</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Res. 1983 Dec;287(3):211-24</Citation><ArticleIdList><ArticleId IdType="pubmed">6140979</ArticleId></ArticleIdList></Reference><Reference><Citation>Ther Adv Psychopharmacol. 2014 Feb;4(1):53-5</Citation><ArticleIdList><ArticleId IdType="pubmed">24490033</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Pharmacol. 1981 Jun 10;72(1):131-5</Citation><ArticleIdList><ArticleId IdType="pubmed">7262191</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Res. 1983 Dec;287(3):237-46</Citation><ArticleIdList><ArticleId IdType="pubmed">6318882</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcohol Clin Exp Res. 2000 Mar;24(3):285-90</Citation><ArticleIdList><ArticleId IdType="pubmed">10776664</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1956 Jan;112(7):494-501</Citation><ArticleIdList><ArticleId IdType="pubmed">13283130</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuropsychiatry Clin Neurosci. 2005 Summer;17(3):310-23</Citation><ArticleIdList><ArticleId IdType="pubmed">16179652</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2015 Jan;76(1):e91-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25650685</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Pharmacol. 1984 Oct 15;105(3-4):257-63</Citation><ArticleIdList><ArticleId IdType="pubmed">6510470</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Pharmacol. 2015 Apr 5;752:49-54</Citation><ArticleIdList><ArticleId IdType="pubmed">25661848</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 1993;110(1-2):152-8</Citation><ArticleIdList><ArticleId IdType="pubmed">7870876</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroscience. 2016 May 3;321:163-88</Citation><ArticleIdList><ArticleId IdType="pubmed">26314632</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychopharmacol. 1995 Jan;9(3):207-13</Citation><ArticleIdList><ArticleId IdType="pubmed">22297759</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Brain Res. 2004 May 5;151(1-2):201-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15084436</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Pharmacol. 2001 Mar 23;416(1-2):107-11</Citation><ArticleIdList><ArticleId IdType="pubmed">11282119</ArticleId></ArticleIdList></Reference><Reference><Citation>Synapse. 1994 Feb;16(2):137-47</Citation><ArticleIdList><ArticleId IdType="pubmed">8197575</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2007 Mar;64(3):327-37</Citation><ArticleIdList><ArticleId IdType="pubmed">17339521</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Rev. 1987 Oct;94(4):469-92</Citation><ArticleIdList><ArticleId IdType="pubmed">3317472</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Res Commun. 1980 Jun;12(6):619-24</Citation><ArticleIdList><ArticleId IdType="pubmed">7403234</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmakopsychiatr Neuropsychopharmakol. 1980 Jul;13(4):156-67</Citation><ArticleIdList><ArticleId IdType="pubmed">6108577</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 2005 Jul 13;25(28):6651-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16014726</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 1994 Aug;115(4):454-62</Citation><ArticleIdList><ArticleId IdType="pubmed">7871089</ArticleId></ArticleIdList></Reference><Reference><Citation>Riv Psichiatr. 2014 Jul-Aug;49(4):192-4</Citation><ArticleIdList><ArticleId IdType="pubmed">25174697</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Pharmacol. 2003 Jan 1;458(1-2):129-34</Citation><ArticleIdList><ArticleId IdType="pubmed">12498916</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychopharmacol. 2013 Oct;33(5):715-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24002206</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Clin Pharmacol. 2005 Apr;59(4):475-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15801943</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatr Pract. 2014 May;20(3):232-6</Citation><ArticleIdList><ArticleId IdType="pubmed">24847998</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2005 May;86(1):37-45</Citation><ArticleIdList><ArticleId IdType="pubmed">15820269</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Alcohol Depend. 1995 Feb;37(2):95-100</Citation><ArticleIdList><ArticleId IdType="pubmed">7758408</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1995 Jun;52(6):471-7</Citation><ArticleIdList><ArticleId IdType="pubmed">7771917</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomed Res Int. 2013;2013:158746</Citation><ArticleIdList><ArticleId IdType="pubmed">24286073</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcohol Clin Exp Res. 2003 Oct;27(10):1535-47</Citation><ArticleIdList><ArticleId IdType="pubmed">14574223</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Pharmacopsychiatry. 1981;16(2):119-23</Citation><ArticleIdList><ArticleId IdType="pubmed">7333788</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Neuropsychopharmacol. 2013 Jul;23(7):697-708</Citation><ArticleIdList><ArticleId IdType="pubmed">22743048</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Pharmacol. 2000 Sep 29;405(1-3):365-73</Citation><ArticleIdList><ArticleId IdType="pubmed">11033341</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1958 Nov;115(5):459-64</Citation><ArticleIdList><ArticleId IdType="pubmed">13583250</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 2000 Aug;151(2-3):184-91</Citation><ArticleIdList><ArticleId IdType="pubmed">10972464</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Pharmacol. 1997 Dec 11;340(2-3):121-32</Citation><ArticleIdList><ArticleId IdType="pubmed">9537806</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Res. 1990 Sep 17;527(2):234-43</Citation><ArticleIdList><ArticleId IdType="pubmed">1979237</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcohol Alcohol. 1999 May-Jun;34(3):283-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10414602</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 1992 Mar-Apr;33(2):115-20</Citation><ArticleIdList><ArticleId IdType="pubmed">1347497</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann N Y Acad Sci. 2002 Jun;965:233-46</Citation><ArticleIdList><ArticleId IdType="pubmed">12105099</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Pharmacol. 1980 Jun 13;64(2-3):203-4</Citation><ArticleIdList><ArticleId IdType="pubmed">7398766</ArticleId></ArticleIdList></Reference><Reference><Citation>Naunyn Schmiedebergs Arch Pharmacol. 2004 Feb;369(2):228-31</Citation><ArticleIdList><ArticleId IdType="pubmed">14673514</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Neurodegener. 2013 Apr 26;8:14</Citation><ArticleIdList><ArticleId IdType="pubmed">23621954</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Pharmacol. 1994 Sep 1;262(1-2):107-11</Citation><ArticleIdList><ArticleId IdType="pubmed">7813561</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 1988;94(4):545-50</Citation><ArticleIdList><ArticleId IdType="pubmed">3131802</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Res. 2006 Apr 26;1085(1):77-86</Citation><ArticleIdList><ArticleId IdType="pubmed">16574078</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pharm Sci. 1972 Jun;61(6):821-37</Citation><ArticleIdList><ArticleId IdType="pubmed">4558257</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurotox Res. 2002 Jun;4(4):373-91</Citation><ArticleIdList><ArticleId IdType="pubmed">12829426</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Geriatr Psychiatry. 1999 Spring;7(2):110-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10322237</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkinsonism Relat Disord. 2014 Apr;20(4):421-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24467817</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand Suppl. 2007;(434):41-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17688462</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropharmacology. 2009 Jan;56(1):47-55</Citation><ArticleIdList><ArticleId IdType="pubmed">18789340</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2010 May;12(3):348-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20565444</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychopharmacol. 2012 Jun;32(3):428-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22561478</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2010 Jun;121(6):404-14</Citation><ArticleIdList><ArticleId IdType="pubmed">19958306</ArticleId></ArticleIdList></Reference><Reference><Citation>Life Sci. 1979 Jan 29;24(5):383-94</Citation><ArticleIdList><ArticleId IdType="pubmed">372718</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Pharmacol. 2004 May 10;492(1):61-3</Citation><ArticleIdList><ArticleId IdType="pubmed">15145707</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Ther. 1987;35(1-2):227-63</Citation><ArticleIdList><ArticleId IdType="pubmed">3321101</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Biochem Behav. 2000 Oct;67(2):241-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11124387</ArticleId></ArticleIdList></Reference><Reference><Citation>Synapse. 1997 Mar;25(3):309-11</Citation><ArticleIdList><ArticleId IdType="pubmed">9068130</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 1987;93(3):358-64</Citation><ArticleIdList><ArticleId IdType="pubmed">3124165</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Pharmacol. 2000 Apr 28;395(2):157-60</Citation><ArticleIdList><ArticleId IdType="pubmed">10794822</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 1994 Mar;14(3 Pt 2):1735-45</Citation><ArticleIdList><ArticleId IdType="pubmed">8126567</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1981 Nov 6;214(4521):683-5</Citation><ArticleIdList><ArticleId IdType="pubmed">7197394</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Res. 1983 Dec;287(3):225-36</Citation><ArticleIdList><ArticleId IdType="pubmed">6362771</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1980 Oct 2;287(5781):451-4</Citation><ArticleIdList><ArticleId IdType="pubmed">7432470</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Biochem Behav. 2006 Jul;84(3):436-52</Citation><ArticleIdList><ArticleId IdType="pubmed">16844210</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Biobehav Rev. 1992 Winter;16(4):525-34</Citation><ArticleIdList><ArticleId IdType="pubmed">1480349</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Pharmacol. 1997 Jul 2;330(1):11-4</Citation><ArticleIdList><ArticleId IdType="pubmed">9228409</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Neuropharmacol. 2009 Jul-Aug;32(4):199-204</Citation><ArticleIdList><ArticleId IdType="pubmed">19620854</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Pharmacol. 2006 Feb;17(1):1-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16377958</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2014 Feb;155:247-54</Citation><ArticleIdList><ArticleId IdType="pubmed">24287168</ArticleId></ArticleIdList></Reference><Reference><Citation>Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 3;43:89-95</Citation><ArticleIdList><ArticleId IdType="pubmed">23268190</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2007 Jan 15;61(2):145-53</Citation><ArticleIdList><ArticleId IdType="pubmed">16934770</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Res Bull. 1996;40(3):201-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8736582</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Biochem Behav. 1994 Jul;48(3):587-91</Citation><ArticleIdList><ArticleId IdType="pubmed">7938110</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neural Transm Gen Sect. 1991;84(3):237-40</Citation><ArticleIdList><ArticleId IdType="pubmed">1652984</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Pharmacol. 2007 Feb;7(1):69-76</Citation><ArticleIdList><ArticleId IdType="pubmed">17174602</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Pharmacol. 1982 Aug 27;82(3-4):173-8</Citation><ArticleIdList><ArticleId IdType="pubmed">6813129</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurotox Res. 2008 Oct;14(2-3):169-83</Citation><ArticleIdList><ArticleId IdType="pubmed">19073424</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 2005 Apr;179(1):230-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15517195</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 2000 Aug;151(2-3):175-83</Citation><ArticleIdList><ArticleId IdType="pubmed">10972463</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2012 Jan;136(1-2):163-6</Citation><ArticleIdList><ArticleId IdType="pubmed">22030128</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Pharmacol. 1992 Dec 2;224(2-3):199-202</Citation><ArticleIdList><ArticleId IdType="pubmed">1361447</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Biochem Psychopharmacol. 1995;49:43-66</Citation><ArticleIdList><ArticleId IdType="pubmed">7653334</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Clin Psychopharmacol. 1997 Jul;12 Suppl 3:S7-14</Citation><ArticleIdList><ArticleId IdType="pubmed">9347387</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Pharmacol. 1981 Sep 11;74(2-3):195-206</Citation><ArticleIdList><ArticleId IdType="pubmed">7198991</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2008 Mar;165(3):300-2</Citation><ArticleIdList><ArticleId IdType="pubmed">18316425</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Pharmacol. 1997 Nov;8(6-7):607-18</Citation><ArticleIdList><ArticleId IdType="pubmed">9832973</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Pharmacol. 2006 Mar 27;535(1-3):208-11</Citation><ArticleIdList><ArticleId IdType="pubmed">16533507</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropharmacology. 2004;47 Suppl 1:227-41</Citation><ArticleIdList><ArticleId IdType="pubmed">15464140</ArticleId></ArticleIdList></Reference><Reference><Citation>Life Sci. 1979 Jul 30;25(5):415-23</Citation><ArticleIdList><ArticleId IdType="pubmed">481130</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 1981;73(2):194-6</Citation><ArticleIdList><ArticleId IdType="pubmed">6785815</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">7573584</PMID><DateCompleted><Year>1995</Year><Month>10</Month><Day>31</Day></DateCompleted><DateRevised><Year>2006</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0002-953X</ISSN><JournalIssue CitedMedium="Print"><Volume>152</Volume><Issue>10</Issue><PubDate><Year>1995</Year><Month>Oct</Month></PubDate></JournalIssue><Title>The American journal of psychiatry</Title><ISOAbbreviation>Am J Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Negative, psychoticism, and disorganized dimensions in patients with familial schizophrenia or bipolar disorder: continuity and discontinuity between the major psychoses.</ArticleTitle><Pagination><MedlinePgn>1458-63</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aimed to answer the following questions: 1) Can we reliably measure the psychopathologic dimensions of schizophrenia by using a lifetime frame and by rating acute and interepisode periods separately? 2) Can we reproduce in subjects with familial schizophrenia the characteristic three-factor structure of schizophrenic symptoms that has been found previously in general groups of schizophrenic patients? 3) Is the factor structure also present in familial bipolar disorder?</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">Lifetime measures of psychotic symptoms were taken through a slightly modified version of the Comprehensive Assessment of Symptoms and History for 138 patients with highly familial DSM-III-R schizophrenia (N = 51), bipolar disorder (N = 44), or spectrum disorders (N = 43). Symptoms were rated separately in the acute episodes and in the stabilized interepisode intervals across the patients' lives.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A satisfactory level of reliability was obtained. In this highly familial study group, the positive/negative factorial distinction was replicated, as was a three-factor model similar to that observed in prior general groups of schizophrenic patients. These factors were also present in bipolar affective disorder. The negative, psychoticism, and disorganized factor model applied more to the acute phase of illness than to the stabilized state.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These findings offer an empirical basis for testing biological or genetic variables in relation to negative/positive symptom dimensions, rather than diagnoses. Observations of a shared structure for schizophrenia and bipolar disorder suggest some continuity in the causes of these disorders.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maziade</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre de recherche, Université Laval Robert-Giffard, Québec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roy</LastName><ForeName>M A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Martinez</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Cliche</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Fournier</LastName><ForeName>J P</ForeName><Initials>JP</Initials></Author><Author ValidYN="Y"><LastName>Garneau</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Nicole</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Montgrain</LastName><ForeName>N</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Dion</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Ponton</LastName><ForeName>A M</ForeName><Initials>AM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Psychiatry</MedlineTA><NlmUniqueID>0370512</NlmUniqueID><ISSNLinking>0002-953X</ISSNLinking></MedlineJournalInfo><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Am J Psychiatry. 1997 Jan;154(1):132-4</RefSource><PMID Version="1">8988980</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017668" MajorTopicYN="N">Age of Onset</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016002" MajorTopicYN="N">Discriminant Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005163" MajorTopicYN="N">Factor Analysis, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005190" MajorTopicYN="N">Family</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008960" MajorTopicYN="N">Models, Psychological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012559" MajorTopicYN="N">Schizophrenia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012565" MajorTopicYN="Y">Schizophrenic Psychology</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1995</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1995</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1995</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">7573584</ArticleId><ArticleId IdType="doi">10.1176/ajp.152.10.1458</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">28826088</PMID><DateCompleted><Year>2018</Year><Month>04</Month><Day>23</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-2517</ISSN><JournalIssue CitedMedium="Internet"><Volume>225</Volume><PubDate><Year>2018</Year><Month>01</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of affective disorders</Title><ISOAbbreviation>J Affect Disord</ISOAbbreviation></Journal><ArticleTitle>Predictors of recurrence during long-term treatment of bipolar I and II disorders. A 4 year prospective naturalistic study.</ArticleTitle><Pagination><MedlinePgn>123-128</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0165-0327(17)30710-3</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jad.2017.08.013</ELocationID><Abstract><AbstractText Label="BACKGROUND">Despite the large number of treatments available for bipolar disorder (BD), more than one half of patients have a recurrence within 2 years, and over 90% experience at least one additional affective episode during their lifetime.</AbstractText><AbstractText Label="METHODS">The aim of this study was to test the impact of a number of demographic and clinical features on the risk to recurrence in a real- word representative sample of 266 outpatients with BD-I or II treated in a naturalistic setting during a 4-years-follow-up period.</AbstractText><AbstractText Label="RESULTS">We found that the number of episodes per year after study entry, compared to the number of episodes per year before study entry,significantly decreased and that about one third of patients had no recurrences during the observation period. The length of follow-up and the number of previous episodes, mainly depressive, predicted the risk of recurrence, while female gender, higher age at intake, and a higher frequency of past mixed episodes predicted a higher frequency of recurrences.</AbstractText><AbstractText Label="LIMITATIONS">The study had some limitations to consider: i.e. the risk of poor reliability of information on the previous course of illness or the naturalistic treatment during the follow-up.</AbstractText><AbstractText Label="CONCLUSIONS">Our study suggests that (a) an evidence-based long-term treatment, with regular follow-up visits could improve the course of disease and prognosis; (b) clinicians should carefully consider the presence of a high number of mixed episodes, to provide more targeted treatment strategies; (c) an appropriate use of antidepressants in selected patients did not worsen the course of illness.</AbstractText><CopyrightInformation>Copyright © 2017 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tundo</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Istituto di Psicopatologia, Rome, Italy. Electronic address: tundo@istitutodipsicopatologia.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Musetti</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benedetti</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Massimetti</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>ASST, Bergamo ovest, Bergamo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pergentini</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cambiali</LastName><ForeName>Erika</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dell'Osso</LastName><ForeName>Liliana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>08</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Affect Disord</MedlineTA><NlmUniqueID>7906073</NlmUniqueID><ISSNLinking>0165-0327</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000928">Antidepressive Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000928" MajorTopicYN="N">Antidepressive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008134" MajorTopicYN="Y">Long-Term Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063127" MajorTopicYN="N">Secondary Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Bipolar disorder I</Keyword><Keyword MajorTopicYN="Y">Bipolar disorder II</Keyword><Keyword MajorTopicYN="Y">Mixed states</Keyword><Keyword MajorTopicYN="Y">Predictors</Keyword><Keyword MajorTopicYN="Y">Recurrences</Keyword><Keyword MajorTopicYN="Y">Relapse</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>04</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>06</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>08</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28826088</ArticleId><ArticleId IdType="pii">S0165-0327(17)30710-3</ArticleId><ArticleId IdType="doi">10.1016/j.jad.2017.08.013</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31228639</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>30</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-4216</ISSN><JournalIssue CitedMedium="Internet"><Volume>94</Volume><PubDate><Year>2019</Year><Month>08</Month><Day>30</Day></PubDate></JournalIssue><Title>Progress in neuro-psychopharmacology &amp; biological psychiatry</Title><ISOAbbreviation>Prog Neuropsychopharmacol Biol Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Social cognition in psychosis: Predictors and effects of META-cognitive training.</ArticleTitle><Pagination><MedlinePgn>109672</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0278-5846(19)30181-2</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.pnpbp.2019.109672</ELocationID><Abstract><AbstractText>Social cognition deficits are found in schizophrenia and bipolar disorder, but its neural underpinnings are poorly understood. Given the complexity of psychological functions underlying this kind of cognition, we hypothesized that alterations in global structural connectivity could contribute to those deficits. To test this hypothesis, we studied a group of schizophrenia and bipolar patients with connectomics based on diffusion magnetic resonance imaging and assessments of general and social cognition. The latter was assessed using the Mayer, Salovey and Caruso Emotional Intelligence Test (MSCEIT) for emotional intelligence and the Spanish Group for Schizophrenia Treatment Optimization (Grupo Español para la OPtimización del Tratamiento de la Esquizofrenia, GEOPTE) test for behavioral aspects of social cognition. Graph theory applied to fractional anisotropy for the connections among cortical regions was used to obtain the small-world (SW) index of the structural connectivity network. In addition, we assessed the possibility of predicting the response of social cognition deficits to Meta-cognitive Training based on their possible underpinnings in a subgroup of patients. Patients showed lower scores in emotional intelligence and behavioral social cognition. MSCEIT scores were associated with SW index and working memory, and GEOPTE scores were related to verbal memory. Improvement in social cognition after Meta-cognitive Training was associated with lower scores of the social cognition in the baseline, according to the GEOPTE scale. Our findings support structural connectivity as one of the factors underlying emotional intelligence in schizophrenia, and the use of Meta-cognitive Training to improve social cognition in patients with larger deficits.</AbstractText><CopyrightInformation>Copyright © 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alvarez-Astorga</LastName><ForeName>Aldara</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Psychiatry Service, Clinical University Hospital of Valladolid, Valladolid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sotelo</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Psychiatry Service, Clinical University Hospital of Valladolid, Valladolid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lubeiro</LastName><ForeName>Alba</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Psychiatry Department, School of Medicine, University of Valladolid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Luis</LastName><ForeName>Rodrigo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Imaging Processing Laboratory, University of Valladolid, Valladolid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomez-Pilar</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Biomedical Engineering Group, University of Valladolid, Valladolid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Becoechea</LastName><ForeName>Begoña</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Psychiatry Service, Clinical University Hospital of Valladolid, Valladolid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molina</LastName><ForeName>Vicente</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Psychiatry Service, Clinical University Hospital of Valladolid, Valladolid, Spain; Psychiatry Department, School of Medicine, University of Valladolid, Spain. Electronic address: vicente.molina@uva.es.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>06</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Prog Neuropsychopharmacol Biol Psychiatry</MedlineTA><NlmUniqueID>8211617</NlmUniqueID><ISSNLinking>0278-5846</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016880" MajorTopicYN="N">Anisotropy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002540" MajorTopicYN="N">Cerebral Cortex</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="Y">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056324" MajorTopicYN="N">Diffusion Tensor Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056348" MajorTopicYN="N">Emotional Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067489" MajorTopicYN="Y">Metacognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059906" MajorTopicYN="N">Neuroimaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011615" MajorTopicYN="N">Psychotherapy, Group</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012559" MajorTopicYN="N">Schizophrenia</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012565" MajorTopicYN="Y">Schizophrenic Psychology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012919" MajorTopicYN="Y">Social Behavior</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Fractional anisotropy</Keyword><Keyword MajorTopicYN="Y">Metacognitive training</Keyword><Keyword MajorTopicYN="Y">Prefrontal cortex</Keyword><Keyword MajorTopicYN="Y">Schizophrenia</Keyword><Keyword MajorTopicYN="Y">Social cognition</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>03</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>06</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>06</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31228639</ArticleId><ArticleId IdType="pii">S0278-5846(19)30181-2</ArticleId><ArticleId IdType="doi">10.1016/j.pnpbp.2019.109672</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21099378</PMID><DateCompleted><Year>2011</Year><Month>03</Month><Day>16</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1533-4112</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>4</Issue><PubDate><Year>2010</Year><Month>Dec</Month></PubDate></JournalIssue><Title>The journal of ECT</Title><ISOAbbreviation>J ECT</ISOAbbreviation></Journal><ArticleTitle>Electroconvulsive therapy in a patient with Klippel-Trenaunay-Weber syndrome complicated by partial popliteal vein thrombosis.</ArticleTitle><Pagination><MedlinePgn>332</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/YCT.0b013e3181cfc8d1</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Amritwar</LastName><ForeName>Ameya</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nilesh</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Andrade</LastName><ForeName>Chittaranjan</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J ECT</MedlineTA><NlmUniqueID>9808943</NlmUniqueID><ISSNLinking>1095-0680</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="N">Anesthesia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000075202" MajorTopicYN="N">Contraindications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004351" MajorTopicYN="N">Drug Resistance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004565" MajorTopicYN="Y">Electroconvulsive Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007715" MajorTopicYN="N">Klippel-Trenaunay-Weber Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014463" MajorTopicYN="N">Ultrasonography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>11</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21099378</ArticleId><ArticleId IdType="doi">10.1097/YCT.0b013e3181cfc8d1</ArticleId><ArticleId IdType="pii">00124509-201012000-00020</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">1961868</PMID><DateCompleted><Year>1992</Year><Month>01</Month><Day>07</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0033-3182</ISSN><JournalIssue CitedMedium="Print"><Volume>32</Volume><Issue>4</Issue><PubDate><Year>1991</Year><Season>Fall</Season></PubDate></JournalIssue><Title>Psychosomatics</Title><ISOAbbreviation>Psychosomatics</ISOAbbreviation></Journal><ArticleTitle>Depersonalization syndrome induced by fluoxetine.</ArticleTitle><Pagination><MedlinePgn>468-9</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Black</LastName><ForeName>D W</ForeName><Initials>DW</Initials></Author><Author ValidYN="Y"><LastName>Wojcieszek</LastName><ForeName>J</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Psychosomatics</MedlineTA><NlmUniqueID>0376506</NlmUniqueID><ISSNLinking>0033-3182</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>01K63SUP8D</RegistryNumber><NameOfSubstance UI="D005473">Fluoxetine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Psychosomatics. 1992 Summer;33(3):361-2</RefSource><PMID Version="1">1410214</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001143" MajorTopicYN="N">Arousal</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003861" MajorTopicYN="N">Depersonalization</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005473" MajorTopicYN="N">Fluoxetine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1991</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1991</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1991</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1961868</ArticleId><ArticleId IdType="pii">S0033-3182(91)72058-6</ArticleId><ArticleId IdType="doi">10.1016/S0033-3182(91)72058-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">7262950</PMID><DateCompleted><Year>1981</Year><Month>10</Month><Day>25</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0971-5916</ISSN><JournalIssue CitedMedium="Print"><Volume>73</Volume><PubDate><Year>1981</Year><Month>May</Month></PubDate></JournalIssue><Title>The Indian journal of medical research</Title><ISOAbbreviation>Indian J Med Res</ISOAbbreviation></Journal><ArticleTitle>Lithium excretion and therapeutic response in mania.</ArticleTitle><Pagination><MedlinePgn>768-71</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sampath</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Channabasavanna</LastName><ForeName>S M</ForeName><Initials>SM</Initials></Author><Author ValidYN="Y"><LastName>Rao</LastName><ForeName>B S</ForeName><Initials>BS</Initials></Author><Author ValidYN="Y"><LastName>Subhash</LastName><ForeName>M N</ForeName><Initials>MN</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Indian J Med Res</MedlineTA><NlmUniqueID>0374701</NlmUniqueID><ISSNLinking>0971-5916</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9FN79X2M3F</RegistryNumber><NameOfSubstance UI="D008094">Lithium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000341" MajorTopicYN="N">Affective Disorders, Psychotic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008094" MajorTopicYN="N">Lithium</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000652" MajorTopicYN="Y">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1981</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1981</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1981</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">7262950</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">119166</PMID><DateCompleted><Year>1980</Year><Month>04</Month><Day>25</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0028-2804</ISSN><JournalIssue CitedMedium="Print"><Volume>50</Volume><Issue>8</Issue><PubDate><Year>1979</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Der Nervenarzt</Title><ISOAbbreviation>Nervenarzt</ISOAbbreviation></Journal><ArticleTitle>[Lithium maintenance therapy in affective and in schizoaffective psychosis (author's transl)].</ArticleTitle><Pagination><MedlinePgn>524-6</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tress</LastName><ForeName>W</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Haag</LastName><ForeName>H</ForeName><Initials>H</Initials></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Vergleichende Erfahrungen mit der rezidivprophylaktischen Lithium-Langzeitmedikation bei schizoaffektiven Psychosen.</VernacularTitle></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Nervenarzt</MedlineTA><NlmUniqueID>0400773</NlmUniqueID><ISSNLinking>0028-2804</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9FN79X2M3F</RegistryNumber><NameOfSubstance UI="D008094">Lithium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000342" MajorTopicYN="N">Affective Symptoms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008094" MajorTopicYN="N">Lithium</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008134" MajorTopicYN="N">Long-Term Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011618" MajorTopicYN="N">Psychotic Disorders</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012559" MajorTopicYN="N">Schizophrenia</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1979</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1979</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1979</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">119166</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29553307</PMID><DateCompleted><Year>2018</Year><Month>11</Month><Day>09</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1461-7471</ISSN><JournalIssue CitedMedium="Internet"><Volume>55</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>06</Month></PubDate></JournalIssue><Title>Transcultural psychiatry</Title><ISOAbbreviation>Transcult Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Angry characters and frightened souls: Patients and family explanatory models of bipolar disorder in Taiwan.</ArticleTitle><Pagination><MedlinePgn>317-338</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1363461518761924</ELocationID><Abstract><AbstractText>Bipolar disorder (BD) affects a significant proportion of Taiwanese individuals (Weissman et al., 1996; Yang, Yeh, &amp; Hwu, 2012). Psychotropic medications are typically the mainstay of treatment for BD, and there is an abundance of international research on biological etiology and medication options. However, there is comparatively little research on psychosocial aspects of BD, including how it is understood and managed within families. As culture provides the context in which psychiatric disease is managed, there is a need to identify distinct Chinese psychosocial perspectives that might shed light on intervention options. This research explored how Taiwanese patients and family members comprehend and cope with BD. A sample of 42 participants, including 20 Taiwanese patients diagnosed with Bipolar Disorder-I (BD-I) for at least 4 years, and 22 family members, participated in separate interviews on explanatory models of illness. Qualitative thematic analysis focused on features that were distinct from those in current Western research literature. Five themes were identified that represented Taiwanese conceptualizations of BD, notions of etiology, views regarding treatment, and the difficulties in managing the disorder. Participants used Chinese language terms and descriptions of BD that reflected greater concerns about irritability, anger, and family conflict than about other symptoms, and participants also emphasized characterological trait descriptions of the condition. Their responses reflected their acceptance of lifelong family responsibility for caretaking, clashing beliefs regarding biomedical versus traditional Chinese medical and spiritual models of etiology and cure, profound concerns about the effects of psychiatric medication on the liver and kidney systems, and a focus on stress rather than genetic or biological models of etiology.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lan</LastName><ForeName>Yi-Feng Carol</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>California School of Professional Psychology of Alliant International University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zelman</LastName><ForeName>Diane C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>California School of Professional Psychology of Alliant International University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chao</LastName><ForeName>Wen-Tao</ForeName><Initials>WT</Initials><AffiliationInfo><Affiliation>California School of Professional Psychology of Alliant International University.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Transcult Psychiatry</MedlineTA><NlmUniqueID>9708119</NlmUniqueID><ISSNLinking>1363-4615</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="Y">ethnology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005190" MajorTopicYN="N">Family</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="Y">ethnology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007722" MajorTopicYN="N">Health Knowledge, Attitudes, Practice</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="Y">ethnology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013624" MajorTopicYN="N">Taiwan</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Chinese</Keyword><Keyword MajorTopicYN="Y">East Asia</Keyword><Keyword MajorTopicYN="Y">Taiwan</Keyword><Keyword MajorTopicYN="Y">bipolar disorder</Keyword><Keyword MajorTopicYN="Y">family</Keyword><Keyword MajorTopicYN="Y">psychosocial</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29553307</ArticleId><ArticleId IdType="doi">10.1177/1363461518761924</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">31969278</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>05</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-2517</ISSN><JournalIssue CitedMedium="Internet"><Volume>263</Volume><PubDate><Year>2020</Year><Month>02</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of affective disorders</Title><ISOAbbreviation>J Affect Disord</ISOAbbreviation></Journal><ArticleTitle>Risk of bipolar disorder in patients with polycystic ovary syndrome: A nationwide population-based cohort study.</ArticleTitle><Pagination><MedlinePgn>458-462</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0165-0327(19)32721-1</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jad.2019.12.007</ELocationID><Abstract><AbstractText Label="BACKGROUND">The study investigated the risk of newly developed bipolar disorder (BD) in patients with polycystic ovary syndrome (PCOS) and examined the relationship between PCOS treatment (hormone therapy (clomiphene or cyproterone) or metformin) and risk of BD development.</AbstractText><AbstractText Label="METHODS">In all, 7175 PCOS patients and 28,697 non-PCOS controls matched by age, index year, and Charlson Comorbidity Index (CCI) score were included between 2000 and 2012, then followed until the end of 2013. Participants newly diagnosed as BD by board-certified psychiatrists were defined as incidents. Cox regression analysis was used to calculate the hazard ratio (HR) with 95% confidence interval (CI) of the BD incidence rate between two studied groups.</AbstractText><AbstractText Label="RESULTS">PCOS patients had a significantly increased risk of developing BD compared to unaffected controls after adjusting for age, CCI score, and different treatment options (1.05 vs. 0.12 per 1,000 person-years, HR: 8.29, 95% CI: 4.65-14.7). Also, the use of metformin in PCOS patients showed a significantly reduced risk of developing BD compared to non-users after adjusting for the above-mentioned variables (HR: 0.36, 95% CI: 0.16-0.81). Although hormone therapy in PCOS patients showed a lower incidence rate of BD development compared to non-users, the risk estimate was not statistically significant (HR: 0.68, 95% CI: 0.35-1.32).</AbstractText><AbstractText Label="LIMITATIONS">This study didn't assess the PCOS severity, which reduced the chances of showing the effects of PCOS severity on BD development.</AbstractText><AbstractText Label="CONCLUSION">This study shows PCOS patients have an increased risk of developing BD, and the use of metformin may reduce its risk.</AbstractText><CopyrightInformation>Copyright © 2019 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Shih-Fen</ForeName><Initials>SF</Initials><AffiliationInfo><Affiliation>Center of Medical Genetics, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yu-Cih</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Management Office for Health Data, China Medical University Hospital, and College of Medicine, China Medical University, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Chung-Y</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Graduate Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Yu-Chih</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, and School of Medicine, Tzu Chi University, 707, Sec. 3, Chung Yang Rd, Hualien 970, Taiwan. Electronic address: shengmp@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Affect Disord</MedlineTA><NlmUniqueID>7906073</NlmUniqueID><ISSNLinking>0165-0327</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>1HRS458QU2</RegistryNumber><NameOfSubstance UI="D002996">Clomiphene</NameOfSubstance></Chemical><Chemical><RegistryNumber>9100L32L2N</RegistryNumber><NameOfSubstance UI="D008687">Metformin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Affect Disord. 2020 Jun 1;270:83-84</RefSource><PMID Version="1">32275224</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Affect Disord. 2020 Jul 1;272:15-16</RefSource><PMID Version="1">32379607</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="Y">Bipolar Disorder</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002996" MajorTopicYN="N">Clomiphene</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008687" MajorTopicYN="N">Metformin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011085" MajorTopicYN="Y">Polycystic Ovary Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Bipolar disorder</Keyword><Keyword MajorTopicYN="Y">Clomiphene</Keyword><Keyword MajorTopicYN="Y">Cohort</Keyword><Keyword MajorTopicYN="Y">Cyproterone</Keyword><Keyword MajorTopicYN="Y">Metformin</Keyword><Keyword MajorTopicYN="Y">Polycystic ovary syndrome</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31969278</ArticleId><ArticleId IdType="pii">S0165-0327(19)32721-1</ArticleId><ArticleId IdType="doi">10.1016/j.jad.2019.12.007</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27310226</PMID><DateCompleted><Year>2017</Year><Month>11</Month><Day>16</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1497-0015</ISSN><JournalIssue CitedMedium="Internet"><Volume>61</Volume><Issue>10</Issue><PubDate><Year>2016</Year><Month>10</Month></PubDate></JournalIssue><Title>Canadian journal of psychiatry. Revue canadienne de psychiatrie</Title><ISOAbbreviation>Can J Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Socio-demographic and Clinical Correlates of Facial Expression Recognition Disorder in the Euthymic Phase of Bipolar Patients.</ArticleTitle><Pagination><MedlinePgn>633-42</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/0706743716639927</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Bipolar patients show social cognitive disorders. The objective of this study is to review facial expression recognition (FER) disorders in bipolar patients (BP) and explore clinical heterogeneity factors that could affect them in the euthymic phase: socio-demographic level, clinical and changing characteristics of the disorder, history of suicide attempt, and abuse.</AbstractText><AbstractText Label="METHOD">Thirty-four euthymic bipolar patients and 29 control subjects completed a computer task of explicit facial expression recognition and were clinically evaluated.</AbstractText><AbstractText Label="RESULTS">Compared with control subjects, BP patients show: a decrease in fear, anger, and disgust recognition; an extended reaction time for disgust, surprise and neutrality recognition; confusion between fear and surprise, anger and disgust, disgust and sadness, sadness and neutrality. In BP patients, age negatively affects anger and neutrality recognition, as opposed to education level which positively affects recognizing these emotions. The history of patient abuse negatively affects surprise and disgust recognition, and the number of suicide attempts negatively affects disgust and anger recognition.</AbstractText><AbstractText Label="CONCLUSIONS">Cognitive heterogeneity in euthymic phase BP patients is affected by several factors inherent to bipolar disorder complexity that should be considered in social cognition study.</AbstractText><CopyrightInformation>© The Author(s) 2016.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Iakimova</LastName><ForeName>Galina</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Université de Nice Sophia Antipolis, Laboratoire d'Anthropologie et de Psychologie cognitives et sociales (LAPCOS, EA 7278), Nice, France iakimova@unice.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moriano</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Clinique de la Costière, Nice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farruggio</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Université de Nice Sophia Antipolis, Laboratoire d'Anthropologie et de Psychologie cognitives et sociales (LAPCOS, EA 7278), Nice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jover</LastName><ForeName>Frédéric</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Clinique de psychiatrie et de psychologie médicale, CHU de Nice, avenue de la Voie Romaine, Nice cedex, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>03</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Can J Psychiatry</MedlineTA><NlmUniqueID>7904187</NlmUniqueID><ISSNLinking>0706-7437</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005149" MajorTopicYN="Y">Facial Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000066499" MajorTopicYN="N">Facial Recognition</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012938" MajorTopicYN="Y">Social Perception</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">bipolaire</Keyword><Keyword MajorTopicYN="Y">cognition sociale</Keyword><Keyword MajorTopicYN="Y">euthymie</Keyword><Keyword MajorTopicYN="Y">maltraitance</Keyword><Keyword MajorTopicYN="Y">tentative de suicide</Keyword><Keyword MajorTopicYN="Y">émotions faciales</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>04</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>11</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27310226</ArticleId><ArticleId IdType="pii">0706743716639927</ArticleId><ArticleId IdType="doi">10.1177/0706743716639927</ArticleId><ArticleId IdType="pmc">PMC5348087</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schizophr Bull. 2011 Sep;37 Suppl 2:S63-70</Citation><ArticleIdList><ArticleId IdType="pubmed">21860049</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2011 Oct 30;189(3):379-84</Citation><ArticleIdList><ArticleId IdType="pubmed">21620484</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2003 Mar;182:190-2</Citation><ArticleIdList><ArticleId IdType="pubmed">12611778</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2006 Apr;8(2):103-16</Citation><ArticleIdList><ArticleId IdType="pubmed">16542180</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2012 Jun;14(4):326-39</Citation><ArticleIdList><ArticleId IdType="pubmed">22631618</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2013 Apr 25;146(3):295-309</Citation><ArticleIdList><ArticleId IdType="pubmed">23218848</ArticleId></ArticleIdList></Reference><Reference><Citation>J Int Neuropsychol Soc. 2014 Feb;20(2):200-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24423084</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Geriatr Psychiatry. 2012 Mar;20(3):257-65</Citation><ArticleIdList><ArticleId IdType="pubmed">22354116</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2002 Feb 15;51(4):298-304</Citation><ArticleIdList><ArticleId IdType="pubmed">11958780</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Psychiatry. 2009 Mar;22(2):140-6</Citation><ArticleIdList><ArticleId IdType="pubmed">19553867</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Cogn Neurosci Rev. 2002 Mar;1(1):21-62</Citation><ArticleIdList><ArticleId IdType="pubmed">17715585</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Biol Psychiatry. 2011 Aug;12(5):319-39</Citation><ArticleIdList><ArticleId IdType="pubmed">21385016</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2008 Dec;10(8):916-27</Citation><ArticleIdList><ArticleId IdType="pubmed">19594507</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cogn Neurosci. 2006 Jun;18(6):889-97</Citation><ArticleIdList><ArticleId IdType="pubmed">16839297</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2008 Jun;165(6):740-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18346998</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 1995 May;166(5):654-9</Citation><ArticleIdList><ArticleId IdType="pubmed">7620753</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2006 Mar;91(1):53-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16413611</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2014 Jan;152-154:288-94</Citation><ArticleIdList><ArticleId IdType="pubmed">24211178</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 1978 Nov;133:429-35</Citation><ArticleIdList><ArticleId IdType="pubmed">728692</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2015 Jun;131(6):472-82</Citation><ArticleIdList><ArticleId IdType="pubmed">25645449</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Bras Psiquiatr. 2009 Jun;31(2):171-80</Citation><ArticleIdList><ArticleId IdType="pubmed">19578691</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuropsychiatry Clin Neurosci. 2009 Winter;21(1):59-67</Citation><ArticleIdList><ArticleId IdType="pubmed">19359453</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Exp Neuropsychol. 2009 Apr;31(3):257-77</Citation><ArticleIdList><ArticleId IdType="pubmed">18720177</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2015 May;17(3):323-30</Citation><ArticleIdList><ArticleId IdType="pubmed">25307301</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Jan 20;9(1):e86093</Citation><ArticleIdList><ArticleId IdType="pubmed">24465891</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2011 Aug-Sep;13(5-6):537-44</Citation><ArticleIdList><ArticleId IdType="pubmed">22017222</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2004 Aug;81(2):123-31</Citation><ArticleIdList><ArticleId IdType="pubmed">15306137</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2005 Apr;7(2):111-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15762851</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2012 Jul;138(2-3):262-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22464728</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2005 Feb;186:121-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15684234</ArticleId></ArticleIdList></Reference><Reference><Citation>Soc Cogn Affect Neurosci. 2013 Apr;8(4):362-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22258799</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2006 Aug;94(1-3):67-87</Citation><ArticleIdList><ArticleId IdType="pubmed">16730070</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2014 Jan;152-154:491-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24070906</ArticleId></ArticleIdList></Reference><Reference><Citation>Br Med Bull. 2008;88(1):43-58</Citation><ArticleIdList><ArticleId IdType="pubmed">18812413</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage Clin. 2014 Sep 04;6:156-65</Citation><ArticleIdList><ArticleId IdType="pubmed">25379427</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2010 May;122(3):285-93</Citation><ArticleIdList><ArticleId IdType="pubmed">19800130</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2004 Aug;6(4):286-93</Citation><ArticleIdList><ArticleId IdType="pubmed">15225145</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2007 Jun;9(4):345-57</Citation><ArticleIdList><ArticleId IdType="pubmed">17547581</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Clin Psychol. 2009 Nov;48(Pt 4):363-75</Citation><ArticleIdList><ArticleId IdType="pubmed">19220936</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2000 Dec;61(1-2):81-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11099744</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2014 Oct;168:37-43</Citation><ArticleIdList><ArticleId IdType="pubmed">25036007</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2014 Feb;152(2-3):440-5</Citation><ArticleIdList><ArticleId IdType="pubmed">24361305</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2007 Oct;116(4):263-70</Citation><ArticleIdList><ArticleId IdType="pubmed">17803756</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2010 Oct 15;53(1):58-64</Citation><ArticleIdList><ArticleId IdType="pubmed">20595014</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2010 Dec;12(8):843-50</Citation><ArticleIdList><ArticleId IdType="pubmed">21176031</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 1998 Aug 17;32(3):171-81</Citation><ArticleIdList><ArticleId IdType="pubmed">9720122</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatry Neurosci. 2009 Nov;34(6):418-32</Citation><ArticleIdList><ArticleId IdType="pubmed">19949718</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2011 Aug 15;188(3):303-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21601927</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 2014 Apr;55(3):542-6</Citation><ArticleIdList><ArticleId IdType="pubmed">24485982</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2012 Apr;125(4):266-80</Citation><ArticleIdList><ArticleId IdType="pubmed">22211280</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2002 Feb;159(2):302-4</Citation><ArticleIdList><ArticleId IdType="pubmed">11823275</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Psychotraumatol. 2014 Jun 03;5:null</Citation><ArticleIdList><ArticleId IdType="pubmed">24936284</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013;8(3):e57664</Citation><ArticleIdList><ArticleId IdType="pubmed">23520477</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2013 Sep 5;150(2):590-3</Citation><ArticleIdList><ArticleId IdType="pubmed">23489393</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62</Citation><ArticleIdList><ArticleId IdType="pubmed">14399272</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2015 Aug;17(5):471-85</Citation><ArticleIdList><ArticleId IdType="pubmed">25951752</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2000 Sep;2(3 Pt 2):237-48</Citation><ArticleIdList><ArticleId IdType="pubmed">11249801</ArticleId></ArticleIdList></Reference><Reference><Citation>Dev Psychol. 2000 Sep;36(5):679-88</Citation><ArticleIdList><ArticleId IdType="pubmed">10976606</ArticleId></ArticleIdList></Reference><Reference><Citation>Prog Neuropsychopharmacol Biol Psychiatry. 2009 Nov 13;33(8):1409-16</Citation><ArticleIdList><ArticleId IdType="pubmed">19632283</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2008 Nov 30;164(2):106-13</Citation><ArticleIdList><ArticleId IdType="pubmed">18930635</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">8831438</PMID><DateCompleted><Year>1996</Year><Month>11</Month><Day>04</Day></DateCompleted><DateRevised><Year>2016</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0002-953X</ISSN><JournalIssue CitedMedium="Print"><Volume>153</Volume><Issue>10</Issue><PubDate><Year>1996</Year><Month>Oct</Month></PubDate></JournalIssue><Title>The American journal of psychiatry</Title><ISOAbbreviation>Am J Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Serum lithium levels and psychosocial function in patients with bipolar I disorder.</ArticleTitle><Pagination><MedlinePgn>1301-7</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study compared the effect of two different serum lithium levels on the psychosocial functioning of patients with bipolar I disorder.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">Ninety patients with bipolar I disorder were enrolled in a prospective, double-blind, maintenance trial of lithium. The patients were randomly assigned to treatment with doses of lithium adjusted to achieve a serum lithium concentration of either 0.8 to 1.0 mmol/liter (standard) or 0.4 to 0.6 mmol/liter (low). The Longitudinal Interval Follow-Up Evaluation was used to assess psychosocial functioning in the areas of work, interpersonal relationships, and global functioning. All observed values were analyzed with a mixed-effects analysis of covariance. Independent variables included treatment group (low or standard lithium serum level), relapse status, socioeconomic status, time from random treatment assignment to assessment, termination of protocol before or after relapse, length of remission before random treatment assignment, polarity of the last mood episode before random treatment assignment, and number of mood episodes in the 3 years before random treatment assignment.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Relapse was associated with large negative effects on psychosocial functioning. Patients in higher socioeconomic brackets had better psychosocial functioning than did those in lower brackets. Patients receiving lithium doses that achieved standard serum levels had better psychosocial functioning than those receiving doses that achieved low serum levels; this effect was partially but not wholly mediated through relapse prevention.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">For patients with bipolar I disorder, standard serum lithium levels may enhance psychosocial functioning, above and beyond the effects of relapse prevention.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Solomon</LastName><ForeName>D A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Hillside Hospital of Long Island Jewish Medical Center, New York, USA. David-Solomon@Brown.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ristow</LastName><ForeName>W R</ForeName><Initials>WR</Initials></Author><Author ValidYN="Y"><LastName>Keller</LastName><ForeName>M B</ForeName><Initials>MB</Initials></Author><Author ValidYN="Y"><LastName>Kane</LastName><ForeName>J M</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Gelenberg</LastName><ForeName>A J</ForeName><Initials>AJ</Initials></Author><Author ValidYN="Y"><LastName>Rosenbaum</LastName><ForeName>J F</ForeName><Initials>JF</Initials></Author><Author ValidYN="Y"><LastName>Warshaw</LastName><ForeName>M G</ForeName><Initials>MG</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 MH025478</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Psychiatry</MedlineTA><NlmUniqueID>0370512</NlmUniqueID><ISSNLinking>0002-953X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9FN79X2M3F</RegistryNumber><NameOfSubstance UI="D008094">Lithium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Am J Psychiatry. 1997 Oct;154(10):1477</RefSource><PMID Version="1">9326844</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004651" MajorTopicYN="N">Employment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007398" MajorTopicYN="N">Interpersonal Relations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008094" MajorTopicYN="N">Lithium</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009790" MajorTopicYN="N">Occupations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012917" MajorTopicYN="Y">Social Adjustment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012923" MajorTopicYN="N">Social Class</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1996</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1996</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1996</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">8831438</ArticleId><ArticleId IdType="doi">10.1176/ajp.153.10.1301</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18456508</PMID><DateCompleted><Year>2008</Year><Month>10</Month><Day>07</Day></DateCompleted><DateRevised><Year>2015</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1043-6618</ISSN><JournalIssue CitedMedium="Print"><Volume>57</Volume><Issue>5</Issue><PubDate><Year>2008</Year><Month>May</Month></PubDate></JournalIssue><Title>Pharmacological research</Title><ISOAbbreviation>Pharmacol Res</ISOAbbreviation></Journal><ArticleTitle>The PDLIM5 gene and lithium prophylaxis: an association and gene expression analysis in Sardinian patients with bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>369-73</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.phrs.2008.03.011</ELocationID><Abstract><AbstractText>A number of studies support the notion that lithium interacts with the protein kinase C (PKC) pathway, an important mediator of several intracellular responses to neurotransmitter signaling. PDLIM5 (PDZ and LIM domain 5; LIM) is an adaptor protein that selectively binds the isozyme PKC(epsilon) to N-type Ca(2+) channels in neurons. We tested for an association between three single nucleotide polymorphisms (SNPs) at the PDLIM5 gene and lithium prophylaxis in a Sardinian sample comprised of 155 bipolar patients treated with lithium. In order to evaluate whether PDLIM5 expression interacts with lithium response, we carried out gene expression analysis in lymphoblastoid cells of 30 bipolar patients. No association was shown between PDLIM5 polymorphisms and lithium response. When PDLIM5 expression was evaluated, no significant differences were detected between Full Responders to lithium (total score&gt;or=7) and other patients (total score&lt;or=6). Our negative findings do not exclude involvement of PDLIM5 in lithium prophylaxis, and further investigation is warranted.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Squassina</LastName><ForeName>Alessio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Section of Clinical Pharmacology, Department of Neurosciences B.B. Brodie, University of Cagliari, SS 554, km. 4,500, 09042 Monserrato, Cagliari, Italy. cortgen@yahoo.it</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Congiu</LastName><ForeName>Donatella</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Manconi</LastName><ForeName>Francesca</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Manchia</LastName><ForeName>Mirko</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Chillotti</LastName><ForeName>Caterina</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Lampus</LastName><ForeName>Simona</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Severino</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Zompo</LastName><ForeName>Maria Del</ForeName><Initials>MD</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2008</Year><Month>04</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Pharmacol Res</MedlineTA><NlmUniqueID>8907422</NlmUniqueID><ISSNLinking>1043-6618</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D060588">LIM Domain Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018020">Lithium Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C512485">PDLIM5 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.13</RegistryNumber><NameOfSubstance UI="D051744">Protein Kinase C-epsilon</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060588" MajorTopicYN="N">LIM Domain Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018020" MajorTopicYN="N">Lithium Compounds</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008214" MajorTopicYN="N">Lymphocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051744" MajorTopicYN="N">Protein Kinase C-epsilon</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2007</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2008</Year><Month>03</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2008</Year><Month>03</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>5</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>10</Month><Day>8</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>5</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18456508</ArticleId><ArticleId IdType="pii">S1043-6618(08)00062-5</ArticleId><ArticleId IdType="doi">10.1016/j.phrs.2008.03.011</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">25571524</PMID><DateCompleted><Year>2015</Year><Month>11</Month><Day>04</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2694-0604</ISSN><JournalIssue CitedMedium="Internet"><Volume>2014</Volume><PubDate><Year>2014</Year></PubDate></JournalIssue><Title>Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference</Title><ISOAbbreviation>Annu Int Conf IEEE Eng Med Biol Soc</ISOAbbreviation></Journal><ArticleTitle>Maximal-radius multiscale entropy of cardiovascular variability: a promising biomarker of pathological mood states in bipolar disorders.</ArticleTitle><Pagination><MedlinePgn>6663-6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1109/EMBC.2014.6945156</ELocationID><Abstract><AbstractText>Complexity measures from Multiscale Entropy (MSE) analysis of cardiovascular variability may provide potential biomarkers of pathological mental states such as major depression. To this extent, in this study we investigate whether complexity of Heart Rate Variability (HRV) is also affected in mental disorders such as bipolar disorders (BD). As part of the European project PSYCHE, eight BD patients experiencing multiple pathological mood states among depression, hypomania, and euthymia (i.e., good affective balance) underwent long-term night recordings through a comfortable sensing t-shirt with integrated fabric electrodes and sensors. Standard radius, i.e., 20% of the HRV standard deviation, and a maximal-radius choice for the sample entropy estimation were compared along with a further multiscale Renyi Entropy analysis. We found that, despite the inter-subject variability, the maximal-radius MSE analysis is able to discern the considered pathological mental states of BD. As the current clinical practice in diagnosing BD is only based on verbal interviews and scores from specific questionnaires, these findings provide evidence on the possibility of using heartbeat complexity as the basis of novel clinical biomarkers of mental disorders. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Valenza</LastName><ForeName>Gaetano</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Nardelli</LastName><ForeName>Mimma</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Bertschy</LastName><ForeName>Gilles</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Lanatà</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Barbieri</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Scilingo</LastName><ForeName>Enzo Pasquale</ForeName><Initials>EP</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Annu Int Conf IEEE Eng Med Biol Soc</MedlineTA><NlmUniqueID>101763872</NlmUniqueID><ISSNLinking>2375-7477</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000339" MajorTopicYN="N">Affect</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019277" MajorTopicYN="N">Entropy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="Y">Heart Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012044" MajorTopicYN="N">Regression Analysis</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25571524</ArticleId><ArticleId IdType="doi">10.1109/EMBC.2014.6945156</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17932733</PMID><DateCompleted><Year>2008</Year><Month>04</Month><Day>09</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0165-005X</ISSN><JournalIssue CitedMedium="Print"><Volume>31</Volume><Issue>4</Issue><PubDate><Year>2007</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Culture, medicine and psychiatry</Title><ISOAbbreviation>Cult Med Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Qi-gong psychotic reaction in a Chinese American woman.</ArticleTitle><Pagination><MedlinePgn>547-60</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hwang</LastName><ForeName>Wei-Chin</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>Department of Psychology, Claremont McKenna College, 850 Columbia Avenue, Claremont, CA 91711, USA. whwang@cmc.edu</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Cult Med Psychiatry</MedlineTA><NlmUniqueID>7707467</NlmUniqueID><ISSNLinking>0165-005X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001213" MajorTopicYN="N">Asian Americans</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003134" MajorTopicYN="N">Commitment of Mentally Ill</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054521" MajorTopicYN="N">Cultural Competency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003617" MajorTopicYN="N">Dangerous Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003865" MajorTopicYN="N">Depressive Disorder, Major</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039721" MajorTopicYN="N">Diagnostic and Statistical Manual of Mental Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054242" MajorTopicYN="N">Emigrants and Immigrants</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008016" MajorTopicYN="N">Life Change Events</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019122" MajorTopicYN="N">Meditation</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011613" MajorTopicYN="N">Psychotherapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011618" MajorTopicYN="N">Psychotic Disorders</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="Y">ethnology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012017" MajorTopicYN="N">Referral and Consultation</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>10</Month><Day>13</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>4</Month><Day>10</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>10</Month><Day>13</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17932733</ArticleId><ArticleId IdType="doi">10.1007/s11013-007-9065-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Altern Complement Med. 2004 Feb;10(1):163-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15025890</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Psychol. 2006 Oct;61(7):702-15</Citation><ArticleIdList><ArticleId IdType="pubmed">17032070</ArticleId></ArticleIdList></Reference><Reference><Citation>Aust N Z J Psychiatry. 2000 Jun;34(3):458-67</Citation><ArticleIdList><ArticleId IdType="pubmed">10881970</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatr Serv. 2003 Apr;54(4):535-41</Citation><ArticleIdList><ArticleId IdType="pubmed">12663842</ArticleId></ArticleIdList></Reference><Reference><Citation>J Nerv Ment Dis. 1982 Nov;170(11):657-63</Citation><ArticleIdList><ArticleId IdType="pubmed">7119765</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 1968 Nov;114(516):1313-23</Citation><ArticleIdList><ArticleId IdType="pubmed">5702272</ArticleId></ArticleIdList></Reference><Reference><Citation>Cult Med Psychiatry. 1996 Sep;20(3):369-78</Citation><ArticleIdList><ArticleId IdType="pubmed">8899286</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17224185</PMID><DateCompleted><Year>2007</Year><Month>08</Month><Day>17</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0165-0327</ISSN><JournalIssue CitedMedium="Print"><Volume>101</Volume><Issue>1-3</Issue><PubDate><Year>2007</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of affective disorders</Title><ISOAbbreviation>J Affect Disord</ISOAbbreviation></Journal><ArticleTitle>Neurocognitive impairment in middle-aged and older adults with bipolar disorder: comparison to schizophrenia and normal comparison subjects.</ArticleTitle><Pagination><MedlinePgn>201-9</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The frequency, pattern, and correlates of neurocognitive impairment in older patients with bipolar disorder have received little study. We examined neurocognitive abilities in middle-aged and older adults with bipolar disorder to groups with schizophrenia or normal subjects, as well as the relation of neurocognition to clinical characteristics.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">We administered a battery of neurocognitive and clinical measures to older (45-85 years) outpatients with bipolar disorder (n=67), schizophrenia (n=150), and normal comparison subjects (n=85). Within the bipolar group, we assessed the association between neurocognitive performance and psychiatric symptoms, quality of life, and medication status.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The group with bipolar disorder differed on nearly all neuropsychological tests compared to normal subjects, with medium effect sizes. Bipolar patients as impaired as those with schizophrenia on half of the tests administered, and performed better on the remaining tests, with small effect sizes. Neurocognitive deficits in bipolar disorder group related to lower quality of life, but not to psychiatric symptom severity or duration of illness.</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">Samples were outpatients with mild-moderate symptoms, and findings may not generalize to acutely ill populations. We lacked data on illness history to examine the cumulative impact of psychopathology.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Among clinically stable middle-aged and older outpatients, bipolar disorder was associated with substantial neurocognitive impairment, with a pattern that was somewhat distinct from that found in schizophrenia. Deficits in the bipolar group were not related to severity or duration of psychiatric symptoms, but were related to quality of life. Bipolar disorder often involve disabling and enduring cognitive impairments in older outpatients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Depp</LastName><ForeName>Colin A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of California, San Diego, United States. cdepp@ucsd.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>David J</ForeName><Initials>DJ</Initials></Author><Author ValidYN="Y"><LastName>Sitzer</LastName><ForeName>David</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Palmer</LastName><ForeName>Barton W</ForeName><Initials>BW</Initials></Author><Author ValidYN="Y"><LastName>Eyler</LastName><ForeName>Lisa T</ForeName><Initials>LT</Initials></Author><Author ValidYN="Y"><LastName>Roesch</LastName><ForeName>Scott</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Lebowitz</LastName><ForeName>Barry D</ForeName><Initials>BD</Initials></Author><Author ValidYN="Y"><LastName>Jeste</LastName><ForeName>Dilip V</ForeName><Initials>DV</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 MH066248-05</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 MH066248</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 MH066248-04</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 DA031098</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 MH077225</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MH66248</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MH64722</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 MH077225-01A1</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH059101</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MH59101</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH064722</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2007</Year><Month>01</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Affect Disord</MedlineTA><NlmUniqueID>7906073</NlmUniqueID><ISSNLinking>0165-0327</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="Y">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012559" MajorTopicYN="N">Schizophrenia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012565" MajorTopicYN="Y">Schizophrenic Psychology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013223" MajorTopicYN="N">Statistics as Topic</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2006</Year><Month>08</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2006</Year><Month>11</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2006</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>1</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>8</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>1</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17224185</ArticleId><ArticleId IdType="pii">S0165-0327(06)00504-0</ArticleId><ArticleId IdType="doi">10.1016/j.jad.2006.11.022</ArticleId><ArticleId IdType="pmc">PMC1974900</ArticleId><ArticleId IdType="mid">NIHMS26459</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Neuropsychiatry Neuropsychol Behav Neurol. 2000 Oct;13(4):246-53</Citation><ArticleIdList><ArticleId IdType="pubmed">11186160</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2006 Jul;93(1-3):105-15</Citation><ArticleIdList><ArticleId IdType="pubmed">16677713</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2001 Jun;3(3):106-50; discussion 151-3</Citation><ArticleIdList><ArticleId IdType="pubmed">11465675</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1999 Sep;56(9):848-53</Citation><ArticleIdList><ArticleId IdType="pubmed">12884891</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2004 Feb;161(2):262-70</Citation><ArticleIdList><ArticleId IdType="pubmed">14754775</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2004 Apr;161(4):736-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15056521</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2004 Jun 1;68(2-3):331-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15099614</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2004 Jun;61(6):587-95</Citation><ArticleIdList><ArticleId IdType="pubmed">15184238</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Geriatr Psychiatry. 2004 Jul-Aug;12(4):342-57</Citation><ArticleIdList><ArticleId IdType="pubmed">15249272</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2004 Oct 15;56(8):560-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15476685</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Soc Clin Psychol. 1967 Dec;6(4):278-96</Citation><ArticleIdList><ArticleId IdType="pubmed">6080235</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 1978 Nov;133:429-35</Citation><ArticleIdList><ArticleId IdType="pubmed">728692</ArticleId></ArticleIdList></Reference><Reference><Citation>J Nerv Ment Dis. 1980 May;168(5):297-304</Citation><ArticleIdList><ArticleId IdType="pubmed">7365494</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 1987;13(2):261-76</Citation><ArticleIdList><ArticleId IdType="pubmed">3616518</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1994 Jun;51(6):469-76</Citation><ArticleIdList><ArticleId IdType="pubmed">8192549</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 1997 Apr;170:369-74</Citation><ArticleIdList><ArticleId IdType="pubmed">9246257</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Qual Health Care. 1998 Dec;10(6):509-20</Citation><ArticleIdList><ArticleId IdType="pubmed">9928590</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Geriatr Soc. 1999 Jun;47(6):716-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10366172</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 1999 Sep 29;39(2):127-32; discussion 161-2</Citation><ArticleIdList><ArticleId IdType="pubmed">10507523</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2004 Nov 30;129(1):45-53</Citation><ArticleIdList><ArticleId IdType="pubmed">15572184</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Psychol. 2005 Apr;60(3):229-42</Citation><ArticleIdList><ArticleId IdType="pubmed">15796677</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2004;30(4):739-54</Citation><ArticleIdList><ArticleId IdType="pubmed">15957196</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2005 Dec 15;80(2-3):137-49</Citation><ArticleIdList><ArticleId IdType="pubmed">16183257</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2006 Apr;8(2):103-16</Citation><ArticleIdList><ArticleId IdType="pubmed">16542180</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2006 May;92(1):125-31</Citation><ArticleIdList><ArticleId IdType="pubmed">16469389</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2001 Jan;58(1):24-32</Citation><ArticleIdList><ArticleId IdType="pubmed">11146755</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19170690</PMID><DateCompleted><Year>2009</Year><Month>08</Month><Day>25</Day></DateCompleted><DateRevised><Year>2009</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-2982</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>4</Issue><PubDate><Year>2009</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Cephalalgia : an international journal of headache</Title><ISOAbbreviation>Cephalalgia</ISOAbbreviation></Journal><ArticleTitle>Transient hypnic headache syndrome in a patient with bipolar disorder after the withdrawal of long-term lithium treatment: a case report.</ArticleTitle><Pagination><MedlinePgn>484-6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1468-2982.2008.01758.x</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Karlovasitou</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>1st Department of Neurology, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avdelidi</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Andriopoulou</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Baloyannis</LastName><ForeName>S</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2008</Year><Month>12</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cephalalgia</MedlineTA><NlmUniqueID>8200710</NlmUniqueID><ISSNLinking>0333-1024</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018020">Lithium Compounds</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051270" MajorTopicYN="N">Headache Disorders, Primary</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018020" MajorTopicYN="N">Lithium Compounds</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013375" MajorTopicYN="N">Substance Withdrawal Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>1</Month><Day>28</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>1</Month><Day>28</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>8</Month><Day>26</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19170690</ArticleId><ArticleId IdType="pii">CHA1758</ArticleId><ArticleId IdType="doi">10.1111/j.1468-2982.2008.01758.x</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15465573</PMID><DateCompleted><Year>2005</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2009</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0165-0327</ISSN><JournalIssue CitedMedium="Print"><Volume>82</Volume><Issue>1</Issue><PubDate><Year>2004</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of affective disorders</Title><ISOAbbreviation>J Affect Disord</ISOAbbreviation></Journal><ArticleTitle>Clinical features related to age at onset in bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>21-7</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Early age at illness onset has been associated with poor functional and syndromal outcome in bipolar disorder, although debate remains about the likely robustness of this variable, especially while controlling for other illness parameters.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">Fifty-six consecutive bipolar outpatients underwent semistructured interviews to assess psychopathology and outcome. We hypothesized that early age at onset would be linked with more prevalent rapid cycling, psychosis, comorbid substance abuse, and suicide attempts.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Illness onset before age 19 arose in 46% of subjects. Separate logistic regression analyses revealed that onset before age 19 was associated with developing comorbid substance abuse/dependence (OR=7.714, 95% CI=1.863-31.944, Wald chi(2)=7.949, df=1, P=0.005), as well as the eventual development of rapid cycling (OR=6.000, 95% CI=1.250-25.893, Wald chi(2)=5.348, df=1, P=0.021). No significant or near-significant associations were observed between age at onset and lifetime suicide attempts or lifetime psychosis. After an initial manic or mixed episode, delaying the introduction of antidepressants tended to be protective against the eventual development of rapid cycling (OR=0.927, 95% CI=0.856-1.004, Wald chi(2)=3.440, df=1, P=0.064).</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">The sample size may have been too small to detect group differences of small magnitude. The use of retrospective life chart assessments to ascertain age at onset and lifetime illness course may impose limitations on generalizability in the absence of prospective data.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Early onset of bipolar illness appears related to the development of rapid cycling and of comorbid substance abuse/dependence. The findings raise developmental implications for the pathogenesis of illness complexity and poor outcome states.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ernst</LastName><ForeName>Carrie L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Cambridge Hospital, Harvard Medical School, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldberg</LastName><ForeName>Joseph F</ForeName><Initials>JF</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 01936</GrantID><Agency>PHS HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Affect Disord</MedlineTA><NlmUniqueID>7906073</NlmUniqueID><ISSNLinking>0165-0327</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017668" MajorTopicYN="N">Age of Onset</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010507" MajorTopicYN="N">Periodicity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019966" MajorTopicYN="N">Substance-Related Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2003</Year><Month>02</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2003</Year><Month>10</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>10</Month><Day>7</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>2</Month><Day>8</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>10</Month><Day>7</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15465573</ArticleId><ArticleId IdType="pii">S0165032703002581</ArticleId><ArticleId IdType="doi">10.1016/j.jad.2003.10.002</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">569523</PMID><DateCompleted><Year>1979</Year><Month>03</Month><Day>13</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0007-1250</ISSN><JournalIssue CitedMedium="Print"><Volume>133</Volume><PubDate><Year>1978</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The British journal of psychiatry : the journal of mental science</Title><ISOAbbreviation>Br J Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Lithium accumulation in erythrocytes of manic-depressive patients: an in vivo twin study.</ArticleTitle><Pagination><MedlinePgn>436-44</MedlinePgn></Pagination><Abstract><AbstractText>Genetic factors play an important role in drug metabolism and drug response. In order to investigate genetic variables in lithium prophylaxis and lithium distribution across the erythrocyte in manic-depression, we have examined forty-two pairs of twins monozygotic (n = 25) and dizygotic (n = 17) with manic-depression. Concordant twins as a group show better lithium prophylaxis than do discordant twins. These results are consistent with previously published family studies of affective illness suggesting a positive relationship between genetic background and success of lithium prophylaxis. Lithium distribution across the red blood cell (RBC) was assessed by estimating lithium RBC/plasma ratios. The lithium ratio's intrapair differences in both groups of twins were minimal with a high heritability index suggesting that genetic factors play a role in lithium ion distribution. A high linear correlation was found between lithium ratio and plasma lithium and there was no difference in lithium ratios according to sex, affective state and response to lithium. The distribution of lithium ratios was homogenous in the lithium responders' population but this was not the case in the non-responders, suggesting biological heterogeneity of lithium distribution in lithium failures. The implications of these results are discussed as they relate to the genetic determinates of lithium prophylaxis in manic-depressive illness. These results indicate that lithium ratios are of limited value in lithium maintenance therapy. Our lithium kinetic data, however, are consistent with the concept of a lithium extrusion mechanism from red blood cells.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mendlewicz</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Verbanck</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Linkowski</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Wilmotte</LastName><ForeName>J</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Psychiatry</MedlineTA><NlmUniqueID>0342367</NlmUniqueID><ISSNLinking>0007-1250</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9FN79X2M3F</RegistryNumber><NameOfSubstance UI="D008094">Lithium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004200" MajorTopicYN="Y">Diseases in Twins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004912" MajorTopicYN="N">Erythrocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008094" MajorTopicYN="N">Lithium</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014429" MajorTopicYN="N">Twins, Dizygotic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014430" MajorTopicYN="N">Twins, Monozygotic</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1978</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1978</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1978</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">569523</ArticleId><ArticleId IdType="pii">S0007125000198563</ArticleId><ArticleId IdType="doi">10.1192/bjp.133.5.436</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19776668</PMID><DateCompleted><Year>2010</Year><Month>01</Month><Day>14</Day></DateCompleted><DateRevised><Year>2009</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1423-033X</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>6</Issue><PubDate><Year>2009</Year></PubDate></JournalIssue><Title>Psychopathology</Title><ISOAbbreviation>Psychopathology</ISOAbbreviation></Journal><ArticleTitle>Psychopathological correlates of lifetime anxiety comorbidity in bipolar I patients: findings from a French national cohort.</ArticleTitle><Pagination><MedlinePgn>380-6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1159/000241193</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Despite numerous studies on the comorbidity of bipolar and anxiety disorders, there is no satisfactory psychopathological model for their overlap.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">1,090 hospitalized patients meeting DSM-IV criteria for a manic episode of bipolar I disorder were subtyped according to the presence or not of lifetime anxiety comorbidity and assessed for demographic, illness course, clinical, associated condition, temperament, and treatment characteristics.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Lifetime anxiety comorbidity, defined as presence of at least one anxiety disorder in lifetime, was found in 27.2% (n = 297) of the sample. Compared to patients without such a comorbidity (n = 793), those who had it experienced a higher number of mood episodes and suicide attempts in the previous year, more stressors, organic disorders and less free intervals; furthermore, they showed more temperaments with depressive features and complex treatment. At study entry, they also experienced manic episodes with higher levels of depression, psychosis and hostility. The following independent variables were associated with lifetime anxiety comorbidity: higher scores on the Montgomery-Asberg Depression Rating Scale, depressive temperament, irritable temperament, higher scores on the Scale for the Assessment of Positive Symptoms, episodes without free intervals and at least one stressor before the index episode.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Factors associated with lifetime anxiety comorbidity in bipolar I patients may be integrated into a comprehensive diathesis-stress model emphasizing the role of irritable temperament as a source of mood instability and stress, and interacting with other temperamental characteristics to trigger the outbreak of both anxiety and bipolar symptoms.</AbstractText><CopyrightInformation>Copyright 2009 S. Karger AG, Basel.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Azorin</LastName><ForeName>Jean-Michel</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Sainte Marguerite Hospital, University of Marseilles, Marseilles, France. jazorin@ap-hm.fr</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaladjian</LastName><ForeName>Arthur</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Adida</LastName><ForeName>Marc</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Hantouche</LastName><ForeName>Elie G</ForeName><Initials>EG</Initials></Author><Author ValidYN="Y"><LastName>Hameg</LastName><ForeName>Ahcene</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Lancrenon</LastName><ForeName>Sylvie</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Akiskal</LastName><ForeName>Hagop S</ForeName><Initials>HS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>09</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Psychopathology</MedlineTA><NlmUniqueID>8401537</NlmUniqueID><ISSNLinking>0254-4962</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001008" MajorTopicYN="N">Anxiety Disorders</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039721" MajorTopicYN="N">Diagnostic and Statistical Manual of Mental Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="N">Patient Selection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010552" MajorTopicYN="Y">Personality Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012044" MajorTopicYN="N">Regression Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013694" MajorTopicYN="N">Temperament</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2008</Year><Month>09</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2009</Year><Month>02</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19776668</ArticleId><ArticleId IdType="pii">000241193</ArticleId><ArticleId IdType="doi">10.1159/000241193</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15212611</PMID><DateCompleted><Year>2004</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1465-6566</ISSN><JournalIssue CitedMedium="Print"><Volume>5</Volume><Issue>7</Issue><PubDate><Year>2004</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Expert opinion on pharmacotherapy</Title><ISOAbbreviation>Expert Opin Pharmacother</ISOAbbreviation></Journal><ArticleTitle>Olanzapine in bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>1613-9</MedlinePgn></Pagination><Abstract><AbstractText>Olanzapine is currently marketed not only for the treatment of schizophrenia, but also for the treatment of acute mania and the prevention of relapse in patients successfully treated with this drug for a manic episode. A large body of good clinical trials supports these indications. In the mania trials, olanzapine was more efficacious than placebo, equal or more efficacious than valproate and more efficacious than lithium or valproate monotherapy when used in combination with either drug. A trial that compared olanzapine with haloperidol failed to show superiority of the atypical versus the conventional. Olanzapine showed a modest but statistically significant effect in the treatment of bipolar depression; this modest effect was substantially enhanced in combination with fluoxetine. The long-term trials showed that olanzapine was better than placebo in the prevention of manic and depressive relapse and not inferior to lithium or valproate. The combination of olanzapine with lithium or valproate was also more efficacious than lithium or valproate alone in the prevention of manic relapse in patients partially non-responding to monotherapy with lithium or valproate. All these trials suggest that olanzapine may be a valuable drug in the short- and long-term treatment of bipolar I disorder. However, there are some concerns about the safety and tolerability of olanzapine in this population, as far as weight gain and metabolic syndrome are concerned, which may be addressed in future pharmacovigilance studies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vieta</LastName><ForeName>Eduard</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University of Barcelona, Bipolar Disorders Program, Hospital Clinic, Villarroel 170, Rosselló 140, 08036 Barcelona, Spain. evieta@clinic.ub.es</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Expert Opin Pharmacother</MedlineTA><NlmUniqueID>100897346</NlmUniqueID><ISSNLinking>1465-6566</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>12794-10-4</RegistryNumber><NameOfSubstance UI="D001569">Benzodiazepines</NameOfSubstance></Chemical><Chemical><RegistryNumber>N7U69T4SZR</RegistryNumber><NameOfSubstance UI="D000077152">Olanzapine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001569" MajorTopicYN="N">Benzodiazepines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015337" MajorTopicYN="N">Multicenter Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077152" MajorTopicYN="N">Olanzapine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N">Spain</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>6</Month><Day>24</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>11</Month><Day>4</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>6</Month><Day>24</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15212611</ArticleId><ArticleId IdType="pii">EOP050716</ArticleId><ArticleId IdType="doi">10.1517/14656566.5.7.1613</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26683251</PMID><DateCompleted><Year>2016</Year><Month>10</Month><Day>05</Day></DateCompleted><DateRevised><Year>2016</Year><Month>12</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1550-4271</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>3-4</Issue><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>Journal of dual diagnosis</Title><ISOAbbreviation>J Dual Diagn</ISOAbbreviation></Journal><ArticleTitle>Psychological Outcomes and Medical Morbidity of Patients With Bipolar Disorder and Co-Occurring Alcohol Use Disorder.</ArticleTitle><Pagination><MedlinePgn>184-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/15504263.2015.1113099</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Patients with bipolar disorder are at a high risk for comorbid alcohol use disorder, and both disorders are associated with poor outcomes and multiple morbidities. This study aimed to explore not only the psychosocial functioning and psychopathological outcomes but also the medical morbidity of patients with bipolar disorder with and without alcohol use disorder.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Outpatients with bipolar I disorder (DSM-IV) were recruited from a psychiatric teaching hospital in Taiwan (N = 393). Data on psychiatric symptoms, psychosocial functioning, and physical health were obtained through interviews with patients and collaterals, patient self-report, and medical record reviews.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Participants had a mean age of 41.1 years (SD = 11.9) and were mostly female (n = 255, 64.9%). Fewer than 10% (n = 34, 8.7%) met criteria for alcohol use disorder, and these participants were more likely to be male, to smoke, and to have a history of rapid cycling, higher mean body mass index, and higher incidences of gastrointestinal and hepatobiliary morbidities. A multiple logistic regression analysis revealed that patients with, versus those without, alcohol use disorder were more prone to gastrointestinal diseases (adjusted OR = 4.25, 95% CI [1.44-12.53], p &lt;.01), hepatobiliary diseases (adjusted OR = 3.14, 95% CI [1.20-8.25], p &lt;.025), and history of rapid cycling (adjusted OR = 2.53, 95% CI [0.91-7.01], p &lt;.075).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Comorbid alcohol use disorders may have a stronger impact on physical health than on psychosocial or psychopathological outcomes of patients with bipolar disorder.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Han-Ching</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>a Department of Psychiatry and Psychiatric Research Center , Taipei Medical University Hospital , Taipei , Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Department of Psychiatry , School of Medicine, College of Medicine, Taipei Medical University , Taipei , Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Pao-Huan</ForeName><Initials>PH</Initials><AffiliationInfo><Affiliation>a Department of Psychiatry and Psychiatric Research Center , Taipei Medical University Hospital , Taipei , Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Department of Psychiatry , School of Medicine, College of Medicine, Taipei Medical University , Taipei , Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Kuo-Hsuan</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>a Department of Psychiatry and Psychiatric Research Center , Taipei Medical University Hospital , Taipei , Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Department of Psychiatry , School of Medicine, College of Medicine, Taipei Medical University , Taipei , Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuo</LastName><ForeName>Chian-Jue</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>b Department of Psychiatry , School of Medicine, College of Medicine, Taipei Medical University , Taipei , Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>c Taipei City Psychiatric Center, Taipei City Hospital, Songde Branch , Taipei , Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Shou-Hung</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>a Department of Psychiatry and Psychiatric Research Center , Taipei Medical University Hospital , Taipei , Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Department of Psychiatry , School of Medicine, College of Medicine, Taipei Medical University , Taipei , Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Shang-Ying</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>a Department of Psychiatry and Psychiatric Research Center , Taipei Medical University Hospital , Taipei , Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Department of Psychiatry , School of Medicine, College of Medicine, Taipei Medical University , Taipei , Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Dual Diagn</MedlineTA><NlmUniqueID>101197457</NlmUniqueID><ISSNLinking>1550-4271</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000437" MajorTopicYN="N">Alcoholism</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017831" MajorTopicYN="N">Diagnosis, Dual (Psychiatry)</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005767" MajorTopicYN="N">Gastrointestinal Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008107" MajorTopicYN="N">Liver Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057566" MajorTopicYN="N">Self Report</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012907" MajorTopicYN="N">Smoking</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">alcohol use disorders</Keyword><Keyword MajorTopicYN="N">bipolar disorder</Keyword><Keyword MajorTopicYN="N">comorbidity</Keyword><Keyword MajorTopicYN="N">gastrointestinal diseases</Keyword><Keyword MajorTopicYN="N">outcome</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26683251</ArticleId><ArticleId IdType="doi">10.1080/15504263.2015.1113099</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25082489</PMID><DateCompleted><Year>2014</Year><Month>09</Month><Day>23</Day></DateCompleted><DateRevised><Year>2014</Year><Month>11</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1535-7228</ISSN><JournalIssue CitedMedium="Internet"><Volume>171</Volume><Issue>8</Issue><PubDate><Year>2014</Year><Month>Aug</Month></PubDate></JournalIssue><Title>The American journal of psychiatry</Title><ISOAbbreviation>Am J Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Delirium presenting as mania in a patient with end-stage COPD.</ArticleTitle><Pagination><MedlinePgn>821-4</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1176/appi.ajp.2013.12060810</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wilkinson</LastName><ForeName>Samuel T</ForeName><Initials>ST</Initials></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Shin-Bey</ForeName><Initials>SB</Initials></Author><Author ValidYN="Y"><LastName>Foley</LastName><ForeName>Teresa</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Lipsey</LastName><ForeName>John R</ForeName><Initials>JR</Initials></Author><Author ValidYN="Y"><LastName>MacKinnon</LastName><ForeName>Dean F</ForeName><Initials>DF</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Psychiatry</MedlineTA><NlmUniqueID>0370512</NlmUniqueID><ISSNLinking>0002-953X</ISSNLinking></MedlineJournalInfo><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003693" MajorTopicYN="N">Delirium</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029424" MajorTopicYN="N">Pulmonary Disease, Chronic Obstructive</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25082489</ArticleId><ArticleId IdType="pii">1892893</ArticleId><ArticleId IdType="doi">10.1176/appi.ajp.2013.12060810</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16337008</PMID><DateCompleted><Year>2006</Year><Month>05</Month><Day>09</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0165-0327</ISSN><JournalIssue CitedMedium="Print"><Volume>90</Volume><Issue>1</Issue><PubDate><Year>2006</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of affective disorders</Title><ISOAbbreviation>J Affect Disord</ISOAbbreviation></Journal><ArticleTitle>Type A behaviour differentiates bipolar II from unipolar depressed patients.</ArticleTitle><Pagination><MedlinePgn>7-13</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">A relation between the type A behaviour pattern (TABP) and coronary heart disease has been found in many studies and the existence of a psychiatric coronary-prone mood profile has been suggested. TABP consist of fairly stable character traits such as time urgency, impatience, irritability and competitiveness, which in patients with affective disorders could be bipolar traits. The aim of this study was to compare TABP in depressed unipolar and bipolar II patients, and explore the relation between TABP, affective temperaments and migraine headaches, another disorder associated with bipolar II disorder.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The Jenkins Activity Survey (JAS) (Form C), a self-report multiple-choice questionnaire designed to measure TABP, was given to 99 patients diagnosed with a DSM-IV major affective disorder. Affective temperaments were diagnosed according to Akiskal's criteria and migraine diagnosed according to the criteria of the International Headache Society. The JAS was scored in the traditional manner, yielding scores for TABP and three factorially independent components, speed and impatiens (factor S), job involvement (factor J) and hard-driving and competitive (factor H).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">65 patients diagnosed with a unipolar (n = 42) or bipolar II (n = 23) disorder had valid scores on the JAS. Patients with bipolar II diagnosis had significantly higher JAS scores than the unipolar patients (Wilks' lambda = 0.851, F = 2.62, df = 4, 60, p &lt; 0.05). Type A behaviour differed (total JAS score: mean square 509.3, df = 1, F = 9.4, p &lt; 0.005), mainly due to a divergence in factor S (mean square 465.5, df = 1, F = 6.0, p &lt; 0.02). Higher JAS scores were significantly associated with having a cyclothymic temperament (Wilks' lambda = 0.728, F = 4.30, df = 4, p = 0.005) and lower JAS scores with having a depressive temperament (Wilks' lambda = 0.747, F = 3.13, df = 4, p = 0.026). TABP was not associated with migraine.</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">Non-blind, cross-sectional assessment of affective disorders and migraine headaches and questionnaire-based type A behaviour assessment.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These results indicate that a well-established questionnaire designed to recognize the type A behaviour pattern, distinguishes depressed unipolar from depressed bipolar II patients as well.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oedegaard</LastName><ForeName>Ketil Joachim</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Haukeland University Hospital, University of Bergen, N-5021 Bergen, Norway. keti@haukeland.no</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neckelmann</LastName><ForeName>Dag</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Fasmer</LastName><ForeName>Ole Bernt</ForeName><Initials>OB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2005</Year><Month>12</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Affect Disord</MedlineTA><NlmUniqueID>7906073</NlmUniqueID><ISSNLinking>0165-0327</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003327" MajorTopicYN="N">Coronary Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003866" MajorTopicYN="N">Depressive Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008881" MajorTopicYN="N">Migraine Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010554" MajorTopicYN="N">Personality Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013694" MajorTopicYN="Y">Temperament</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014434" MajorTopicYN="Y">Type A Personality</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2005</Year><Month>06</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2005</Year><Month>10</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>12</Month><Day>13</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>5</Month><Day>10</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>12</Month><Day>13</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16337008</ArticleId><ArticleId IdType="pii">S0165-0327(05)00308-3</ArticleId><ArticleId IdType="doi">10.1016/j.jad.2005.10.005</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17430301</PMID><DateCompleted><Year>2007</Year><Month>07</Month><Day>10</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1398-5647</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>3</Issue><PubDate><Year>2007</Year><Month>May</Month></PubDate></JournalIssue><Title>Bipolar disorders</Title><ISOAbbreviation>Bipolar Disord</ISOAbbreviation></Journal><ArticleTitle>Prevalence and correlates of burden among caregivers of patients with bipolar disorder enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder.</ArticleTitle><Pagination><MedlinePgn>262-73</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Caring for a relative with schizophrenia or dementia is associated with reports of high caregiver burden, symptoms of depression, poor physical health, negligence of the caregiver's own health needs, elevated health service use, low use of social supports, and financial strain. This study presents the design and preliminary data on the costs and consequences of caring for a relative or friend with bipolar disorder from the Family Experience Study, a longitudinal study of the primary caregivers to 500 patients enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Subjects were primary caregivers of 500 patients with bipolar disorder diagnosed by the Mini International Neuropsychiatric Interview and the Affective Disorder Evaluation. Caregivers were evaluated within 1 month after patients entered Systematic Treatment Enhancement Program using measures of burden, coping, health/mental health, and use of resources and costs.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eighty-nine percent, 52%, and 61% of caregivers, respectively, experienced moderate or higher burden in relation to patient problem behaviors, role dysfunction, or disruption of household routine. High burden caregivers reported more physical health problems, depressive symptoms, health risk behavior and health service use, and less social support than less burden caregivers. They also provided more financial support to their bipolar relative.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Burdens experienced by family caregivers of people with bipolar disorder are associated with problems in health, mental health, and cost. Psychosocial interventions targeting the strains of caregiving for a patient with bipolar disorder are needed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Perlick</LastName><ForeName>Deborah A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Mt. Sinai School of Medicine, New York, NY 10029, USA. deborah.perlick@mssm.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosenheck</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials></Author><Author ValidYN="Y"><LastName>Miklowitz</LastName><ForeName>David J</ForeName><Initials>DJ</Initials></Author><Author ValidYN="Y"><LastName>Chessick</LastName><ForeName>Cheryl</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Wolff</LastName><ForeName>Nancy</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Kaczynski</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Ostacher</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Jayendra</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Desai</LastName><ForeName>Rani</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><CollectiveName>STEP-BD Family Experience Collaborative Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MH-65015</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MH-8001</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Bipolar Disord</MedlineTA><NlmUniqueID>100883596</NlmUniqueID><ISSNLinking>1398-5647</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000223" MajorTopicYN="N">Adaptation, Psychological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017281" MajorTopicYN="Y">Cost of Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003710" MajorTopicYN="N">Demography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017048" MajorTopicYN="N">Health Care Costs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016730" MajorTopicYN="Y">Program Development</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012944" MajorTopicYN="N">Social Support</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>4</Month><Day>14</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>7</Month><Day>11</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>4</Month><Day>14</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17430301</ArticleId><ArticleId IdType="pii">BDI365</ArticleId><ArticleId IdType="doi">10.1111/j.1399-5618.2007.00365.x</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18837861</PMID><DateCompleted><Year>2009</Year><Month>04</Month><Day>08</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1399-5618</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>6</Issue><PubDate><Year>2008</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Bipolar disorders</Title><ISOAbbreviation>Bipolar Disord</ISOAbbreviation></Journal><ArticleTitle>Service delivery in older patients with bipolar disorder: a review and development of a medical care model.</ArticleTitle><Pagination><MedlinePgn>672-83</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1399-5618.2008.00602.x</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Medical comorbidities, especially cardiovascular disease (CVD), occur disproportionately in older patients with bipolar disorder. We describe the development, implementation, and feasibility/tolerability results of a manual-based medical care model (BCM) designed to improve medical outcomes in older patients with bipolar disorder.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The BCM consisted of (i) self-management sessions focused on bipolar disorder symptom control, healthy habits, and provider engagement, (ii) telephone care management to coordinate care and reinforce self-management goals, and (iii) guideline dissemination focused on medical issues in bipolar disorder. Older patients with bipolar disorder and a CVD-related risk factor (n = 58) were consented, enrolled, and randomized to receive BCM or usual care.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Baseline assessment (mean age = 55, 9% female, 9% African American) revealed a vulnerable population: 21% were substance users, 31% relied on public transportation, and 22% reported problems accessing medical care. Evaluation of BCM feasibility revealed high overall patient satisfaction with the intervention, high fidelity (e.g., majority of self-management sessions and follow-up contacts completed), and good tolerability (dropout rate &lt;5%). Use of telephone contacts may have mitigated barriers to medical care (e.g., transportation).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The BCM is a feasible model for older, medically ill patients with bipolar disorder, and could be an alternative to more costly treatment models that involve co-location and/or additional hiring of medical providers in mental health clinics. Future research directions pertinent to the development of the BCM and other medical care models for older patients with bipolar disorder include assessment of their long-term effects on physical health and their cost-effectiveness across different treatment settings.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kilbourne</LastName><ForeName>Amy M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>VA Ann Arbor National Serious Mental Illness Treatment Research and Evaluation Center, Ann Arbor, MI 48105, USA. amykilbo@umich.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Post</LastName><ForeName>Edward P</ForeName><Initials>EP</Initials></Author><Author ValidYN="Y"><LastName>Nossek</LastName><ForeName>Agnes</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Sonel</LastName><ForeName>Elif</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Drill</LastName><ForeName>Larry J</ForeName><Initials>LJ</Initials></Author><Author ValidYN="Y"><LastName>Cooley</LastName><ForeName>Susan</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Bauer</LastName><ForeName>Mark S</ForeName><Initials>MS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Bipolar Disord</MedlineTA><NlmUniqueID>100883596</NlmUniqueID><ISSNLinking>1398-5647</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005853" MajorTopicYN="Y">Geriatrics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017408" MajorTopicYN="N">Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006302" MajorTopicYN="Y">Health Services Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006701" MajorTopicYN="N">Home Nursing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008605" MajorTopicYN="Y">Mental Health Services</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="Y">Models, Theoretical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="Y">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017060" MajorTopicYN="N">Patient Satisfaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017216" MajorTopicYN="N">Telemedicine</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>10</Month><Day>8</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>4</Month><Day>9</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>10</Month><Day>8</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18837861</ArticleId><ArticleId IdType="pii">BDI602</ArticleId><ArticleId IdType="doi">10.1111/j.1399-5618.2008.00602.x</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19452498</PMID><DateCompleted><Year>2011</Year><Month>01</Month><Day>11</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1099-1166</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>12</Issue><PubDate><Year>2009</Year><Month>Dec</Month></PubDate></JournalIssue><Title>International journal of geriatric psychiatry</Title><ISOAbbreviation>Int J Geriatr Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Gray and white matter brain volumes in older adults with bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>1445-52</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/gps.2285</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Structural magnetic resonance imaging (MRI) studies have been inconsistent in demonstrating volumetric differences in subjects with bipolar disorder. Most studies have not found difference in total gray or white matter in bipolar patients compared with controls, but there have been several studies suggesting that regional abnormalities are present. These have predominately been located in the frontal and temporal lobes. Since age has been inversely correlated with total gray matter in patients, analyses of gray matter changes in older adults or in studies that have included older subjects have been difficult. This study assessed the presence of gray matter volume, and the potential for regional volumetric differences in older adults with bipolar disorder.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Fifty-six older adults with DSM-IV bipolar disorder (mean age 60.5) and 43 non-psychiatrically ill controls (mean age 58.1) had structured interviews and MRI scanning on a 1.5T GE Scanner. Image parcellation divided the cerebrum into 16 units. Volumetric differences were examined using the multivariate linear regression models with alpha = 0.05.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Relative to controls, the older adults with bipolar disorder had significantly smaller gray matter volumes bilaterally in the inferior frontal areas. White matter volume was also reduced in these same areas but did not reach statistical significance when controlled for gender and age. No significant difference was noted in total gray or white matter volumes.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Older adults with bipolar disorder showed gray matter volumetric deficits in inferior frontal lobe regions which include structures identified as contributing to the anterior limbic network.</AbstractText><CopyrightInformation>Copyright (c) 2009 John Wiley &amp; Sons, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Beyer</LastName><ForeName>John L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Duke University Medical Center, Department of Psychiatry and Behavioral Sciences, Neuropsychiatric Imaging Research Laboratory, USA. Beyer001@mc.duke.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuchibhatla</LastName><ForeName>Maragatha</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Payne</LastName><ForeName>Martha E</ForeName><Initials>ME</Initials></Author><Author ValidYN="Y"><LastName>Macfall</LastName><ForeName>James</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Cassidy</LastName><ForeName>Frederick</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Krishnan</LastName><ForeName>K Ranga R</ForeName><Initials>KR</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 MH057027</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 MH068848</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MH57027</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MH68848</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Geriatr Psychiatry</MedlineTA><NlmUniqueID>8710629</NlmUniqueID><ISSNLinking>0885-6230</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016014" MajorTopicYN="N">Linear Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>5</Month><Day>20</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>5</Month><Day>20</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19452498</ArticleId><ArticleId IdType="doi">10.1002/gps.2285</ArticleId><ArticleId IdType="pmc">PMC4441218</ArticleId><ArticleId IdType="mid">NIHMS662518</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Neurobiol Aging. 2000 Jul-Aug;21(4):569-76</Citation><ArticleIdList><ArticleId IdType="pubmed">10924774</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2004 Oct 1;56(7):467-75</Citation><ArticleIdList><ArticleId IdType="pubmed">15450781</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2005 May;186:369-77</Citation><ArticleIdList><ArticleId IdType="pubmed">15863740</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1999 Jul;156(7):1091-3</Citation><ArticleIdList><ArticleId IdType="pubmed">10401458</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2007 Oct 15;62(8):894-900</Citation><ArticleIdList><ArticleId IdType="pubmed">17617385</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurobiol Aging. 2001 Jul-Aug;22(4):581-94</Citation><ArticleIdList><ArticleId IdType="pubmed">11445259</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2002 Jul 15;52(2):93-100</Citation><ArticleIdList><ArticleId IdType="pubmed">12114000</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Neurol. 2001 Sep;58(9):1403-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11559311</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2009 Apr;114(1-3):50-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18691766</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1998 Jul;55(7):663-4</Citation><ArticleIdList><ArticleId IdType="pubmed">9672058</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2006 Apr 1;30(2):485-97</Citation><ArticleIdList><ArticleId IdType="pubmed">16256376</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2005 Apr 1;57(7):733-42</Citation><ArticleIdList><ArticleId IdType="pubmed">15820230</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Neurol. 1994 Sep;51(9):874-87</Citation><ArticleIdList><ArticleId IdType="pubmed">8080387</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1999 Jan;156(1):139-41</Citation><ArticleIdList><ArticleId IdType="pubmed">9892312</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2008 Sep;65(9):1017-32</Citation><ArticleIdList><ArticleId IdType="pubmed">18762588</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1999 Mar;56(3):254-60</Citation><ArticleIdList><ArticleId IdType="pubmed">10078503</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1994 Jun;151(6):842-8</Citation><ArticleIdList><ArticleId IdType="pubmed">8184992</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology. 2000 Sep;216(3):672-82</Citation><ArticleIdList><ArticleId IdType="pubmed">10966694</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychobiology. 2001;43(4):242-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11340363</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 2003 Apr 15;23(8):3295-301</Citation><ArticleIdList><ArticleId IdType="pubmed">12716936</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2005 Jan;10(1):105-16</Citation><ArticleIdList><ArticleId IdType="pubmed">15340357</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2005 Jun;62(6):617-27</Citation><ArticleIdList><ArticleId IdType="pubmed">15939839</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2002 Aug 20;115(1-2):63-77</Citation><ArticleIdList><ArticleId IdType="pubmed">12165368</ArticleId></ArticleIdList></Reference><Reference><Citation>Cereb Cortex. 2004 Sep;14(9):966-73</Citation><ArticleIdList><ArticleId IdType="pubmed">15115735</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 1990 Jun 1;27(11):1188-96</Citation><ArticleIdList><ArticleId IdType="pubmed">2354225</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1991 May;48(5):482-3</Citation><ArticleIdList><ArticleId IdType="pubmed">2021303</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 1997 Jan 1;41(1):1-14</Citation><ArticleIdList><ArticleId IdType="pubmed">8988790</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 1993 Apr 15-May 1;33(8-9):602-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8329491</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2000 Sep;2(3 Pt 1):148-64</Citation><ArticleIdList><ArticleId IdType="pubmed">11256682</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2004 Jan;161(1):99-108</Citation><ArticleIdList><ArticleId IdType="pubmed">14702257</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 1997 Aug 29;26(2-3):85-92</Citation><ArticleIdList><ArticleId IdType="pubmed">9323337</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 1992 Mar;42(3 Pt 1):527-36</Citation><ArticleIdList><ArticleId IdType="pubmed">1549213</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2000 Jul 15;48(2):147-62</Citation><ArticleIdList><ArticleId IdType="pubmed">10903411</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 1994 Aug;24(3):689-99</Citation><ArticleIdList><ArticleId IdType="pubmed">7991751</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2004 Feb 10;62(3):433-8</Citation><ArticleIdList><ArticleId IdType="pubmed">14872026</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 1978 Oct;4(4):345-56</Citation><ArticleIdList><ArticleId IdType="pubmed">727739</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychopharmacology. 1992 Feb;6(2):95-100</Citation><ArticleIdList><ArticleId IdType="pubmed">1319168</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1995 Sep;52(9):747-55</Citation><ArticleIdList><ArticleId IdType="pubmed">7654126</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1997 Apr 24;386(6627):824-7</Citation><ArticleIdList><ArticleId IdType="pubmed">9126739</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">10867113</PMID><DateCompleted><Year>2000</Year><Month>08</Month><Day>24</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-3956</ISSN><JournalIssue CitedMedium="Print"><Volume>34</Volume><Issue>3</Issue><PubDate><MedlineDate>2000 May-Jun</MedlineDate></PubDate></JournalIssue><Title>Journal of psychiatric research</Title><ISOAbbreviation>J Psychiatr Res</ISOAbbreviation></Journal><ArticleTitle>Construct validity of life chart functioning scales for use in naturalistic studies of bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>187-92</MedlinePgn></Pagination><Abstract><AbstractText>This study examined the construct validity of the functional impairment scales of the National Institute of Mental Health (NIMH) prospective life-charting methodology (LCM-p(TM)). Twelve male and 28 female bipolar participants were recruited from the community through advertisements. Diagnoses of bipolar I or II were confirmed using Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I). Patients completed life charts for three consecutive months. At the end of each month, a trained clinician administered the Hamilton Depression Rating Scale (HDRS) and the Young Mania Rating Scale YMRS by telephone, followed by ratings using the Global Asessment of Functioning (GAF), and Clinical Global Impression (CGI) for bipolar disorder. Data was analyzed separately for each month (time 1, time 2, and time 3). Complete data was available for 35 participants at time 1, 36 at time 2 and 32 at time 3. Spearman correlations demonstrated significant convergent validity at times 2 and 3 for life chart measures of mania (HIGH) and CGI-mania, and at all three times for life chart depression (LOW) and CGI-depression, with corresponding discriminant validities. The GAF was positively correlated with HIGH and negatively correlated with LOW at time 2 and 3 only. HAM-D and LOW also showed convergent and discriminant validity for all three times. For HIGH and YMRS, however, there was a strong significant correlation at time 3 only. While the use of heterogeneous methods maximizes differences between measures, it also appears that bipolar patients are less consistent in reporting functional impairment due to mania than due to depression. The construct of life chart dysfunction due to mania does not consistently measure the same construct as similar clinician ratings of mania. Life chart dysfunction due to depression shows higher construct validity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Meaden</LastName><ForeName>P M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Rush-Presbyterian-St. Luke's Medical Center, 1725 W. Harrison, Chicago, IL 60612, USA. pmeaden@enteract.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daniels</LastName><ForeName>R E</ForeName><Initials>RE</Initials></Author><Author ValidYN="Y"><LastName>Zajecka</LastName><ForeName>J</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Psychiatr Res</MedlineTA><NlmUniqueID>0376331</NlmUniqueID><ISSNLinking>0022-3956</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011594" MajorTopicYN="N">Psychometrics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012650" MajorTopicYN="N">Self Disclosure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012917" MajorTopicYN="Y">Social Adjustment</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2000</Year><Month>6</Month><Day>27</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2000</Year><Month>8</Month><Day>29</Day><Hour>11</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2000</Year><Month>6</Month><Day>27</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">10867113</ArticleId><ArticleId IdType="pii">S0022-3956(00)00008-X</ArticleId><ArticleId IdType="doi">10.1016/s0022-3956(00)00008-x</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">24999173</PMID><DateCompleted><Year>2015</Year><Month>06</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7123</ISSN><JournalIssue CitedMedium="Internet"><Volume>219</Volume><Issue>3</Issue><PubDate><Year>2014</Year><Month>Nov</Month><Day>30</Day></PubDate></JournalIssue><Title>Psychiatry research</Title><ISOAbbreviation>Psychiatry Res</ISOAbbreviation></Journal><ArticleTitle>Differential hedonic experience and behavioral activation in schizophrenia and bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>470-6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.psychres.2014.06.030</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0165-1781(14)00533-2</ELocationID><Abstract><AbstractText>The Kraepelinian distinction between schizophrenia (SZ) and bipolar disorder (BP) emphasizes affective and volitional impairment in the former, but data directly comparing the two disorders for hedonic experience are scarce. This study examined whether hedonic experience and behavioral activation may be useful phenotypes distinguishing SZ and BP. Participants were 39 SZ and 24 BP patients without current mood episode matched for demographics and negative affect, along with 36 healthy controls (HC). They completed the Chapman Physical and Social Anhedonia Scales, Temporal Experience of Pleasure Scale (TEPS), and Behavioral Activation Scale (BAS). SZ and BP showed equally elevated levels of self-report negative affect and trait anhedonia compared to HC. However, SZ reported significantly lower pleasure experience (TEPS) and behavioral activation (BAS) than BP, who did not differ from HC. SZ and BP showed differential patterns of relationships between the hedonic experience and behavioral activation measures. Overall, the results suggest that reduced hedonic experience and behavioral activation may be effective phenotypes distinguishing SZ from BP even when affective symptoms are minimal. However, hedonic experience differences between SZ and BP are sensitive to measurement strategy, calling for further research on the nature of anhedonia and its relation to motivation in these disorders. </AbstractText><CopyrightInformation>Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tso</LastName><ForeName>Ivy F</ForeName><Initials>IF</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Michigan, 4250 Plymouth Road, Ann Arbor, MI 48109, USA. Electronic address: ivytso@umich.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grove</LastName><ForeName>Tyler B</ForeName><Initials>TB</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Michigan, 4250 Plymouth Road, Ann Arbor, MI 48109, USA; Department of Psychology, University of Michigan, 530 Church Street, Ann Arbor, MI 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Stephan F</ForeName><Initials>SF</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Michigan, 4250 Plymouth Road, Ann Arbor, MI 48109, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 MH064148</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>06</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Psychiatry Res</MedlineTA><NlmUniqueID>7911385</NlmUniqueID><ISSNLinking>0165-1781</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000339" MajorTopicYN="N">Affect</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000342" MajorTopicYN="N">Affective Symptoms</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059445" MajorTopicYN="N">Anhedonia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057181" MajorTopicYN="Y">Pleasure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011581" MajorTopicYN="N">Psychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012559" MajorTopicYN="N">Schizophrenia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012565" MajorTopicYN="Y">Schizophrenic Psychology</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anhedonia</Keyword><Keyword MajorTopicYN="N">Emotional experience</Keyword><Keyword MajorTopicYN="N">Mania</Keyword><Keyword MajorTopicYN="N">Motivation</Keyword><Keyword MajorTopicYN="N">Psychosis</Keyword><Keyword MajorTopicYN="N">Reward processing</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>06</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>03</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>06</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24999173</ArticleId><ArticleId IdType="pii">S0165-1781(14)00533-2</ArticleId><ArticleId IdType="doi">10.1016/j.psychres.2014.06.030</ArticleId><ArticleId IdType="pmc">PMC4143463</ArticleId><ArticleId IdType="mid">NIHMS611295</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arch Gen Psychiatry. 2012 Feb;69(2):121-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21969420</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2014 Mar;40 Suppl 2:S107-16</Citation><ArticleIdList><ArticleId IdType="pubmed">24375459</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2004 Jun 1;68(2-3):283-97</Citation><ArticleIdList><ArticleId IdType="pubmed">15099610</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2000;26(4):847-54</Citation><ArticleIdList><ArticleId IdType="pubmed">11087017</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2013 Mar;15(2):188-98</Citation><ArticleIdList><ArticleId IdType="pubmed">23437962</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2008 Sep;34(5):835-47</Citation><ArticleIdList><ArticleId IdType="pubmed">18591195</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatr Res. 1999 Nov-Dec;33(6):473-5</Citation><ArticleIdList><ArticleId IdType="pubmed">10628522</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Psychiatry. 2010 Mar;23(2):91-6</Citation><ArticleIdList><ArticleId IdType="pubmed">20051858</ArticleId></ArticleIdList></Reference><Reference><Citation>J Abnorm Psychol. 2008 Nov;117(4):776-787</Citation><ArticleIdList><ArticleId IdType="pubmed">19025225</ArticleId></ArticleIdList></Reference><Reference><Citation>Value Health. 2010 Dec;13(8):984-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20667057</ArticleId></ArticleIdList></Reference><Reference><Citation>J Abnorm Psychol. 1994 Nov;103(4):719-28</Citation><ArticleIdList><ArticleId IdType="pubmed">7822573</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2013 May;147(1-3):446-50</Citation><ArticleIdList><ArticleId IdType="pubmed">23122985</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2007 Nov;9(7):706-12</Citation><ArticleIdList><ArticleId IdType="pubmed">17988360</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2012 Apr;169(4):364-73</Citation><ArticleIdList><ArticleId IdType="pubmed">22407079</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2006 Apr;32(2):238-45</Citation><ArticleIdList><ArticleId IdType="pubmed">16254064</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2011 Oct;133(3):457-66</Citation><ArticleIdList><ArticleId IdType="pubmed">21665287</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2001 Dec;58(12):1137-44</Citation><ArticleIdList><ArticleId IdType="pubmed">11735842</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychopharmacology. 2008 Aug;33(9):2217-27</Citation><ArticleIdList><ArticleId IdType="pubmed">17987058</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2011 May 15;187(1-2):36-41</Citation><ArticleIdList><ArticleId IdType="pubmed">21295860</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2013 Mar;39(2):247-50</Citation><ArticleIdList><ArticleId IdType="pubmed">23328158</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2008 Jul 15;64(2):162-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18242583</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2006 Apr;32(2):259-73</Citation><ArticleIdList><ArticleId IdType="pubmed">16221997</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 2006 Sep;36(9):1213-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16707029</ArticleId></ArticleIdList></Reference><Reference><Citation>J Abnorm Psychol. 1976 Aug;85(4):374-82</Citation><ArticleIdList><ArticleId IdType="pubmed">956504</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2003 May 1;61(1):59-66</Citation><ArticleIdList><ArticleId IdType="pubmed">12648736</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2011 Mar;168(3):276-85</Citation><ArticleIdList><ArticleId IdType="pubmed">21205806</ArticleId></ArticleIdList></Reference><Reference><Citation>J Abnorm Psychol. 2008 Feb;117(1):164-70</Citation><ArticleIdList><ArticleId IdType="pubmed">18266494</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 1999 Aug 1;46(3):352-60</Citation><ArticleIdList><ArticleId IdType="pubmed">10435200</ArticleId></ArticleIdList></Reference><Reference><Citation>J Abnorm Psychol. 2001 Aug;110(3):363-71</Citation><ArticleIdList><ArticleId IdType="pubmed">11502079</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2012 Jun;14(4):326-39</Citation><ArticleIdList><ArticleId IdType="pubmed">22631618</ArticleId></ArticleIdList></Reference><Reference><Citation>J Epidemiol Community Health. 2005 Aug;59(8):619-27</Citation><ArticleIdList><ArticleId IdType="pubmed">16020636</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2008 Sep;34(5):856-74</Citation><ArticleIdList><ArticleId IdType="pubmed">18667393</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2008 Sep;34(5):819-34</Citation><ArticleIdList><ArticleId IdType="pubmed">18579556</ArticleId></ArticleIdList></Reference><Reference><Citation>Emotion. 2008 Feb;8(1):23-33</Citation><ArticleIdList><ArticleId IdType="pubmed">18266513</ArticleId></ArticleIdList></Reference><Reference><Citation>Cognit Ther Res. 2008 Oct 1;32(5):702-713</Citation><ArticleIdList><ArticleId IdType="pubmed">20360996</ArticleId></ArticleIdList></Reference><Reference><Citation>J Abnorm Psychol. 2007 Feb;116(1):105-15</Citation><ArticleIdList><ArticleId IdType="pubmed">17324021</ArticleId></ArticleIdList></Reference><Reference><Citation>J Abnorm Psychol. 2011 Nov;120(4):956-61</Citation><ArticleIdList><ArticleId IdType="pubmed">21553935</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry Suppl. 1993 Dec;(22):39-44</Citation><ArticleIdList><ArticleId IdType="pubmed">8110442</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2007 Feb-Mar;9(1-2):144-57</Citation><ArticleIdList><ArticleId IdType="pubmed">17391357</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychopathol Behav Assess. 2001 Sep 1;23(3):133-143</Citation><ArticleIdList><ArticleId IdType="pubmed">21765592</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 1986 Nov-Dec;27(6):549-58</Citation><ArticleIdList><ArticleId IdType="pubmed">3536286</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2009 Jan 30;165(1-2):193-6</Citation><ArticleIdList><ArticleId IdType="pubmed">18973955</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1994 Oct;151(10):1453-62</Citation><ArticleIdList><ArticleId IdType="pubmed">7916540</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2006 Jan 15;29(2):409-16</Citation><ArticleIdList><ArticleId IdType="pubmed">16139525</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Res Ther. 2009 Aug;47(8):697-704</Citation><ArticleIdList><ArticleId IdType="pubmed">19501814</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2010 Jan;36(1):143-50</Citation><ArticleIdList><ArticleId IdType="pubmed">18562345</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2012 Jan 30;195(1-2):39-44</Citation><ArticleIdList><ArticleId IdType="pubmed">21788084</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 1998;24(3):413-24</Citation><ArticleIdList><ArticleId IdType="pubmed">9718633</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2007 Jul;93(1-3):253-60</Citation><ArticleIdList><ArticleId IdType="pubmed">17490858</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pers Soc Psychol. 2001 May;80(5):797-803</Citation><ArticleIdList><ArticleId IdType="pubmed">11374750</ArticleId></ArticleIdList></Reference><Reference><Citation>J Abnorm Psychol. 2000 Nov;109(4):721-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11195996</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Clin Psychol. 2013;9:409-33</Citation><ArticleIdList><ArticleId IdType="pubmed">23245340</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatr Res. 2006 Oct;40(7):638-45</Citation><ArticleIdList><ArticleId IdType="pubmed">16643947</ArticleId></ArticleIdList></Reference><Reference><Citation>J Abnorm Psychol. 1994 Feb;103(1):148-58</Citation><ArticleIdList><ArticleId IdType="pubmed">8040476</ArticleId></ArticleIdList></Reference><Reference><Citation>Soc Psychiatry Psychiatr Epidemiol. 1990 Jan;25(1):41-7</Citation><ArticleIdList><ArticleId IdType="pubmed">2406949</ArticleId></ArticleIdList></Reference><Reference><Citation>J Abnorm Psychol. 1985 Aug;94(3):384-96</Citation><ArticleIdList><ArticleId IdType="pubmed">4031235</ArticleId></ArticleIdList></Reference><Reference><Citation>J Abnorm Psychol. 1992 Feb;101(1):184-91</Citation><ArticleIdList><ArticleId IdType="pubmed">1537965</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2009 Apr 30;166(2-3):132-40</Citation><ArticleIdList><ArticleId IdType="pubmed">19272653</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">10862802</PMID><DateCompleted><Year>2000</Year><Month>07</Month><Day>12</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0006-3223</ISSN><JournalIssue CitedMedium="Print"><Volume>47</Volume><Issue>12</Issue><PubDate><Year>2000</Year><Month>Jun</Month><Day>15</Day></PubDate></JournalIssue><Title>Biological psychiatry</Title><ISOAbbreviation>Biol Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Family history and symptom levels during treatment for bipolar I affective disorder.</ArticleTitle><Pagination><MedlinePgn>1034-42</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Studies of family history and lithium response in patients with bipolar affective disorder have produced mixed results, but the majority have shown relationships between the presence of affective disorder among relatives and positive responses to lithium in probands. The analysis presented here sought to confirm and to further characterize such relationships.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Subjects described here participated in a long-term, prospective follow-up; had a history of Research Diagnostic Criteria manic disorder or schizoaffective disorder, manic type; and took lithium for periods of 26 weeks or longer. The majority participated in a family study in which first-degree relatives were directly interviewed. Morbidity during lithium and during anticonvulsant trials was quantified in alternative ways, as were the risks among first-degree relatives for bipolar I and nonbipolar affective disorders.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Familial loading for bipolar affective disorder was not associated with better outcomes during lithium treatment. Rather, the presence of major depressive disorder (MDD) among relatives was associated with slower improvement during acute treatment and with higher symptom levels during continuing treatment. Findings for morbidity during anticonvulsant treatment were similar. The patients who experienced symptom persistence with lithium did so as well during periods of anticonvulsant treatment and during periods without thymoleptics.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">A family history of MDD may have an enduring and negative prognostic significance that manifests across treatment conditions. Though difficult to reconcile with several earlier studies, these findings invite replication and further exploration.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Coryell</LastName><ForeName>W</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Iowa, Iowa City 52242-1000, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akiskal</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Leon</LastName><ForeName>A C</ForeName><Initials>AC</Initials></Author><Author ValidYN="Y"><LastName>Turvey</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Solomon</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Endicott</LastName><ForeName>J</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MH25416</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MH51324</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biol Psychiatry</MedlineTA><NlmUniqueID>0213264</NlmUniqueID><ISSNLinking>0006-3223</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000927">Anticonvulsants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018692">Antimanic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>9FN79X2M3F</RegistryNumber><NameOfSubstance UI="D008094">Lithium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000927" MajorTopicYN="N">Anticonvulsants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018692" MajorTopicYN="N">Antimanic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005190" MajorTopicYN="N">Family</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008094" MajorTopicYN="N">Lithium</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2000</Year><Month>6</Month><Day>23</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2000</Year><Month>7</Month><Day>15</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2000</Year><Month>6</Month><Day>23</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">10862802</ArticleId><ArticleId IdType="pii">S0006322300002420</ArticleId><ArticleId IdType="doi">10.1016/s0006-3223(00)00242-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">28850853</PMID><DateCompleted><Year>2018</Year><Month>04</Month><Day>13</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-2517</ISSN><JournalIssue CitedMedium="Internet"><Volume>225</Volume><PubDate><Year>2018</Year><Month>01</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of affective disorders</Title><ISOAbbreviation>J Affect Disord</ISOAbbreviation></Journal><ArticleTitle>Quantitative genetic analysis of anxiety trait in bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>395-398</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0165-0327(17)30649-3</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jad.2017.08.023</ELocationID><Abstract><AbstractText Label="BACKGROUND">Bipolar disorder type I (BPI) affects approximately 1% of the world population. Although genetic influences on bipolar disorder are well established, identification of genes that predispose to the illness has been difficult. Most genetic studies are based on categorical diagnosis. One strategy to overcome this obstacle is the use of quantitative endophenotypes, as has been done for other medical disorders.</AbstractText><AbstractText Label="METHODS">We studied 619 individuals, 568 participants from 61 extended families and 51 unrelated healthy controls. The sample was 55% female and had a mean age of 43.25 (SD 13.90; range 18-78). Heritability and genetic correlation of the trait scale from the Anxiety State and Trait Inventory (STAI) was computed by using the general linear model (SOLAR package software).</AbstractText><AbstractText Label="RESULTS">we observed that anxiety trait meets the following criteria for an endophenotype of bipolar disorder type I (BPI): 1) association with BPI (individuals with BPI showed the highest trait score (F = 15.20 [5,24], p = 0.009), 2) state-independence confirmed after conducting a test-retest in 321 subjects, 3) co-segregation within families 4) heritability of 0.70 (SE: 0.060), p = 2.33 × 10<sup>-14</sup> and 5) genetic correlation with BPI was 0.20, (SE = 0.17, p = 3.12 × 10<sup>-5</sup>).</AbstractText><AbstractText Label="LIMITATIONS">Confounding factors such as comorbid disorders and pharmacological treatment could affect the clinical relationship between BPI and anxiety trait. Further research is needed to evaluate if anxiety traits are specially related to BPI in comparison with other traits such as anger, attention or response inhibition deficit, pathological impulsivity or low self-directedness.</AbstractText><AbstractText Label="CONCLUSIONS">Anxiety trait is a heritable phenotype that follows a normal distribution when measured not only in subjects with BPI but also in unrelated healthy controls. It could be used as an endophenotype in BPI for the identification of genomic regions with susceptibility genes for this disorder.</AbstractText><CopyrightInformation>Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Contreras</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centro de Investigación en Biología Celular y Molecular, Universidad de Costa Rica, Costa Rica. Electronic address: dr.javiercontreras@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hare</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Genetics and Genomics Research and Breeding Program Planning, Dog Genetics LLC., Sunnyside, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chavarría</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Escuela de Biología, Universidad de Costa Rica, Costa Rica.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raventós</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Centro de Investigación en Biología Celular y Molecular, Universidad de Costa Rica, Costa Rica; Escuela de Biología, Universidad de Costa Rica, Costa Rica.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 EB015611</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 TW008290</GrantID><Acronym>TW</Acronym><Agency>FIC NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>08</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Affect Disord</MedlineTA><NlmUniqueID>7906073</NlmUniqueID><ISSNLinking>0165-0327</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001008" MajorTopicYN="N">Anxiety Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058068" MajorTopicYN="N">Endophenotypes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005190" MajorTopicYN="N">Family</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005820" MajorTopicYN="N">Genetic Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007175" MajorTopicYN="N">Impulsive Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010555" MajorTopicYN="N">Personality Inventory</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019655" MajorTopicYN="Y">Quantitative Trait, Heritable</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Anxiety</Keyword><Keyword MajorTopicYN="Y">Bipolar disorder</Keyword><Keyword MajorTopicYN="Y">Central Valley of Costa Rica</Keyword><Keyword MajorTopicYN="Y">Endophenotype</Keyword><Keyword MajorTopicYN="Y">Genetics</Keyword><Keyword MajorTopicYN="Y">Heritability</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>03</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>08</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28850853</ArticleId><ArticleId IdType="pii">S0165-0327(17)30649-3</ArticleId><ArticleId IdType="doi">10.1016/j.jad.2017.08.023</ArticleId><ArticleId IdType="pmc">PMC5626643</ArticleId><ArticleId IdType="mid">NIHMS902372</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schizophr Bull. 2002;28(4):683-95</Citation><ArticleIdList><ArticleId IdType="pubmed">12795498</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2001 Mar;158(3):420-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11229983</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2008 Dec;111(2-3):366-71</Citation><ArticleIdList><ArticleId IdType="pubmed">18442858</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2006 Jul 15;60(2):93-105</Citation><ArticleIdList><ArticleId IdType="pubmed">16406007</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2003 Apr;160(4):636-45</Citation><ArticleIdList><ArticleId IdType="pubmed">12668349</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropharmacology. 2010 Jan;58(1):56-61</Citation><ArticleIdList><ArticleId IdType="pubmed">19589349</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet B Neuropsychiatr Genet. 2014 Mar;165B(2):122-30</Citation><ArticleIdList><ArticleId IdType="pubmed">24464604</ArticleId></ArticleIdList></Reference><Reference><Citation>J Child Adolesc Psychopharmacol. 2002 Summer;12(2):101-11</Citation><ArticleIdList><ArticleId IdType="pubmed">12188979</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1982 Aug;39(8):879-83</Citation><ArticleIdList><ArticleId IdType="pubmed">7103676</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Bull. 2007 Sep;133(5):833-58</Citation><ArticleIdList><ArticleId IdType="pubmed">17723032</ArticleId></ArticleIdList></Reference><Reference><Citation>J Nerv Ment Dis. 2009 Jul;197(7):530-5</Citation><ArticleIdList><ArticleId IdType="pubmed">19597361</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Clin Psychiatry. 2016 Aug;28(3):213-20</Citation><ArticleIdList><ArticleId IdType="pubmed">27490837</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 1973 Jan;122(566):15-30</Citation><ArticleIdList><ArticleId IdType="pubmed">4683020</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 1998 May;62(5):1198-211</Citation><ArticleIdList><ArticleId IdType="pubmed">9545414</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2005 Mar;85(1-2):153-68</Citation><ArticleIdList><ArticleId IdType="pubmed">15780686</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2010 May;122(3):267-72</Citation><ArticleIdList><ArticleId IdType="pubmed">19733400</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2008 May;108(1-2):25-32</Citation><ArticleIdList><ArticleId IdType="pubmed">18006072</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet C Semin Med Genet. 2003 Nov 15;123C(1):76-84</Citation><ArticleIdList><ArticleId IdType="pubmed">14601039</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1994 Nov;51(11):849-59; discussion 863-4</Citation><ArticleIdList><ArticleId IdType="pubmed">7944874</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2013 Jan;170(1):1-5</Citation><ArticleIdList><ArticleId IdType="pubmed">23288382</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pers Assess. 2008 May;90(3):280-5</Citation><ArticleIdList><ArticleId IdType="pubmed">18444124</ArticleId></ArticleIdList></Reference><Reference><Citation>Percept Mot Skills. 1988 Dec;67(3):926</Citation><ArticleIdList><ArticleId IdType="pubmed">3226849</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">10512603</PMID><DateCompleted><Year>1999</Year><Month>11</Month><Day>10</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0165-0327</ISSN><JournalIssue CitedMedium="Print"><Volume>55</Volume><Issue>1</Issue><PubDate><Year>1999</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of affective disorders</Title><ISOAbbreviation>J Affect Disord</ISOAbbreviation></Journal><ArticleTitle>Autoantibody disturbances in affective disorders: a function of age and gender?</ArticleTitle><Pagination><MedlinePgn>29-37</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Numerous investigators have reported increased autoantibodies to a wide variety of native antigens in patients with affective disorders. However, association of autoimmunity with affective subtypes, mood state, psychotropic medications, age, and gender has not been extensively explored.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The present study assessed 79 bipolar I, 24 bipolar II, and 46 unipolar major depression patients along with 22 healthy, nonpsychiatric controls for the presence of serum antinuclear (ANA), anti-double stranded DNA, antithyroid microsomal, antithyroglobulin, anticardiolipin (ACA) IgM, and ACA IgG antibodies.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Consistent with their higher prevalence of autoimmune disease, women exhibited increased levels of ANA and ACA IgM compared to men. ACA IgG antibody titers also increased significantly with age. Contrary to prior reports of general, overall increases in autoantibodies and specific increases in ANA and antithyroid antibodies in depressed patients, we did not see a significant association between any of the autoantibodies and affective subtype, mood state, or psychotropic medications.</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">Affective subgroups were heterogeneous with respect to psychotropic medications, affective state, age, and gender in this retrospective analysis. Subgroup sample size was insufficient to determine whether interactions of these clinical variables may have influenced results.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">These results suggest that gender and age may have more influence on autoantibodies than affective diagnosis, affective state, or medications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hornig</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory for the Study of Emerging Diseases, University of California Irvine, 92697-4292, USA. mhornig@uci.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amsterdam</LastName><ForeName>J D</ForeName><Initials>JD</Initials></Author><Author ValidYN="Y"><LastName>Kamoun</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Goodman</LastName><ForeName>D B</ForeName><Initials>DB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Affect Disord</MedlineTA><NlmUniqueID>7906073</NlmUniqueID><ISSNLinking>0165-0327</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="N">Autoimmune Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003865" MajorTopicYN="N">Depressive Disorder, Major</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1999</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1999</Year><Month>10</Month><Day>8</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1999</Year><Month>10</Month><Day>8</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">10512603</ArticleId><ArticleId IdType="pii">S0165-0327(98)00190-6</ArticleId><ArticleId IdType="doi">10.1016/s0165-0327(98)00190-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16938147</PMID><DateCompleted><Year>2007</Year><Month>03</Month><Day>02</Day></DateCompleted><DateRevised><Year>2017</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0033-2917</ISSN><JournalIssue CitedMedium="Print"><Volume>36</Volume><Issue>12</Issue><PubDate><Year>2006</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Psychological medicine</Title><ISOAbbreviation>Psychol Med</ISOAbbreviation></Journal><ArticleTitle>Bipolar I and bipolar II disorder: cognition and emotion processing.</ArticleTitle><Pagination><MedlinePgn>1799-809</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cognitive impairment may be part of the endophenotype of bipolar disorder (BP), but little is known about patterns and severity of impairment in BP subgroups and their relation to depression. The same applies to deficits in emotion processing known to be present in BP.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">To explore the relationship between depression and impairment in cognition and emotion processing and the differences between BP subgroups, we assessed 36 (25 BP I and 11 BP II) patients using a cognitive battery and a facial emotion recognition task.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">BP patients were impaired compared to published norms on memory, naming and executive measures (Binomial Single Proportion tests, p&lt;0.05). Cognitive performance was largely unrelated to depression ratings. Surprise recognition was the only emotion processing impairment in BP patients compared to controls (patients' recognition score 75% v. controls' 89%, p=0.024). Patients with higher depression ratings were more impaired in recognizing expressions of anger (t23=2.21, p=0.037). BP II patients were more impaired than BP I patients in IQ, memory and executive measures (Mann-Whitney tests, p&lt;0.05). Depression severity or exposure to medication or electroconvulsive therapy (ECT) did not explain these differences.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We confirm cognitive impairment and an isolated facial emotion processing deficit in BP patients and suggest that these deficits are largely unrelated to depressive symptoms. Our study also provides evidence that cognitive deficits are more severe and pervasive in BP II patients, suggesting that recurrent depressive episodes, rather than mania, may have a more detrimental and lasting effect on cognition.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Summers</LastName><ForeName>Mary</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>NMR Research Unit, Institute of Neurology, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papadopoulou</LastName><ForeName>Kyriaki</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Bruno</LastName><ForeName>Stefania</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Cipolotti</LastName><ForeName>Lisa</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Ron</LastName><ForeName>Maria A</ForeName><Initials>MA</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>748</GrantID><Agency>Multiple Sclerosis Society</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2006</Year><Month>08</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Psychol Med</MedlineTA><NlmUniqueID>1254142</NlmUniqueID><ISSNLinking>0033-2917</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000339" MajorTopicYN="Y">Affect</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D039721" MajorTopicYN="N">Diagnostic and Statistical Manual of Mental Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>8</Month><Day>30</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>3</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>8</Month><Day>30</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16938147</ArticleId><ArticleId IdType="pii">S0033291706008804</ArticleId><ArticleId IdType="doi">10.1017/S0033291706008804</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">4441237</PMID><DateCompleted><Year>1975</Year><Month>02</Month><Day>27</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0003-990X</ISSN><JournalIssue CitedMedium="Print"><Volume>31</Volume><Issue>5</Issue><PubDate><Year>1974</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Archives of general psychiatry</Title><ISOAbbreviation>Arch Gen Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Manic-depressive illness and paranoid schizophrenia. A phenomenologic, family history, and treatment-response study.</ArticleTitle><Pagination><MedlinePgn>640-2</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abrams</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>M A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Gaztanaga</LastName><ForeName>P</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Arch Gen Psychiatry</MedlineTA><NlmUniqueID>0372435</NlmUniqueID><ISSNLinking>0003-990X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014149">Tranquilizing Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>9FN79X2M3F</RegistryNumber><NameOfSubstance UI="D008094">Lithium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003951" MajorTopicYN="N">Diagnostic Errors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004565" MajorTopicYN="N">Electroconvulsive Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008094" MajorTopicYN="N">Lithium</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019965" MajorTopicYN="N">Neurocognitive Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010554" MajorTopicYN="N">Personality Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011599" MajorTopicYN="N">Psychopathology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012563" MajorTopicYN="N">Schizophrenia, Paranoid</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014149" MajorTopicYN="N">Tranquilizing Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1974</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1974</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1974</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">4441237</ArticleId><ArticleId IdType="doi">10.1001/archpsyc.1974.01760170040006</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">5000023</PMID><DateCompleted><Year>1971</Year><Month>12</Month><Day>21</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0028-2804</ISSN><JournalIssue CitedMedium="Print"><Volume>42</Volume><Issue>10</Issue><PubDate><Year>1971</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Der Nervenarzt</Title><ISOAbbreviation>Nervenarzt</ISOAbbreviation></Journal><ArticleTitle>[Phasic depression and epilepsy. Two polar cases].</ArticleTitle><Pagination><MedlinePgn>539-45</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bechthold</LastName><ForeName>H G</ForeName><Initials>HG</Initials></Author><Author ValidYN="Y"><LastName>Schottky</LastName><ForeName>A</ForeName><Initials>A</Initials></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Phasische Verstimmung und Epilepsie. Zwei polare Fälle.</VernacularTitle></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Nervenarzt</MedlineTA><NlmUniqueID>0400773</NlmUniqueID><ISSNLinking>0028-2804</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007093">Imidazoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010640">Phenothiazines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010879">Piperazines</NameOfSubstance></Chemical><Chemical><RegistryNumber>13AFD7670Q</RegistryNumber><NameOfSubstance UI="D011324">Primidone</NameOfSubstance></Chemical><Chemical><RegistryNumber>9S7OD60EWP</RegistryNumber><NameOfSubstance UI="D002749">Chlorprothixene</NameOfSubstance></Chemical><Chemical><RegistryNumber>BL03SY4LXB</RegistryNumber><NameOfSubstance UI="D009661">Nortriptyline</NameOfSubstance></Chemical><Chemical><RegistryNumber>J6292F8L3D</RegistryNumber><NameOfSubstance UI="D006220">Haloperidol</NameOfSubstance></Chemical><Chemical><RegistryNumber>N3D6TG58NI</RegistryNumber><NameOfSubstance UI="D013881">Thioridazine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002749" MajorTopicYN="N">Chlorprothixene</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004569" MajorTopicYN="N">Electroencephalography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004830" MajorTopicYN="N">Epilepsy, Tonic-Clonic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006220" MajorTopicYN="N">Haloperidol</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007093" MajorTopicYN="N">Imidazoles</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009661" MajorTopicYN="N">Nortriptyline</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010640" MajorTopicYN="N">Phenothiazines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010879" MajorTopicYN="N">Piperazines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011324" MajorTopicYN="N">Primidone</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013881" MajorTopicYN="N">Thioridazine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1971</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1971</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1971</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">5000023</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">24880581</PMID><DateCompleted><Year>2015</Year><Month>03</Month><Day>18</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7123</ISSN><JournalIssue CitedMedium="Internet"><Volume>219</Volume><Issue>1</Issue><PubDate><Year>2014</Year><Month>Sep</Month><Day>30</Day></PubDate></JournalIssue><Title>Psychiatry research</Title><ISOAbbreviation>Psychiatry Res</ISOAbbreviation></Journal><ArticleTitle>Eye movement desensitization and reprocessing therapy in subsyndromal bipolar patients with a history of traumatic events: a randomized, controlled pilot-study.</ArticleTitle><Pagination><MedlinePgn>122-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.psychres.2014.05.012</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0165-1781(14)00383-7</ELocationID><Abstract><AbstractText>Traumatic events are frequent in bipolar patients and can worsen the course of the disease. Psychotherapeutic interventions for these events have not been studied so far. Twenty DSM-IV bipolar I and II patients with subsyndromal mood symptoms and a history of traumatic events were randomly assigned to Eye Movement Desensitization and Reprocessing therapy (n=10) or treatment as usual (n=10). The treatment group received between 14 and 18 Eye Movement Desensitization and Reprocessing sessions during 12 weeks. Evaluations of affective symptoms, symptoms of trauma and trauma impact were carried out by a blind rater at baseline, 2 weeks, 5 weeks, 8 weeks, 12 weeks and at 24 weeks follow-up. Patients in the treatment group showed a statistically significant improvement in depressive and hypomanic symptoms, symptoms of trauma and trauma impact compared to the treatment as usual group after intervention. This effect was only partly maintained in trauma impact at the 24 weeks follow-up visit. One patient dropped from Eye Movement Desensitization and Reprocessing group whereas four from the treatment as usual group. This pilot study suggests that Eye Movement Desensitization and Reprocessing therapy may be an effective and safe intervention to treat subsyndromal mood and trauma symptoms in traumatized bipolar patients. </AbstractText><CopyrightInformation>Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Novo</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain; Departament de Psiquiatria i Medicina Legal, Doctorat de Psiquiatria i Psicología Clínica, Universitat Autònoma de Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landin-Romero</LastName><ForeName>Ramon</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain; CIBERSAM, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radua</LastName><ForeName>Joaquim</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain; CIBERSAM, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vicens</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain; CIBERSAM, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandez</LastName><ForeName>Isabel</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Psychotraumatology Research Center, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia</LastName><ForeName>Francisca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>EMDR Spain, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pomarol-Clotet</LastName><ForeName>Edith</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain; CIBERSAM, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McKenna</LastName><ForeName>Peter J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain; CIBERSAM, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shapiro</LastName><ForeName>Francine</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Mental Research Institute, Palo Alto, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amann</LastName><ForeName>Benedikt L</ForeName><Initials>BL</Initials><AffiliationInfo><Affiliation>FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain; CIBERSAM, Madrid, Spain. Electronic address: benedikt.amann@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>05</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Psychiatry Res</MedlineTA><NlmUniqueID>7911385</NlmUniqueID><ISSNLinking>0165-1781</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057169" MajorTopicYN="Y">Eye Movement Desensitization Reprocessing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013313" MajorTopicYN="N">Stress Disorders, Post-Traumatic</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bipolar disorder</Keyword><Keyword MajorTopicYN="N">Clinical trial</Keyword><Keyword MajorTopicYN="N">EMDR</Keyword><Keyword MajorTopicYN="N">PTSD</Keyword><Keyword MajorTopicYN="N">Subsyndromal symptoms</Keyword><Keyword MajorTopicYN="N">Traumatic events</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>11</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>04</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>05</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24880581</ArticleId><ArticleId IdType="pii">S0165-1781(14)00383-7</ArticleId><ArticleId IdType="doi">10.1016/j.psychres.2014.05.012</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16848652</PMID><DateCompleted><Year>2007</Year><Month>08</Month><Day>27</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1555-2101</ISSN><JournalIssue CitedMedium="Internet"><Volume>67</Volume><Issue>6</Issue><PubDate><Year>2006</Year><Month>Jun</Month></PubDate></JournalIssue><Title>The Journal of clinical psychiatry</Title><ISOAbbreviation>J Clin Psychiatry</ISOAbbreviation></Journal><ArticleTitle>A gender-focused perspective on health service utilization in comorbid bipolar I disorder and alcohol use disorders: results from the national epidemiologic survey on alcohol and related conditions.</ArticleTitle><Pagination><MedlinePgn>925-32</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This study compares health service utilization by individuals with comorbid lifetime bipolar I disorder and lifetime alcohol use disorders (AUD) to that of individuals with either diagnosis alone, using nationally representative data.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">The 2001-2002 National Epidemiologic Survey on Alcohol and Related Conditions was used to identify respondents with bipolar I disorder only (BD-only; N = 636), AUD only (N = 11,068), and comorbid bipolar I disorder and AUD (BD-AUD; N = 775). Diagnoses were generated using the National Institute on Alcohol Abuse and Alcoholism Alcohol Use Disorder and Associated Disabilities Interview Schedule-DSM-IV Version. The 3 groups were compared with respect to self-reported health service utilization.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">For both men and women, respondents in the BD-AUD group were significantly more likely than AUD-only respondents to report any alcohol-related service utilization (p &lt; .001). BD-AUD respondents were significantly more likely to report bipolar disorder-related hospital admissions as compared with BD-only respondents among males only (p = .009). Within the BD-AUD group, males reported significantly greater utilization of AUD treatment only (p &lt; .001), and females reported significantly greater utilization of bipolar disorder treatment only (p &lt; .001) and significantly greater likelihood of utilizing mental health services overall (p &lt; .001). There was no gender difference in the proportion of respondents who utilized both AUD and bipolar disorder services.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">As expected, individuals with comorbid bipolar I disorder and AUD utilize significantly more mental health services than individuals with either disorder alone. The primary original finding is that among those with comorbid bipolar I disorder and AUD, bipolar I disorder is more likely to go untreated among males and AUD is more likely to go untreated among females. Gender may be an important factor to consider in future health service planning for comorbid bipolar I disorder and AUD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Goldstein</LastName><ForeName>Benjamin I</ForeName><Initials>BI</Initials><AffiliationInfo><Affiliation>Mood Disorders Program, Department of Psychiatry, Sunnybrook and Women's College Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada. benjamin.goldstein@utoronto.ca</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levitt</LastName><ForeName>Anthony J</ForeName><Initials>AJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Psychiatry</MedlineTA><NlmUniqueID>7801243</NlmUniqueID><ISSNLinking>0160-6689</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000437" MajorTopicYN="N">Alcoholism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017831" MajorTopicYN="N">Diagnosis, Dual (Psychiatry)</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006296" MajorTopicYN="N">Health Services</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006306" MajorTopicYN="N">Health Surveys</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>7</Month><Day>20</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>8</Month><Day>28</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>7</Month><Day>20</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16848652</ArticleId><ArticleId IdType="doi">10.4088/jcp.v67n0609</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">34190952</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>02</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1518-8345</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Revista latino-americana de enfermagem</Title><ISOAbbreviation>Rev Lat Am Enfermagem</ISOAbbreviation></Journal><ArticleTitle>Pain in the bipolar disorder: prevalence, characteristics and relationship with suicide risk.</ArticleTitle><Pagination><MedlinePgn>e3463</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0104-11692021000100354</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1590/1518-8345.4737.3463</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">to know the prevalence and characteristics of pain, to verify how pain management has been carried out by the health services, and to correlate suicide risk with pain intensity in patients with bipolar disorder.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">an observational study with a quantitative approach. The study included people with bipolar disorder assessed by the McGill-Reduced Pain Questionnaire, Body Diagram, Visual Numerical Scale, and the Suicidal Ideation Scale (Beck).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">the sample of 60 participants was mainly composed of women with a mean age of 40 years old and a mean psychiatric treatment time of approximately 13 years. Of these, 83% reported feeling pain at the time of the interview. Half of the participants indicated that pain interferes with routine and 80% did not receive care in health institutions. The main descriptors that qualify the painful experience were as follows: painful, heavy and sensitive for the sensory descriptors, tiring and punishing in the affective category. Suicide attempt was reported by 57% of the participants. There was a correlation between suicide risk and pain intensity.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">pain presented a high prevalence. Suicide risk was identified in more than half of the participants. Pain intensity showed a significant correlation with suicide risk.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rosa</LastName><ForeName>Ana Carolina Ferreira</ForeName><Initials>ACF</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-6262-2145</Identifier><AffiliationInfo><Affiliation>Instituto Israelita de Ensino e Pesquisa Albert Einstein, Faculdade Israelita de Ciências da Saúde Albert Einstein, São Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leão</LastName><ForeName>Eliseth Ribeiro</ForeName><Initials>ER</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-0352-0549</Identifier><AffiliationInfo><Affiliation>Instituto Israelita de Ensino e Pesquisa Albert Einstein, Faculdade Israelita de Ciências da Saúde Albert Einstein, São Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>por</Language><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Rev Lat Am Enfermagem</MedlineTA><NlmUniqueID>9420934</NlmUniqueID><ISSNLinking>0104-1169</ISSNLinking></MedlineJournalInfo><CitationSubset>N</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="Y">Bipolar Disorder</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059020" MajorTopicYN="N">Suicidal Ideation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013406" MajorTopicYN="N">Suicide, Attempted</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>08</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>30</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34190952</ArticleId><ArticleId IdType="pii">S0104-11692021000100354</ArticleId><ArticleId IdType="doi">10.1590/1518-8345.4737.3463</ArticleId><ArticleId IdType="pmc">PMC8253371</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Acta Psychiatr Scand. 2015 Feb;131(2):75-88</Citation><ArticleIdList><ArticleId IdType="pubmed">25098864</ArticleId></ArticleIdList></Reference><Reference><Citation>Cad Saude Publica. 2010 Mar;26(3):591-602</Citation><ArticleIdList><ArticleId IdType="pubmed">20464077</ArticleId></ArticleIdList></Reference><Reference><Citation>World Psychiatry. 2011 Feb;10(1):52-77</Citation><ArticleIdList><ArticleId IdType="pubmed">21379357</ArticleId></ArticleIdList></Reference><Reference><Citation>Arq Neuropsiquiatr. 2016 Dec;74(12):990-998</Citation><ArticleIdList><ArticleId IdType="pubmed">27991997</ArticleId></ArticleIdList></Reference><Reference><Citation>Braz J Psychiatry. 2018 Jul-Sep;40(3):238-243</Citation><ArticleIdList><ArticleId IdType="pubmed">29451588</ArticleId></ArticleIdList></Reference><Reference><Citation>Cien Saude Colet. 2018 Jun;23(6):2067-2074</Citation><ArticleIdList><ArticleId IdType="pubmed">29972514</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Res Ther. 1997 Nov;35(11):1039-46</Citation><ArticleIdList><ArticleId IdType="pubmed">9431735</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2011 Jan;68(1):12-20</Citation><ArticleIdList><ArticleId IdType="pubmed">21199962</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pain. 2012 Dec;13(12):1250-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23182230</ArticleId></ArticleIdList></Reference><Reference><Citation>Pain. 1987 Aug;30(2):191-197</Citation><ArticleIdList><ArticleId IdType="pubmed">3670870</ArticleId></ArticleIdList></Reference><Reference><Citation>Braz J Psychiatry. 2017 Jan 09;39(2):133-139</Citation><ArticleIdList><ArticleId IdType="pubmed">28076649</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatr Q. 2017 Dec;88(4):687-700</Citation><ArticleIdList><ArticleId IdType="pubmed">28091795</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1994 Jan;51(1):8-19</Citation><ArticleIdList><ArticleId IdType="pubmed">8279933</ArticleId></ArticleIdList></Reference><Reference><Citation>J Consult Clin Psychol. 1979 Apr;47(2):343-52</Citation><ArticleIdList><ArticleId IdType="pubmed">469082</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Esc Enferm USP. 1996 Dec;30(3):473-83</Citation><ArticleIdList><ArticleId IdType="pubmed">9016160</ArticleId></ArticleIdList></Reference><Reference><Citation>Cien Saude Colet. 2014 Apr;19(4):1263-74</Citation><ArticleIdList><ArticleId IdType="pubmed">24820609</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pain. 2014 Nov;15(11):1081-1091</Citation><ArticleIdList><ArticleId IdType="pubmed">25038400</ArticleId></ArticleIdList></Reference><Reference><Citation>Cad Saude Publica. 2019 Oct 31;35(11):e00129519</Citation><ArticleIdList><ArticleId IdType="pubmed">31691781</ArticleId></ArticleIdList></Reference><Reference><Citation>Pain Rep. 2019 Dec 06;4(6):e792</Citation><ArticleIdList><ArticleId IdType="pubmed">31984297</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21451499</PMID><DateCompleted><Year>2012</Year><Month>03</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1740-634X</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>8</Issue><PubDate><Year>2011</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</Title><ISOAbbreviation>Neuropsychopharmacology</ISOAbbreviation></Journal><ArticleTitle>The MATRICS consensus cognitive battery in patients with bipolar I disorder.</ArticleTitle><Pagination><MedlinePgn>1587-92</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/npp.2011.36</ELocationID><Abstract><AbstractText>The Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) initiative was devised to identify a neurocognitive battery to be used in clinical trials targeting cognition in schizophrenia, a process, which resulted in the MATRICS Consensus Cognitive Battery (MCCB). The MCCB has been selected by the United States Food and Drug Administration to be used as the primary outcome measure in registry trials for cognitive agents in schizophrenia. Given the clinical and cognitive overlap between schizophrenia and bipolar disorder (BPD), it is likely that any compound shown to have cognitive benefits in schizophrenia will subsequently be tested in BPD. Unlike the MCCB for schizophrenia, there remains no consensus regarding outcome measures if cognitive trials were to be undertaken in BPD. The utility of the MCCB in BPD has not yet been systematically investigated. We administered the MCCB to 80 bipolar I patients; 37 were strictly euthymic and 43 were symptomatic. We compared their performance with a demographically matched healthy sample (n=148) on seven MCCB domains, and the composite. BPD patients were statistically significantly impaired on five of seven MCCB domains at levels consistent with meta-analytic studies of cognition in BPD. In contrast, patients' performance was less impaired on the Reasoning and Problem-solving and Social Cognition domains, differences that did not survive statistical correction for multiple testing. Symptomatic status only modestly influenced performance. These data suggest that the MCCB, devised for use in schizophrenia, may also represent a useful outcome measure in cognitive trials for BPD. Additional studies should address important psychometric features such as repeatability and potential practice and/or ceiling effects.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Burdick</LastName><ForeName>Katherine E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, The Zucker Hillside Hospital, North Shore-Long Island Jewish Health System, Glen Oaks, NY 11004, USA. kburdick@nshs.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldberg</LastName><ForeName>Terry E</ForeName><Initials>TE</Initials></Author><Author ValidYN="Y"><LastName>Cornblatt</LastName><ForeName>Barbara A</ForeName><Initials>BA</Initials></Author><Author ValidYN="Y"><LastName>Keefe</LastName><ForeName>Richard S</ForeName><Initials>RS</Initials></Author><Author ValidYN="Y"><LastName>Gopin</LastName><ForeName>Chaya B</ForeName><Initials>CB</Initials></Author><Author ValidYN="Y"><LastName>Derosse</LastName><ForeName>Pamela</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Braga</LastName><ForeName>Raphael J</ForeName><Initials>RJ</Initials></Author><Author ValidYN="Y"><LastName>Malhotra</LastName><ForeName>Anil K</ForeName><Initials>AK</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K99 MH086756</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23MH077807</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R00 MH086756</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R03 MH079995</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 MH077807</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>03</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Neuropsychopharmacology</MedlineTA><NlmUniqueID>8904907</NlmUniqueID><ISSNLinking>0893-133X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21451499</ArticleId><ArticleId IdType="pii">npp201136</ArticleId><ArticleId IdType="doi">10.1038/npp.2011.36</ArticleId><ArticleId IdType="pmc">PMC3138672</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Affect Disord. 2002 Dec;72(3):209-26</Citation><ArticleIdList><ArticleId IdType="pubmed">12450638</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2008 Feb;165(2):214-20</Citation><ArticleIdList><ArticleId IdType="pubmed">18172018</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2007 Feb-Mar;9(1-2):103-13</Citation><ArticleIdList><ArticleId IdType="pubmed">17391354</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2009 Feb;113(1-2):1-20</Citation><ArticleIdList><ArticleId IdType="pubmed">18684514</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 2008 Jun;38(6):771-85</Citation><ArticleIdList><ArticleId IdType="pubmed">17922938</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2010 Sep;167(9):1116-24</Citation><ArticleIdList><ArticleId IdType="pubmed">20478878</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2011 Feb;125(2-3):161-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21075600</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand Suppl. 2007;(434):17-26</Citation><ArticleIdList><ArticleId IdType="pubmed">17688459</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychother Psychosom. 2006;75(2):72-84</Citation><ArticleIdList><ArticleId IdType="pubmed">16508342</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2004 Dec 15;72(1):1-3</Citation><ArticleIdList><ArticleId IdType="pubmed">15531401</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2010 Dec;122(6):499-506</Citation><ArticleIdList><ArticleId IdType="pubmed">20637012</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2010 Jun;12(4):364-75</Citation><ArticleIdList><ArticleId IdType="pubmed">20636633</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2008 Feb;69(2):233-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18232725</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2004 Dec 15;72(1):29-39</Citation><ArticleIdList><ArticleId IdType="pubmed">15531405</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2009 Oct;120(4):253-64</Citation><ArticleIdList><ArticleId IdType="pubmed">19489747</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2007 Jul 15;62(2):179-86</Citation><ArticleIdList><ArticleId IdType="pubmed">17161829</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2007 Feb-Mar;9(1-2):93-102</Citation><ArticleIdList><ArticleId IdType="pubmed">17391353</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychother Psychosom. 2000;69(1):2-18</Citation><ArticleIdList><ArticleId IdType="pubmed">10601830</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2008 Feb;165(2):203-13</Citation><ArticleIdList><ArticleId IdType="pubmed">18172019</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2006 Apr;8(2):103-16</Citation><ArticleIdList><ArticleId IdType="pubmed">16542180</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2004 Feb;161(2):262-70</Citation><ArticleIdList><ArticleId IdType="pubmed">14754775</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2008 Aug;109(3):286-99</Citation><ArticleIdList><ArticleId IdType="pubmed">18289698</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2010 Jun;12(4):351-63</Citation><ArticleIdList><ArticleId IdType="pubmed">20636632</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2007 Feb-Mar;9(1-2):114-25</Citation><ArticleIdList><ArticleId IdType="pubmed">17391355</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2011 Nov;37(6):1209-17</Citation><ArticleIdList><ArticleId IdType="pubmed">20410237</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2006 Jul;93(1-3):105-15</Citation><ArticleIdList><ArticleId IdType="pubmed">16677713</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Clin Neuropsychol. 1998 Oct;13(7):623-8</Citation><ArticleIdList><ArticleId IdType="pubmed">14590623</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2010 Jan;36(1):112-25</Citation><ArticleIdList><ArticleId IdType="pubmed">19767349</ArticleId></ArticleIdList></Reference><Reference><Citation>CNS Drugs. 2007;21(12):971-81</Citation><ArticleIdList><ArticleId IdType="pubmed">18020478</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">1605051</PMID><DateCompleted><Year>1992</Year><Month>07</Month><Day>15</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0001-690X</ISSN><JournalIssue CitedMedium="Print"><Volume>85</Volume><Issue>5</Issue><PubDate><Year>1992</Year><Month>May</Month></PubDate></JournalIssue><Title>Acta psychiatrica Scandinavica</Title><ISOAbbreviation>Acta Psychiatr Scand</ISOAbbreviation></Journal><ArticleTitle>Course of schizoaffective psychosis: further data from a retrospective study.</ArticleTitle><Pagination><MedlinePgn>328-30</MedlinePgn></Pagination><Abstract><AbstractText>This study investigated the clinical course and outcome of 72 patients, diagnosed as suffering from schizoaffective psychosis (according to ICD-9 criteria) who also satisfied Research Diagnostic Criteria for schizoaffective disorder. The current overall functioning of these patients was related to the number and frequency of episodes, regardless of the duration of the illness: the lesser the number or frequency of relapses, the better the overall functioning. In addition, there were no statistically significant differences in psychosocial impairment between bipolar and unipolar schizoaffective disorder.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>del Rio Vega</LastName><ForeName>J M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Medical Psychology, Complutense University, Hospital Universitario San Carlos, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayuso-Gutierrez</LastName><ForeName>J L</ForeName><Initials>JL</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Acta Psychiatr Scand</MedlineTA><NlmUniqueID>0370364</NlmUniqueID><ISSNLinking>0001-690X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="Y">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010553" MajorTopicYN="Y">Personality Development</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011618" MajorTopicYN="N">Psychotic Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012917" MajorTopicYN="Y">Social Adjustment</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1992</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1992</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1992</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1605051</ArticleId><ArticleId IdType="doi">10.1111/j.1600-0447.1992.tb10313.x</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">2795649</PMID><DateCompleted><Year>1989</Year><Month>11</Month><Day>17</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-264X</ISSN><JournalIssue CitedMedium="Print"><Volume>33 ( Pt 5)</Volume><PubDate><Year>1989</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of mental deficiency research</Title><ISOAbbreviation>J Ment Defic Res</ISOAbbreviation></Journal><ArticleTitle>Computer-assisted linguistic analysis of two mentally retarded psychotic female's texts.</ArticleTitle><Pagination><MedlinePgn>429-35</MedlinePgn></Pagination><Abstract><AbstractText>Prompted monologues from a schizophrenic and manic mentally handicapped female were analysed using a computer program designed to generate 118 syntactic variables. The procedure was repeated after several years. The linguistic profiles and their change over time were characteristic of chronic schizophrenia and mania, respectively: the schizophrenic-illness-based profile showed further linguistic disintegration; the manic-illness-based profile showed linguistic recovery, mirroring clinical improvement.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fraser</LastName><ForeName>W I</ForeName><Initials>WI</Initials><AffiliationInfo><Affiliation>Gogarburn Hospital, Edinburgh, Scotland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>King</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>P</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Ment Defic Res</MedlineTA><NlmUniqueID>0375401</NlmUniqueID><ISSNLinking>0022-264X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003201" MajorTopicYN="N">Computers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008607" MajorTopicYN="N">Intellectual Disability</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007802" MajorTopicYN="Y">Language</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008037" MajorTopicYN="N">Linguistics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012559" MajorTopicYN="N">Schizophrenia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012564" MajorTopicYN="Y">Schizophrenic Language</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1989</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1989</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1989</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">2795649</ArticleId><ArticleId IdType="doi">10.1111/j.1365-2788.1989.tb01498.x</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">3949726</PMID><DateCompleted><Year>1986</Year><Month>04</Month><Day>18</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0160-6689</ISSN><JournalIssue CitedMedium="Print"><Volume>47</Volume><Issue>3</Issue><PubDate><Year>1986</Year><Month>Mar</Month></PubDate></JournalIssue><Title>The Journal of clinical psychiatry</Title><ISOAbbreviation>J Clin Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Suppression of tardive dyskinesia with amoxapine: case report.</ArticleTitle><Pagination><MedlinePgn>148</MedlinePgn></Pagination><Abstract><AbstractText>Evidence of the neuroleptic potency of amoxapine is rapidly accumulating. A case history is presented which complements the growing literature in this area. A depressed patient with persistent orofacial dyskinesia was placed on amoxapine and experienced a suppression of her involuntary movements. The therapeutic implications of this observation are discussed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>D'Mello</LastName><ForeName>D A</ForeName><Initials>DA</Initials></Author><Author ValidYN="Y"><LastName>Nasrallah</LastName><ForeName>H A</ForeName><Initials>HA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Psychiatry</MedlineTA><NlmUniqueID>7801243</NlmUniqueID><ISSNLinking>0160-6689</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003989">Dibenzoxazepines</NameOfSubstance></Chemical><Chemical><RegistryNumber>R63VQ857OT</RegistryNumber><NameOfSubstance UI="D000657">Amoxapine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000657" MajorTopicYN="N">Amoxapine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003989" MajorTopicYN="N">Dibenzoxazepines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004409" MajorTopicYN="N">Dyskinesia, Drug-Induced</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1986</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1986</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1986</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">3949726</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">3949721</PMID><DateCompleted><Year>1986</Year><Month>04</Month><Day>18</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0160-6689</ISSN><JournalIssue CitedMedium="Print"><Volume>47</Volume><Issue>3</Issue><PubDate><Year>1986</Year><Month>Mar</Month></PubDate></JournalIssue><Title>The Journal of clinical psychiatry</Title><ISOAbbreviation>J Clin Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Verapamil treatment of acute mania.</ArticleTitle><Pagination><MedlinePgn>136-8</MedlinePgn></Pagination><Abstract><AbstractText>Six acutely manic patients were openly treated with verapamil, a calcium channel blocker, as part of their medication regimen in an inpatient setting. All patients had a prompt reduction in their manic symptoms and have been maintained on this medication. Further controlled trials of verapamil in acute mania seem warranted.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brotman</LastName><ForeName>A W</ForeName><Initials>AW</Initials></Author><Author ValidYN="Y"><LastName>Farhadi</LastName><ForeName>A M</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Gelenberg</LastName><ForeName>A J</ForeName><Initials>AJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Psychiatry</MedlineTA><NlmUniqueID>7801243</NlmUniqueID><ISSNLinking>0160-6689</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>CJ0O37KU29</RegistryNumber><NameOfSubstance UI="D014700">Verapamil</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014700" MajorTopicYN="N">Verapamil</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1986</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1986</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1986</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">3949721</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16844346</PMID><DateCompleted><Year>2007</Year><Month>02</Month><Day>06</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0920-9964</ISSN><JournalIssue CitedMedium="Print"><Volume>88</Volume><Issue>1-3</Issue><PubDate><Year>2006</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Schizophrenia research</Title><ISOAbbreviation>Schizophr Res</ISOAbbreviation></Journal><ArticleTitle>Bipolar and schizophrenic patients differ in patterns of visual motion discrimination.</ArticleTitle><Pagination><MedlinePgn>208-16</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Since Kraepelin's early distinction between bipolar disorder and schizophrenia, it has been assumed that these disorders represent two different pathophysiological processes, although they share many clinical symptoms. Previous studies showed that velocity discrimination, a sensitive psychophysiological measure of the visual motion system, is deficient in schizophrenia. Here we examined whether the motion processing impairment found in schizophrenia also occurs in bipolar disorder.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We compared 16 bipolar patients, 25 schizophrenic patients, and 25 normal controls on a velocity discrimination task. We measured the psychophysical threshold for velocity discrimination and contrast detection (as a control task) in all subjects.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Bipolar patients showed normal velocity discrimination thresholds at intermediate velocities, the range in which velocity cues dominate velocity discrimination, and at low velocities. Schizophrenic patients, however, showed elevated velocity discrimination thresholds at intermediate and low velocities. At higher velocities, both bipolar and schizophrenic patients showed elevated thresholds. All subjects showed normal contrast detection thresholds.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Normal velocity discrimination in the intermediate range of velocity indicates unimpaired motion processing in bipolar disorder. The abnormal velocity discrimination of both schizophrenic and bipolar patients at higher velocities may reflect impaired temporal processing rather than impaired motion processing per se. These results suggest that the pathophysiological processes of bipolar disorder and schizophrenia diverge at the stage of visual motion processing, a sensory component mediated primarily in the extrastriate cortex.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Harvard Medical School/McLean Hospital, Belmont, MA 02478, USA. ychen@wjh.harvard.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levy</LastName><ForeName>Deborah L</ForeName><Initials>DL</Initials></Author><Author ValidYN="Y"><LastName>Sheremata</LastName><ForeName>Summer</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Holzman</LastName><ForeName>Philip S</ForeName><Initials>PS</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>49487</GrantID><Agency>PHS HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>31340</GrantID><Agency>PHS HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MH 61824</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>01020</GrantID><Agency>PHS HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>31154</GrantID><Agency>PHS HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH031340</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH061824</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2006</Year><Month>07</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Schizophr Res</MedlineTA><NlmUniqueID>8804207</NlmUniqueID><ISSNLinking>0920-9964</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000927">Anticonvulsants</NameOfSubstance></Chemical><Chemical><RegistryNumber>U42B7VYA4P</RegistryNumber><NameOfSubstance UI="D002746">Chlorpromazine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000927" MajorTopicYN="N">Anticonvulsants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010054" MajorTopicYN="N">Brief Psychiatric Rating Scale</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002746" MajorTopicYN="N">Chlorpromazine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D039721" MajorTopicYN="N">Diagnostic and Statistical Manual of Mental Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009039" MajorTopicYN="N">Motion Perception</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010468" MajorTopicYN="N">Perceptual Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012559" MajorTopicYN="N">Schizophrenia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017603" MajorTopicYN="N">Signal Detection, Psychological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014796" MajorTopicYN="N">Visual Perception</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2005</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2006</Year><Month>06</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2006</Year><Month>06</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>7</Month><Day>18</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>2</Month><Day>7</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>7</Month><Day>18</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16844346</ArticleId><ArticleId IdType="pii">S0920-9964(06)00272-6</ArticleId><ArticleId IdType="doi">10.1016/j.schres.2006.06.004</ArticleId><ArticleId IdType="pmc">PMC1764462</ArticleId><ArticleId IdType="mid">NIHMS15374</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Can J Psychiatry. 2002 Feb;47(1):27-38</Citation><ArticleIdList><ArticleId IdType="pubmed">11873706</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2003 Apr;160(4):696-702</Citation><ArticleIdList><ArticleId IdType="pubmed">12668358</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1999 Feb;56(2):155-61</Citation><ArticleIdList><ArticleId IdType="pubmed">10025440</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2003 Jun;64(6):663-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12823080</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2003 Oct;160(10):1795-801</Citation><ArticleIdList><ArticleId IdType="pubmed">14514493</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2004 Apr 15;55(8):834-41</Citation><ArticleIdList><ArticleId IdType="pubmed">15050865</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand Suppl. 1966;194:102-17</Citation><ArticleIdList><ArticleId IdType="pubmed">5229224</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1973 Jul 13;181(4095):179-81</Citation><ArticleIdList><ArticleId IdType="pubmed">4711736</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1974 Aug;31(2):143-51</Citation><ArticleIdList><ArticleId IdType="pubmed">4851993</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 1974 Dec;9(3):245-60</Citation><ArticleIdList><ArticleId IdType="pubmed">4441576</ArticleId></ArticleIdList></Reference><Reference><Citation>Percept Psychophys. 1978 Sep;24(3):285-94</Citation><ArticleIdList><ArticleId IdType="pubmed">704289</ArticleId></ArticleIdList></Reference><Reference><Citation>Vision Res. 1981;21(4):491-500</Citation><ArticleIdList><ArticleId IdType="pubmed">7269327</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 1981 Aug;5(1):47-58</Citation><ArticleIdList><ArticleId IdType="pubmed">6944709</ArticleId></ArticleIdList></Reference><Reference><Citation>Vision Res. 1987;27(9):1491-500</Citation><ArticleIdList><ArticleId IdType="pubmed">3445483</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 1991 May 15;29(10):1001-15</Citation><ArticleIdList><ArticleId IdType="pubmed">2065136</ArticleId></ArticleIdList></Reference><Reference><Citation>Cold Spring Harb Symp Quant Biol. 1990;55:717-27</Citation><ArticleIdList><ArticleId IdType="pubmed">2132849</ArticleId></ArticleIdList></Reference><Reference><Citation>J Abnorm Psychol. 1992 Feb;101(1):104-16</Citation><ArticleIdList><ArticleId IdType="pubmed">1537957</ArticleId></ArticleIdList></Reference><Reference><Citation>J Abnorm Psychol. 1982 Feb;91(1):35-44</Citation><ArticleIdList><ArticleId IdType="pubmed">7056941</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 1983 Jun;106 (Pt 2):313-40</Citation><ArticleIdList><ArticleId IdType="pubmed">6850272</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4724-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10200329</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurophysiol. 1983 May;49(5):1127-47</Citation><ArticleIdList><ArticleId IdType="pubmed">6864242</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1984 Feb;41(2):136-9</Citation><ArticleIdList><ArticleId IdType="pubmed">6696594</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 1983 Dec;10(4):285-93</Citation><ArticleIdList><ArticleId IdType="pubmed">6583717</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1985 Apr;42(4):335-41</Citation><ArticleIdList><ArticleId IdType="pubmed">3919684</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1985 Sep 13;229(4718):1107-9</Citation><ArticleIdList><ArticleId IdType="pubmed">4035351</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurophysiol. 1986 Jun;55(6):1328-39</Citation><ArticleIdList><ArticleId IdType="pubmed">3734858</ArticleId></ArticleIdList></Reference><Reference><Citation>Vision Res. 1986;26(4):609-19</Citation><ArticleIdList><ArticleId IdType="pubmed">3739236</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Biol. 2000 Apr 6;10(7):383-92</Citation><ArticleIdList><ArticleId IdType="pubmed">10753744</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2001 Jul;158(7):1126-33</Citation><ArticleIdList><ArticleId IdType="pubmed">11431235</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychophysiology. 1993 Jan;30(1):3-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8416059</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 1993;19(3):461-536</Citation><ArticleIdList><ArticleId IdType="pubmed">8235455</ArticleId></ArticleIdList></Reference><Reference><Citation>J Abnorm Psychol. 1994 May;103(2):222-30</Citation><ArticleIdList><ArticleId IdType="pubmed">8040491</ArticleId></ArticleIdList></Reference><Reference><Citation>Cereb Cortex. 1994 May-Jun;4(3):247-59</Citation><ArticleIdList><ArticleId IdType="pubmed">8075530</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1994 Dec;51(12):939-44</Citation><ArticleIdList><ArticleId IdType="pubmed">7979881</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 1995 Mar;25(2):387-403</Citation><ArticleIdList><ArticleId IdType="pubmed">7675926</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 1997 Jan;27(1):143-52</Citation><ArticleIdList><ArticleId IdType="pubmed">9122294</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 1997 Feb 7;66(2-3):121-30</Citation><ArticleIdList><ArticleId IdType="pubmed">9075276</ArticleId></ArticleIdList></Reference><Reference><Citation>J Abnorm Psychol. 1998 Feb;107(1):49-62</Citation><ArticleIdList><ArticleId IdType="pubmed">9505038</ArticleId></ArticleIdList></Reference><Reference><Citation>Vision Res. 1998 May;38(9):1265-72</Citation><ArticleIdList><ArticleId IdType="pubmed">9666994</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1998 Sep;55(9):830-6</Citation><ArticleIdList><ArticleId IdType="pubmed">9736010</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Biol Sci. 1998 Nov 22;265(1411):2141-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9872002</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1999 Feb;56(2):149-54</Citation><ArticleIdList><ArticleId IdType="pubmed">10025439</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30981755</PMID><DateCompleted><Year>2019</Year><Month>11</Month><Day>11</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2215-0374</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>9</Issue><PubDate><Year>2019</Year><Month>09</Month></PubDate></JournalIssue><Title>The lancet. Psychiatry</Title><ISOAbbreviation>Lancet Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Childbirth and prevention of bipolar disorder: an opportunity for change.</ArticleTitle><Pagination><MedlinePgn>786-792</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S2215-0366(19)30092-6</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/S2215-0366(19)30092-6</ELocationID><Abstract><AbstractText>The recent conceptualisation of bipolar disorder as a neuroprogressive illness has highlighted the potential importance of prevention and early intervention in high-risk populations. Undiagnosed bipolar disorder early in the disease course is associated with adverse clinical outcomes and impaired functioning for patients, which in turn has economic consequences. Despite the mounting evidence that childbirth is one of the most potent and specific triggers of manic symptoms, studies are not available on the effectiveness of targeted interventions in the prevention of bipolar disorder in women who have recently given birth. In this Personal View, we describe the clinical characteristics of women at risk of developing bipolar disorder after childbirth, before discussing opportunities for prevention and early intervention and outlining challenges in the assessment and management of women at risk of transitioning to bipolar disorder after childbirth. Existing evidence, although scarce, supports a clinical staging model by which at-risk women are managed with a variety of behavioural and pharmacological interventions aimed at preventing bipolar disorder. Close monitoring and early intervention might reduce the risk of hypomanic or manic symptoms in women at risk of developing bipolar disorder after childbirth; however, the potential benefits of early identification and intervention need to be carefully balanced against the additional risks for affected women.</AbstractText><CopyrightInformation>Copyright © 2019 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Verinder</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Department of Obstetrics and Gynecology, Western University, London, ON, Canada; Parkwood Institute, London, ON, Canada. Electronic address: vsharma@uwo.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bergink</LastName><ForeName>Veerle</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Department of Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Psychiatry, Erasmus Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berk</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Innovation in Mental and Physical Health and Clinical Treatment Strategic Research Centre, School of Medicine, Deakin University, Geelong, VIC, Australia; Orygen, the National Centre of Excellence in Youth Mental Health, Florey Institute for Neuroscience and Mental Health, and the Department of Psychiatry, University of Melbourne, Parkville, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chandra</LastName><ForeName>Prabha S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munk-Olsen</LastName><ForeName>Trine</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>National Centre for Register-based Research, Aarhus University, Aarhus, Denmark; Lundbeck Foundation Initiative for Integrative Psychiatric Research, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viguera</LastName><ForeName>Adele C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Cleveland Clinic, Cleveland, OH, USA; Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yatham</LastName><ForeName>Lakshmi N</ForeName><Initials>LN</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>04</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Psychiatry</MedlineTA><NlmUniqueID>101638123</NlmUniqueID><ISSNLinking>2215-0366</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003527" MajorTopicYN="N">Cyclothymic Disorder</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042241" MajorTopicYN="N">Early Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006305" MajorTopicYN="N">Health Status Indicators</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007237" MajorTopicYN="N">Infanticide</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008991" MajorTopicYN="N">Monitoring, Physiologic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036801" MajorTopicYN="N">Parturition</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049590" MajorTopicYN="N">Postpartum Period</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011644" MajorTopicYN="N">Puerperal Disorders</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013406" MajorTopicYN="N">Suicide, Attempted</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>02</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>02</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>11</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30981755</ArticleId><ArticleId IdType="pii">S2215-0366(19)30092-6</ArticleId><ArticleId IdType="doi">10.1016/S2215-0366(19)30092-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">8919423</PMID><DateCompleted><Year>1997</Year><Month>03</Month><Day>19</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0706-7437</ISSN><JournalIssue CitedMedium="Print"><Volume>41</Volume><Issue>1</Issue><PubDate><Year>1996</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Canadian journal of psychiatry. Revue canadienne de psychiatrie</Title><ISOAbbreviation>Can J Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Undue mood elevation in unipolar patients following cessation of lithium augmentation treatment: implications for the understanding of mood disorders.</ArticleTitle><Pagination><MedlinePgn>46-8</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The precipitation of hypomania or mania in some patients with apparent unipolar (UP) depression by the use of antidepressants, lithium augmentation, or antidepressant withdrawal has been described in the literature. However, only 4 cases have been reported where undue mood elevation in UP patients followed lithium termination. To add to the literature, we report 2 cases where mood elevation followed cessation of lithium augmentation treatment.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">Observations were continued on 2 patients receiving an antidepressant plus lithium augmentation after cessation of the lithium treatment.</AbstractText><AbstractText Label="RESULT" NlmCategory="RESULTS">There was undue mood elevation in these patients immediately following lithium termination.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This observation supports the view that there is extensive vulnerability to bipolar disorder among patients with multiple depressions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hoaken</LastName><ForeName>P C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Queen's University, Kingston, Ontario.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoaken</LastName><ForeName>P</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Can J Psychiatry</MedlineTA><NlmUniqueID>7904187</NlmUniqueID><ISSNLinking>0706-7437</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000928">Antidepressive Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>2BMD2GNA4V</RegistryNumber><NameOfSubstance UI="D016651">Lithium Carbonate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000928" MajorTopicYN="N">Antidepressive Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003866" MajorTopicYN="N">Depressive Disorder</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016651" MajorTopicYN="N">Lithium Carbonate</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013375" MajorTopicYN="N">Substance Withdrawal Syndrome</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1996</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1996</Year><Month>2</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1996</Year><Month>2</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">8919423</ArticleId><ArticleId IdType="doi">10.1177/070674379604100110</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26845265</PMID><DateCompleted><Year>2016</Year><Month>06</Month><Day>13</Day></DateCompleted><DateRevised><Year>2016</Year><Month>02</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1555-2101</ISSN><JournalIssue CitedMedium="Internet"><Volume>77</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Jan</Month></PubDate></JournalIssue><Title>The Journal of clinical psychiatry</Title><ISOAbbreviation>J Clin Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Baseline disability and poor functioning in bipolar disorder predict worse outcomes: results from the Bipolar CHOICE study.</ArticleTitle><Pagination><MedlinePgn>100-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4088/JCP.14m09210</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To examine the effects of treatment on functioning impairments and quality of life and assess baseline functioning and employment status as predictors of treatment response in symptomatic individuals from the Bipolar Clinical Health Outcomes Initiative in Comparative Effectiveness (Bipolar CHOICE) study.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">Bipolar CHOICE was an 11-site, 6-month randomized effectiveness study comparing lithium to quetiapine, each with adjunctive personalized treatments (APTs). We examined post hoc (1) the effects of treatment on functioning, (2) how changes in functioning differed between treatment responders and nonresponders, and (3) whether functioning and employment status mediated treatment response in 482 participants with DSM-IV-TR bipolar I or II disorder from September 2010 to September 2013.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Treatment was associated with significant improvements in functioning and quality of life, regardless of treatment group (P values &lt; .0001). Responders showed greater improvements in quality of life (Quality of Life Enjoyment and Satisfaction Questionnaire P values &lt; .05) and functioning (Longitudinal Interval Follow-up Evaluation-Range of Impaired Functioning Tool P values &lt; .05) than nonresponders. Unemployed or disabled participants at baseline had significantly greater illness severity at baseline than employed participants (P values &lt; .05). Over the study duration, employed participants reported greater improvements in physical health and quality of life in leisure activities than both unemployed and disabled participants (P values &lt; .05). Individuals who saw greater improvement in functioning and quality of life tended to show greater improvements in depressive and anxiety symptoms (P values ≤ .0001), as well as overall illness severity (P values &lt; .001). Early (8 weeks) and very early (4 weeks) clinical changes in mood symptoms predicted changes in functioning and quality of life at 6 months (P values &lt; .001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Prior disability status was associated with a worse treatment response and prospective illness course. Results implicate functioning and employment status as important markers of illness severity and likelihood of recovery in bipolar disorder, suggesting that interventions that target functional impairment may improve outcomes.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">ClinicalTrials.gov identifier for the Bipolar CHOICE study: NCT01331304.</AbstractText><CopyrightInformation>© Copyright 2016 Physicians Postgraduate Press, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Deckersbach</LastName><ForeName>Thilo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Massachusetts General Hospital, 50 Staniford St, Ste 580, Boston, MA 02114 tdeckersbach@partners.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nierenberg</LastName><ForeName>Andrew A</ForeName><Initials>AA</Initials></Author><Author ValidYN="Y"><LastName>McInnis</LastName><ForeName>Melvin G</ForeName><Initials>MG</Initials></Author><Author ValidYN="Y"><LastName>Salcedo</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Bernstein</LastName><ForeName>Emily E</ForeName><Initials>EE</Initials></Author><Author ValidYN="Y"><LastName>Kemp</LastName><ForeName>David E</ForeName><Initials>DE</Initials></Author><Author ValidYN="Y"><LastName>Shelton</LastName><ForeName>Richard C</ForeName><Initials>RC</Initials></Author><Author ValidYN="Y"><LastName>McElroy</LastName><ForeName>Susan L</ForeName><Initials>SL</Initials></Author><Author ValidYN="Y"><LastName>Sylvia</LastName><ForeName>Louisa G</ForeName><Initials>LG</Initials></Author><Author ValidYN="Y"><LastName>Kocsis</LastName><ForeName>James H</ForeName><Initials>JH</Initials></Author><Author ValidYN="Y"><LastName>Bobo</LastName><ForeName>William V</ForeName><Initials>WV</Initials></Author><Author ValidYN="Y"><LastName>Friedman</LastName><ForeName>Edward S</ForeName><Initials>ES</Initials></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Vivek</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Tohen</LastName><ForeName>Mauricio</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Bowden</LastName><ForeName>Charles L</ForeName><Initials>CL</Initials></Author><Author ValidYN="Y"><LastName>Ketter</LastName><ForeName>Terence A</ForeName><Initials>TA</Initials></Author><Author ValidYN="Y"><LastName>Calabrese</LastName><ForeName>Joseph R</ForeName><Initials>JR</Initials></Author><Author ValidYN="Y"><LastName>Thase</LastName><ForeName>Michael E</ForeName><Initials>ME</Initials></Author><Author ValidYN="Y"><LastName>Reilly-Harrington</LastName><ForeName>Noreen A</ForeName><Initials>NA</Initials></Author><Author ValidYN="Y"><LastName>Rabideau</LastName><ForeName>Dustin J</ForeName><Initials>DJ</Initials></Author><Author ValidYN="Y"><LastName>Kinrys</LastName><ForeName>Gustavo</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Kamali</LastName><ForeName>Masoud</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT01331304</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>1R01HS019371-01</GrantID><Acronym>HS</Acronym><Agency>AHRQ HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Psychiatry</MedlineTA><NlmUniqueID>7801243</NlmUniqueID><ISSNLinking>0160-6689</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>2S3PL1B6UJ</RegistryNumber><NameOfSubstance UI="D000069348">Quetiapine Fumarate</NameOfSubstance></Chemical><Chemical><RegistryNumber>9FN79X2M3F</RegistryNumber><NameOfSubstance UI="D008094">Lithium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014150" MajorTopicYN="N">Antipsychotic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004185" MajorTopicYN="Y">Disability Evaluation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004651" MajorTopicYN="N">Employment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008094" MajorTopicYN="N">Lithium</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069348" MajorTopicYN="N">Quetiapine Fumarate</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>04</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>03</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26845265</ArticleId><ArticleId IdType="doi">10.4088/JCP.14m09210</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">14742592</PMID><DateCompleted><Year>2004</Year><Month>03</Month><Day>11</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-3050</ISSN><JournalIssue CitedMedium="Print"><Volume>75</Volume><Issue>2</Issue><PubDate><Year>2004</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of neurology, neurosurgery, and psychiatry</Title><ISOAbbreviation>J Neurol Neurosurg Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Corpus callosum signal intensity in patients with bipolar and unipolar disorder.</ArticleTitle><Pagination><MedlinePgn>221-5</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Anatomical abnormalities in the corpus callosum have been reported in magnetic resonance imaging (MRI) studies in patients with bipolar but not unipolar disorder. MRI signal intensity can be used as a putative index of corpus callosum myelination.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To measure MRI signal intensity in patients with bipolar and unipolar disorder to investigate abnormalities of corpus callosum myelination.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The study involved 29 DSM-IV bipolar patients (mean (SD) age, 35 (11) years; 16 male, 13 female), 23 DSM-IV unipolar patients (41 (10) years; 4 male, 19 female), and 36 healthy controls (37 (10) years; 23 male, 13 female). A 1.5T GE Signa magnet was employed, with a fast spin echo sequence. Corpus callosum signal intensity was obtained blindly using the semiautomated software NIH Image 1.62.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Bipolar patients had lower corpus callosum signal intensity for all callosal subregions (genu, anterior and posterior body, isthmus, splenium) than healthy controls (ANCOVA, age and sex as covariates, p&lt;0.05). No significant differences were found between unipolar and healthy subjects (ANCOVA, age and sex as covariates, p&gt;0.05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The findings suggest abnormalities in corpus callosum white matter in bipolar but not unipolar patients, possibly because of altered myelination. Such abnormalities could lead to impaired interhemispheric communication in bipolar disorder. Longitudinal MRI studies involving first episode and early onset bipolar patients will be necessary for a better understanding of the potential role of abnormalities of corpus callosum myelination in the pathophysiology of bipolar disorder.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brambilla</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicoletti</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Sassi</LastName><ForeName>R B</ForeName><Initials>RB</Initials></Author><Author ValidYN="Y"><LastName>Mallinger</LastName><ForeName>A G</ForeName><Initials>AG</Initials></Author><Author ValidYN="Y"><LastName>Frank</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Keshavan</LastName><ForeName>M S</ForeName><Initials>MS</Initials></Author><Author ValidYN="Y"><LastName>Soares</LastName><ForeName>J C</ForeName><Initials>JC</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MH 01736</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MH 29618</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MH 30915</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Neurol Neurosurg Psychiatry</MedlineTA><NlmUniqueID>2985191R</NlmUniqueID><ISSNLinking>0022-3050</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003337" MajorTopicYN="N">Corpus Callosum</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003866" MajorTopicYN="N">Depressive Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007839" MajorTopicYN="N">Functional Laterality</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009186" MajorTopicYN="N">Myelin Sheath</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009434" MajorTopicYN="N">Neural Pathways</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>1</Month><Day>27</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>3</Month><Day>12</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>1</Month><Day>27</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14742592</ArticleId><ArticleId IdType="pmc">PMC1738899</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brain. 2000 Jul;123 ( Pt 7):1293-326</Citation><ArticleIdList><ArticleId IdType="pubmed">10869045</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 1998 Nov 9;84(1):7-15</Citation><ArticleIdList><ArticleId IdType="pubmed">9870413</ArticleId></ArticleIdList></Reference><Reference><Citation>Magn Reson Med. 2000 Aug;44(2):259-68</Citation><ArticleIdList><ArticleId IdType="pubmed">10918325</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2000 Oct 10;55(7):1033-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11061265</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2000 Sep;2(3 Pt 1):148-64</Citation><ArticleIdList><ArticleId IdType="pubmed">11256682</ArticleId></ArticleIdList></Reference><Reference><Citation>Prog Neuropsychopharmacol Biol Psychiatry. 1999 May;23(4):571-88</Citation><ArticleIdList><ArticleId IdType="pubmed">10390717</ArticleId></ArticleIdList></Reference><Reference><Citation>Prog Neuropsychopharmacol Biol Psychiatry. 1999 May;23(4):601-12</Citation><ArticleIdList><ArticleId IdType="pubmed">10390719</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Res Bull. 2001 Feb;54(3):255-66</Citation><ArticleIdList><ArticleId IdType="pubmed">11287130</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2001 Apr;3(2):58-62</Citation><ArticleIdList><ArticleId IdType="pubmed">11333063</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2001 Apr;3(2):79-87</Citation><ArticleIdList><ArticleId IdType="pubmed">11333067</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2001 Apr;3(2):88-94</Citation><ArticleIdList><ArticleId IdType="pubmed">11333068</ArticleId></ArticleIdList></Reference><Reference><Citation>Life Sci. 2002 Mar 8;70(16):1909-22</Citation><ArticleIdList><ArticleId IdType="pubmed">12005176</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Neurosurg Psychiatry. 2002 Jun;72(6):757-60</Citation><ArticleIdList><ArticleId IdType="pubmed">12023420</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychother Psychosom. 2000;69(1):2-18</Citation><ArticleIdList><ArticleId IdType="pubmed">10601830</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychiatry Neuropsychol Behav Neurol. 2000 Jan;13(1):20-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10645733</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 1994 Jun;55(2):85-99</Citation><ArticleIdList><ArticleId IdType="pubmed">10711797</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Neurol. 2000;43(4):233-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10828655</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Res. 1975 Nov 7;98(1):166-71</Citation><ArticleIdList><ArticleId IdType="pubmed">809118</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Neurol. 1976 Oct;53(1):115-27</Citation><ArticleIdList><ArticleId IdType="pubmed">964332</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 1977 Mar;100 Pt 1:105-18</Citation><ArticleIdList><ArticleId IdType="pubmed">861710</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Psychol Gen. 1979 Jun;108(2):251-79</Citation><ArticleIdList><ArticleId IdType="pubmed">528905</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurochem Res. 1984 Nov;9(11):1615-26</Citation><ArticleIdList><ArticleId IdType="pubmed">6521822</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuropathol Exp Neurol. 1985 Nov;44(6):578-91</Citation><ArticleIdList><ArticleId IdType="pubmed">4056827</ArticleId></ArticleIdList></Reference><Reference><Citation>AJNR Am J Neuroradiol. 1989 Jan-Feb;10(1):99-103</Citation><ArticleIdList><ArticleId IdType="pubmed">2492735</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 1989 Jun;112 ( Pt 3):799-835</Citation><ArticleIdList><ArticleId IdType="pubmed">2731030</ArticleId></ArticleIdList></Reference><Reference><Citation>AJNR Am J Neuroradiol. 1989 Jul-Aug;10(4):731-40</Citation><ArticleIdList><ArticleId IdType="pubmed">2505502</ArticleId></ArticleIdList></Reference><Reference><Citation>J Comp Neurol. 1990 Jan 22;291(4):520-37</Citation><ArticleIdList><ArticleId IdType="pubmed">2329189</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 1990 Jun 1;27(11):1188-96</Citation><ArticleIdList><ArticleId IdType="pubmed">2354225</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 1991 Apr;11(4):933-42</Citation><ArticleIdList><ArticleId IdType="pubmed">2010816</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Neurol. 1991 Apr;48(4):410-6</Citation><ArticleIdList><ArticleId IdType="pubmed">2012516</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 1991 Feb 1;29(3):300-1</Citation><ArticleIdList><ArticleId IdType="pubmed">2015336</ArticleId></ArticleIdList></Reference><Reference><Citation>J Learn Disabil. 1991 Mar;24(3):141-6</Citation><ArticleIdList><ArticleId IdType="pubmed">2026955</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroradiol. 1991;18(4):291-307</Citation><ArticleIdList><ArticleId IdType="pubmed">1804933</ArticleId></ArticleIdList></Reference><Reference><Citation>Cereb Cortex. 1991 Nov-Dec;1(6):492-8</Citation><ArticleIdList><ArticleId IdType="pubmed">1822754</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Res. 1992 Dec 11;598(1-2):143-53</Citation><ArticleIdList><ArticleId IdType="pubmed">1486477</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 1993 Jul;34(1):71-5</Citation><ArticleIdList><ArticleId IdType="pubmed">8517683</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 1993 May;28(1):15-25</Citation><ArticleIdList><ArticleId IdType="pubmed">8326077</ArticleId></ArticleIdList></Reference><Reference><Citation>J Inherit Metab Dis. 1993;16(4):771-86</Citation><ArticleIdList><ArticleId IdType="pubmed">8412020</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1994 May;151(5):665-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8166306</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Child Adolesc Psychiatry. 1994 Jul-Aug;33(6):875-81</Citation><ArticleIdList><ArticleId IdType="pubmed">8083145</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Brain Res. 1994 Oct 20;64(1-2):179-84</Citation><ArticleIdList><ArticleId IdType="pubmed">7840885</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Brain Res. 1994 Oct 20;64(1-2):65-78</Citation><ArticleIdList><ArticleId IdType="pubmed">7840893</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroreport. 1994 Nov 21;5(17):2385-8</Citation><ArticleIdList><ArticleId IdType="pubmed">7881064</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Neurol. 1995 Aug;52(8):794-801</Citation><ArticleIdList><ArticleId IdType="pubmed">7639631</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 1996 May 1;39(9):769-75</Citation><ArticleIdList><ArticleId IdType="pubmed">8731517</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 1996 Aug;47(2):477-82</Citation><ArticleIdList><ArticleId IdType="pubmed">8757024</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychologia. 1996 Sep;34(9):927-35</Citation><ArticleIdList><ArticleId IdType="pubmed">8822739</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Res Dev Brain Res. 1996 Feb 26;91(2):274-80</Citation><ArticleIdList><ArticleId IdType="pubmed">8852379</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 1997 Jan 1;41(1):86-106</Citation><ArticleIdList><ArticleId IdType="pubmed">8988799</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 1997 Aug;49(2):410-5</Citation><ArticleIdList><ArticleId IdType="pubmed">9270569</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatr Res. 1997 Jul-Aug;31(4):393-432</Citation><ArticleIdList><ArticleId IdType="pubmed">9352470</ArticleId></ArticleIdList></Reference><Reference><Citation>Prog Neuropsychopharmacol Biol Psychiatry. 1997 Nov;21(8):1269-83</Citation><ArticleIdList><ArticleId IdType="pubmed">9460091</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Res. 1998 Nov 23;812(1-2):38-49</Citation><ArticleIdList><ArticleId IdType="pubmed">9813233</ArticleId></ArticleIdList></Reference><Reference><Citation>Ment Retard Dev Disabil Res Rev. 2000;6(1):59-67</Citation><ArticleIdList><ArticleId IdType="pubmed">10899798</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20230117</PMID><DateCompleted><Year>2010</Year><Month>06</Month><Day>15</Day></DateCompleted><DateRevised><Year>2019</Year><Month>02</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1931-1559</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>2</Issue><PubDate><Year>2010</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Neuropsychology</Title><ISOAbbreviation>Neuropsychology</ISOAbbreviation></Journal><ArticleTitle>Are working memory deficits in bipolar disorder markers for psychosis?</ArticleTitle><Pagination><MedlinePgn>244-254</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1037/a0018159</ELocationID><Abstract><AbstractText>Working memory deficits have been identified in bipolar disorder, but there is evidence suggesting that these deficits may be markers for psychosis rather than affective disorder. The current study examined this issue by comparing two groups of individuals with bipolar disorder, one with psychotic features and one without psychotic features, with a group of normal controls. Working memory was conceptualized as a multicomponent system that includes auditory and visuospatial short-term stores, executive control processes, and an episodic buffer that allows for communication between short- and long-term memory stores (Baddeley &amp; Logie, 1999). Results indicated that only executive control processes significantly differentiated the psychotic and nonpsychotic bipolar groups, although visuospatial working memory differentiated both bipolar groups from controls. The results support the idea that some aspects of working memory performance are markers for psychosis, while others may be more general markers for bipolar disorders.</AbstractText><CopyrightInformation>Copyright 2010 APA, all rights reserved</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Allen</LastName><ForeName>Daniel N</ForeName><Initials>DN</Initials><AffiliationInfo><Affiliation>Department of Psychology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Randall</LastName><ForeName>Carol</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Psychology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bello</LastName><ForeName>Danielle</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Psychology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Armstrong</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Psychology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frantom</LastName><ForeName>Linda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Psychology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cross</LastName><ForeName>Chad</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Psychology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kinney</LastName><ForeName>Jefferson</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Psychology.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuropsychology</MedlineTA><NlmUniqueID>8904467</NlmUniqueID><ISSNLinking>0894-4105</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000161" MajorTopicYN="N">Acoustic Stimulation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D039721" MajorTopicYN="N">Diagnostic and Statistical Manual of Mental Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008569" MajorTopicYN="N">Memory Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008570" MajorTopicYN="N">Memory, Short-Term</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025341" MajorTopicYN="N">Principal Component Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011618" MajorTopicYN="N">Psychotic Disorders</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013223" MajorTopicYN="N">Statistics as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20230117</ArticleId><ArticleId IdType="pii">2010-04449-011</ArticleId><ArticleId IdType="doi">10.1037/a0018159</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21562142</PMID><DateCompleted><Year>2013</Year><Month>05</Month><Day>16</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1745-1701</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>6</Issue><PubDate><Year>2012</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Schizophrenia bulletin</Title><ISOAbbreviation>Schizophr Bull</ISOAbbreviation></Journal><ArticleTitle>Impairment in functional capacity as an endophenotype candidate in severe mental illness.</ArticleTitle><Pagination><MedlinePgn>1318-26</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/schbul/sbr046</ELocationID><Abstract><AbstractText>Impairment in everyday functioning (also referred to as "disability") is a central feature of schizophrenia (SZ) and bipolar disorder, as well as other neuropsychiatric conditions. There is a genetic contribution to both SZ and bipolar illness (BPI), and the primary putative determinant of impairments in everyday functioning across these 2 conditions, cognitive impairments, also show substantial heritability and in fact have been proposed to be endophenotypes for these disorders. In this article, we review data and make our case that impairments in functional capacity, the functional abilities that result in functional disability, may also be a heritable trait that is common across neuropsychiatric illnesses such BPI and SZ. While there has been little previous research on the heritability of these abilities, it is an area receiving substantial research attention. We consider advances in the measurement of cognitive functioning in SZ that may facilitate the discovery of genetic influences on functional capacity. Functional capacity measures are proximal to real-world impairments, measured with suitable psychometric precision to be used in heritability analyses, and appear to be minimally influenced by environmental factors that may cause disability such as environmental factors, symptoms, and disability compensation. Our conclusion is that these functional capacity measures have potential to be the target of genetic analyses and that these measures should be considered across neuropsychiatric conditions where impairments in everyday functioning are present.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Harvey</LastName><ForeName>Philip D</ForeName><Initials>PD</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, 1120 NW 14th Street, Suite 1450, Miami, FL 33136, USA. Philipdharvey1@cs.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McClure</LastName><ForeName>Margaret M</ForeName><Initials>MM</Initials></Author><Author ValidYN="Y"><LastName>Patterson</LastName><ForeName>Thomas L</ForeName><Initials>TL</Initials></Author><Author ValidYN="Y"><LastName>McGrath</LastName><ForeName>John A</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Pulver</LastName><ForeName>Ann E</ForeName><Initials>AE</Initials></Author><Author ValidYN="Y"><LastName>Bowie</LastName><ForeName>Christopher R</ForeName><Initials>CR</Initials></Author><Author ValidYN="Y"><LastName>Siever</LastName><ForeName>Larry J</ForeName><Initials>LJ</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MH 78775</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MH 56140</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH056140</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MH079784</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH078775</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MH78737</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>05</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Schizophr Bull</MedlineTA><NlmUniqueID>0236760</NlmUniqueID><ISSNLinking>0586-7614</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="N">Activities of Daily Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004651" MajorTopicYN="N">Employment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058068" MajorTopicYN="Y">Endophenotypes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012559" MajorTopicYN="N">Schizophrenia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012565" MajorTopicYN="Y">Schizophrenic Psychology</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>5</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>5</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21562142</ArticleId><ArticleId IdType="pii">sbr046</ArticleId><ArticleId IdType="doi">10.1093/schbul/sbr046</ArticleId><ArticleId IdType="pmc">PMC3494058</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schizophr Bull. 2007 Jan;33(1):1-2</Citation><ArticleIdList><ArticleId IdType="pubmed">17116653</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2001 Jun;3(3):106-50; discussion 151-3</Citation><ArticleIdList><ArticleId IdType="pubmed">11465675</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2003 Feb 15;117(2):103-12</Citation><ArticleIdList><ArticleId IdType="pubmed">12606013</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 1990 Jul-Aug;3(4):253-60</Citation><ArticleIdList><ArticleId IdType="pubmed">2278987</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1995 Apr;52(4):296-303</Citation><ArticleIdList><ArticleId IdType="pubmed">7702446</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2009 Nov;115(1):82-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19775869</ArticleId></ArticleIdList></Reference><Reference><Citation>Turk Psikiyatri Derg. 2009 Fall;20(3):282-93</Citation><ArticleIdList><ArticleId IdType="pubmed">19757227</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2002 Dec;72(3):209-26</Citation><ArticleIdList><ArticleId IdType="pubmed">12450638</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2002 Jun 1;55(3):229-37</Citation><ArticleIdList><ArticleId IdType="pubmed">12048146</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2004 Oct;161(10):1814-21</Citation><ArticleIdList><ArticleId IdType="pubmed">15465978</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2002;7(4):405-11</Citation><ArticleIdList><ArticleId IdType="pubmed">11986984</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2003;29(2):299-309</Citation><ArticleIdList><ArticleId IdType="pubmed">14552505</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1997 Feb;54(2):169-76</Citation><ArticleIdList><ArticleId IdType="pubmed">9040285</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2010 Feb;12(1):45-55</Citation><ArticleIdList><ArticleId IdType="pubmed">20148866</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2010 Feb;67(2):168-77</Citation><ArticleIdList><ArticleId IdType="pubmed">20124116</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 1990 Feb;46(2):222-8</Citation><ArticleIdList><ArticleId IdType="pubmed">2301392</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2006 Jul;85(1-3):49-57</Citation><ArticleIdList><ArticleId IdType="pubmed">16626941</ArticleId></ArticleIdList></Reference><Reference><Citation>J Consult Clin Psychol. 1981 Dec;49(6):807-21</Citation><ArticleIdList><ArticleId IdType="pubmed">7309951</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2009 Sep;35(5):1022-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18495643</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2009 Feb;113(1-2):1-20</Citation><ArticleIdList><ArticleId IdType="pubmed">18684514</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1996 Mar;153(3):321-30</Citation><ArticleIdList><ArticleId IdType="pubmed">8610818</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet B Neuropsychiatr Genet. 2003 Jan 1;116B(1):90-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12497621</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2009 Jul;166(7):821-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19487393</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2001 Aug;69(2):428-33</Citation><ArticleIdList><ArticleId IdType="pubmed">11443544</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Psychol. 2005 Apr;60(3):229-42</Citation><ArticleIdList><ArticleId IdType="pubmed">15796677</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 1991 Mar-Apr;4(2):157-71</Citation><ArticleIdList><ArticleId IdType="pubmed">2039759</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuropsychiatry Clin Neurosci. 2000 Spring;12(2):257-64</Citation><ArticleIdList><ArticleId IdType="pubmed">11001606</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2000;26(1):119-36</Citation><ArticleIdList><ArticleId IdType="pubmed">10755673</ArticleId></ArticleIdList></Reference><Reference><Citation>Prog Neuropsychopharmacol Biol Psychiatry. 2004 May;28(3):505-16</Citation><ArticleIdList><ArticleId IdType="pubmed">15093958</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2007 Feb-Mar;9(1-2):183-96</Citation><ArticleIdList><ArticleId IdType="pubmed">17391360</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2005 Jul;162(7):1243-52</Citation><ArticleIdList><ArticleId IdType="pubmed">15994704</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2009 Mar;11(2):113-25</Citation><ArticleIdList><ArticleId IdType="pubmed">19267694</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2006 Mar;163(3):411-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16513861</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2011 Sep;168(9):930-46</Citation><ArticleIdList><ArticleId IdType="pubmed">21498463</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2009 Jun;66(6):591-600</Citation><ArticleIdList><ArticleId IdType="pubmed">19487624</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2010 Sep;167(9):1116-24</Citation><ArticleIdList><ArticleId IdType="pubmed">20478878</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2002 Jan 1;53(1-2):31-44</Citation><ArticleIdList><ArticleId IdType="pubmed">11728836</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2000 Nov;5(6):650-3</Citation><ArticleIdList><ArticleId IdType="pubmed">11126395</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2003 Dec;60(12):1187-92</Citation><ArticleIdList><ArticleId IdType="pubmed">14662550</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2009 Jan 17;373(9659):234-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19150704</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1993 May;150(5):720-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8480816</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2004 Mar;161(3):473-9</Citation><ArticleIdList><ArticleId IdType="pubmed">14992973</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2007 Nov;64(11):1242-50</Citation><ArticleIdList><ArticleId IdType="pubmed">17984393</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2004 Nov;75(5):862-72</Citation><ArticleIdList><ArticleId IdType="pubmed">15386212</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatr Serv. 1997 Jul;48(7):948-50</Citation><ArticleIdList><ArticleId IdType="pubmed">9219306</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2003 Dec;160(12):2099-107</Citation><ArticleIdList><ArticleId IdType="pubmed">14638578</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 1990 Jul;157:50-4</Citation><ArticleIdList><ArticleId IdType="pubmed">2397362</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2003 May;8(5):511-23</Citation><ArticleIdList><ArticleId IdType="pubmed">12808431</ArticleId></ArticleIdList></Reference><Reference><Citation>J Int Neuropsychol Soc. 2008 May;14(3):479-88</Citation><ArticleIdList><ArticleId IdType="pubmed">18419846</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet C Semin Med Genet. 2003 Nov 15;123C(1):59-64</Citation><ArticleIdList><ArticleId IdType="pubmed">14601037</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2010 Dec;124(1-3):192-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20889312</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1994 Dec;51(12):945-51</Citation><ArticleIdList><ArticleId IdType="pubmed">7979882</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Neurol. 1995 May;52(5):525-30</Citation><ArticleIdList><ArticleId IdType="pubmed">7733849</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2007 Jun;9(4):370-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17547583</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1994 Dec;51(12):939-44</Citation><ArticleIdList><ArticleId IdType="pubmed">7979881</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2007 Jan;33(1):49-68</Citation><ArticleIdList><ArticleId IdType="pubmed">17101692</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2008 Mar 1;63(5):505-11</Citation><ArticleIdList><ArticleId IdType="pubmed">17662256</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2009 Jan;14(1):10-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19002139</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2007 Jan;33(1):21-32</Citation><ArticleIdList><ArticleId IdType="pubmed">17088422</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 2000 Sep;30(5):1155-67</Citation><ArticleIdList><ArticleId IdType="pubmed">12027051</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2001 Mar;103(3):163-70</Citation><ArticleIdList><ArticleId IdType="pubmed">11240572</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2005 Jan;10(1):40-68; image 5</Citation><ArticleIdList><ArticleId IdType="pubmed">15263907</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 1989;15(3):453-64</Citation><ArticleIdList><ArticleId IdType="pubmed">2683041</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Geriatr Psychiatry. 2003 Nov-Dec;11(6):610-9</Citation><ArticleIdList><ArticleId IdType="pubmed">14609801</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2007 May;164(5):813-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17475741</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2005 Jan;10(1):6-13</Citation><ArticleIdList><ArticleId IdType="pubmed">15618952</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2010 Jun;119(1-3):246-52</Citation><ArticleIdList><ArticleId IdType="pubmed">20399613</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2003 Sep;60(9):889-96</Citation><ArticleIdList><ArticleId IdType="pubmed">12963670</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2004 Dec 1;71(2-3):285-95</Citation><ArticleIdList><ArticleId IdType="pubmed">15474899</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2006 Jul;32(3):578-83</Citation><ArticleIdList><ArticleId IdType="pubmed">16436627</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28814728</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>13</Day></DateCompleted><DateRevised><Year>2019</Year><Month>03</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>08</Month><Day>16</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Prevalence of smoking in patients with bipolar disorder, major depressive disorder and schizophrenia and their relationships with quality of life.</ArticleTitle><Pagination><MedlinePgn>8430</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-017-07928-9</ELocationID><Abstract><AbstractText>Few studies have compared the prevalence of smoking between patients with bipolar disorder, major depressive disorder (MDD) and schizophrenia. This study examined the prevalence of smoking and its relationships with demographic and clinical characteristics, and quality of life (QOL) in patients with these psychiatric disorders. A total of 1,102 inpatients were consecutively screened. Psychopathology and QOL were measured with standardized instruments. The prevalence of current smoking in the whole sample was 16.7%; 17.5% in bipolar disorder, 10.6% in MDD and 18.5% in schizophrenia. The rates of smoking in bipolar disorder (p = 0.004, OR = 2.5, 95%CI: 1.3-4.7) and schizophrenia (p = 0.03, OR = 2.0, 95%CI: 1.06-3.8) were significantly higher than in MDD, while no difference was found between bipolar disorder and schizophrenia. Smokers had a higher mental QOL than non-smokers (p = 0.007) in MDD, but no difference was found in the other two groups. Male gender, living alone, higher personal income, older age of onset, health insurance coverage, and first episode was significantly associated with smoking in one or more diagnostic groups. Smoking appears more common in bipolar disorder and schizophrenia than in MDD in China. The figures in all disorders were lower than that reported in most of other countries.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiao-Hong</ForeName><Initials>XH</Initials><AffiliationInfo><Affiliation>The National Clinical Research Center for Mental Disorders &amp; Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit of Psychiatry, Faculty of Health Sciences, University of Macau, Macao, SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>An</LastName><ForeName>Feng-Rong</ForeName><Initials>FR</Initials><AffiliationInfo><Affiliation>The National Clinical Research Center for Mental Disorders &amp; Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ungvari</LastName><ForeName>Gabor S</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>The University of Notre Dame Australia/Marian Centre, Perth, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Psychiatry &amp; Clinical Neurosciences, University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Chee H</ForeName><Initials>CH</Initials><Identifier Source="ORCID">0000-0002-3811-2732</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiu</LastName><ForeName>Helen F K</ForeName><Initials>HFK</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Chinese University of Hong Kong, Hong Kong, SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Ping-Ping</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>The National Clinical Research Center for Mental Disorders &amp; Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The National Clinical Research Center for Mental Disorders &amp; Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiang</LastName><ForeName>Yu-Tao</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Unit of Psychiatry, Faculty of Health Sciences, University of Macau, Macao, SAR, China. xyutly@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>08</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003865" MajorTopicYN="N">Depressive Disorder, Major</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012559" MajorTopicYN="N">Schizophrenia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012565" MajorTopicYN="N">Schizophrenic Psychology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012907" MajorTopicYN="N">Smoking</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>03</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>07</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28814728</ArticleId><ArticleId IdType="doi">10.1038/s41598-017-07928-9</ArticleId><ArticleId IdType="pii">10.1038/s41598-017-07928-9</ArticleId><ArticleId IdType="pmc">PMC5559601</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arch Gen Psychiatry. 2002 Dec;59(12):1085-96</Citation><ArticleIdList><ArticleId IdType="pubmed">12470124</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Alcohol Depend. 2016 May 1;162:146-53</Citation><ArticleIdList><ArticleId IdType="pubmed">26996743</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2009 Jun 13;373(9680):2041-53</Citation><ArticleIdList><ArticleId IdType="pubmed">19524780</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatr Serv. 2006 Jul;57(7):1035-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16816291</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Public Health. 1999 Dec;89(12):1837-40</Citation><ArticleIdList><ArticleId IdType="pubmed">10589312</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1998 Nov;155(11):1490-501</Citation><ArticleIdList><ArticleId IdType="pubmed">9812108</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2008 Sep;104(1-3):214-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18650069</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatr Res. 2010 Oct;44(14):986-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20334878</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer. 2014 Feb 1;120(3):323-34</Citation><ArticleIdList><ArticleId IdType="pubmed">24151022</ArticleId></ArticleIdList></Reference><Reference><Citation>Soc Psychiatry Psychiatr Epidemiol. 2007 Apr;42(4):268-76</Citation><ArticleIdList><ArticleId IdType="pubmed">17370043</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2015 Sep;17(6):575-97</Citation><ArticleIdList><ArticleId IdType="pubmed">26238269</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2007 Dec;97(1-3):88-96</Citation><ArticleIdList><ArticleId IdType="pubmed">17628430</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Biobehav Rev. 2005;29(6):1021-34</Citation><ArticleIdList><ArticleId IdType="pubmed">15964073</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2003 Dec;160(12):2216-21</Citation><ArticleIdList><ArticleId IdType="pubmed">14638593</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 1990 Sep 26;264(12):1550-5</Citation><ArticleIdList><ArticleId IdType="pubmed">2395195</ArticleId></ArticleIdList></Reference><Reference><Citation>J Health Serv Res Policy. 1997 Jan;2(1):14-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10180648</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatr Res. 2007 Jan-Feb;41(1-2):43-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16360170</ArticleId></ArticleIdList></Reference><Reference><Citation>Depress Anxiety. 2013 Jun;30(6):580-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23606190</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Alcohol Depend. 2004 Dec 7;76(3):287-95</Citation><ArticleIdList><ArticleId IdType="pubmed">15561479</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatr Genet. 2013 Feb;23(1):20-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23196875</ArticleId></ArticleIdList></Reference><Reference><Citation>Addiction. 2013 Feb;108(2):294-306</Citation><ArticleIdList><ArticleId IdType="pubmed">23072580</ArticleId></ArticleIdList></Reference><Reference><Citation>Tob Control. 2006 Jun;15 Suppl 3:iii59-64</Citation><ArticleIdList><ArticleId IdType="pubmed">16754948</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2009 Mar;11(2):154-65</Citation><ArticleIdList><ArticleId IdType="pubmed">19267698</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 1998 Sep 7;33(1-2):113-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9783351</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1995 Mar;152(3):453-5</Citation><ArticleIdList><ArticleId IdType="pubmed">7864277</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatr Res. 2011 Dec;45(12):1551-6</Citation><ArticleIdList><ArticleId IdType="pubmed">21820671</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Psychiatry. 2009 Mar;54(3):204-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19321025</ArticleId></ArticleIdList></Reference><Reference><Citation>NCHS Data Brief. 2010 Apr;(34):1-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20604991</ArticleId></ArticleIdList></Reference><Reference><Citation>Gen Hosp Psychiatry. 2016 Jan-Feb;38:79-83</Citation><ArticleIdList><ArticleId IdType="pubmed">26633862</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2016 Dec 30;246:246-249</Citation><ArticleIdList><ArticleId IdType="pubmed">27723522</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2001 Jun 16;357(9272):1929-32</Citation><ArticleIdList><ArticleId IdType="pubmed">11425414</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1993 Jan;50(1):36-43</Citation><ArticleIdList><ArticleId IdType="pubmed">8422220</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 1998 May;59(5):225-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9632031</ArticleId></ArticleIdList></Reference><Reference><Citation>J Consult Clin Psychol. 2003 Aug;71(4):657-63</Citation><ArticleIdList><ArticleId IdType="pubmed">12924670</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatr Serv. 2013 Jan;64(1):44-50</Citation><ArticleIdList><ArticleId IdType="pubmed">23280457</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2002 Jul 1;56(1-2):47-54</Citation><ArticleIdList><ArticleId IdType="pubmed">12084419</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(2):e30937</Citation><ArticleIdList><ArticleId IdType="pubmed">22347412</ArticleId></ArticleIdList></Reference><Reference><Citation>Aust Fam Physician. 2012 May;41(5):304-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22558621</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicotine Tob Res. 2008 Dec;10(12):1691-715</Citation><ArticleIdList><ArticleId IdType="pubmed">19023823</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Psychiatry. 2014 Feb;29(2):65-82</Citation><ArticleIdList><ArticleId IdType="pubmed">24485753</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1997 Jan 21;94(2):587-92</Citation><ArticleIdList><ArticleId IdType="pubmed">9012828</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2008 Aug;103(1-3):161-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18550339</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2005 Jul 15;76(2-3):135-57</Citation><ArticleIdList><ArticleId IdType="pubmed">15949648</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 2016 Nov;71:71-76</Citation><ArticleIdList><ArticleId IdType="pubmed">27639124</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2002 Jul 1;56(1-2):55-65</Citation><ArticleIdList><ArticleId IdType="pubmed">12084420</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2016 Jan 30;235:203-5</Citation><ArticleIdList><ArticleId IdType="pubmed">26688158</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2000 Nov 22-29;284(20):2606-10</Citation><ArticleIdList><ArticleId IdType="pubmed">11086367</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2017 Mar 1;210:303-311</Citation><ArticleIdList><ArticleId IdType="pubmed">28068619</ArticleId></ArticleIdList></Reference><Reference><Citation>Gen Hosp Psychiatry. 2005 Sep-Oct;27(5):321-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16168792</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1986 Aug;143(8):993-7</Citation><ArticleIdList><ArticleId IdType="pubmed">3487983</ArticleId></ArticleIdList></Reference><Reference><Citation>J Subst Abuse. 1995;7(3):373-8</Citation><ArticleIdList><ArticleId IdType="pubmed">8749796</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Addict Behav. 2003 Dec;17(4):259-65</Citation><ArticleIdList><ArticleId IdType="pubmed">14640821</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 1992 Dec;8(2):93-102</Citation><ArticleIdList><ArticleId IdType="pubmed">1360812</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Alcohol Depend. 2009 Feb 1;100(1-2):146-52</Citation><ArticleIdList><ArticleId IdType="pubmed">19028024</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">8444752</PMID><DateCompleted><Year>1993</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0890-8567</ISSN><JournalIssue CitedMedium="Print"><Volume>32</Volume><Issue>2</Issue><PubDate><Year>1993</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of the American Academy of Child and Adolescent Psychiatry</Title><ISOAbbreviation>J Am Acad Child Adolesc Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Comparison of preventive interventions for families with parental affective disorder.</ArticleTitle><Pagination><MedlinePgn>254-63</MedlinePgn></Pagination><Abstract><AbstractText>Twenty families participated in a random assignment trial of two cognitive psychoeducational preventive interventions for families with parental affective disorder. Twelve families were assigned to a clinician-based intervention and eight to a lecture-based intervention, with assessment prior to intervention and an average of 18 weeks following intervention. Both groups were satisfied and believed they received help from the intervention. The clinician-based group was significantly more satisfied overall, and reported significantly more changes in both behaviors and attitudes about their illness from pre- to postintervention. Both groups showed significant decrease in degree of upset over issues of concern from pre- to postintervention. The clinician-based group reported receiving significantly more help with their primary concern. The implications of these findings are discussed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Beardslee</LastName><ForeName>W R</ForeName><Initials>WR</Initials><AffiliationInfo><Affiliation>Harvard Medical School Department of Psychiatry, Judge Baker Children's Center, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salt</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Porterfield</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Rothberg</LastName><ForeName>P C</ForeName><Initials>PC</Initials></Author><Author ValidYN="Y"><LastName>van de Velde</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Swatling</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Hoke</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Moilanen</LastName><ForeName>D L</ForeName><Initials>DL</Initials></Author><Author ValidYN="Y"><LastName>Wheelock</LastName><ForeName>I</ForeName><Initials>I</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Acad Child Adolesc Psychiatry</MedlineTA><NlmUniqueID>8704565</NlmUniqueID><ISSNLinking>0890-8567</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001008" MajorTopicYN="N">Anxiety Disorders</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016241" MajorTopicYN="N">Child of Impaired Parents</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015928" MajorTopicYN="N">Cognitive Behavioral Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003866" MajorTopicYN="N">Depressive Disorder</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005196" MajorTopicYN="N">Family Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010553" MajorTopicYN="Y">Personality Development</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012931" MajorTopicYN="N">Social Environment</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1993</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1993</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1993</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">8444752</ArticleId><ArticleId IdType="pii">S0890-8567(09)65212-6</ArticleId><ArticleId IdType="doi">10.1097/00004583-199303000-00004</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">8292689</PMID><DateCompleted><Year>1994</Year><Month>02</Month><Day>25</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0006-3223</ISSN><JournalIssue CitedMedium="Print"><Volume>34</Volume><Issue>9</Issue><PubDate><Year>1993</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>Biological psychiatry</Title><ISOAbbreviation>Biol Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Convulsive threshold differences in right unilateral and bilateral ECT.</ArticleTitle><Pagination><MedlinePgn>606-11</MedlinePgn></Pagination><Abstract><AbstractText Label="UNLABELLED">This study examines how the convulsive threshold in electroconvulsive therapy (ECT) varies with electrode placement (bilateral [BL] versus right unilateral [RUL]), age, gender, weight, and the nasion-inion measurements of the head.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">Twenty-eight subjects underwent stimulus dose titration to determine the convulsive threshold. Titration was accomplished for each subject with both electrode placements during the first and second ECT in a balanced design. Head measurements were made prior to the first ECT. Results indicated that the convulsive threshold was higher for BL than RUL, higher for men than women, increased with age, and increased with an increasing nasion-inion measurement in women but not in men. We concluded that the convulsive threshold varies according to the choice of electrode placement, gender, and age as has been reported by others. We additionally report that the convulsive threshold increases with increasing head size as reflected in the nasion-inion distance.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McCall</LastName><ForeName>W V</ForeName><Initials>WV</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Medicine, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, NC 27157.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shelp</LastName><ForeName>F E</ForeName><Initials>FE</Initials></Author><Author ValidYN="Y"><LastName>Weiner</LastName><ForeName>R D</ForeName><Initials>RD</Initials></Author><Author ValidYN="Y"><LastName>Austin</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Norris</LastName><ForeName>J</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biol Psychiatry</MedlineTA><NlmUniqueID>0213264</NlmUniqueID><ISSNLinking>0006-3223</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003866" MajorTopicYN="N">Depressive Disorder</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004292" MajorTopicYN="N">Dominance, Cerebral</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004565" MajorTopicYN="N">Electroconvulsive Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004569" MajorTopicYN="Y">Electroencephalography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005071" MajorTopicYN="N">Evoked Potentials</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005625" MajorTopicYN="N">Frontal Lobe</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012559" MajorTopicYN="N">Schizophrenia</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012565" MajorTopicYN="Y">Schizophrenic Psychology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1993</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1993</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1993</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">8292689</ArticleId><ArticleId IdType="pii">0006-3223(93)90152-4</ArticleId><ArticleId IdType="doi">10.1016/0006-3223(93)90152-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">14638572</PMID><DateCompleted><Year>2004</Year><Month>01</Month><Day>21</Day></DateCompleted><DateRevised><Year>2004</Year><Month>11</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0002-953X</ISSN><JournalIssue CitedMedium="Print"><Volume>160</Volume><Issue>12</Issue><PubDate><Year>2003</Year><Month>Dec</Month></PubDate></JournalIssue><Title>The American journal of psychiatry</Title><ISOAbbreviation>Am J Psychiatry</ISOAbbreviation></Journal><ArticleTitle>The course of bipolar disorder and the nature of agitated depression.</ArticleTitle><Pagination><MedlinePgn>2077-9</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Goodwin</LastName><ForeName>Frederick K</ForeName><Initials>FK</Initials></Author><Author ValidYN="Y"><LastName>Ghaemi</LastName><ForeName>S Nassir</ForeName><Initials>SN</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016420">Comment</PublicationType><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Psychiatry</MedlineTA><NlmUniqueID>0370512</NlmUniqueID><ISSNLinking>0002-953X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000928">Antidepressive Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Am J Psychiatry. 2003 Dec;160(12):2099-107</RefSource><PMID Version="1">14638578</PMID></CommentsCorrections><CommentsCorrections RefType="CommentOn"><RefSource>Am J Psychiatry. 2003 Dec;160(12):2134-40</RefSource><PMID Version="1">14638583</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000928" MajorTopicYN="N">Antidepressive Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003627" MajorTopicYN="N">Data Interpretation, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003865" MajorTopicYN="N">Depressive Disorder, Major</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011595" MajorTopicYN="N">Psychomotor Agitation</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>11</Month><Day>26</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>1</Month><Day>22</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>11</Month><Day>26</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14638572</ArticleId><ArticleId IdType="doi">10.1176/appi.ajp.160.12.2077</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21443568</PMID><DateCompleted><Year>2011</Year><Month>07</Month><Day>29</Day></DateCompleted><DateRevised><Year>2011</Year><Month>03</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1399-5618</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>2</Issue><PubDate><Year>2011</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Bipolar disorders</Title><ISOAbbreviation>Bipolar Disord</ISOAbbreviation></Journal><ArticleTitle>Bipolar mixed episodes and antidepressants: a cohort study of bipolar I disorder patients.</ArticleTitle><Pagination><MedlinePgn>145-54</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1399-5618.2011.00908.x</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The aim of this study was to elucidate the factors associated with the occurrence of mixed episodes, characterized by the presence of concomitant symptoms of both affective poles, during the course of illness in bipolar I disorder patients treated with an antidepressant, as well as the role of antidepressants in the course and outcome of the disorder.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">We enrolled a sample of 144 patients followed for up to 20 years in the referral Barcelona Bipolar Disorder Program and compared subjects who had experienced at least one mixed episode during the follow-up (n=60) with subjects who had never experienced a mixed episode (n=84) regarding clinical variables.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Nearly 40% of bipolar I disorder patients treated with antidepressants experienced at least one mixed episode during the course of their illness; no gender differences were found between two groups. Several differences regarding clinical variables were found between the two groups, but after performing logistic regression analysis, only suicide attempts (p&lt;0.001), the use of serotonin norepinephrine reuptake inhibitors (p=0.041), switch rates (p=0.010), and years spent ill (p=0.022) were significantly associated with the occurrence of at least one mixed episode during follow-up.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The occurrence of mixed episodes is associated with a tendency to chronicity, with a poorer outcome, a higher number of depressive episodes, and greater use of antidepressants, especially serotonin norepinephrine reuptake inhibitors.</AbstractText><CopyrightInformation>© 2011 John Wiley and Sons A/S.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Valentí</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Bipolar Disorders Program, Clinical Institute of Neuroscience, Hospital Clínic Barcelona, IDIBAPS, CIBERSAM, University of Barcelona, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pacchiarotti</LastName><ForeName>Isabella</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Rosa</LastName><ForeName>Adriane R</ForeName><Initials>AR</Initials></Author><Author ValidYN="Y"><LastName>Bonnín</LastName><ForeName>C Mar</ForeName><Initials>CM</Initials></Author><Author ValidYN="Y"><LastName>Popovic</LastName><ForeName>Dina</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Nivoli</LastName><ForeName>Alessandra M A</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Murru</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Grande</LastName><ForeName>Iria</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Colom</LastName><ForeName>Francesc</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Vieta</LastName><ForeName>Eduard</ForeName><Initials>E</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Bipolar Disord</MedlineTA><NlmUniqueID>100883596</NlmUniqueID><ISSNLinking>1398-5647</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000928">Antidepressive Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000928" MajorTopicYN="N">Antidepressive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21443568</ArticleId><ArticleId IdType="doi">10.1111/j.1399-5618.2011.00908.x</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">14705583</PMID><DateCompleted><Year>2004</Year><Month>02</Month><Day>13</Day></DateCompleted><DateRevised><Year>2004</Year><Month>11</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0025-4800</ISSN><JournalIssue CitedMedium="Print"><Volume>52</Volume><Issue>3</Issue><PubDate><Year>2003</Year><Season>Fall</Season></PubDate></JournalIssue><Title>Journal of the Massachusetts Dental Society</Title><ISOAbbreviation>J Mass Dent Soc</ISOAbbreviation></Journal><ArticleTitle>Mood disorders and dental implications.</ArticleTitle><Pagination><MedlinePgn>38-42</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reebye</LastName><ForeName>Uday N</ForeName><Initials>UN</Initials><AffiliationInfo><Affiliation>Boston University, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reebye</LastName><ForeName>Pratibha N</ForeName><Initials>PN</Initials></Author><Author ValidYN="Y"><LastName>Cottrell</LastName><ForeName>David A</ForeName><Initials>DA</Initials></Author><Author ValidYN="Y"><LastName>Misri</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Mass Dent Soc</MedlineTA><NlmUniqueID>7503082</NlmUniqueID><ISSNLinking>0025-4800</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000928">Antidepressive Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018692">Antimanic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>D</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000928" MajorTopicYN="N">Antidepressive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018692" MajorTopicYN="N">Antimanic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017742" MajorTopicYN="N">Dental Care for Chronically Ill</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003866" MajorTopicYN="N">Depressive Disorder</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019964" MajorTopicYN="N">Mood Disorders</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009059" MajorTopicYN="N">Mouth Diseases</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014076" MajorTopicYN="N">Tooth Diseases</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>1</Month><Day>7</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>2</Month><Day>14</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>1</Month><Day>7</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14705583</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17894061</PMID><DateCompleted><Year>2007</Year><Month>10</Month><Day>10</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0012-3714</ISSN><JournalIssue CitedMedium="Print"><Volume>35</Volume><Issue>10</Issue><PubDate><Year>1974</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Diseases of the nervous system</Title><ISOAbbreviation>Dis Nerv Syst</ISOAbbreviation></Journal><ArticleTitle>The current status of lithium prophylaxis.</ArticleTitle><Pagination><MedlinePgn>470-1</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Prien</LastName><ForeName>R F</ForeName><Initials>RF</Initials><AffiliationInfo><Affiliation>Central Neuropsychiatric Research Laboratory, VA Hospital, Perry Point, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caffey</LastName><ForeName>E M</ForeName><Initials>EM</Initials><Suffix>Jr</Suffix></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Nerv Syst</MedlineTA><NlmUniqueID>0370666</NlmUniqueID><ISSNLinking>0012-3714</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011619">Psychotropic Drugs</NameOfSubstance></Chemical><Chemical><RegistryNumber>2BMD2GNA4V</RegistryNumber><NameOfSubstance UI="D016651">Lithium Carbonate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003866" MajorTopicYN="N">Depressive Disorder</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016651" MajorTopicYN="N">Lithium Carbonate</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011570" MajorTopicYN="N">Psychiatry</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011619" MajorTopicYN="N">Psychotropic Drugs</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055502" MajorTopicYN="N">Secondary Prevention</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>18</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1974</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>10</Month><Day>11</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1974</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17894061</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15935230</PMID><DateCompleted><Year>2005</Year><Month>09</Month><Day>23</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0165-0327</ISSN><JournalIssue CitedMedium="Print"><Volume>86</Volume><Issue>2-3</Issue><PubDate><Year>2005</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of affective disorders</Title><ISOAbbreviation>J Affect Disord</ISOAbbreviation></Journal><ArticleTitle>Comorbidity of bipolar and eating disorders: distinct or related disorders with shared dysregulations?</ArticleTitle><Pagination><MedlinePgn>107-27</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The co-occurrence of bipolar and eating disorders, though of major clinical and public health importance, remains relatively unexamined.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In reviewing the literature on this comorbidity, we compared bulimia, anorexia nervosa, bulimia nervosa, binge eating disorders and bipolar disorders on phenomenology, course, family history, biology, and treatment response.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Epidemiological studies show an association between subthreshold bipolar disorder and eating disorders in adolescents, and between hypomania and eating disorders, especially binge eating behavior, in adults. Of the clinical studies, most show that patients with bipolar disorder have elevated rates of eating disorders, and vice versa. Finally, the phenomenology, course, comorbidity, family history, and pharmacologic treatment response of these disorders show considerable overlap on all of these parameters. In particular, on phenomenologic grounds--eating dysregulation, mood dysregulation, impulsivity and compulsivity, craving for activity and/or exercise--we find many parallels between bipolar and eating disorders. Overall, the similarities between these disorders were more apparent when examined in their spectrum rather than full-blown expressions.</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">Despite an extensive literature on each of these disorders, studies examining their overlap across all these parameters are relatively sparse and insufficiently systematic.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Nonetheless, the reviewed literature leaves little doubt that bipolar and eating disorders--particularly bulimia nervosa and bipolar II disorder--are related. Although several antidepressants and mood stabilizers have shown promise for eating disorders, their clinical use when these disorders co-exist with bipolarity is still very much of an art. We trust that this review will stimulate more rigorous research in their shared putative underlying psychobiologic mechanisms which, in turn, could lead to more rational targeted treatments.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McElroy</LastName><ForeName>Susan L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Psychopharmacology Research Program, University of Cincinnati College of Medicine, P.O. Box 670559, 231 Bethesda Avenue, Cincinnati, OH 45267-0559, USA. susan.mcelroy@uc.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotwal</LastName><ForeName>Renu</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Keck</LastName><ForeName>Paul E</ForeName><Initials>PE</Initials><Suffix>Jr</Suffix></Author><Author ValidYN="Y"><LastName>Akiskal</LastName><ForeName>Hagop S</ForeName><Initials>HS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Affect Disord</MedlineTA><NlmUniqueID>7906073</NlmUniqueID><ISSNLinking>0165-0327</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000927">Anticonvulsants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000928">Antidepressive Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>9FN79X2M3F</RegistryNumber><NameOfSubstance UI="D008094">Lithium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000856" MajorTopicYN="N">Anorexia Nervosa</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000927" MajorTopicYN="N">Anticonvulsants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000928" MajorTopicYN="N">Antidepressive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002032" MajorTopicYN="N">Bulimia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005247" MajorTopicYN="N">Feeding Behavior</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008094" MajorTopicYN="N">Lithium</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011613" MajorTopicYN="N">Psychotherapy</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>203</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2004</Year><Month>04</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2004</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>6</Month><Day>7</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>9</Month><Day>24</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>6</Month><Day>7</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15935230</ArticleId><ArticleId IdType="pii">S0165-0327(04)00436-7</ArticleId><ArticleId IdType="doi">10.1016/j.jad.2004.11.008</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31648654</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-7979</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><PubDate><Year>2019</Year><Month>Oct</Month><Day>25</Day></PubDate></JournalIssue><Title>Epidemiology and psychiatric sciences</Title><ISOAbbreviation>Epidemiol Psychiatr Sci</ISOAbbreviation></Journal><ArticleTitle>Prevalence of suicide attempts in bipolar disorder: a systematic review and meta-analysis of observational studies.</ArticleTitle><Pagination><MedlinePgn>e63</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1017/S2045796019000593</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">Bipolar disorder (BD) is a severe psychiatric disorder associated with a high risk of suicide. This meta-analysis examined the prevalence of suicide attempts (SA) in patients with BD and its associated factors.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic literature search was conducted in the PubMed, PsycINFO, EMBASE and Web of Science databases from their inception to 11 June 2018. The prevalence of SA in BD was synthesised using the random-effects model.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The search identified 3451 articles of which 79 studies with 33 719 subjects met the study entry criteria. The lifetime prevalence of SA was 33.9% (95% CI 31.3-36.6%; I2 = 96.4%). Subgroup and meta-regression analyses revealed that the lifetime prevalence of SA was positively associated with female gender, BD-I, BD Not Otherwise Specified and rapid cycling BD subtypes, income level and geographic region.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This meta-analysis confirmed that SA is common in BD and identified a number of factors related to SA. Further efforts are necessary to facilitate the identification and prevention of SA in BD. Long-term use of mood stabilisers coupled with psycho-social interventions should be available to BD patients to reduce the risk of suicidal behaviour.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Guangdong Mental Health Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit of Psychiatry, Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macao SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Unit of Psychiatry, Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macao SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The National Clinical Research Center for Mental Disorders &amp; Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital &amp; the Advanced Innovation Center for Human Brain Protection, Capital Medical University, School of Mental Health, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Qinge</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>The National Clinical Research Center for Mental Disorders &amp; Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital &amp; the Advanced Innovation Center for Human Brain Protection, Capital Medical University, School of Mental Health, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ungvari</LastName><ForeName>Gabor S</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Division of Psychiatry, School of Medicine, University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Notre Dame Australia, Fremantle, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Chee H</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, The Melbourne Clinic and St Vincent's Hospital, University of Melbourne, Richmond, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Unit of Psychiatry, Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macao SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiang</LastName><ForeName>Yifan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Pui Ching Middle School Macau, Macau SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Gang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>The National Clinical Research Center for Mental Disorders &amp; Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital &amp; the Advanced Innovation Center for Human Brain Protection, Capital Medical University, School of Mental Health, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiang</LastName><ForeName>Yu-Tao</ForeName><Initials>YT</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-2906-0029</Identifier><AffiliationInfo><Affiliation>Unit of Psychiatry, Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macao SAR, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Cognition and Brain Sciences, University of Macau, Macao SAR, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Epidemiol Psychiatr Sci</MedlineTA><NlmUniqueID>101561091</NlmUniqueID><ISSNLinking>2045-7960</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005843" MajorTopicYN="N">Geography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007182" MajorTopicYN="N">Income</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013406" MajorTopicYN="N">Suicide, Attempted</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bipolar disorder</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">prevalence</Keyword><Keyword MajorTopicYN="N">suicide attempt</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31648654</ArticleId><ArticleId IdType="doi">10.1017/S2045796019000593</ArticleId><ArticleId IdType="pii">S2045796019000593</ArticleId><ArticleId IdType="pmc">PMC8061290</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Shanghai Arch Psychiatry. 2013 Apr;25(2):70-80</Citation><ArticleIdList><ArticleId IdType="pubmed">24991138</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2001;62 Suppl 25:27-30</Citation><ArticleIdList><ArticleId IdType="pubmed">11765092</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 1999;60 Suppl 2:63-9; discussion 75-6, 113-6</Citation><ArticleIdList><ArticleId IdType="pubmed">10073390</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2017 May;135(5):470-478</Citation><ArticleIdList><ArticleId IdType="pubmed">28190254</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2004 Oct;161(10):1902-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15465989</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2007 Aug;101(1-3):27-34</Citation><ArticleIdList><ArticleId IdType="pubmed">17074395</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Arch Psychiatry Clin Neurosci. 2018 Mar;268(2):169-177</Citation><ArticleIdList><ArticleId IdType="pubmed">28365865</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2016 Mar;133(3):174-86</Citation><ArticleIdList><ArticleId IdType="pubmed">26555604</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2012 Dec 20;143(1-3):16-26</Citation><ArticleIdList><ArticleId IdType="pubmed">22763038</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2011 Jun;13(4):343-54</Citation><ArticleIdList><ArticleId IdType="pubmed">21843274</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Psychiatry. 2000 Sep;15(6):343-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11004728</ArticleId></ArticleIdList></Reference><Reference><Citation>Medicine (Baltimore). 2016 Jul;95(30):e4354</Citation><ArticleIdList><ArticleId IdType="pubmed">27472724</ArticleId></ArticleIdList></Reference><Reference><Citation>CNS Drugs. 2003;17(7):491-511</Citation><ArticleIdList><ArticleId IdType="pubmed">12751919</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatr Res. 2008 Oct;42(13):1068-75</Citation><ArticleIdList><ArticleId IdType="pubmed">18262204</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2005 Sep;162(9):1680-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16135628</ArticleId></ArticleIdList></Reference><Reference><Citation>Evid Based Ment Health. 2005 May;8(2):52</Citation><ArticleIdList><ArticleId IdType="pubmed">15851815</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2010 Aug;71(8):1000-6</Citation><ArticleIdList><ArticleId IdType="pubmed">20361912</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2013 Apr;24(4):895-900</Citation><ArticleIdList><ArticleId IdType="pubmed">23175625</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatr Clin North Am. 2016 Mar;39(1):111-23</Citation><ArticleIdList><ArticleId IdType="pubmed">26876322</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2003 May;64(5):506-15</Citation><ArticleIdList><ArticleId IdType="pubmed">12755652</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2015 Feb;17(1):1-16</Citation><ArticleIdList><ArticleId IdType="pubmed">25329791</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2008 Jul;109(1-2):57-63</Citation><ArticleIdList><ArticleId IdType="pubmed">18221790</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Psychiatry Med. 2015;49(4):296-308</Citation><ArticleIdList><ArticleId IdType="pubmed">26060259</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2007 Aug;9(5):526-30</Citation><ArticleIdList><ArticleId IdType="pubmed">17680924</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2014 Sep;16(6):652-61</Citation><ArticleIdList><ArticleId IdType="pubmed">24636453</ArticleId></ArticleIdList></Reference><Reference><Citation>J Nerv Ment Dis. 2012 Nov;200(11):978-84</Citation><ArticleIdList><ArticleId IdType="pubmed">23124183</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2000 Aug;59(2):107-17</Citation><ArticleIdList><ArticleId IdType="pubmed">10837879</ArticleId></ArticleIdList></Reference><Reference><Citation>Chronic Dis Can. 1998;19(4):170-6</Citation><ArticleIdList><ArticleId IdType="pubmed">10029513</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 1985 Jan-Feb;26(1):90-100</Citation><ArticleIdList><ArticleId IdType="pubmed">3881217</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1999 Aug;156(8):1276-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10450275</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2005 Oct;7(5):441-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16176437</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatr Genet. 2014 Jun;24(3):110-5</Citation><ArticleIdList><ArticleId IdType="pubmed">24710129</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2016 May;77(5):e555-60</Citation><ArticleIdList><ArticleId IdType="pubmed">27135375</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2014 Oct;130(4):244-56</Citation><ArticleIdList><ArticleId IdType="pubmed">24916190</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 2019 Jul;49(10):1691-1704</Citation><ArticleIdList><ArticleId IdType="pubmed">30178722</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2015 Nov;17(7):795-803</Citation><ArticleIdList><ArticleId IdType="pubmed">26415692</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2016 Dec 30;246:796-802</Citation><ArticleIdList><ArticleId IdType="pubmed">28029441</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2009 Jan;70(1):13-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19026263</ArticleId></ArticleIdList></Reference><Reference><Citation>Braz J Psychiatry. 2008 Jun;30(2):139-43</Citation><ArticleIdList><ArticleId IdType="pubmed">18176725</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2005 May 25;293(20):2487-95</Citation><ArticleIdList><ArticleId IdType="pubmed">15914749</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Arch Psychiatry Clin Neurosci. 2004 Apr;254(2):59-60</Citation><ArticleIdList><ArticleId IdType="pubmed">15146333</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2016 Dec 6;316(21):2214-2236</Citation><ArticleIdList><ArticleId IdType="pubmed">27923088</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatr Res. 2013 Nov;47(11):1800-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24018102</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2013 Dec;128(6):413-21</Citation><ArticleIdList><ArticleId IdType="pubmed">23521361</ArticleId></ArticleIdList></Reference><Reference><Citation>Inj Prev. 2006 Dec;12 Suppl 2:ii22-ii27</Citation><ArticleIdList><ArticleId IdType="pubmed">17170166</ArticleId></ArticleIdList></Reference><Reference><Citation>Soc Psychiatry Psychiatr Epidemiol. 1998 Apr;33(4):155-61</Citation><ArticleIdList><ArticleId IdType="pubmed">9567665</ArticleId></ArticleIdList></Reference><Reference><Citation>J Consult Clin Psychol. 2000 Jun;68(3):371-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10883553</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2017 Feb;209:182-187</Citation><ArticleIdList><ArticleId IdType="pubmed">27936451</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Neurother. 2009 Jan;9(1):109-36</Citation><ArticleIdList><ArticleId IdType="pubmed">19102673</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2010 Jul;71(7):902-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20667292</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2014 Jan;152-154:250-5</Citation><ArticleIdList><ArticleId IdType="pubmed">24200153</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Gen Psychiatry. 2018 Jun 1;17:23</Citation><ArticleIdList><ArticleId IdType="pubmed">29881440</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Psychiatry Clin Pract. 2017 Jun;21(2):118-124</Citation><ArticleIdList><ArticleId IdType="pubmed">27854557</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatr Danub. 2014 Jun;26(2):108-14</Citation><ArticleIdList><ArticleId IdType="pubmed">24909246</ArticleId></ArticleIdList></Reference><Reference><Citation>Braz J Psychiatry. 2017 Jan 09;39(2):133-139</Citation><ArticleIdList><ArticleId IdType="pubmed">28076649</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2005 Jun;66(6):693-704</Citation><ArticleIdList><ArticleId IdType="pubmed">15960561</ArticleId></ArticleIdList></Reference><Reference><Citation>Aust N Z J Psychiatry. 2015 Nov;49(11):1006-20</Citation><ArticleIdList><ArticleId IdType="pubmed">26175498</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Psychiatry Psychother. 2015 Jul-Sep;37(3):152-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26630406</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2011 Mar;68(3):241-51</Citation><ArticleIdList><ArticleId IdType="pubmed">21383262</ArticleId></ArticleIdList></Reference><Reference><Citation>Encephale. 2016 Jun;42(3):234-41</Citation><ArticleIdList><ArticleId IdType="pubmed">27000268</ArticleId></ArticleIdList></Reference><Reference><Citation>Respir Med. 2016 Aug;117:154-61</Citation><ArticleIdList><ArticleId IdType="pubmed">27492526</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2017 Mar 01;210:19-21</Citation><ArticleIdList><ArticleId IdType="pubmed">27992854</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiol Psychiatr Sci. 2019 Jun;28(3):290-299</Citation><ArticleIdList><ArticleId IdType="pubmed">28944747</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2000 Apr 19;283(15):2008-12</Citation><ArticleIdList><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 May 20;10(5):e0126530</Citation><ArticleIdList><ArticleId IdType="pubmed">25992560</ArticleId></ArticleIdList></Reference><Reference><Citation>Iran J Psychiatry Behav Sci. 2013 Spring;7(1):16-23</Citation><ArticleIdList><ArticleId IdType="pubmed">24644495</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2003 Jun 1;53(11):1028-42</Citation><ArticleIdList><ArticleId IdType="pubmed">12788248</ArticleId></ArticleIdList></Reference><Reference><Citation>Gen Hosp Psychiatry. 2013 May-Jun;35(3):309-13</Citation><ArticleIdList><ArticleId IdType="pubmed">23352318</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatr Res. 2009 Jan;43(3):230-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18590916</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2005 Jul;162(7):1273-80</Citation><ArticleIdList><ArticleId IdType="pubmed">15994709</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Suicide Res. 2005;9(3):279-300</Citation><ArticleIdList><ArticleId IdType="pubmed">16020171</ArticleId></ArticleIdList></Reference><Reference><Citation>Braz J Psychiatry. 2016 Jun 14;38(4):270-274</Citation><ArticleIdList><ArticleId IdType="pubmed">27304255</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2010 Feb;12(1):1-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20148862</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Manag Care. 2005 Oct;11(9 Suppl):S271-4</Citation><ArticleIdList><ArticleId IdType="pubmed">16232009</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2008 Mar;165(3):370-7; quiz 410</Citation><ArticleIdList><ArticleId IdType="pubmed">18198271</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2007 Nov;103(1-3):181-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17324469</ArticleId></ArticleIdList></Reference><Reference><Citation>CNS Spectr. 2006 Jun;11(6):465-71</Citation><ArticleIdList><ArticleId IdType="pubmed">16816785</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2019 Jan 1;242:111-122</Citation><ArticleIdList><ArticleId IdType="pubmed">30173059</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2018 Jan 1;225:489-494</Citation><ArticleIdList><ArticleId IdType="pubmed">28865370</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1978 Jun;35(6):773-82</Citation><ArticleIdList><ArticleId IdType="pubmed">655775</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2003 Apr;60(4):409-14</Citation><ArticleIdList><ArticleId IdType="pubmed">12695319</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27993232</PMID><DateCompleted><Year>2017</Year><Month>12</Month><Day>27</Day></DateCompleted><DateRevised><Year>2018</Year><Month>10</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1527-5418</ISSN><JournalIssue CitedMedium="Internet"><Volume>56</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>01</Month></PubDate></JournalIssue><Title>Journal of the American Academy of Child and Adolescent Psychiatry</Title><ISOAbbreviation>J Am Acad Child Adolesc Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Cortical Morphology Characteristics of Young Offspring of Patients With Schizophrenia or Bipolar Disorder.</ArticleTitle><Pagination><MedlinePgn>79-88</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0890-8567(16)31858-5</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jaac.2016.09.516</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Cortical surface area and thickness abnormalities have been observed in patients with schizophrenia and bipolar disorders; however, no study thus far has examined cortical morphologic measurements in children and adolescents at genetic risk for the disorders comparatively.</AbstractText><AbstractText Label="METHOD">One hundred thirty-seven participants, including 36 offspring of patients with schizophrenia (SzO), 54 offspring of patients with bipolar disorder (BpO), and 47 offspring of community controls (CcO), 6 to 17 years old, were assessed with clinical and neuroimaging methods. Sixty-nine percent of the sample was reassessed at a 27.6-month (mean) follow-up. Cortical surface reconstruction was applied to measure cortical area and thickness using FreeSurfer; mixed-effects models were used to investigate cross-sectional and longitudinal differences in global and lobar morphologic measurements.</AbstractText><AbstractText Label="RESULTS">The SzO group exhibited a cross-sectional decrease in global, parietal, and occipital lobe surface area compared with the CcO group, and in the occipital lobe compared with the BpO group. In the SzO group, global and parietal surface area values were inversely associated with attenuated positive and negative prodromal symptom scores. No cross-sectional differences in cortical thickness were observed. Division of the sample by pubertal status showed group-by-time interactions in the pubertal and postpubertal SzO subgroup, with less longitudinal decrease in cortical surface area and thickness than in the CcO and BpO subgroups, respectively.</AbstractText><AbstractText Label="CONCLUSION">The SzO, but not the BpO, group was characterized by cross-sectional decreases in surface area, and this was associated with prodromal symptoms. Longitudinal changes in cortical morphology associated with risk for schizophrenia may be expressed differently according to developmental stage.</AbstractText><CopyrightInformation>Copyright © 2016 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sugranyes</LastName><ForeName>Gisela</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>August Pi i Sunyer Biomedical Research Institute, Barcelona; Institute of Neuroscience, Hospital Clínic, Barcelona; Biomedical Research Networking Center Consortium. Electronic address: gernest@clinic.cat.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solé-Padullés</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>August Pi i Sunyer Biomedical Research Institute, Barcelona.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de la Serna</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute of Neuroscience, Hospital Clínic, Barcelona; Biomedical Research Networking Center Consortium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borras</LastName><ForeName>Roger</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>August Pi i Sunyer Biomedical Research Institute, Barcelona.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romero</LastName><ForeName>Soledad</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Neuroscience, Hospital Clínic, Barcelona; Biomedical Research Networking Center Consortium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanchez-Gistau</LastName><ForeName>Vanessa</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>August Pi i Sunyer Biomedical Research Institute, Barcelona; Institute of Neuroscience, Hospital Clínic, Barcelona; Biomedical Research Networking Center Consortium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia-Rizo</LastName><ForeName>Clemente</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>August Pi i Sunyer Biomedical Research Institute, Barcelona; Institute of Neuroscience, Hospital Clínic, Barcelona; Biomedical Research Networking Center Consortium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goikolea</LastName><ForeName>Jose Manuel</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>August Pi i Sunyer Biomedical Research Institute, Barcelona; Institute of Neuroscience, Hospital Clínic, Barcelona; Biomedical Research Networking Center Consortium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bargallo</LastName><ForeName>Nuria</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>August Pi i Sunyer Biomedical Research Institute, Barcelona; Biomedical Research Networking Center Consortium; Image Diagnosis Center, Hospital Clínic, Barcelona.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno</LastName><ForeName>Dolores</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Biomedical Research Networking Center Consortium; Hospital General Universitario Gregorio Marañón and School of Medicine, Universidad Complutense, Madrid.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baeza</LastName><ForeName>Inmaculada</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>August Pi i Sunyer Biomedical Research Institute, Barcelona; Institute of Neuroscience, Hospital Clínic, Barcelona; Biomedical Research Networking Center Consortium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castro-Fornieles</LastName><ForeName>Josefina</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>August Pi i Sunyer Biomedical Research Institute, Barcelona; Institute of Neuroscience, Hospital Clínic, Barcelona; Biomedical Research Networking Center Consortium; University of Barcelona.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Acad Child Adolesc Psychiatry</MedlineTA><NlmUniqueID>8704565</NlmUniqueID><ISSNLinking>0890-8567</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002540" MajorTopicYN="N">Cerebral Cortex</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016241" MajorTopicYN="Y">Child of Impaired Parents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062706" MajorTopicYN="Y">Prodromal Symptoms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012559" MajorTopicYN="N">Schizophrenia</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">bipolar disorder</Keyword><Keyword MajorTopicYN="Y">gray matter</Keyword><Keyword MajorTopicYN="Y">neuroimaging</Keyword><Keyword MajorTopicYN="Y">schizophrenia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>03</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>09</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27993232</ArticleId><ArticleId IdType="pii">S0890-8567(16)31858-5</ArticleId><ArticleId IdType="doi">10.1016/j.jaac.2016.09.516</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18377675</PMID><DateCompleted><Year>2008</Year><Month>09</Month><Day>30</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0033-2917</ISSN><JournalIssue CitedMedium="Print"><Volume>38</Volume><Issue>7</Issue><PubDate><Year>2008</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Psychological medicine</Title><ISOAbbreviation>Psychol Med</ISOAbbreviation></Journal><ArticleTitle>Changes in self-reported sleep duration predict mood changes in bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>1069-71</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1017/S0033291708003280</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bauer</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Glenn</LastName><ForeName>Tasha</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Whybrow</LastName><ForeName>Peter C</ForeName><Initials>PC</Initials></Author><Author ValidYN="Y"><LastName>Grof</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Rasgon</LastName><ForeName>Natalie</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Alda</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Marsh</LastName><ForeName>Wendy</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Sagduyu</LastName><ForeName>Kemal</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Schmid</LastName><ForeName>Rita</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Adli</LastName><ForeName>Mazda</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2008</Year><Month>04</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Psychol Med</MedlineTA><NlmUniqueID>1254142</NlmUniqueID><ISSNLinking>0033-2917</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D039721" MajorTopicYN="N">Diagnostic and Statistical Manual of Mental Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005544" MajorTopicYN="N">Forecasting</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019964" MajorTopicYN="N">Mood Disorders</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012893" MajorTopicYN="N">Sleep Wake Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013223" MajorTopicYN="N">Statistics as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>4</Month><Day>2</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>10</Month><Day>1</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>4</Month><Day>2</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18377675</ArticleId><ArticleId IdType="pii">S0033291708003280</ArticleId><ArticleId IdType="doi">10.1017/S0033291708003280</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25814521</PMID><DateCompleted><Year>2017</Year><Month>04</Month><Day>13</Day></DateCompleted><DateRevised><Year>2017</Year><Month>04</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1049-7323</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Qualitative health research</Title><ISOAbbreviation>Qual Health Res</ISOAbbreviation></Journal><ArticleTitle>Creativity and Bipolar Disorder: Igniting a Dialogue.</ArticleTitle><Pagination><MedlinePgn>32-40</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1049732315578403</ELocationID><Abstract><AbstractText>Bipolar disorder (BD) has been related to heightened creativity, yet core questions remain unaddressed about this association. We used qualitative methods to investigate how highly creative individuals with BD understand the role of symptoms and treatment in their creativity, and possible mechanisms underpinning this link. Twenty-two individuals self-identified as highly creative and living with BD took part in focus groups and completed quantitative measures of symptoms, quality of life (QoL), and creativity. Using thematic analysis, five themes emerged: the pros and cons of mania for creativity, benefits of altered thinking, the relationship between creativity and medication, creativity as central to one's identity, and creativity's importance in stigma reduction and treatment. Despite reliance on a small sample who self-identified as having BD, findings shed light on previously mixed results regarding the influence of mania and treatment and suggest new directions for the study of mechanisms driving the creative advantage in BD. </AbstractText><CopyrightInformation>© The Author(s) 2015.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Sheri L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>University of California, Berkeley, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moezpoor</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of California, Berkeley, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murray</LastName><ForeName>Greg</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Swinburne University of Technology, Hawthorn, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hole</LastName><ForeName>Rachelle</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of British Columbia, Okanagan, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barnes</LastName><ForeName>Steven J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>CREST.BD</CollectiveName></Author><Author ValidYN="Y"><LastName>Michalak</LastName><ForeName>Erin E</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>University of British Columbia, Vancouver, British Columbia, Canada erin.michalak@ubc.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>RN117262-248227</GrantID><Agency>Canadian Institutes of Health Research</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>03</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Qual Health Res</MedlineTA><NlmUniqueID>9202144</NlmUniqueID><ISSNLinking>1049-7323</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>T</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014150" MajorTopicYN="N">Antipsychotic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055812" MajorTopicYN="N">Community-Based Participatory Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003405" MajorTopicYN="Y">Creativity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004644" MajorTopicYN="N">Emotions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017144" MajorTopicYN="N">Focus Groups</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bipolar disorder</Keyword><Keyword MajorTopicYN="N">qualitative</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25814521</ArticleId><ArticleId IdType="pii">1049732315578403</ArticleId><ArticleId IdType="doi">10.1177/1049732315578403</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18444252</PMID><DateCompleted><Year>2008</Year><Month>11</Month><Day>17</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1552-485X</ISSN><JournalIssue CitedMedium="Internet"><Volume>147B</Volume><Issue>7</Issue><PubDate><Year>2008</Year><Month>Oct</Month><Day>05</Day></PubDate></JournalIssue><Title>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</Title><ISOAbbreviation>Am J Med Genet B Neuropsychiatr Genet</ISOAbbreviation></Journal><ArticleTitle>Neurotransmission and bipolar disorder: a systematic family-based association study.</ArticleTitle><Pagination><MedlinePgn>1270-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ajmg.b.30769</ELocationID><Abstract><AbstractText>Neurotransmission pathways/systems have been proposed to be involved in the pathophysiology and treatment of bipolar disorder for over 40 years. In order to test the hypothesis that common variants of genes in one or more of five neurotransmission systems confer risk for bipolar disorder, we analyzed 1,005 tag single nucleotide polymorphisms in 90 genes from dopaminergic, serotonergic, noradrenergic, GABAergic, and glutamatergic neurotransmitter systems in 101 trios and 203 quads from Caucasian bipolar families. Our sample has 80% power to detect ORs &gt;or= 1.82 and &gt;or=1.57 for minor allele frequencies of 0.1 and 0.5, respectively. Nominally significant allelic and haplotypic associations were found for genes from each neurotransmission system, with several reaching gene-wide significance (allelic: GRIA1, GRIN2D, and QDPR; haplotypic: GRIN2C, QDPR, and SLC6A3). However, none of these associations survived correction for multiple testing in an individual system, or in all systems considered together. Significant single nucleotide polymorphism associations were not found with sub-phenotypes (alcoholism, psychosis, substance abuse, and suicide attempts) or significant gene-gene interactions. These results suggest that, within the detectable odds ratios of this study, common variants of the selected genes in the five neurotransmission systems do not play major roles in influencing the risk for bipolar disorder or comorbid sub-phenotypes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Jiajun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Chicago, Chicago, Illinois 60637, USA. kjacobso@bsd.uchicago.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badner</LastName><ForeName>Judith A</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Hattori</LastName><ForeName>Eiji</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Potash</LastName><ForeName>James B</ForeName><Initials>JB</Initials></Author><Author ValidYN="Y"><LastName>Willour</LastName><ForeName>Virginia L</ForeName><Initials>VL</Initials></Author><Author ValidYN="Y"><LastName>McMahon</LastName><ForeName>Francis J</ForeName><Initials>FJ</Initials></Author><Author ValidYN="Y"><LastName>Gershon</LastName><ForeName>Elliot S</ForeName><Initials>ES</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Chunyu</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>5R01DA018662</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AA00231</GrantID><Acronym>AA</Acronym><Agency>NIAAA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U10AA0503</GrantID><Acronym>AA</Acronym><Agency>NIAAA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH061613</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH080425-01</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH080425</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH061613-08</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH065560</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH065560-05</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Med Genet B Neuropsychiatr Genet</MedlineTA><NlmUniqueID>101235742</NlmUniqueID><ISSNLinking>1552-4841</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018377">Neurotransmitter Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044465" MajorTopicYN="N">European Continental Ancestry Group</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005192" MajorTopicYN="Y">Family Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="Y">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018377" MajorTopicYN="N">Neurotransmitter Agents</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>4</Month><Day>30</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>11</Month><Day>18</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>4</Month><Day>30</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18444252</ArticleId><ArticleId IdType="doi">10.1002/ajmg.b.30769</ArticleId><ArticleId IdType="pmc">PMC2574701</ArticleId><ArticleId IdType="mid">NIHMS59745</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mol Psychiatry. 2006 Feb;11(2):125-33, 115</Citation><ArticleIdList><ArticleId IdType="pubmed">16261167</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Brain Behav. 2006 Feb;5(1):85-95</Citation><ArticleIdList><ArticleId IdType="pubmed">16436192</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2001 Nov;6(6):671-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11673795</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Clin Psychopharmacol. 2002 Jun;17 Suppl 1:S1-12</Citation><ArticleIdList><ArticleId IdType="pubmed">12369606</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Neurosci. 2002 May;5(5):405-14</Citation><ArticleIdList><ArticleId IdType="pubmed">11953750</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet B Neuropsychiatr Genet. 2004 Feb 15;125B(1):83-6</Citation><ArticleIdList><ArticleId IdType="pubmed">14755450</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet B Neuropsychiatr Genet. 2005 Feb 5;133B(1):110-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15578606</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2007 Aug;164(8):1229-37</Citation><ArticleIdList><ArticleId IdType="pubmed">17671286</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann N Y Acad Sci. 2003 Nov;1003:250-72</Citation><ArticleIdList><ArticleId IdType="pubmed">14684451</ArticleId></ArticleIdList></Reference><Reference><Citation>Prog Neuropsychopharmacol Biol Psychiatry. 2002 Dec;26(7-8):1273-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12502013</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2002;7 Suppl 1:S71-80</Citation><ArticleIdList><ArticleId IdType="pubmed">11986998</ArticleId></ArticleIdList></Reference><Reference><Citation>CNS Neurol Disord Drug Targets. 2006 Apr;5(2):135-45</Citation><ArticleIdList><ArticleId IdType="pubmed">16611088</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Psychiatry. 2004 Dec;49(12):802-12</Citation><ArticleIdList><ArticleId IdType="pubmed">15679203</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet B Neuropsychiatr Genet. 2007 Jul 5;144B(5):701-3</Citation><ArticleIdList><ArticleId IdType="pubmed">17192893</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Pharmacol. 2007 Feb;7(1):3-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17169613</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Psychiatry. 2007 Jan;20(1):8-12</Citation><ArticleIdList><ArticleId IdType="pubmed">17143075</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2003 Sep 1;54(5):499-503</Citation><ArticleIdList><ArticleId IdType="pubmed">12946878</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2002 May;105(5):396-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11942948</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2007 Jan 15;61(2):145-53</Citation><ArticleIdList><ArticleId IdType="pubmed">16934770</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Brain Behav. 2005 Feb;4(1):45-50</Citation><ArticleIdList><ArticleId IdType="pubmed">15660667</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 1992 Mar-Apr;33(2):115-20</Citation><ArticleIdList><ArticleId IdType="pubmed">1347497</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2005 Jul 29;122(2):275-87</Citation><ArticleIdList><ArticleId IdType="pubmed">16051151</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2002;7(9):954-61</Citation><ArticleIdList><ArticleId IdType="pubmed">12399948</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2006 Jan 1;34(Database issue):D354-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16381885</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2008 Feb;13(2):197-207</Citation><ArticleIdList><ArticleId IdType="pubmed">17486107</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2000 Sep 15;48(6):505-17</Citation><ArticleIdList><ArticleId IdType="pubmed">11018223</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 2004 Jul 21;24(29):6578-89</Citation><ArticleIdList><ArticleId IdType="pubmed">15269270</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Res. 2007 Jan 5;1127(1):108-18</Citation><ArticleIdList><ArticleId IdType="pubmed">17113057</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2002 Feb 14;415(6873):793-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11823786</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Genet. 1999 Aug;36(8):585-94</Citation><ArticleIdList><ArticleId IdType="pubmed">10465107</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2006 May;11(5):446-58</Citation><ArticleIdList><ArticleId IdType="pubmed">16505837</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2004 Jan;74(1):106-20</Citation><ArticleIdList><ArticleId IdType="pubmed">14681826</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Genomics. 2006 Apr 04;7:70</Citation><ArticleIdList><ArticleId IdType="pubmed">16594998</ArticleId></ArticleIdList></Reference><Reference><Citation>CNS Spectr. 2005 Oct;10(10):808-19</Citation><ArticleIdList><ArticleId IdType="pubmed">16400244</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Clin Neurosci. 2007 Feb;61(1):3-19</Citation><ArticleIdList><ArticleId IdType="pubmed">17239033</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Hum Genet. 2006 Jun;14(6):660-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16721402</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychopharmacology. 2002 Mar;26(3):368-75</Citation><ArticleIdList><ArticleId IdType="pubmed">11850151</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2006;67 Suppl 11:8-11</Citation><ArticleIdList><ArticleId IdType="pubmed">17029490</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1965 Dec;13(6):483-94</Citation><ArticleIdList><ArticleId IdType="pubmed">5320621</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 1999 Jan;64(1):210-7</Citation><ArticleIdList><ArticleId IdType="pubmed">9915960</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2002;7 Suppl 1:S15-22</Citation><ArticleIdList><ArticleId IdType="pubmed">11986991</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Biobehav Rev. 2005;29(4-5):805-28</Citation><ArticleIdList><ArticleId IdType="pubmed">15925701</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2007 Mar;64(3):327-37</Citation><ArticleIdList><ArticleId IdType="pubmed">17339521</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1965 Nov;122(5):509-22</Citation><ArticleIdList><ArticleId IdType="pubmed">5319766</ArticleId></ArticleIdList></Reference><Reference><Citation>Genet Epidemiol. 1997;14(6):699-704</Citation><ArticleIdList><ArticleId IdType="pubmed">9433566</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet. 1997 May 31;74(3):254-62</Citation><ArticleIdList><ArticleId IdType="pubmed">9184307</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2001 Nov;58(11):1025-31</Citation><ArticleIdList><ArticleId IdType="pubmed">11695948</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2007 Oct 15;62(8):870-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17678634</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurotox Res. 2007 Jan;11(1):73-83</Citation><ArticleIdList><ArticleId IdType="pubmed">17449450</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Neurosci. 2003 Sep;6(9):939-47</Citation><ArticleIdList><ArticleId IdType="pubmed">12897788</ArticleId></ArticleIdList></Reference><Reference><Citation>Prog Neurobiol. 2002 Jun;67(3):173-202</Citation><ArticleIdList><ArticleId IdType="pubmed">12169296</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacopsychiatry. 2006 Feb;39 Suppl 1:S10-4</Citation><ArticleIdList><ArticleId IdType="pubmed">16508890</ArticleId></ArticleIdList></Reference><Reference><Citation>Aust N Z J Psychiatry. 2006 May;40(5):402-5</Citation><ArticleIdList><ArticleId IdType="pubmed">16683965</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2003 Jun 18;289(23):3125-34</Citation><ArticleIdList><ArticleId IdType="pubmed">12813118</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2007 Sep;9(6):580-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17845272</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2002 Jan;30(1):97-101</Citation><ArticleIdList><ArticleId IdType="pubmed">11731797</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Psychiatry Rep. 2002 Apr;4(2):130-3</Citation><ArticleIdList><ArticleId IdType="pubmed">11914174</ArticleId></ArticleIdList></Reference><Reference><Citation>NeuroRx. 2006 Jan;3(1):22-41</Citation><ArticleIdList><ArticleId IdType="pubmed">16490411</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Psychiatry. 2007 Mar;52(3):146-57</Citation><ArticleIdList><ArticleId IdType="pubmed">17479522</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2006 Jan;78(1):15-27</Citation><ArticleIdList><ArticleId IdType="pubmed">16385446</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Res. 2007 May 4;1144:142-5</Citation><ArticleIdList><ArticleId IdType="pubmed">17316573</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2001 Dec;3(6):284-98</Citation><ArticleIdList><ArticleId IdType="pubmed">11843779</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 1993 Apr;87(4):279-84</Citation><ArticleIdList><ArticleId IdType="pubmed">8488750</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet B Neuropsychiatr Genet. 2003 May 15;119B(1):69-76</Citation><ArticleIdList><ArticleId IdType="pubmed">12707942</ArticleId></ArticleIdList></Reference><Reference><Citation>CNS Neurol Disord Drug Targets. 2006 Aug;5(4):453-79</Citation><ArticleIdList><ArticleId IdType="pubmed">16918397</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Psychiatry Rep. 2005 Apr;7(2):143-51</Citation><ArticleIdList><ArticleId IdType="pubmed">15802092</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2006 Sep;163(9):1636-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16946192</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2005 Aug;10(8):719-40</Citation><ArticleIdList><ArticleId IdType="pubmed">15940293</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):585-90</Citation><ArticleIdList><ArticleId IdType="pubmed">11149935</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Lett. 2007 May 18;418(3):272-5</Citation><ArticleIdList><ArticleId IdType="pubmed">17433541</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2005 Aug;10(8):771-81</Citation><ArticleIdList><ArticleId IdType="pubmed">15824745</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1999 Jun 11;284(5421):1805-11</Citation><ArticleIdList><ArticleId IdType="pubmed">10364547</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci STKE. 2004 Mar 16;2004(225):re5</Citation><ArticleIdList><ArticleId IdType="pubmed">15039492</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2005 Jan 15;21(2):263-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15297300</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet. 1999 Oct 15;88(5):522-6</Citation><ArticleIdList><ArticleId IdType="pubmed">10490710</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2004 Jul;61(7):649-57</Citation><ArticleIdList><ArticleId IdType="pubmed">15237077</ArticleId></ArticleIdList></Reference><Reference><Citation>CNS Neurol Disord Drug Targets. 2007 Apr;6(2):127-40</Citation><ArticleIdList><ArticleId IdType="pubmed">17430150</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2003 Aug;8(8):721-37, 715</Citation><ArticleIdList><ArticleId IdType="pubmed">12888801</ArticleId></ArticleIdList></Reference><Reference><Citation>Handb Exp Pharmacol. 2006;(175):215-32</Citation><ArticleIdList><ArticleId IdType="pubmed">16722238</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2006;67 Suppl 6:3-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16848670</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Psychiatry Clin. 1969;6(2):53-81</Citation><ArticleIdList><ArticleId IdType="pubmed">5817856</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2007 Jun 7;447(7145):661-78</Citation><ArticleIdList><ArticleId IdType="pubmed">17554300</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet B Neuropsychiatr Genet. 2007 Sep 5;144B(6):715-23</Citation><ArticleIdList><ArticleId IdType="pubmed">17373692</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2006 Oct;8(5 Pt 1):490-5</Citation><ArticleIdList><ArticleId IdType="pubmed">17042887</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2006 Sep;86(1-3):1-14</Citation><ArticleIdList><ArticleId IdType="pubmed">16842972</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2006 Jul 15;60(2):84-92</Citation><ArticleIdList><ArticleId IdType="pubmed">16300747</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2003 Mar 7;112(5):631-43</Citation><ArticleIdList><ArticleId IdType="pubmed">12628184</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 1998 Jul;63(1):259-66</Citation><ArticleIdList><ArticleId IdType="pubmed">9634505</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2007 Jan;35(Database issue):D247-52</Citation><ArticleIdList><ArticleId IdType="pubmed">17130144</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Psychiatry. 2002 Jul;17 Suppl 3:306-10</Citation><ArticleIdList><ArticleId IdType="pubmed">15177086</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2004 May;61(5):450-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15123489</ArticleId></ArticleIdList></Reference><Reference><Citation>Handb Exp Pharmacol. 2006;(175):417-56</Citation><ArticleIdList><ArticleId IdType="pubmed">16722245</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 1992 Jul 1;32(1):1-17</Citation><ArticleIdList><ArticleId IdType="pubmed">1391289</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatr Genet. 1996 Winter;6(4):209-12</Citation><ArticleIdList><ArticleId IdType="pubmed">9149327</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Pharmacogenomics. 2005;5(1):45-52</Citation><ArticleIdList><ArticleId IdType="pubmed">15727488</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2007 Sep;81(3):559-75</Citation><ArticleIdList><ArticleId IdType="pubmed">17701901</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1998 Jan;55(1):33-7</Citation><ArticleIdList><ArticleId IdType="pubmed">9435758</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet B Neuropsychiatr Genet. 2005 May 5;135B(1):47-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15768394</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2004 Jun;9(6):609-20, 544</Citation><ArticleIdList><ArticleId IdType="pubmed">14708030</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Res Mol Brain Res. 2003 Mar 17;111(1-2):31-41</Citation><ArticleIdList><ArticleId IdType="pubmed">12654503</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet. 1996 Nov 22;67(6):551-5</Citation><ArticleIdList><ArticleId IdType="pubmed">8950413</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2005 Dec;77(6):918-36</Citation><ArticleIdList><ArticleId IdType="pubmed">16380905</ArticleId></ArticleIdList></Reference><Reference><Citation>Genetics. 2000 Jun;155(2):945-59</Citation><ArticleIdList><ArticleId IdType="pubmed">10835412</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2006 Sep;11(9):847-57</Citation><ArticleIdList><ArticleId IdType="pubmed">16819533</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Pharmacol. 2006 Jan;147 Suppl 1:S82-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16402124</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2005 Jan;10(1):40-68; image 5</Citation><ArticleIdList><ArticleId IdType="pubmed">15263907</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2003 Jul;73(1):107-14</Citation><ArticleIdList><ArticleId IdType="pubmed">12772088</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Med. 2007;39(7):531-44</Citation><ArticleIdList><ArticleId IdType="pubmed">17852035</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2007 Jan;12(1):94-104</Citation><ArticleIdList><ArticleId IdType="pubmed">16940976</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Pharmacol Toxicol. 2001;41:237-60</Citation><ArticleIdList><ArticleId IdType="pubmed">11264457</ArticleId></ArticleIdList></Reference><Reference><Citation>Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jan 30;31(1):275-82</Citation><ArticleIdList><ArticleId IdType="pubmed">16876306</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Neurosci. 2006 Feb;7(2):137-51</Citation><ArticleIdList><ArticleId IdType="pubmed">16429123</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2005 Feb;7(1):11-21</Citation><ArticleIdList><ArticleId IdType="pubmed">15654928</ArticleId></ArticleIdList></Reference><Reference><Citation>Biotechniques. 2002 Jun;Suppl:56-8, 60-1</Citation><ArticleIdList><ArticleId IdType="pubmed">12083399</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2005 Nov;66(11):1376-85</Citation><ArticleIdList><ArticleId IdType="pubmed">16420074</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28327444</PMID><DateCompleted><Year>2018</Year><Month>03</Month><Day>23</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-1379</ISSN><JournalIssue CitedMedium="Internet"><Volume>91</Volume><PubDate><Year>2017</Year><Month>08</Month></PubDate></JournalIssue><Title>Journal of psychiatric research</Title><ISOAbbreviation>J Psychiatr Res</ISOAbbreviation></Journal><ArticleTitle>Unblending Borderline Personality and Bipolar Disorders.</ArticleTitle><Pagination><MedlinePgn>90-97</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0022-3956(16)30484-8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jpsychires.2017.03.006</ELocationID><Abstract><AbstractText>Borderline Personality (BPD) and Bipolar (BP) disorders stimulate an academic debate between their distinction and the inclusion of Borderline in the Bipolar spectrum. Opponents to this inclusion attribute the important differences and possible diagnostic incomprehension to overlapping symptoms. We tested 248 Borderline and 113 Bipolar patients, consecutively admitted to the Psychiatric Unit, through DSM-IV Axis I and II Disorders (SCID-I/II), Hamilton Depression Rating Scale (HAM-D), Hamilton Anxiety Rating Scale (HAM-A), Young Mania Rating Scale (YMRS) and Borderline Personality Disorder Severity Index-IV (BPDSI-IV). All the tests statistically discriminated the disorders (p &lt; 0.0001). Overlapping symptoms resulted significantly different (impulsivity = 5.32 in BPD vs 1.55 in BP, p &lt; 0.0001; emotional instability = 7.11 in BPD vs 0.55 in BP, p &lt; 0.0001) and the range of their scores gives the opportunity for an even more precise discrimination. Distinctive traits (e.g. irritability or sexual arousal) are also discussed in order to try to qualify the core of these disorders to a higher degree. Comorbidity proves to be extremely small (3.6%). However, Borderline patients with manic features offer a privileged point of view for a deeper analysis. This allows for the possibility of a more precise examination of the nature and load of each symptom. Borderline Personality and Bipolar Disorders can be distinguished with high precision using common and time-sparing tests. The importance of discriminating these clinical features may benefit from this evidence.</AbstractText><CopyrightInformation>Copyright © 2017. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>di Giacomo</LastName><ForeName>Ester</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>School of Medicine and Surgery, University of Milano Bicocca, Italy; Psychiatric Department-S.Gerardo, Health Care Trust, Monza, Italy; Doctorate School of the University of Milano-Bicocca, Italy. Electronic address: ester.digiacomo@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aspesi</LastName><ForeName>Flora</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Psychiatric Department-S.Gerardo, Health Care Trust, Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fotiadou</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Female Medium Secure Forensic Service, South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital, Beckenham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arntz</LastName><ForeName>Arnoud</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical Psychology, University of Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguglia</LastName><ForeName>Eugenio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Clinical and Molecular Biomedicine, University of Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barone</LastName><ForeName>Lavinia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University of Pavia, Department of Brain and Behavioral Science, Psychology Section, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellino</LastName><ForeName>Silvio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Personality Disorders, Psychiatric Clinic, Department of Neuroscience, University of Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carpiniello</LastName><ForeName>Bernardo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Public Health, Clinical and Molecular Medicine - Psychiatric Unit, University of Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colmegna</LastName><ForeName>Fabrizia</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Psychiatric Department-S.Gerardo, Health Care Trust, Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lazzari</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Psychiatric Department-S.Gerardo, Health Care Trust, Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorettu</LastName><ForeName>Liliana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biomedical Science, Psychiatric Clinic, University of Sassari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinna</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Public Health, Clinical and Molecular Medicine - Psychiatric Unit, University of Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sicaro</LastName><ForeName>Aldo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Psychiatric Department-S.Gerardo, Health Care Trust, Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Signorelli</LastName><ForeName>Maria Salvina</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Clinical and Molecular Biomedicine, University of Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>BRT Group</CollectiveName></Author><Author ValidYN="Y"><LastName>Clerici</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Medicine and Surgery, University of Milano Bicocca, Italy; Psychiatric Department-S.Gerardo, Health Care Trust, Monza, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>03</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Psychiatr Res</MedlineTA><NlmUniqueID>0376331</NlmUniqueID><ISSNLinking>0022-3956</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000704" MajorTopicYN="N">Analysis of Variance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001883" MajorTopicYN="N">Borderline Personality Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Bipolar Disorder</Keyword><Keyword MajorTopicYN="Y">Borderline Personality Disorder</Keyword><Keyword MajorTopicYN="Y">Clinical aspects</Keyword><Keyword MajorTopicYN="Y">Diagnosis</Keyword><Keyword MajorTopicYN="Y">Epidemiology</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>di Giacomo</LastName><ForeName>Ester</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clerici</LastName><ForeName>Massimo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aspesi</LastName><ForeName>Flora</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aguglia</LastName><ForeName>Eugenio</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barone</LastName><ForeName>Lavinia</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bellino</LastName><ForeName>Silvio</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bozzatello</LastName><ForeName>Paola</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brignolo</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carpiniello</LastName><ForeName>Bernardo</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Colmegna</LastName><ForeName>Fabrizia</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ghiani</LastName><ForeName>Alice</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lazzari</LastName><ForeName>Marina</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lorettu</LastName><ForeName>Liliana</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sicaro</LastName><ForeName>Aldo</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Battiato</LastName><ForeName>Maria Catena</ForeName><Initials>MC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bon</LastName><ForeName>Roberta</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Contiero</LastName><ForeName>Luana</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Denti</LastName><ForeName>Antonella</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fotiadou</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Franco</LastName><ForeName>Lucia</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ginanneschi</LastName><ForeName>Anna Maria</ForeName><Initials>AM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lai</LastName><ForeName>Alice</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Laneri</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marchini</LastName><ForeName>Monica</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miragliotta</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ostaldo</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Paggi</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ravasi</LastName><ForeName>Sara</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roletto</LastName><ForeName>Filippo</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ruta</LastName><ForeName>Sara</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Signorelli</LastName><ForeName>Maria Salvina</ForeName><Initials>MS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zaccheroni</LastName><ForeName>Dario</ForeName><Initials>D</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>10</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>02</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>03</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28327444</ArticleId><ArticleId IdType="pii">S0022-3956(16)30484-8</ArticleId><ArticleId IdType="doi">10.1016/j.jpsychires.2017.03.006</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30977426</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>23</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1741-2854</ISSN><JournalIssue CitedMedium="Internet"><Volume>65</Volume><Issue>4</Issue><PubDate><Year>2019</Year><Month>06</Month></PubDate></JournalIssue><Title>The International journal of social psychiatry</Title><ISOAbbreviation>Int J Soc Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Work motivation in patients with bipolar disorder: Associated factors.</ArticleTitle><Pagination><MedlinePgn>300-304</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/0020764019842270</ELocationID><Abstract><AbstractText Label="BACKGROUND">Occupational functioning is severely impaired in patients with bipolar disorder (BD). Work motivation (WM), defined as the psychological processes that determine the direction, intensity, and persistence of action within the work, is an essential component of work-related functioning.</AbstractText><AbstractText Label="AIM">To assess whether WM is affected in patients with BD and which clinical and sociodemographic factors are related to low WM.</AbstractText><AbstractText Label="METHODS">In all, 95 euthymic BD patients were invited to answer the Motivation for Work Questionnaire and the Rating Scale on Subjective Cognitive Deficits in Bipolar Disorder (COBRA).</AbstractText><AbstractText Label="RESULTS">A total of 49.5% ( n = 47) of the patients were classified in the Low Motivated (LM) group. Unemployment and the report of more subjective cognitive complaints were predictors of poor WM in this sample ((OR) = 3.01 and 7.10, respectively).</AbstractText><AbstractText Label="CONCLUSIONS">Perceived cognitive deficits related to the disorder and current unemployment negatively impact WM in patients with BD. In addition to symptomatic recovery, the need of the inclusion of personal and occupational areas in the comprehensive treatment of patients with BD is necessary.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Martínez-Camarillo</LastName><ForeName>Sara</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4284-2831</Identifier><AffiliationInfo><Affiliation>1 Affective Disorders' Clinic, National Institute of Psychiatry Ramón de la Fuente Muñiz, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoldi-Negrete</LastName><ForeName>María</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8000-6434</Identifier><AffiliationInfo><Affiliation>1 Affective Disorders' Clinic, National Institute of Psychiatry Ramón de la Fuente Muñiz, Mexico City, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>2 National Council of Science and Technology, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fresán-Orellana</LastName><ForeName>Ana</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9160-6988</Identifier><AffiliationInfo><Affiliation>3 Clinical Research Division, National Institute of Psychiatry Ramón de la Fuente Muñiz, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ortega-Ortiz</LastName><ForeName>Hiram</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>1 Affective Disorders' Clinic, National Institute of Psychiatry Ramón de la Fuente Muñiz, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Becerra-Palars</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>1 Affective Disorders' Clinic, National Institute of Psychiatry Ramón de la Fuente Muñiz, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>04</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Soc Psychiatry</MedlineTA><NlmUniqueID>0374726</NlmUniqueID><ISSNLinking>0020-7640</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004651" MajorTopicYN="N">Employment</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007588" MajorTopicYN="N">Job Satisfaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009042" MajorTopicYN="Y">Motivation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Cognition</Keyword><Keyword MajorTopicYN="Y">bipolar disorder</Keyword><Keyword MajorTopicYN="Y">employment</Keyword><Keyword MajorTopicYN="Y">job satisfaction</Keyword><Keyword MajorTopicYN="Y">motivation</Keyword><Keyword MajorTopicYN="Y">rehabilitation</Keyword><Keyword MajorTopicYN="Y">severe mental illness</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30977426</ArticleId><ArticleId IdType="doi">10.1177/0020764019842270</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">27647671</PMID><DateCompleted><Year>2017</Year><Month>09</Month><Day>22</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-5618</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>6</Issue><PubDate><Year>2016</Year><Month>09</Month></PubDate></JournalIssue><Title>Bipolar disorders</Title><ISOAbbreviation>Bipolar Disord</ISOAbbreviation></Journal><ArticleTitle>fMRI brain activation changes following treatment of a first bipolar manic episode.</ArticleTitle><Pagination><MedlinePgn>490-501</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/bdi.12426</ELocationID><Abstract><AbstractText Label="OBJECTIVES">We tested the hypothesis that, with treatment, functional magnetic resonance imaging (fMRI) regional brain activation in first-episode mania would normalize - i.e., that differences from healthy subjects would diminish over time, and would be associated with clinical remission status, potentially identifying neuroanatomic treatment response markers.</AbstractText><AbstractText Label="METHODS">Forty-two participants with bipolar I disorder were recruited during their first manic episode, pseudo-randomized to open-label lithium or quetiapine, and followed for 8 weeks. fMRI scans were obtained at baseline and then after 1 and 8 weeks of treatment, while participants performed a continuous performance task with emotional distracters. Healthy participants received fMRI scans at these same intervals. Specific region-of-interest (ROI) activations within prefrontal emotional networks were assessed as potential measures of treatment response.</AbstractText><AbstractText Label="RESULTS">ROI data were reduced using exploratory factor analysis, which identified five factors that were organizationally consistent with functional anatomic models of human emotion modulation. Half of the participants with bipolar disorder achieved remission by Week 8 and were contrasted with the other half that did not. Analyses demonstrated that, in the bipolar disorder group in general, treatment led to decreases in activation across brain regions toward healthy subject values. However, differences in activation changes were observed between subjects with bipolar disorder who did or did not achieve remission in subcortical and amygdala factors.</AbstractText><AbstractText Label="CONCLUSIONS">These findings provide evidence for potential neuroanatomic treatment response markers in first-episode bipolar disorder.</AbstractText><CopyrightInformation>© 2016 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Strakowski</LastName><ForeName>Stephen M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Neuroscience and Center for Imaging Research, University of Cincinnati College of Medicine, Cincinnati, OH, USA. steve.strakowski@austin.utexas.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Dell Medical School, University of Texas at Austin, Austin, TX, USA. steve.strakowski@austin.utexas.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fleck</LastName><ForeName>David E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Neuroscience and Center for Imaging Research, University of Cincinnati College of Medicine, Cincinnati, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Welge</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Neuroscience and Center for Imaging Research, University of Cincinnati College of Medicine, Cincinnati, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eliassen</LastName><ForeName>James C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Neuroscience and Center for Imaging Research, University of Cincinnati College of Medicine, Cincinnati, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Norris</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Neuroscience and Center for Imaging Research, University of Cincinnati College of Medicine, Cincinnati, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Durling</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Neuroscience and Center for Imaging Research, University of Cincinnati College of Medicine, Cincinnati, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Komoroski</LastName><ForeName>Richard A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Neuroscience and Center for Imaging Research, University of Cincinnati College of Medicine, Cincinnati, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Wen-Jang</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Neuroscience and Center for Imaging Research, University of Cincinnati College of Medicine, Cincinnati, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>Wade</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Neuroscience and Center for Imaging Research, University of Cincinnati College of Medicine, Cincinnati, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dudley</LastName><ForeName>Jonathan A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Neuroscience and Center for Imaging Research, University of Cincinnati College of Medicine, Cincinnati, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blom</LastName><ForeName>Thomas J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Neuroscience and Center for Imaging Research, University of Cincinnati College of Medicine, Cincinnati, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stover</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Neuroscience and Center for Imaging Research, University of Cincinnati College of Medicine, Cincinnati, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klein</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Neuroscience and Center for Imaging Research, University of Cincinnati College of Medicine, Cincinnati, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strawn</LastName><ForeName>Jeffrey R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Neuroscience and Center for Imaging Research, University of Cincinnati College of Medicine, Cincinnati, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DelBello</LastName><ForeName>Melissa P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Neuroscience and Center for Imaging Research, University of Cincinnati College of Medicine, Cincinnati, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jing-Huei</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Neuroscience and Center for Imaging Research, University of Cincinnati College of Medicine, Cincinnati, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adler</LastName><ForeName>Caleb M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Neuroscience and Center for Imaging Research, University of Cincinnati College of Medicine, Cincinnati, OH, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT00609193</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>P50 MH077138</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Bipolar Disord</MedlineTA><NlmUniqueID>100883596</NlmUniqueID><ISSNLinking>1398-5647</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018692">Antimanic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>2S3PL1B6UJ</RegistryNumber><NameOfSubstance UI="D000069348">Quetiapine Fumarate</NameOfSubstance></Chemical><Chemical><RegistryNumber>9FN79X2M3F</RegistryNumber><NameOfSubstance UI="D008094">Lithium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000679" MajorTopicYN="Y">Amygdala</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018692" MajorTopicYN="N">Antimanic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="Y">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004644" MajorTopicYN="N">Emotions</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017050" MajorTopicYN="N">Episode of Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008094" MajorTopicYN="N">Lithium</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069348" MajorTopicYN="N">Quetiapine Fumarate</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013647" MajorTopicYN="N">Task Performance and Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">amygdala</Keyword><Keyword MajorTopicYN="Y">bipolar disorder</Keyword><Keyword MajorTopicYN="Y">fMRI</Keyword><Keyword MajorTopicYN="Y">first-episode</Keyword><Keyword MajorTopicYN="Y">mania</Keyword><Keyword MajorTopicYN="Y">prefrontal</Keyword><Keyword MajorTopicYN="Y">treatment</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>05</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>07</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>07</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27647671</ArticleId><ArticleId IdType="doi">10.1111/bdi.12426</ArticleId><ArticleId IdType="pmc">PMC5951160</ArticleId><ArticleId IdType="mid">NIHMS809278</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Affect Disord. 2018 Jul;234:14-19</Citation><ArticleIdList><ArticleId IdType="pubmed">29522938</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2015 Jun;17(4):444-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25359589</ArticleId></ArticleIdList></Reference><Reference><Citation>Magn Reson Med. 1995 Sep;34(3):308-12</Citation><ArticleIdList><ArticleId IdType="pubmed">7500867</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2014 Sep 30;223(3):268-70</Citation><ArticleIdList><ArticleId IdType="pubmed">25035298</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2004 Jun 15;55(12):1163-70</Citation><ArticleIdList><ArticleId IdType="pubmed">15184035</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cogn Neurosci. 1998 Jul;10 (4):525-35</Citation><ArticleIdList><ArticleId IdType="pubmed">9712681</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Brain Res. 1995;102(3):461-73</Citation><ArticleIdList><ArticleId IdType="pubmed">7737392</ArticleId></ArticleIdList></Reference><Reference><Citation>Isr J Psychiatry Relat Sci. 2012;49(2):112-20</Citation><ArticleIdList><ArticleId IdType="pubmed">22801290</ArticleId></ArticleIdList></Reference><Reference><Citation>Early Interv Psychiatry. 2008 Nov;2(4):225-33</Citation><ArticleIdList><ArticleId IdType="pubmed">19190727</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2003 Dec;160(12):2099-107</Citation><ArticleIdList><ArticleId IdType="pubmed">14638578</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2008 May;10(3):426-31</Citation><ArticleIdList><ArticleId IdType="pubmed">18402630</ArticleId></ArticleIdList></Reference><Reference><Citation>Magn Reson Med. 1999 Dec;42(6):1014-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10571921</ArticleId></ArticleIdList></Reference><Reference><Citation>NMR Biomed. 1997 Jun-Aug;10(4-5):171-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9430344</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurorehabil Neural Repair. 2010 Feb;24(2):195-203</Citation><ArticleIdList><ArticleId IdType="pubmed">20107135</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2004 Aug;61(8):781-92</Citation><ArticleIdList><ArticleId IdType="pubmed">15289277</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2007 Apr;164(4):582-90</Citation><ArticleIdList><ArticleId IdType="pubmed">17403971</ArticleId></ArticleIdList></Reference><Reference><Citation>J Child Adolesc Psychopharmacol. 2013 Apr;23(3):214-21</Citation><ArticleIdList><ArticleId IdType="pubmed">23607410</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 1978 Nov;133:429-35</Citation><ArticleIdList><ArticleId IdType="pubmed">728692</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2002 Jun;16(2):331-48</Citation><ArticleIdList><ArticleId IdType="pubmed">12030820</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 2011 Aug;216(4):485-99</Citation><ArticleIdList><ArticleId IdType="pubmed">21390505</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2005 Nov 15;58(10):763-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16310510</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2012 Jun;14(4):375-410</Citation><ArticleIdList><ArticleId IdType="pubmed">22631621</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 2011 Jan;41(1):33-40</Citation><ArticleIdList><ArticleId IdType="pubmed">20459884</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2012 Apr 1;71(7):603-10</Citation><ArticleIdList><ArticleId IdType="pubmed">22206876</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Child Adolesc Psychiatry. 1997 Jul;36(7):980-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9204677</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2012 Jun;14(4):313-25</Citation><ArticleIdList><ArticleId IdType="pubmed">22631617</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Med Imaging. 2001 Jun;20(6):535-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11437113</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychopharmacology. 2004 Sep;29(9):1734-40</Citation><ArticleIdList><ArticleId IdType="pubmed">15173843</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2011 Feb 15;69(4):381-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21051038</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2012 Mar;14(2):175-84</Citation><ArticleIdList><ArticleId IdType="pubmed">22420593</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Biomed Res. 1996 Jun;29(3):162-73</Citation><ArticleIdList><ArticleId IdType="pubmed">8812068</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62</Citation><ArticleIdList><ArticleId IdType="pubmed">14399272</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11447-51</Citation><ArticleIdList><ArticleId IdType="pubmed">12177452</ArticleId></ArticleIdList></Reference><Reference><Citation>J Subst Abuse Treat. 1992;9(3):199-213</Citation><ArticleIdList><ArticleId IdType="pubmed">1334156</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">33438502</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>10</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1741-2811</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>1</Issue><PubDate><MedlineDate>2021 Jan-Mar</MedlineDate></PubDate></JournalIssue><Title>Health informatics journal</Title><ISOAbbreviation>Health Informatics J</ISOAbbreviation></Journal><ArticleTitle>Acoustic and prosodic information for home monitoring of bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>1460458220972755</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1460458220972755</ELocationID><Abstract><AbstractText>Epidemiological studies suggest that bipolar disorder has a prevalence of about 1% in European countries, becoming one of the most disabling illnesses in working age adults, and often long-term and persistent with complex management and treatment. Therefore, the capacity of home monitoring for patients with this disorder is crucial for their quality of life. The current paper introduces the use of speech-based information as an easy-to-record, ubiquitous and non-intrusive health sensor suitable for home monitoring, and its application in the framework on the NYMPHA-MD project. Some preliminary results also show the potential of acoustic and prosodic features to detect and classify bipolar disorder, by predicting the values of the Hamilton Depression Rating Scale (HDRS) and the Young Mania Rating Scale (YMRS) from speech.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Farrús</LastName><ForeName>Mireia</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7160-9513</Identifier></Author><Author ValidYN="Y"><LastName>Codina-Filbà</LastName><ForeName>Joan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Universitat Pompeu Fabra, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Escudero</LastName><ForeName>Joan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Pulso Ediciones SL, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Health Informatics J</MedlineTA><NlmUniqueID>100883604</NlmUniqueID><ISSNLinking>1460-4582</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000162" MajorTopicYN="N">Acoustics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="Y">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">bipolar disorder</Keyword><Keyword MajorTopicYN="Y">home monitoring app</Keyword><Keyword MajorTopicYN="Y">prosody</Keyword><Keyword MajorTopicYN="Y">speech</Keyword><Keyword MajorTopicYN="Y">voice</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>13</Day><Hour>8</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33438502</ArticleId><ArticleId IdType="doi">10.1177/1460458220972755</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">3752303</PMID><DateCompleted><Year>1986</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0002-953X</ISSN><JournalIssue CitedMedium="Print"><Volume>143</Volume><Issue>9</Issue><PubDate><Year>1986</Year><Month>Sep</Month></PubDate></JournalIssue><Title>The American journal of psychiatry</Title><ISOAbbreviation>Am J Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Hyponatremia associated with carbamazepine therapy.</ArticleTitle><Pagination><MedlinePgn>1190</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Palladino</LastName><ForeName>A</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Psychiatry</MedlineTA><NlmUniqueID>0370512</NlmUniqueID><ISSNLinking>0002-953X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>33CM23913M</RegistryNumber><NameOfSubstance UI="D002220">Carbamazepine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002220" MajorTopicYN="N">Carbamazepine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007010" MajorTopicYN="N">Hyponatremia</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011618" MajorTopicYN="N">Psychotic Disorders</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014869" MajorTopicYN="N">Water Intoxication</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1986</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1986</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1986</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">3752303</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">7578661</PMID><DateCompleted><Year>1995</Year><Month>12</Month><Day>01</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0006-3223</ISSN><JournalIssue CitedMedium="Print"><Volume>38</Volume><Issue>3</Issue><PubDate><Year>1995</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>Biological psychiatry</Title><ISOAbbreviation>Biol Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Reduced echogenicity of brainstem raphe specific to unipolar depression: a transcranial color-coded real-time sonography study.</ArticleTitle><Pagination><MedlinePgn>180-4</MedlinePgn></Pagination><Abstract><AbstractText>Echogenicity of the brainstem raphe was assessed in patients with major depression, bipolar affective disorders, and schizophrenia and compared with healthy adults employing transcranial color-coded real-time sonography. Forty probands were enrolled in each group. A highly significant reduction in raphe echogenicity was detected only in patients suffering from major depression. Echogenicity of the raphe was independent of age or sex and did not correlate with severity of the depressive syndrome or patient state. These findings are suggestive of structural desintegration of the brainstem raphe in unipolar depression, an anatomical region assumed to be a biological focus in the pathogenesis of depressive syndromes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Becker</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Neurologische Universitätsklinik Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Becker</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Struck</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Lindner</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Burzer</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Retz</LastName><ForeName>W</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Bogdahn</LastName><ForeName>U</ForeName><Initials>U</Initials></Author><Author ValidYN="Y"><LastName>Beckmann</LastName><ForeName>H</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biol Psychiatry</MedlineTA><NlmUniqueID>0213264</NlmUniqueID><ISSNLinking>0006-3223</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011619">Psychotropic Drugs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001933" MajorTopicYN="N">Brain Stem</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003866" MajorTopicYN="N">Depressive Disorder</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011619" MajorTopicYN="N">Psychotropic Drugs</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011903" MajorTopicYN="N">Raphe Nuclei</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012016" MajorTopicYN="N">Reference Values</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012559" MajorTopicYN="N">Schizophrenia</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012565" MajorTopicYN="N">Schizophrenic Psychology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017585" MajorTopicYN="Y">Ultrasonography, Doppler, Transcranial</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1995</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1995</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1995</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">7578661</ArticleId><ArticleId IdType="pii">0006-3223(94)00263-3</ArticleId><ArticleId IdType="doi">10.1016/0006-3223(94)00263-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">2317731</PMID><DateCompleted><Year>1990</Year><Month>05</Month><Day>07</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0706-7437</ISSN><JournalIssue CitedMedium="Print"><Volume>35</Volume><Issue>1</Issue><PubDate><Year>1990</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Canadian journal of psychiatry. Revue canadienne de psychiatrie</Title><ISOAbbreviation>Can J Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Effect of concurrent medical illness on dexamethasone suppression test results in depressed inpatients.</ArticleTitle><Pagination><MedlinePgn>31-5</MedlinePgn></Pagination><Abstract><AbstractText>A retrospective evaluation of the clinical records of 138 depressed patients, who received the dexamethasone suppression test (DST) as part of a standardized physical and psychiatric assessment protocol, revealed that 60 had acute, chronic (mild or severe), stable or remitted medical conditions. The proportion of DST nonsuppressors did not differ between depressed subjects with medical conditions (45% nonsuppressors) and those without (34.6% nonsuppressors; p greater than 0.2). However, all of the six subjects with acute or chronic-severe medical conditions were found to be nonsuppressors (p = 0.003). These results may help clarify the medical exclusion criteria for the clinical application of the DST.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cooke</LastName><ForeName>R G</ForeName><Initials>RG</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Toronto, Ontario.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warsh</LastName><ForeName>J J</ForeName><Initials>JJ</Initials></Author><Author ValidYN="Y"><LastName>Stancer</LastName><ForeName>H C</ForeName><Initials>HC</Initials></Author><Author ValidYN="Y"><LastName>Hasey</LastName><ForeName>G M</ForeName><Initials>GM</Initials></Author><Author ValidYN="Y"><LastName>Jorna</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Langlet</LastName><ForeName>F</ForeName><Initials>F</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Can J Psychiatry</MedlineTA><NlmUniqueID>7904187</NlmUniqueID><ISSNLinking>0706-7437</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>7S5I7G3JQL</RegistryNumber><NameOfSubstance UI="D003907">Dexamethasone</NameOfSubstance></Chemical><Chemical><RegistryNumber>WI4X0X7BPJ</RegistryNumber><NameOfSubstance UI="D006854">Hydrocortisone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003866" MajorTopicYN="N">Depressive Disorder</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003907" MajorTopicYN="Y">Dexamethasone</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006854" MajorTopicYN="N">Hydrocortisone</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019965" MajorTopicYN="N">Neurocognitive Disorders</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1990</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1990</Year><Month>2</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1990</Year><Month>2</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">2317731</ArticleId><ArticleId IdType="doi">10.1177/070674379003500105</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24053030</PMID><DateCompleted><Year>2013</Year><Month>10</Month><Day>22</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1567-424X</ISSN><JournalIssue CitedMedium="Print"><Volume>62</Volume><PubDate><Year>2013</Year></PubDate></JournalIssue><Title>Supplements to Clinical neurophysiology</Title><ISOAbbreviation>Suppl Clin Neurophysiol</ISOAbbreviation></Journal><ArticleTitle>Brain's alpha, beta, gamma, delta, and theta oscillations in neuropsychiatric diseases: proposal for biomarker strategies.</ArticleTitle><Pagination><MedlinePgn>19-54</MedlinePgn></Pagination><Abstract><AbstractText>Brain oscillations have gained tremendous importance in neuroscience during recent decades as functional building blocks of sensory-cognitive processes. Research also shows that event-related oscillations (EROs) in "alpha," "beta," "gamma," "delta," and "theta" frequency windows are highly modified in pathological brains, especially in patients with cognitive impairment. The strategies and methods applied in the present report reflect the innate organization of the brain: "the whole brain work." The present paper is an account of methods such as evoked/event-related spectra, evoked/ERDs, coherence analysis, and phase-locking. The report does not aim to cover all strategies related to the systems theory applied in brain research literature. However, the essential methods and concepts are applied in several examples from Alzheimer's disease (AD), schizophrenia, and bipolar disorder (BD), and such examples lead to fundamental statements in the search for neurophysiological biomarkers in cognitive impairment. An overview of the results clearly demonstrates that it is obligatory to apply the method of oscillations in multiple electroencephalogram frequency windows in search of functional biomarkers and to detect the effects of drug applications. Again, according to the summary of results in AD patients and BD patients, multiple oscillations and selectively distributed recordings must be analyzed and should include multiple locations. Selective connectivity between selectively distributed neural networks has to be computed by means of spatial coherence. Therefore, by designing a strategy for diagnostics, the differential diagnostics, and application of (preventive) drugs, neurophysiological information should be analyzed within a framework including multiple methods and multiple frequency bands. The application of drugs/neurotransmitters gains a new impact with the analysis of oscillations and coherences. A more clear and differentiated analysis of drug effects can be attained in comparison to the application of the conventional wide-band evoked potential and event-related potential applications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Başar</LastName><ForeName>Erol</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Brain Dynamics, Cognition and Complex Systems Research Center, Istanbul Kultur University, Istanbul 34156, Turkey. e.basar@iku.edu.tr</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Başar-Eroğlu</LastName><ForeName>Canan</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Güntekin</LastName><ForeName>Bahar</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Yener</LastName><ForeName>Görsev Gülmen</ForeName><Initials>GG</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Suppl Clin Neurophysiol</MedlineTA><NlmUniqueID>100967410</NlmUniqueID><ISSNLinking>1567-424X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001683" MajorTopicYN="N">Biological Clocks</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058256" MajorTopicYN="N">Brain Waves</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004569" MajorTopicYN="N">Electroencephalography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001523" MajorTopicYN="N">Mental Disorders</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24053030</ArticleId><ArticleId IdType="pii">B978-0-7020-5307-8.00002-8</ArticleId><ArticleId IdType="doi">10.1016/b978-0-7020-5307-8.00002-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">27391371</PMID><DateCompleted><Year>2017</Year><Month>11</Month><Day>27</Day></DateCompleted><DateRevised><Year>2019</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7123</ISSN><JournalIssue CitedMedium="Internet"><Volume>242</Volume><PubDate><Year>2016</Year><Month>Aug</Month><Day>30</Day></PubDate></JournalIssue><Title>Psychiatry research</Title><ISOAbbreviation>Psychiatry Res</ISOAbbreviation></Journal><ArticleTitle>Internet use by patients with bipolar disorder: Results from an international multisite survey.</ArticleTitle><Pagination><MedlinePgn>388-394</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0165-1781(16)30077-4</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.psychres.2016.05.055</ELocationID><Abstract><AbstractText>There is considerable international interest in online education of patients with bipolar disorder, yet little understanding of how patients use the Internet and other sources to seek information. 1171 patients with a diagnosis of bipolar disorder in 17 countries completed a paper-based, anonymous survey. 81% of the patients used the Internet, a percentage similar to the general public. Older age, less education, and challenges in country telecommunications infrastructure and demographics decreased the odds of using the Internet. About 78% of the Internet users looked online for information on bipolar disorder or 63% of the total sample. More years of education in relation to the country mean, and feeling very confident about managing life decreased the odds of seeking information on bipolar disorder online, while having attended support groups increased the odds. Patients who looked online for information on bipolar disorder consulted medical professionals plus a mean of 2.3 other information sources such as books, physician handouts, and others with bipolar disorder. Patients not using the Internet consulted medical professionals plus a mean of 1.6 other information sources. The percentage of patients with bipolar disorder who use the Internet is about the same as the general public. Other information sources remain important.</AbstractText><CopyrightInformation>Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bauer</LastName><ForeName>Rita</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conell</LastName><ForeName>Jörn</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glenn</LastName><ForeName>Tasha</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>ChronoRecord Association, Fullerton, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alda</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ardau</LastName><ForeName>Raffaella</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Unit of Clinical Pharmacology, University Hospital of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baune</LastName><ForeName>Bernhard T</ForeName><Initials>BT</Initials><AffiliationInfo><Affiliation>Discipline of Psychiatry, School of Medicine, University of Adelaide, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berk</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>IMPACT Strategic Research Centre, School of Medicine, Deakin University, Geelong, VIC, Australia; University Hospital Geelong, Barwon Health, Geelong, VIC, Australia; Department of Psychiatry, The University of Melbourne, Parkville, VIC, Australia; Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia; Orygen Youth Health Research Centre, Parkville, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bersudsky</LastName><ForeName>Yuly</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Beer Sheva Mental Health Center, Beer Sheva, Israel; Department of Psychiatry, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bilderbeck</LastName><ForeName>Amy</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bocchetta</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Section of Neurosciences and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, Sardinia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bossini</LastName><ForeName>Letizia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine and Department of Mental Health (DAI) and University of Siena and University of Siena Medical Center (AOUS), Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castro</LastName><ForeName>Angela M Paredes</ForeName><Initials>AMP</Initials><AffiliationInfo><Affiliation>IMPACT Strategic Research Centre, School of Medicine, Deakin University, Geelong, VIC, Australia; University Hospital Geelong, Barwon Health, Geelong, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheung</LastName><ForeName>Eric Yw</ForeName><Initials>EY</Initials><AffiliationInfo><Affiliation>Department of General Adult Psychiatry, Castle Peak Hospital, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chillotti</LastName><ForeName>Caterina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Unit of Clinical Pharmacology, University Hospital of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choppin</LastName><ForeName>Sabine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>AP-HP, Hôpitaux Universitaires Henri-Mondor, Créteil, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Zompo</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Section of Neurosciences and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, Sardinia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dias</LastName><ForeName>Rodrigo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Bipolar Disorder Research Program, Department of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dodd</LastName><ForeName>Seetal</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>IMPACT Strategic Research Centre, School of Medicine, Deakin University, Geelong, VIC, Australia; University Hospital Geelong, Barwon Health, Geelong, VIC, Australia; Department of Psychiatry, The University of Melbourne, Parkville, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duffy</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Calgary, Calgary, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Etain</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>AP-HP, Hôpitaux Universitaires Henri-Mondor, INSERM U955 (IMRB), Université Paris Est, Créteil, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fagiolini</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine and Department of Mental Health (DAI) and University of Siena and University of Siena Medical Center (AOUS), Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hernandez</LastName><ForeName>Miryam Fernández</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University Hospital of Alava, University of the Basque Country, CIBERSAM, Vitoria, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garnham</LastName><ForeName>Julie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geddes</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gildebro</LastName><ForeName>Jonas</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Affective Disorders, Q, Mood Disorders Research Unit, Aarhus University Hospital, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez-Pinto</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University Hospital of Alava, University of the Basque Country, CIBERSAM, Vitoria, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goodwin</LastName><ForeName>Guy M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grof</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Mood Disorders Center of Ottawa, Ottawa, Canada; Department of Psychiatry, University of Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harima</LastName><ForeName>Hirohiko</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Tokyo Metropolitan Matsuzawa Hospital, Setagaya, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hassel</LastName><ForeName>Stefanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Psychology &amp; Aston Brain Centre, Aston University, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henry</LastName><ForeName>Chantal</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>AP-HP, Hôpitaux Universitaires Henri-Mondor, INSERM U955 (IMRB), Université Paris Est, Créteil, France; Institut Pasteur, Unité Perception et Mémoire, F-75015 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hidalgo-Mazzei</LastName><ForeName>Diego</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Bipolar Disorders Program, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kapur</LastName><ForeName>Vaisnvy</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Clinical Psychology, NIMHANS, Bangalore 560029, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kunigiri</LastName><ForeName>Girish</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Leicestershire Partnership NHS Trust, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lafer</LastName><ForeName>Beny</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Bipolar Disorder Research Program, Department of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larsen</LastName><ForeName>Erik R</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>Department of Affective Disorders, Q, Mood Disorders Research Unit, Aarhus University Hospital, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lewitzka</LastName><ForeName>Ute</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Licht</LastName><ForeName>Rasmus W</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Aalborg University Hospital, Psychiatry, Aalborg, Denmark; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lund</LastName><ForeName>Anne Hvenegaard</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Department of Affective Disorders, Q, Mood Disorders Research Unit, Aarhus University Hospital, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Misiak</LastName><ForeName>Blazej</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Wroclaw Medical University, Wroclaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monteith</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Michigan State University College of Human Medicine, Traverse City Campus, Traverse City, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munoz</LastName><ForeName>Rodrigo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of California San Diego, San Diego, CA USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakanotani</LastName><ForeName>Takako</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Affective Disorders Research Project, Tokyo Metropolitan Institute of Medical Science, Setagaya, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nielsen</LastName><ForeName>René E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Aalborg University Hospital, Psychiatry, Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Donovan</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okamura</LastName><ForeName>Yasushi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Tokyo Metropolitan Matsuzawa Hospital, Setagaya, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osher</LastName><ForeName>Yamima</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Beer Sheva Mental Health Center, Beer Sheva, Israel; Department of Psychiatry, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piotrowski</LastName><ForeName>Patryk</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Germany; University Hospital Geelong, Barwon Health, Geelong, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reif</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Goethe-University, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ritter</LastName><ForeName>Philipp</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rybakowski</LastName><ForeName>Janusz K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sagduyu</LastName><ForeName>Kemal</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Missouri Kansas City School of Medicine, Kansas City, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sawchuk</LastName><ForeName>Brett</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Calgary, Calgary, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwartz</LastName><ForeName>Elon</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Croton on Hudson, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scippa</LastName><ForeName>Ângela M</ForeName><Initials>ÂM</Initials><AffiliationInfo><Affiliation>Department of Neuroscience and Mental Health, Federal University of Bahia, Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slaney</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sulaiman</LastName><ForeName>Ahmad H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Department of Psychological Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suominen</LastName><ForeName>Kirsi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>City of Helsinki, Department of Social Services and Health Care, Psychiatry, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suwalska</LastName><ForeName>Aleksandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tam</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Department of Medicine, University of Hong Kong, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tatebayashi</LastName><ForeName>Yoshitaka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Affective Disorders Research Project, Tokyo Metropolitan Institute of Medical Science, Setagaya, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tondo</LastName><ForeName>Leonardo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Harvard Medical School-McLean Hospital, Boston, MA, USA; Lucio Bini Center, Cagliari e Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vieta</LastName><ForeName>Eduard</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Bipolar Disorders Program, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vinberg</LastName><ForeName>Maj</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Psychiatric Center Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viswanath</LastName><ForeName>Biju</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, NIMHANS, Bangalore 560029, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Volkert</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Goethe-University, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zetin</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychology, Chapman University, Orange, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whybrow</LastName><ForeName>Peter C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior University of California Los Angeles (UCLA), Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bauer</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Germany. Electronic address: michael.bauer@uniklinikum-dresden.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>06</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Psychiatry Res</MedlineTA><NlmUniqueID>7911385</NlmUniqueID><ISSNLinking>0165-1781</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D038622" MajorTopicYN="Y">Internationality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="N">Internet</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057566" MajorTopicYN="N">Self Report</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="Y">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Bipolar disorder</Keyword><Keyword MajorTopicYN="Y">Information source</Keyword><Keyword MajorTopicYN="Y">Internet</Keyword><Keyword MajorTopicYN="Y">World wide web</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>01</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>03</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>05</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>11</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27391371</ArticleId><ArticleId IdType="pii">S0165-1781(16)30077-4</ArticleId><ArticleId IdType="doi">10.1016/j.psychres.2016.05.055</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">32949870</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-2517</ISSN><JournalIssue CitedMedium="Internet"><Volume>278</Volume><PubDate><Year>2021</Year><Month>01</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of affective disorders</Title><ISOAbbreviation>J Affect Disord</ISOAbbreviation></Journal><ArticleTitle>Does guideline-concordant care predict naturalistic outcomes in youth with early stage bipolar I disorder?</ArticleTitle><Pagination><MedlinePgn>23-32</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0165-0327(20)32732-4</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jad.2020.09.037</ELocationID><Abstract><AbstractText Label="BACKGROUND">The impact of guideline concordance on naturalistic maintenance treatment outcomes in BD is not known. We sought to evaluate the effect of guideline-concordant care on symptomatic, course and functional outcomes in youth with early-stage BD-I.</AbstractText><AbstractText Label="METHODS">In this file audit study, we examined the prospective course of 64 clients with first treatment seeking manic episode of BD-I. Eighteen-month outcome measures included Clinical Global Impressions Scale - Bipolar Version (CGI-BP), Social and Occupational Functioning Assessment Scale (SOFAS) and number of relapses. Correlations and hierarchical linear regressions were used to examine the relationships between guideline concordance and outcomes, while controlling for potential confounders.</AbstractText><AbstractText Label="RESULTS">Although higher guideline-concordant care in the maintenance phase was associated with a higher discharge CGI-BP score and thus worse outcome, baseline CGI-BP and insight were more predictive of illness severity at follow-up than guideline concordance. There was no association with SOFAS and guideline-concordant care at follow-up. Greater concordance with maintenance medication guideline statements was also associated with greater number of relapses even after controlling for sex, medication adherence, duration of care and baseline illness severity.</AbstractText><AbstractText Label="LIMITATIONS">This study was limited by sample size and its single pool of clients which may limit generalizability.</AbstractText><AbstractText Label="CONCLUSIONS">Contrary to our hypotheses, higher guideline concordance was associated with worse outcomes, although this relationship was moderated by the client's illness characteristics, severity and insight. More unwell youth with poor insight, greater severity, and mixed/rapid cycling features may need other interventions or modified guidelines.</AbstractText><CopyrightInformation>Copyright © 2020 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sunder</LastName><ForeName>Priya</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Orygen, Parkville, Australia; Melbourne Medical School, University of Melbourne, Parkville, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chia</LastName><ForeName>Ming-Fang</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Orygen, Parkville, Australia; Melbourne Medical School, University of Melbourne, Parkville, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filia</LastName><ForeName>Kate</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Orygen, Parkville, Australia; Centre for Youth Mental Health, University of Melbourne, Parkville, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Macneil</LastName><ForeName>Craig</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Orygen, Parkville, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasty</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Orygen, Parkville, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davey</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Orygen, Parkville, Australia; Centre for Youth Mental Health, University of Melbourne, Parkville, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGorry</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Orygen, Parkville, Australia; Centre for Youth Mental Health, University of Melbourne, Parkville, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berk</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Orygen, Parkville, Australia; Centre for Youth Mental Health, University of Melbourne, Parkville, Australia; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, Geelong, Australia; Florey Institute of Neuroscience and Mental Health, Parkville, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cotton</LastName><ForeName>Sue</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Orygen, Parkville, Australia; Centre for Youth Mental Health, University of Melbourne, Parkville, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ratheesh</LastName><ForeName>Aswin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Orygen, Parkville, Australia; Centre for Youth Mental Health, University of Melbourne, Parkville, Australia. Electronic address: aswinr@unimelb.edu.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Affect Disord</MedlineTA><NlmUniqueID>7906073</NlmUniqueID><ISSNLinking>0165-0327</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="Y">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Bipolar disorder</Keyword><Keyword MajorTopicYN="Y">Concordance</Keyword><Keyword MajorTopicYN="Y">Early stage</Keyword><Keyword MajorTopicYN="Y">Guidelines</Keyword><Keyword MajorTopicYN="Y">Mania</Keyword><Keyword MajorTopicYN="Y">Treatment</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>05</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>08</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>09</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>19</Day><Hour>20</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32949870</ArticleId><ArticleId IdType="pii">S0165-0327(20)32732-4</ArticleId><ArticleId IdType="doi">10.1016/j.jad.2020.09.037</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25307723</PMID><DateCompleted><Year>2015</Year><Month>09</Month><Day>16</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-0193</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>2</Issue><PubDate><Year>2015</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Human brain mapping</Title><ISOAbbreviation>Hum Brain Mapp</ISOAbbreviation></Journal><ArticleTitle>Functional connectivity and neuronal variability of resting state activity in bipolar disorder--reduction and decoupling in anterior cortical midline structures.</ArticleTitle><Pagination><MedlinePgn>666-82</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/hbm.22655</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The cortical midline structures seem to be involved in the modulation of different resting state networks, such as the default mode network (DMN) and salience network (SN). Alterations in these systems, in particular in the perigenual anterior cingulate cortex (PACC), seem to play a central role in bipolar disorder (BD). However, the exact role of the PACC, and its functional connections to other midline regions (within and outside DMN) still remains unclear in BD.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We investigated functional connectivity (FC), standard deviation (SD, as a measure of neuronal variability) and their correlation in bipolar patients (n = 40) versus healthy controls (n = 40), in the PACC and in its connections in different frequency bands (standard: 0.01-0.10 Hz; Slow-5: 0.01-0.027 Hz; Slow-4: 0.027-0.073 Hz). Finally, we studied the correlations between FC alterations and clinical-neuropsychological parameters and we explored whether subgroups of patients in different phases of the illness present different patterns of FC abnormalities.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We found in BD decreased FC (especially in Slow-5) from the PACC to other regions located predominantly in the posterior DMN (such as the posterior cingulate cortex (PCC) and inferior temporal gyrus) and in the SN (such as the supragenual anterior cingulate cortex and ventrolateral prefrontal cortex). Second, we found in BD a decoupling between PACC-based FC and variability in the various target regions (without alteration in variability itself). Finally, in our subgroups explorative analysis, we found a decrease in FC between the PACC and supragenual ACC (in depressive phase) and between the PACC and PCC (in manic phase).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These findings suggest that in BD the communication, that is, information transfer, between the different cortical midline regions within the cingulate gyrus does not seem to work properly. This may result in dysbalance between different resting state networks like the DMN and SN. A deficit in the anterior DMN-SN connectivity could lead to an abnormal shifting toward the DMN, while a deficit in the anterior DMN-posterior DMN connectivity could lead to an abnormal shifting toward the SN, resulting in excessive focusing on internal contents and reduced transition from idea to action or in excessive focusing on external contents and increased transition from idea to action, respectively, which could represent central dimensions of depression and mania. If confirmed, they could represent diagnostic markers in BD.</AbstractText><CopyrightInformation>© 2014 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Magioncalda</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Section of Psychiatry, IRCCS AOU San Martino-IST, University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martino</LastName><ForeName>Matteo</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Conio</LastName><ForeName>Benedetta</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Escelsior</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Piaggio</LastName><ForeName>Niccolò</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Presta</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Marozzi</LastName><ForeName>Valentina</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Rocchi</LastName><ForeName>Giulio</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Anastasio</LastName><ForeName>Loris</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Vassallo</LastName><ForeName>Linda</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Ferri</LastName><ForeName>Francesca</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Zirui</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Roccatagliata</LastName><ForeName>Luca</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Pardini</LastName><ForeName>Matteo</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Northoff</LastName><ForeName>Georg</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Amore</LastName><ForeName>Mario</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>10</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hum Brain Mapp</MedlineTA><NlmUniqueID>9419065</NlmUniqueID><ISSNLinking>1065-9471</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001931" MajorTopicYN="N">Brain Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009434" MajorTopicYN="N">Neural Pathways</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012146" MajorTopicYN="N">Rest</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bipolar disorder</Keyword><Keyword MajorTopicYN="N">default mode network</Keyword><Keyword MajorTopicYN="N">functional connectivity</Keyword><Keyword MajorTopicYN="N">neuronal variability</Keyword><Keyword MajorTopicYN="N">perigenual anterior cingulate cortex</Keyword><Keyword MajorTopicYN="N">resting state fMRI</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>05</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>09</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>10</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25307723</ArticleId><ArticleId IdType="doi">10.1002/hbm.22655</ArticleId><ArticleId IdType="pmc">PMC6869107</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Psychopathology. 1989;22(5):278-88</Citation><ArticleIdList><ArticleId IdType="pubmed">2602525</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57</Citation><ArticleIdList><ArticleId IdType="pubmed">9881538</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Hum Neurosci. 2013 Apr 02;7:118</Citation><ArticleIdList><ArticleId IdType="pubmed">23565090</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2005 Jan;10(1):105-16</Citation><ArticleIdList><ArticleId IdType="pubmed">15340357</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2011 Mar 1;55(1):287-95</Citation><ArticleIdList><ArticleId IdType="pubmed">21118724</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Dev. 2007 Mar;29(2):83-91</Citation><ArticleIdList><ArticleId IdType="pubmed">16919409</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2011 Aug 1;57(3):1221-33</Citation><ArticleIdList><ArticleId IdType="pubmed">21609772</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2010 Jan 15;49(2):1432-45</Citation><ArticleIdList><ArticleId IdType="pubmed">19782143</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 2014 Aug 13;34(33):10798-807</Citation><ArticleIdList><ArticleId IdType="pubmed">25122883</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2014 May 13;111(19):E2066-75</Citation><ArticleIdList><ArticleId IdType="pubmed">24778245</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2004 Jul;22(3):1390-406</Citation><ArticleIdList><ArticleId IdType="pubmed">15219610</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychopharmacol. 2004 Apr;24(2):192-208</Citation><ArticleIdList><ArticleId IdType="pubmed">15206667</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Brain Mapp. 2014 May;35(5):1997-2008</Citation><ArticleIdList><ArticleId IdType="pubmed">23818102</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Psychol. 2000 Nov;55(11):1196-214</Citation><ArticleIdList><ArticleId IdType="pubmed">11280935</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2007 Jan 19;315(5810):393-5</Citation><ArticleIdList><ArticleId IdType="pubmed">17234951</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychopharmacology. 2011 Sep;36(10):2009-17</Citation><ArticleIdList><ArticleId IdType="pubmed">21654735</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 2007 Feb 28;27(9):2349-56</Citation><ArticleIdList><ArticleId IdType="pubmed">17329432</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Cogn Sci. 2011 Oct;15(10):483-506</Citation><ArticleIdList><ArticleId IdType="pubmed">21908230</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2004 Jun 25;304(5679):1926-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15218136</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Neurol. 2010 Jan;6(1):15-28</Citation><ArticleIdList><ArticleId IdType="pubmed">20057496</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Connect. 2012;2(1):25-32</Citation><ArticleIdList><ArticleId IdType="pubmed">22432927</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 1998 Jun 15;79(2):163-73</Citation><ArticleIdList><ArticleId IdType="pubmed">9705054</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Connect. 2014 May;4(4):242-55</Citation><ArticleIdList><ArticleId IdType="pubmed">24456196</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2013 Mar;39(2):358-65</Citation><ArticleIdList><ArticleId IdType="pubmed">22080493</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Res Rev. 2008 Nov;59(1):9-21</Citation><ArticleIdList><ArticleId IdType="pubmed">18539335</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 1978 Nov;133:429-35</Citation><ArticleIdList><ArticleId IdType="pubmed">728692</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2010 Jul 30;183(1):59-68</Citation><ArticleIdList><ArticleId IdType="pubmed">20553873</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychopharmacol. 1996 Apr;16(2 Suppl 1):4S-14S</Citation><ArticleIdList><ArticleId IdType="pubmed">8707999</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2009 May 26;106(21):8719-24</Citation><ArticleIdList><ArticleId IdType="pubmed">19433790</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 2011 Mar 23;31(12):4496-503</Citation><ArticleIdList><ArticleId IdType="pubmed">21430150</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9673-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15976020</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62</Citation><ArticleIdList><ArticleId IdType="pubmed">14399272</ArticleId></ArticleIdList></Reference><Reference><Citation>Magn Reson Med. 1995 Oct;34(4):537-41</Citation><ArticleIdList><ArticleId IdType="pubmed">8524021</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Neurosci. 2011 Jan;34(1):1-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21067824</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Biomed Res. 1996 Jun;29(3):162-73</Citation><ArticleIdList><ArticleId IdType="pubmed">8812068</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2012 Apr 2;60(2):1528-37</Citation><ArticleIdList><ArticleId IdType="pubmed">22261371</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neuroinform. 2013 Nov 13;7:24</Citation><ArticleIdList><ArticleId IdType="pubmed">24312048</ArticleId></ArticleIdList></Reference><Reference><Citation>J Abnorm Child Psychol. 2003 Oct;31(5):555-62</Citation><ArticleIdList><ArticleId IdType="pubmed">14561062</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2013 Sep 25;150(3):727-35</Citation><ArticleIdList><ArticleId IdType="pubmed">23830141</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Biobehav Rev. 2014 Nov;47:36-52</Citation><ArticleIdList><ArticleId IdType="pubmed">25066091</ArticleId></ArticleIdList></Reference><Reference><Citation>Cereb Cortex. 2014 Nov;24(11):2931-40</Citation><ArticleIdList><ArticleId IdType="pubmed">23749875</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2009 Mar 31;171(3):189-98</Citation><ArticleIdList><ArticleId IdType="pubmed">19230623</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2015 Jan;41(1):280-90</Citation><ArticleIdList><ArticleId IdType="pubmed">25150784</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuron. 2014 Jan 8;81(1):207-17</Citation><ArticleIdList><ArticleId IdType="pubmed">24333054</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2008 Mar;165(3):313-20</Citation><ArticleIdList><ArticleId IdType="pubmed">18245175</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2010 Mar;117(1):13-20</Citation><ArticleIdList><ArticleId IdType="pubmed">19854028</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Arch Psychiatry Clin Neurosci. 2009 Sep;259(6):316-28</Citation><ArticleIdList><ArticleId IdType="pubmed">19255710</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Brain Mapp. 2009 Feb;30(2):625-37</Citation><ArticleIdList><ArticleId IdType="pubmed">18219617</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Neurosci. 2007 Sep;8(9):700-11</Citation><ArticleIdList><ArticleId IdType="pubmed">17704812</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Psychiatry. 2014 Feb;71(2):109-18</Citation><ArticleIdList><ArticleId IdType="pubmed">24306091</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann N Y Acad Sci. 2008 Mar;1124:1-38</Citation><ArticleIdList><ArticleId IdType="pubmed">18400922</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2014 Oct 1;99:180-90</Citation><ArticleIdList><ArticleId IdType="pubmed">24862074</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 2010 Apr 7;30(14):4914-21</Citation><ArticleIdList><ArticleId IdType="pubmed">20371811</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16634715</PMID><DateCompleted><Year>2006</Year><Month>08</Month><Day>03</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1744-7666</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>7</Issue><PubDate><Year>2006</Year><Month>May</Month></PubDate></JournalIssue><Title>Expert opinion on pharmacotherapy</Title><ISOAbbreviation>Expert Opin Pharmacother</ISOAbbreviation></Journal><ArticleTitle>The role of quetiapine in the treatment of bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>929-40</MedlinePgn></Pagination><Abstract><AbstractText>Through a review of randomised, controlled trials, this article evaluates the efficacy and tolerability of quetiapine in the acute and maintenance phases of bipolar disorder. In trials involving mania patients, quetiapine was found to be effective as adjunctive therapy in combination with lithium or valproate, significantly superior to placebo, and equal to lithium or haloperidol as monotherapy. With regard to the prevention of relapses in bipolar disorder, quetiapine seems to differ from other atypical antipsychotics in its characteristics as a mood stabiliser, which are associated with a promising efficacy in the treatment of bipolar depressive episodes. However, further larger controlled long-term prospective studies are needed to confirm the efficacy of quetiapine for the prevention of relapses in bipolar disorder. Quetiapine seems to have a satisfactory safety and tolerability profile, with a low prevalence of extrapyramidal symptom-related adverse events, treatment-emergent depression and weight gain. Sedation is the main side effect of treatment with quetiapine.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pini</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Neurobiology, Pharmacology and Biotechnology, University of Pisa, Via Roma 67, 56100 Pisa, Italy. s.pini@med.unipi.it</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abelli</LastName><ForeName>Marianna</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Cassano</LastName><ForeName>Giovanni B</ForeName><Initials>GB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Expert Opin Pharmacother</MedlineTA><NlmUniqueID>100897346</NlmUniqueID><ISSNLinking>1465-6566</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003987">Dibenzothiazepines</NameOfSubstance></Chemical><Chemical><RegistryNumber>2S3PL1B6UJ</RegistryNumber><NameOfSubstance UI="D000069348">Quetiapine Fumarate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014150" MajorTopicYN="N">Antipsychotic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003987" MajorTopicYN="N">Dibenzothiazepines</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069348" MajorTopicYN="N">Quetiapine Fumarate</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>84</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>4</Month><Day>26</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>8</Month><Day>4</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>4</Month><Day>26</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16634715</ArticleId><ArticleId IdType="doi">10.1517/14656566.7.7.929</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">12084424</PMID><DateCompleted><Year>2002</Year><Month>07</Month><Day>31</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0920-9964</ISSN><JournalIssue CitedMedium="Print"><Volume>56</Volume><Issue>1-2</Issue><PubDate><Year>2002</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>Schizophrenia research</Title><ISOAbbreviation>Schizophr Res</ISOAbbreviation></Journal><ArticleTitle>The relationship between positive symptoms and instrumental work functioning in schizophrenia: a 10 year follow-up study.</ArticleTitle><Pagination><MedlinePgn>95-103</MedlinePgn></Pagination><Abstract><AbstractText>This longitudinal investigation was designed to determine the association between the positive symptoms of psychosis and instrumental work functioning among patients with schizophrenia in comparison to patients with affective disorders. 173 participants were assessed prospectively for the presence of psychosis and concurrent work adjustment using a series of standardized measures at four consecutive follow-ups over a 10 yr period. The data demonstrate a significant relationship between psychosis and increased impairment in work functioning across diagnostic groups for three of the four follow-up periods (p&lt;0.01), with this relationship being most consistent for the schizophrenia patients throughout the course of their disorder (p&lt;0.01). The more severely psychotic patients, regardless of diagnosis, are least likely to be working effectively; however, the debilitating effect of psychosis on work adjustment is most evident for schizophrenia patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Racenstein</LastName><ForeName>J Meg</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Illinois, College of Medicine, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harrow</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Reed</LastName><ForeName>Robyn</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Eileen</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Herbener</LastName><ForeName>Ellen</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Penn</LastName><ForeName>David L</ForeName><Initials>DL</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MH-26341</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Schizophr Res</MedlineTA><NlmUniqueID>8804207</NlmUniqueID><ISSNLinking>0920-9964</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002641" MajorTopicYN="N" Type="Geographic">Chicago</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003702" MajorTopicYN="N">Delusions</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003865" MajorTopicYN="N">Depressive Disorder, Major</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006212" MajorTopicYN="N">Hallucinations</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012050" MajorTopicYN="N">Rehabilitation, Vocational</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012559" MajorTopicYN="N">Schizophrenia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000534" MajorTopicYN="Y">rehabilitation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012565" MajorTopicYN="Y">Schizophrenic Psychology</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2002</Year><Month>6</Month><Day>27</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2002</Year><Month>8</Month><Day>1</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2002</Year><Month>6</Month><Day>27</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12084424</ArticleId><ArticleId IdType="pii">S0920996401002730</ArticleId><ArticleId IdType="doi">10.1016/s0920-9964(01)00273-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">31445343</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>13</Day></DateCompleted><DateRevised><Year>2020</Year><Month>07</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-2517</ISSN><JournalIssue CitedMedium="Internet"><Volume>259</Volume><PubDate><Year>2019</Year><Month>12</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of affective disorders</Title><ISOAbbreviation>J Affect Disord</ISOAbbreviation></Journal><ArticleTitle>Bipolar depression and suicidal ideation: Moderators and mediators of a complex relationship.</ArticleTitle><Pagination><MedlinePgn>164-172</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0165-0327(18)31135-2</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jad.2019.08.032</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Not all patients with bipolar depression have suicidal ideation (SI). This study examines some factors that link bipolar depression to SI.</AbstractText><AbstractText Label="METHODS">482 individuals with bipolar I or II were randomized to either lithium or quetiapine plus adjunctive personalized therapy in a 24 week comparative effectiveness trial. Severity of depression and SI were assessed with the Bipolar Inventory of Symptoms Scale (BISS). We examined potential moderators (age, gender, age of illness onset, bipolar type, comorbid anxiety, substance use, past suicide attempts, childhood abuse and treatment arm) and mediators (severity of anxiety, mania, irritability, impairment in functioning (LIFE-RIFT) and satisfaction and enjoyment of life (Q-LES-Q)) of the effect of depression on SI. Statistical analyses were conducted using generalized estimating equations with repeated measures.</AbstractText><AbstractText Label="RESULTS">Bipolar type and past suicide attempts moderated the effect of depression on SI. Life satisfaction mediated the effect of depression and SI. The relationship between anxiety, depression and SI was complex due to the high level of correlation. Treatment with lithium or quetiapine did not moderate the effect of depression on SI.</AbstractText><AbstractText Label="LIMITATIONS">Suicide assessment was only done using an item on BISS. Patient population was not specifically chosen for high suicide risk.</AbstractText><AbstractText Label="DISCUSSION">Individuals with Bipolar II experienced more SI with lower levels of depression severity. A history of suicide predisposed patients to higher levels of SI given the same severity of depression. Reduced life satisfaction mediates the effect of depression on SI and may be a target for therapeutic interventions.</AbstractText><CopyrightInformation>Copyright © 2019 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kamali</LastName><ForeName>Masoud</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States; Department of Psychiatry, University of Michigan, Ann Arbor, MI, United States. Electronic address: mkamali@mgh.harvard.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reilly-Harrington</LastName><ForeName>Noreen A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Weilynn C</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McInnis</LastName><ForeName>Melvin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Michigan, Ann Arbor, MI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McElroy</LastName><ForeName>Susan L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati OH and Lindner Center of HOPE, Mason, OH, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ketter</LastName><ForeName>Terence A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shelton</LastName><ForeName>Richard C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Alabama at Birmingham, Birmingham, AL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deckersbach</LastName><ForeName>Thilo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tohen</LastName><ForeName>Mauricio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of New Mexico Health Science Center, Albuquerque, NM, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kocsis</LastName><ForeName>James H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Weill Cornell Medical College, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calabrese</LastName><ForeName>Joseph R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Case Western Reserve University, Cleveland, OH, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Keming</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Case Western Reserve University, Cleveland, OH, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thase</LastName><ForeName>Michael E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bowden</LastName><ForeName>Charles L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Texas Health Science Center, San Antonio, TX, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kinrys</LastName><ForeName>Gustavo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bobo</LastName><ForeName>William V</ForeName><Initials>WV</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brody</LastName><ForeName>Benjamin D</ForeName><Initials>BD</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Weill Cornell Medical College, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sylvia</LastName><ForeName>Louisa G</ForeName><Initials>LG</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rabideau</LastName><ForeName>Dustin J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Massachusetts General Hospital, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nierenberg</LastName><ForeName>Andrew A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Affect Disord</MedlineTA><NlmUniqueID>7906073</NlmUniqueID><ISSNLinking>0165-0327</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>2S3PL1B6UJ</RegistryNumber><NameOfSubstance UI="D000069348">Quetiapine Fumarate</NameOfSubstance></Chemical><Chemical><RegistryNumber>9FN79X2M3F</RegistryNumber><NameOfSubstance UI="D008094">Lithium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008094" MajorTopicYN="N">Lithium</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010549" MajorTopicYN="N">Personal Satisfaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069348" MajorTopicYN="N">Quetiapine Fumarate</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059020" MajorTopicYN="Y">Suicidal Ideation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013406" MajorTopicYN="N">Suicide, Attempted</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Bipolar disorder</Keyword><Keyword MajorTopicYN="Y">Depression</Keyword><Keyword MajorTopicYN="Y">Lithium</Keyword><Keyword MajorTopicYN="Y">Quetiapine</Keyword><Keyword MajorTopicYN="Y">Suicidal ideation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>08</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>07</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>08</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31445343</ArticleId><ArticleId IdType="pii">S0165-0327(18)31135-2</ArticleId><ArticleId IdType="doi">10.1016/j.jad.2019.08.032</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19821545</PMID><DateCompleted><Year>2009</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2009</Year><Month>10</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0033-2658</ISSN><JournalIssue CitedMedium="Print"><Volume>111</Volume><Issue>6</Issue><PubDate><Year>2009</Year></PubDate></JournalIssue><Title>Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica</Title><ISOAbbreviation>Seishin Shinkeigaku Zasshi</ISOAbbreviation></Journal><ArticleTitle>[Diagnosis of bipolar spectrum disorders].</ArticleTitle><Pagination><MedlinePgn>633-7</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Teruaki</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Koyama</LastName><ForeName>Tsukasa</ForeName><Initials>T</Initials></Author></AuthorList><Language>jpn</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Seishin Shinkeigaku Zasshi</MedlineTA><NlmUniqueID>9801787</NlmUniqueID><ISSNLinking>0033-2658</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19821545</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">6792189</PMID><DateCompleted><Year>1981</Year><Month>11</Month><Day>18</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0160-6689</ISSN><JournalIssue CitedMedium="Print"><Volume>42</Volume><Issue>9</Issue><PubDate><Year>1981</Year><Month>Sep</Month></PubDate></JournalIssue><Title>The Journal of clinical psychiatry</Title><ISOAbbreviation>J Clin Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Bipolar affective disorder following coronary bypass surgery.</ArticleTitle><Pagination><MedlinePgn>354-5</MedlinePgn></Pagination><Abstract><AbstractText>Bipolar affective disorders characterized by mania and depression have not previously been reported as a complication of coronary bypass surgery, although pure depressive symptoms are well known. This case describes a 46 year old male, with a negative psychiatric history, who developed mania as well as depression after having two vessel bypass surgery on his right coronary artery. The patient's history and symptoms of mania and depression met research criteria for the diagnosis of a bipolar affective disorder, and he responded well to lithium carbonate.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Salinger</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Bond</LastName><ForeName>C A</ForeName><Initials>CA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Psychiatry</MedlineTA><NlmUniqueID>7801243</NlmUniqueID><ISSNLinking>0160-6689</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>2BMD2GNA4V</RegistryNumber><NameOfSubstance UI="D016651">Lithium Carbonate</NameOfSubstance></Chemical><Chemical><RegistryNumber>9FN79X2M3F</RegistryNumber><NameOfSubstance UI="D008094">Lithium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001026" MajorTopicYN="N">Coronary Artery Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008094" MajorTopicYN="N">Lithium</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016651" MajorTopicYN="N">Lithium Carbonate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1981</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1981</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1981</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">6792189</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">7134319</PMID><DateCompleted><Year>1982</Year><Month>12</Month><Day>18</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0033-2917</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>3</Issue><PubDate><Year>1982</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Psychological medicine</Title><ISOAbbreviation>Psychol Med</ISOAbbreviation></Journal><ArticleTitle>An efficacy study of electroconvulsive therapy and antidepressants in the treatment of primary depression.</ArticleTitle><Pagination><MedlinePgn>615-24</MedlinePgn></Pagination><Abstract><AbstractText>At discharge, a significantly larger percentage of unipolar patients treated with electroconvulsive therapy (ECT) respond with marked improvement as compared with those receiving antidepressants or other treatment. No treatment appears to be more efficacious in the bipolar group. In studying the covariables related to the length of time between hospitalizations, we found that the type of treatment is not important for the unipolar patient, whereas a combination of ECT and antidepressants lengthens the time to rehospitalization of the bipolar patient. Previous hospitalization is an important predictor variable for all patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Homan</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Lachenbruch</LastName><ForeName>P A</ForeName><Initials>PA</Initials></Author><Author ValidYN="Y"><LastName>Winokur</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Clayton</LastName><ForeName>P</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Psychol Med</MedlineTA><NlmUniqueID>1254142</NlmUniqueID><ISSNLinking>0033-2917</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000928">Antidepressive Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>9FN79X2M3F</RegistryNumber><NameOfSubstance UI="D008094">Lithium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000928" MajorTopicYN="N">Antidepressive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003866" MajorTopicYN="N">Depressive Disorder</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004565" MajorTopicYN="Y">Electroconvulsive Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008094" MajorTopicYN="N">Lithium</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1982</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1982</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1982</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">7134319</ArticleId><ArticleId IdType="doi">10.1017/s0033291700055720</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18595639</PMID><DateCompleted><Year>2008</Year><Month>08</Month><Day>29</Day></DateCompleted><DateRevised><Year>2016</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0933-4548</ISSN><JournalIssue CitedMedium="Print"><Volume>60</Volume><Issue>2</Issue><PubDate><Year>2008</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>Versicherungsmedizin</Title><ISOAbbreviation>Versicherungsmedizin</ISOAbbreviation></Journal><ArticleTitle>[Predictors of major mental disorders].</ArticleTitle><Pagination><MedlinePgn>59-62</MedlinePgn></Pagination><Abstract><AbstractText>Predictors of several major mental disorders include strong genetic linkage that is modified by biological, psychological and social factors. Insight into the biological mechanisms underlying these interactions is growing. Several candidate genes have been identified but their predictive value is still limited for predictions in the single individual. Comorbidities are common, including combinations of different mental disorders and/or combinations of mental and physical disorders. The combination of a mental and physical disorder often indicates a worse outcome for the physical disorder.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fritze</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Krankenversicherung, Köln.</Affiliation></AffiliationInfo></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Prädiktoren psychischer Krankheiten.</VernacularTitle></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Versicherungsmedizin</MedlineTA><NlmUniqueID>8803623</NlmUniqueID></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003865" MajorTopicYN="N">Depressive Disorder, Major</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004200" MajorTopicYN="N">Diseases in Twins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008016" MajorTopicYN="N">Life Change Events</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001523" MajorTopicYN="N">Mental Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012559" MajorTopicYN="N">Schizophrenia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012931" MajorTopicYN="Y">Social Environment</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>7</Month><Day>4</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>8</Month><Day>30</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>7</Month><Day>4</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18595639</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>